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Nanotechnologies are the fastest growing industry sector ever recorded. The US 
budget for nanotechnology is predicted to reach the 1 trillion dollar threshold in 
2015, meaning that nanotechnologies will indeed be larger than all other 
technologies combined. High aspect ratio nanomaterials (HARN) become 
increasingly important in the nanotechnology industries, and show great promise, 
offering many advantages and improvements to a significant range of products. The 
main feature of HARN is the ratio of the width of a nanomaterial to its height which 
can be up to 1000, making the material fibre or platelet- shaped. However, this 
feature leads to comparison between HARN and other high aspect ratio materials 
including fibre shaped materials, such as asbestos fibres. Due to the structural 
similarities between fibrous HARN and asbestos the question arises- do HARN pose 
the same risk as asbestos?  
This project aimed to assess the potential of a range of HARN to cause similar 
pathological effects as asbestos fibres. In order to address this aim a panel of HARN 
was tested against the fibre pathogenicity paradigm in vivo by examining the 
pulmonary and pleural responses as well as in vitro to reveal the mechanism of 
cell/HARN interaction.  
The first part of the study focused on fibre-shaped HARN, including a panel of 
distinct length classes of silver nanowires (AgNW) which were injected directly into 
the pleural space, a target tissue for asbestos related diseases. Injection of high aspect 
ratio AgNW into the pleural space of mice revealed a length dependent inflammatory 
response in line with the fibre pathogenicity paradigm which explains fibre 
pathogenicity. AgNW from 5 µm in length and above led to a significant increase in 
granulocytes in the pleural space which is similar to that seen after treatment with 
long amosite asbestos. The use of additional HARN with different compositions 
allowed us to identify a threshold length for fibre-induced pleural inflammation, 
which is 5 µm. Frustrated phagocytosis has been stated as an important factor in the 
initiation of an inflammatory response after fibre exposure. A novel technique, 
backscatter scanning electron microscopy (BSEM), was used to study frustrated 
phagocytosis since it provides high-contrast detection of nanowires, allowing clear 
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discrimination between the nanofibres and other cellular features. Using this 
technique we showed that the onset of inflammation does not correlate with the onset 
of frustrated phagocytosis, with a fibre length of ≥5 µm and ≥10 µm, respectively, 
leading to the conclusion that intermediate length fibres fully enclosed within 
macrophages as well as frustrated phagocytosis are associated with a pro-
inflammatory state in the pleural space. We further showed that fibres 
compartmentalise in the mesothelial cells at the parietal pleura as well as in 
inflammatory cells in the pleural space. To investigate the mechanism of the length- 
dependent inflammation caused by AgNW, the NALP3 inflammasome activation 
pathway was studied in vitro, however no clear correlation could be identified. 
We further aimed to investigate the threshold length of fibre-induced inflammation in 
the lung and the effect of fibre length on macrophage locomotion in an in vitro 
macrophage migration assay. Pharyngeal aspiration of AgNW resulted in a length 
dependent inflammatory response in the lungs with threshold at a fibre length of 14 
μm. Shorter fibres including 3, 5 and 10 μm elicited no significant inflammation. 
This identified threshold length differs from that in the pleural space which may be 
explained by differences in clearance mechanism of deposited fibres from the 
airspaces compared to the pleural space. Particle clearance from the lung is partly 
performed by migration of particle-laden macrophages to the mucociliary escalator. 
We investigated if uptake of longer fibres leads to restricted mobility and showed 
that exposure to AgNW in the length of ≥ 5 μm resulted in impaired motility of 
macrophages in the wound closure assay.  
The second part of the study focused on HARN in the form of nanoplatelet-shaped 
particles since nanoplatelets may pose an unusual risk to the lungs and the pleural 
space because of their aerodynamic properties. We first derived the respirability of 
graphene nanoplatelets (GP) from the basic principles of the aerodynamic behaviour 
of plate-shaped particles which allowed us to calculate their aerodynamic diameter. 
This showed that the nanoplatelets, which were up to 25 μm in diameter, were 
respirable and so would deposit beyond the ciliated airways following inhalation. We 
therefore utilized models of pharyngeal aspiration and direct intrapleural installation 
of GP, as well as an in vitro model, to assess their inflammatory potential. These 
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large but respirable GP were inflammogenic in both the lung and the pleural space at 
an acute timepoint although they decreased in their inflammatory potential over a 6 
weeks period. Oxidation of GP in the lung tissue was investigated in order to identify 
if GP degraded over the 6 week period in the lung tissue and therefore showed 
reduced inflammogenicity. Raman spectroscopy was used to measure the oxidation 
state and revealed that no change occurred over the observed timeframe. The 
mechanism underlying acute GP inflammation was studied in THP-1 macrophages 
exposed to GP. These investigations showed that GP exposure led to significant 
expression of IL-1β, which could be blocked via a number of inhibitors related to the 
NALP3 inflammasome activation.  
This study highlights the importance of shape/length of HARN as a driver for in vivo 
and in vitro inflammogenicity by virtue of their respirable aerodynamic diameter, 
despite a considerable 2-dimensional size which leads to an inflammatory response 
when deposited in the distal lungs and the pleural space. The identification of the 
threshold length for nanofibre-induced pathogenicity in the pleura and the lung has 
important implications for the understanding of the structure–toxicity relationship for 
asbestos-induced mesothelioma. It also contributes to risk assessment by offering a 
template for production of safer synthetic nanofibres by the adoption of a benign-by-
design approach. 
The results of this work highlight the importance of testing new HARN to protect 
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NADPH  Nicotinamide adenine dinucleotide phosphate 
NALP3 Nucleotide-binding oligomerisation domain (NOD)-like receptors 
containing a pyrin domain 3 
NF2  Neurofibromatosis type 2 gene 
NF-κB  Nuclear-factor κB 
NiNW  Nickel nanowire 
NIOSH National institute of occupational safety and health 
NiP  Nickel nanoparticulate 
NLRs   Nucleotide-binding oligomerisation domain (NOD)-like receptors 
NO   Nitric oxide 
NOD   Nucleotide-binding oligomerisation domain 
NP   Nanoparticle 
PARP   Poly (ADP-ribose) polymerase 
PBS   Phosphate buffered saline 
PDGF   Platelet derived growth factor 
PMA   Phorbol 12-myristate 13-acetate  
PMN   Polymorphonuclear leukocyte 
PSR   Pico Sirius red 
RANTES Regulated on activation, normal T cell expressed and secreted 
RIP1  Receptor-interacting protein 1 
ROS   Reactive oxygen species 
RPMI  Roswell Park Memorial Institute 
SEM   Scanning electron microscopy 
SFA   Short fibre asbestos 
SP  Surfactant- associated protein  
STAT  Signal transducer and activator of transcription 
STR  Structure Toxicity Relationship 
SV40   Simian Virus 40 
SWCNT  Single-walled carbon nanotube 
TEM   Transmission electron microscopy 
TGF-α  Transforming growth factor α 
28 
 
TGF-β1 Tumour growth factor-1β 
TH   T-helper  
TI   Type I alveolar epithelial cells 
TII  Type II alveolar epithelial cells 
TIR   Toll-interleukin-1 receptor 
TLR4  Toll-like receptor 4 
TNF-α  Tumour necrosis factor α 
TRAF6  TNF receptor-associated factor 6  
TRIF   TIR domain-containing adaptor inducing IFN-β 
VC  Vehicle control 
VCAM-1 Vascular cellular adhesion molecule 
VEGF   Vascular endothelial growth factor 
WHO   World health organisation 
WT  Wild type  
Z  Atomic number 
 




Chapter 1: Introduction 
1.1 Respiratory System 
1.1.1 The anatomy of the respiratory system 
The respiratory system is made up of structures responsible for the exchange of 
oxygen and carbon dioxide between the blood and the atmosphere. The anatomy of 
the human respiratory system consists of the external and internal nose and the 
paranasal sinuses; the pharynx, which connects the mouth and the nose to the larynx; 
the trachea where the air gets cleansed and moistened before entering the bronchi and 
lungs (Figure 1-1). Due to the asymmetrical position of the heart the right lung is 
slightly larger than the left lung, with 10 and 8 airway segments respectively. The 
left lung has two lobes whereas the right lung has three lobes which together make 
up to approximately 2,400 kilometres of airways (Frank and Netter 1979; Stone et al. 
1992). Additional structures necessary for operation of the respiratory system include 
the pleura, the diaphragm, the thoracic wall and the muscles which raise and lower 
the ribs in inspiration and expiration.  
The lower respiratory tract starts at the trachea which divides into two main bronchi 
that enter the right and the left lung. The main bronchus divides further into lobular 
bronchi at the hilus of the lung and bronchioles. The distinguishing feature between 
bronchi and bronchioles is the distribution of cartilage, whereby bronchioles are 
cartilage free. Three to five bronchioles make up a lobule including respiratory 
bronchioles, alveolar ducts and alveolar sacs. The respiratory unit of the lung is 





Figure 1-1: Gross anatomy of the respiratory system. Redrawn and adapted from a 
public domain image by Rastrojo. 
 
1.1.2 Ultrastructure of the tracheal, bronchial and bronchiolar epithelium 
The epithelium in the trachea and the large bronchi is made up of eight epithelial cell 
types, the basal and Kulchitsky cells that are attached to the basement membrane but 
do not reach the lumen as well as the ciliated cells, brush cell (secretory cells), goblet 
(mucous) cell, serous cell and Clara cell which all differentiate from one precursor 
intermediate cell (Roger, 2005). The distal epithelium towards the terminal 
bronchioles consists mainly of cuboidal epithelium containingClara cells with a 
decrease in ciliated cells, goblet cells and serous cells. Serous and Clara cells are the 
common secretory cells in the airways and upon irritation these cells can develop 
into mucus cells.  Ciliated cells which are surrounded by a thin fluid film of mucus 
are present from the trachea to bronchioles and the cilia in the smaller airways are 
not as tall as in the central airways (Roger, 2005). The mucociliary escalator starts in 
the most distal region of the airway epithelium and is responsible for the transport of 
foreign particles and microorganism from the lower region of the respiratory tract 
towards the pharynx by coordinated movement of the cilia to propel rafts of mucus 




1.1.3 Alveolar capillary unit 
The alveoli, 300- 500 million in the human lungs, are the primary gas exchange units 
of the lung with at least two cells, type I alveolar epithelial cells (TI) and endothelial 
cells forming the boundary between blood and the air. TI cells and endothelial cells 
are remarkable thin but make up to a total surface area of approximately 70 m
2
 
(Frank and Netter, 1979) which accounts for 99 % of internal surface of the lung 
(Stone et al., 1992). Additionally, the barrier between the blood and air is composed 
of extracellular material including a surfactant-lining layer, the basement membrane 
and surface coatings composed of mucopolysaccarides.  
The intrapulmonary blood circulation is composed of two arterial systems, the 
pulmonary and the bronchial system. Oxygen depleted blood enters the pulmonary 
arteries from the heart via the semilunar valve, splitting into the right and the left 
pulmonary artery. The arteries are further divided into very fine capillaries which 
enrich the acinus. The bronchial system differs from the pulmonary system by 
supplying the lung tissue with oxygenated blood from the aorta.  
TI cells are very large squamous-like cells with a surface area of approximately 5400 
µm
2
 (Stone et al., 1992) which make up more than 90% of the alveolar surface. They 
provide a tight barrier over the basement membrane which minimises transudation of 
interstitial fluid from interstitium to the airspaces. TI cells are terminally 
differentiated with a simplified cellular machinery which makes them sensitive to 
injury (Shields et al., 2009). TI cells are incapable of cell repair and mitosis after 
injury and are dependent on alveolar type II epithelial cells (TII) for their 
replacement (Shields et al., 2009). TII cells possess the ability to differentiate into TI 
cells to repair the injured alveolar epithelium or differentiate into new TII cells.  TII 
cells are also called granular pneumocytes due to their intracellular stores of 
surfactant lining which gives them a distinct granular appearance (Shields et al., 
2009). TII cells make up 15 % of the cell population in the distal lung and are, in 
contrast to TI cells cuboidal in shape. Their major function is the synthesis and 
secretion of surfactant lining. 
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The surfactant secreted by TII cells plays an important role in the reduction of 
surface tension in the alveoli during inspiration and expiration and prevents the lung 
from collapsing. Additionally the surfactant- associated proteins, especially  SP-A 
and SP-D are opsonins and important modulators of  immune and inflammatory 
regulation within the lung (Crouch et al., 2000). SP-A and SP-D are members of 
collagenous carbohydrate binding proteins which are also known as collectins 
(Crouch et al., 2000). SP-A is the most abundant protein in the surfactant which 
makes up 4 % of the total mass of surfactant.  Recent data has shown that SP-A and 
SP-D can modulate phagocyte function in vitro by binding to carbohydrate structures 
on the surface of the microorganisms (Reid, 1998). Various different receptors have 
been identified on the surface of both endothelial and hematopoietic cells to interact 
with SP, among these are Toll-like receptors and their associated molecule CD14, 
signal regulating protein-α or calreticulin-CD91 receptor complex (Pastva et al., 
2007).  Exposure to particulate matter has also been shown to affect the expression of 
SP-A (Romieu et al., 2010). Another major component of lung surfactant are neutral 
lipids and phospholipids, 1,2- dipalmitoylphosphatidylcholine (DPPC) which form a 
closed bilayer on the surface of the epithelial cell layer.   
 
1.1.4 Pulmonary and thoracic macrophage subpopulations 
Lung macrophages are derived from a hematopoietic stem cell in the bone marrow 
and have monocytes as a putative precursor. Monocytes circulate for 1-3 days in the 
bloodstream before differentiating into mature macrophages in the tissue. Several 
subpopulation of macrophages can be found in the lower respiratory tract. Depending 
on their location they are divided into  
1) airway macrophages on and in the epithelial lining of the conducting 
airways and in the bronchus associated lymphoid tissue; 
2) alveolar macrophages (AM) which reside on the epithelial surfaces of 
the alveoli; 
3) interstitial macrophages found in the perivascular, peribronchiolar, 
visceral pleura sites and the interstitium of the alveolar regions; 
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4) pleural macrophages present in the pleural space; 
5) intravascular macrophages which have direct access to the circulating 
blood (Lehnert, 1992).   
AMs are the most common type of immune cell in the alveolar airspaces and lie in 
close proximity to the air-liquid interface. The primary function of alveolar 
macrophages is scavenging particles and to eliminate deposited microorganism and 
insoluble particles from the lung surfaces, which occurs usually within a day or so of 
deposition. The turnover time of alveolar macrophages varies between species and 
has been reported to be 21-28 days in mice (van oud Alblas and van, 1979) and 81 
days in human (Thomas et al., 1976). AM are a heterogeneous population, depending 
on their maturation/activation state. Mature macrophages are large in size, low in 
density, exhibit increased phagocytosis, superoxide anion and hydrolase activity. In 
contrast, less mature macrophages are less chemotactic and have an increased FcR 
activity (Geiser, 2010). Lavage of the bronchoalveolar region (BAL) of healthy 
humans yields ≥80 % macrophages, 18% lymphocytes and a few neutrophils and 
eosinophils (Spurzem et al., 1987). In comparison rodent BAL yields ≥95%  
macrophages with a few lymphocytes, neutrophils and eosinophils (Warheit et al., 
1988). Differences in immune activity, as reflected in the lymphocyte infiltrate, very 
likely reflect the barrier-maintained pathogen-free status of laboratory mice. The 
average volume of human AM is 1474 µm
3
 whereas mouse macrophages exhibit a 
volume of 493 µm
3
 as summarized by (Geiser, 2010).  
 
1.2 Pleural space 
1.2.1 Anatomy of the Pleura 
The lung parenchyma, the mediastinum, the diaphragm and the rib cage are covered 
by a serous membrane called the pleura. The pleura is divided into the visceral pleura 
which covers the lung parenchyma with its interlobar fissures and the parietal pleura 
which lines the inside of the thoracic cavities (Negrini and Moriondo, 2012). The 
parietal pleura is further subdivided into the costal, mediastinal and diaphragmatic 
parietal pleura. Visceral and parietal pleura consist of several layers which differ 
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from each other markedly in their anatomy. The parietal pleura is composed of a 
deep fibroelastic layer, loose connective tissue layer, a thin superficial elastic layer 
and a thin sub-mesothelial connective tissue layer  which is covered by a single layer 
of mesothelial cells (Jantz and Antony, 2008). In the apical region, the mesothelial 
cells are characterised by a dense microvillous layer. The thickness of the visceral 
pleura differs among species (Lai-Fook and Kaplowitz, 1985). The connective tissue 
layer in the visceral pleura contributes to the elastic recoil of the lung and it restricts 
the volume to which the lung can be inflated.  Within the pleura are blood vessels 
and lymphatic lacunae. The blood vessels are located in the main connective tissue 
layer.  The visceral pleura is supplied by the bronchial circulation and the the parietal 
pleura is supplied by branches of the intercostal arteries  (Lai-Fook, 2004). 
Lymphatic drainage from the pleural is via numerous lymphatic vessels in the pleural 
connective tissue layer which start off as gaps with endothelial lining called 
lymphatic stomata in the parietal pleura. These stomata have a diameter of 2-8 µm 
and are predominantly found in the dorsal caudal intercostal spaces and to a lesser 
degree in the ventro-cranial region of the pleura (Shinohara, 1997). Across 
mammalian species there is a remarkable consistency in the reported size of stomata 
on the diaphragm or parietal pleura as summarized in Table 1-1. Through stomata the 
pleural space communicates directly with the lumen of the lymphatic vessels 
(Mueller, 2002). The lymphatic vessels run along the intercostal spaces and drain 
towards nodes along the internal thoracic artery and the intercostal lymph nodes near 
the head of the ribs. The visceral lymphatic drainage occurs through a completely 









Table 1-1: Size of stomata across mammalian species. 
Species  Stomatal size 
(µm)  
Reference  
Bat 0.8-2 (Azzali, 1999)  
Hedgehog, Gerbil, Bat, 
mouse 
1.8-6 (Azzali, 1999)  
Monkey 3-8 (Oya et al., 1993)  
Sheep  1-3 (Lai-Fook, 2004) 
Human  6.2 (Li, 1993)  
Rat, mouse, rabbit, hamster, 
human  
4-10 (Abu-Hijleh et al., 1995)  
Human  2-8 (Muller et al., 2002)  
 
1.2.2 Pleural Fluid 
The pleural space is the cavity between the visceral and parietal pleura and contains a 
film of fluid which acts as a lubricant during respiratory movements while avoiding 
direct contact between visceral and parietal mesothelial surfaces, thus preventing cell 
damage. The pleural surface has a sub-atmospheric pressure that keeps the lung 
expanded at the end-expiration and allows its inflation during inspiration (Negrini 
and Moriondo, 2012). If this pressure within the pleural space is altered, differences 
in regional lung expansion can occur which can lead to potentially life threatening 
conditions.  
The pleural cavity contains about  ~0.26 ml of fluid  per kg body weight  in healthy 
humans (Noppen et al., 2000) and  ~2.5 ml/kg in rats (Miserocchi et al., 1984) and 
for a pleural surface are of ~90 cm
2
/kg the thickness is approximately 5 µm over the 
flat coastal surface and up to 60- 100 µm in fluid pools (Negrini and Moriondo, 
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2012). The circulation and flow of the pleural fluid in the pleural space has been 
measured via different methods using fluorescently labelled beads injected into the 
pleural space of rabbits (Wang and Lai-Fook, 1993; Wang and Lai-Fook, 1992) and a 
model pump (Butler et al., 1995). The studies showed that the circulation consists of 
a gravity dependent downward flow on the costal lung surface, an upward flow of 
pleural fluid adjacent to a lobar margin and a transverse flow from lobar margins to 
the flat costal surfaces (Wang and Lai-Fook, 1992). The pleural fluid is a 
microvascular filtrate from the parietal pleural capillaries and in large mammals 
pleural fluid can also be filtered from the bronchial capillaries of the visceral pleura 
(Figure 1-2) (Lai-Fook, 2004). In smaller mammals pleural liquid might be 
reabsorbed by pulmonary capillaries underlying the visceral pleura (Noppen et al., 
2000; Lai-Fook, 2004), otherwise the fluid is drained from the pleural space to the 
lymphatics via stomata in the parietal pleura. 
 
 
Figure 1-2: Pleural fluid turnover in small and large mammals. The fluid is a filtrate 
from the capillaries in the parietal pleura as well as from the bronchial capillaries of 
the visceral pleura in large mammals. In small mammals pleural fluid can be 
reabsorbed by pulmonary capillaries. Figure from (Lai-Fook, 2004) with permission 
from Lai-Fook Stephen.  
37 
 
The pleural fluid is composed of a number of proteins including albumin, globulin 
and fibrinogen, as well as a few detached mesothelial cells (1%), lymphocytes 
(23%), monocytes and macrophages (75%) (Lai-Fook, 2004). The cell number in the 
pleural fluid can be used as an indicator for pleural inflammation since the number of 
cells, especially macrophages and neutrophils increases. 
 
1.2.3 Mesothelial cells 
The parietal and visceral mesothelium consists of a monolayer of flat and cuboidal 
mesothelial cells (Mutsaers, 2004) with an average diameter of 25 µm (Wang, 1974), 
whereby the cuboidal mesothelial cells are predominantly found on the parietal 
mesothelial pleura and in specific areas including ‘milky spots’ (Mutsaers, 2004). 
Milky spots can act as a first line defence by increasing their number and size in 
inflammatory conditions (Michailova, 2004). The squamous-like flat cells have 
thickness of about 1-4 µm and contain few microtubules, microfilaments, 
mitrochondria, vacuoles and vesicles, compared to cuboidal mesothelial cells, as well 
as a poorly developed Golgi apparatus (Mutsaers, 2004). The luminal surface of the 
mesothelial cells  is lined with a layer of microvilli which are 1-6 µm long (Lai-
Fook, 2004). The function of microvilli is hypothesised to support the forces between 
the pleural surfaces and to trap hyaluronan, a boundary lubricant, on pleural 
mesothelial cells (Lai-Fook, 2004).  In addition to hyaluronan, the surface of the 
mesothelium is covered by sialomucins (Jantz and Antony, 2008). Sialomucins have 
strong anionic sites which act as a protective layer against microbes, particles and 
invading cells and electro-statically repel the opposing sides of the pleural 
membranes (Jantz and Antony, 2008). Connection between adjacent mesothelial cells 
is via tight and adherens junctions in the apical portion and gap junctions as well as 
desmosomes on the basal side (Mutsaers, 2002). 
Mesothelial cells in the pleura are multipotent and take part in the first line defence 
by recognising foreign substances and subsequently initiating the inflammatory 
response (Jantz and Antony, 2008). They produce fibronectin, a large glycoprotein 
which acts to prevent adherence of foreign organisms, release reactive oxygen 
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species and nitrogen intermediates and possess multiple pattern recognition receptors 
including CD14, integrins and mannose receptors to control infection in the pleural 
space (Jantz and Antony, 2008).  
 
1.3 Particle lung interaction 
The respiratory tract is in constant direct contact with the atmospheric environment, 
composed of numerous gases and particles. Human beings experience intentional and 
unintentional lifelong exposure to aerosol particles which deposit in the respiratory 
tract. Their clearance/retention is dependent upon their size and composition and the 
site of deposition within the respiratory tract and their pathogenicity. Some particles 
may be readily soluble in the lung fluid, whereas others are cleared via the 
mucociliary escalator, get taken up by alveolar macrophages or penetrate into the 
interstitium (Schulz et al., 2000); an unknown proportion, probably small, find their 
way to the pleural space (Donaldson et al., 2010). Aerosol particles are classified in 
three categories depending on their size. Particles with a diameter range of <0.1 µm 
are classified as ultrafine particles, 0.1-1 µm diameter as fine particles and particles 
1-10 µm are defined as coarse particles (Schulz et al., 2000).  
 
1.3.1 Deposition 
The aerodynamic diameter of a particle is the most relevant parameter to determine 
deposition within the respiratory tract. The aerodynamic diameter is defined as the 
diameter of a unit density sphere (1 g/cm
3
) with the same settling speed as the 
particle of interest (Jones, 1993). In other words, an irregular shaped particle has an 
aerodynamic diameter that equates to the diameter of a perfect sphere with a density 
of 1 g/cm
3
 falling at the exact same rate as the irregular shaped particle. The 
aerodynamic diameter for particles with a size greater than 500 nm is  
Dpa=dps    
Dpa= Aerodynamic diameter (µm) 
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Dps= Stokes diameter (µm) 
Pp= Particle density (g/cm
3
) 
The stokes diameter is the diameter of a sphere that has the same density and settling 
velocity as the particle of interest. The aerodynamic drag force caused by the 
difference in the velocity of the particle and the surrounding medium determines the 
stokes value, whereby the Stokes diameter is identical to the actual diameter for 
smooth, spherical particles.   
As mentioned above, particles characteristics are a major determinant for deposition. 
The nose is an effective filter for nanoparticles and for particles larger than  ~2 µm 
(Figure 1-3) (Kreyling et al., 2007). The primary mechanisms for the deposition of 
inhaled particles are impaction, sedimentation, interception, diffusion and 
electrostatic deposition (Heyder, 2004). Impaction occurs when the airflow changes 
course but the particles, because of their mass, maintain trajectory and impact onto 
the airway wall in the upper respiratory tract and trachea-bronchial bifurcations 
which acts on particles > 1.5 µm Dae. Sedimentation of particles occurs due to 
gravimetric force on the mass of the particle and takes place in area where the air 
flow is minimal. Particles with a Dae of >0.5 µm are affected (Kreyling et al., 2007). 
Impaction and sedimentation are the main mechanism by which particles with a 
diameter ≥ 5µm deposit in the respiratory tract. For particles with a diameter ≤ 5 µm 
(< 0.5 µm Dae) the deposition is mainly determined by diffusional transport. The 
smaller the particles are and the longer they remain in the respiratory system the 
higher is their probability to hit the airspace surface. Deposition fraction curve inside 
the respiratory system as shown in Figure 1-3 are generated from mathematical 
models which are based on experimental data. In general, deposition in the alveolar 
region is maximal for particles with a diameter of ~ 3 µm and minimal at a diameter 
of 0.5 µm due to mechanism of sedimentation and diffusion (Heyder, 2004). The 
sub-micron sized particles show the highest deposition in the pulmonary region 
(Figure 1.3).  Interception is seen after inhalation of fibres which follow the airflow 
however may make contact with the airway walls at sides of bifurcation; interception 
increases with increasing fibre length. Lippmann M. performed extensive deposition 
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studies in humans and determined a maximal alveolar deposition for particles with an 
aerodynamic diameter of 3 µm (Lippmann, 1977; Jones, 1993). 
 
Figure 1-3: Deposition patterns of particles in the human respiratory tract. The 
deposition fraction of particles is shown for the tracheobronchial region, the 
pulomary region and the head airways in respect to their particle diameter. 
Reproduced from Kreyling et al.(Kreyling et al., 2007). 
 
1.3.2 Deposition of fibres 
A fibre is defined by the World Health Organisation (WHO) as a particle with a 
length greater than 5 µm, a diameter less than 3 µm and an aspect ratio (length to 
width ratio) greater than 3:1 (WHO, 1997). Taking these geometric properties of 
fibres into account it seems intuitively unlikely that a fibre would penetrate to the 
alveoli following inhalation.  
The mechanisms by which particles deposit in the lungs can be applied, with few 
exceptions, to fibrous materials. The orientation of the fibres within the airways is a 
major determinant for the drag force and the settling speed of a fibre. As the inhaled 
41 
 
fibre is aligned parallel to the airways, due to the laminar flow of the air, the 
aerodynamic diameter is proportional to the fibre diameter for a constant fibre aspect 
ratio. Jones A.D calculated the aerodynamic diameter for a range of aspect ratios of 
fibres and showed that the aerodynamic diameter is between 2.5 to 4 times the actual 
diameter of a fibres with aspect ratios from 3 to 27 (Jones, 1993). 
 
1.3.3 Particle clearance and translocation 
Clearance of deposited particles from the respiratory tract depends on the site of 
deposition. In the nasopharyngeal region particles can either be swallowed or cleared 
via sneezing. Clearance of particles depositing in the trachea-bronchial region is 
facilitated by the mucociliary escalator. The cilia of the epithelial cells are covered 
with a layer of mucus, which is secreted by goblet cells and called the aqueous phase, 
and a surfactant film at the air liquid interface. Inhaled particles that deposit on the 
surfactant layer from air are displaced into the aqueous phase by the surfactant and 
are moved with the flow of mucus from the trachea-bronchial region towards the 
larynx where they get either swallowed or expectorated. The time take for clearance 
of micron-sized deposited particles in the trachea-bronchial region via the 
mucociliary escalator generally does not exceed 24 – 48 hours. Particles which are 
not cleared via the mucociliary escalator can penetrate through the mucus into the 
periciliary zone or deposit beyond the ciliated airways where clearance is mediated 
via phagocytosis by alveolar macrophages. The recognition of particles by 
phagocytes and their subsequent interaction determines the effectiveness of the 
clearance from the lung periphery. Macrophages recognise and ingest foreign 
particles via various receptor/opsonin interactions such as scavenger receptors, Fc 
receptors, complement receptors and integrins. Scavenger receptors are important 
modulators in the innate immune system and play a key role in the phagocytosis of 
unopsonized particles, in particular SR-A and MARCO (Sulahian et al., 2008).  
It is known that particle surface characteristics including crystallinity, curvature, 
porosity, hydrophobicity, hydrophobility and zeta potential, contribute to the 
interaction with biological medium (Nel et al., 2009) and that particles are 
immediately covered by proteins/opsonins upon contact with  the pulmonary 
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surfactant. In recent years, especially due to the increase in research into 
nanoparticles and lung interaction, the hypothesis was formed that  the biological 
response to inhaled  particles is dependent upon the proteins absorbed on the surface 
of the particles rather than the particles themselves (Lynch et al., 2007). However as 
seems likely, the nature of the particle surface dictates the nature of the corona and 
so the two are inseparable. The importance of the coating of particle surfaces with 
pulmonary surfactant which results in the so called ‘protein corona’ that mediates the 
biological interaction remains a controversial aspect. Proteins of particular 
importance in the pulmonary surfactant are the collectins SP-A and SP-D due to their 
immunological function as opsonins and scavenger molecules (Kishore et al., 2006). 
A recent study on the uptake of magnetite nanoparticles by alveolar macrophages 
showed that SP-A treatment of nanoparticles leads to an increase in cellular binding 
and phagocytosis compared to albumin coating (Ruge et al., 2011). In addition to the 
proteins, lipids constitute the major part in the pulmonary surfactant and can 
therefore modulate the protein-corona cell interaction and should be taken into 
consideration when studying these effects (Ruge et al., 2012).  
The clearance rate via alveolar macrophages and transport to the larynx is species 
dependent and one order of magnitude lower in human compared to rodents 
(Kreyling and Scheuch, 2000). The transport of particle- laden macrophages toward 
the ciliated airways can either be via directed movement in reponse to chemotactic 
forces or random migration. Additional mechanisms for the elimination of slowly 
dissolving particles from the epithelium or the peripheral lung is transport to hilar 
lymph nodes, interstitial sites or the subpleural spaces, either as free particles or 
within phagocytes. Uptake of deposited particles by epithelial type I and type II cells 
and subsequent translocation to interstitial spaces and lymphatic system or 
phagocytosis of particle laden macrophages by interstitial macrophages accounts for 
additional clearance mechanisms. Particle translocation to the blood and 
accumulation in secondary organs is minimal for micron sized particles however 




Dissolution of particles in extracellular fluid including epithelial lung lining fluid or 
interstitial fluid as well as intracellular dissolution within macrophages via fusion of 
the phagosome with acidic lysosomes play a major role in the clearance of soluble 
particles (Cho et al., 2011).  
 
1.3.4 Translocation of particles to the pleura 
There is ample evidence that particles depositing in the distal regions of the lung can 
translocate to the pleural space. This was shown in a number of autopsy specimens 
from former coal miners who had  black foci of mixed dust on the parietal pleura 
(Muller et al., 2002). These intrapleural mixed dust accumulations were described as 
‘black spots’ and are mainly seen near stomatas, in the regions of pleural lymphatics. 
Black spots have also been discussed in relation to asbestos fibre exposure as being 
the starting points for mesothelioma development (Boutin et al., 1996).  Due to the 
elongated nature of fibres the passage through the visceral pleura, which is 
approximately 700 µm thick, may be slow which would account for the late 
development of pleural diseases after inhalation exposure. A study by Boutin et al. 
investigated the amount of asbestos fibres, their dimensions and distribution on the 
parietal pleura of human subjects exposed to asbestos fibres (Boutin et al., 1996). 
The results of this study showed that around 22 % of the fibres in the pleural space 
had a length of ≤ 5 µm, confirming the translocation of longer fibres to the pleural 
space. The mechanism and pathway of translocation of fibres through the visceral 
pleura to the pleural space is not understood. An increase in interstitial pressure and 
microvascular permeability due to a raise in lung inflammation leading to a reversal 
of the trans-endothelial pressure gradient has been proposed as a mechanism for fibre 
translocation to the pleural space (Miserocchi et al., 2008). Recent studies on the 
translocation of carbon nanotubes to the pleural space after aspiration exposure 
showed images of carbon nanotube penetrations through the visceral pleura 
suggesting a direct route of translocation (Mercer et al., 2010). The translocation of 
fibrous materials was further confirmed by Bernstein et al. demonstrating the 
penetration of amosite asbestos fibres in the pleural space after inhalation exposure 




1.4.1 History of the toxicology of inhaled particles 
The toxicology of inhaled particles in workplaces and the environment dates back to 
the 15
th
 century and was first described by Georgius Agricola, reporting lung disease 
in mine workers although he  failed to make a clear link between dust exposure and 
disease development. In 1700 Bernardino Ramazzini was the first to put lung disease 
in workers in context to the environmental exposure but it took until the early 20
th
 
century to protect the workforce, especially in mining, from exposure to hazardous 
dust in the workplace (Donaldson and Seaton, 2012). Coal, quartz and asbestos are 
recognized as the major hazardous particles in occupational exposure settings and 
have led to numerous cases of lung diseases over time up to the present. The 
fibrosing lung diseases caused by exposure to airborne dust are termed the 
pneumoconiosis. Workers in coalmines developed coalworker’s pneumoconiosis 
which is characterised by the presence of nodular aggregations of macrophages and a 
minimal collagen network within the lungs in response to very high lung dust 
burdens and leading to progressive massive fibrosis in a few severe cases.   Exposure 
to quartz (or crystalline silica) was most common where there was occupational 
generation of respirable quartz dust during mining, tunnelling and other occupations 
where the surface of the earth is penetrated or disturbed, since quartz is abundant in 
most rock types, notably granites, sandstones, sands and soils.  Exposure to 
crystalline silica causes a severe fibrosing form of pneumoconiosis called silicosis. 
Quartz is also  classified by the IARC as a group 1 carcinogen (Rice, 2000). In the 
1920s the Hawks Nest Tunnel Disaster led to the death of hundreds of workers 
mining mineral silica. The tunnelers died from acute silicosis which in some cases 
developed rapidly, in some cases within a year. At the time the physicochemical 
properties of silica relevant to its pathogenicity were unknown and regulations for 
silica dust exposure were put in place based on mass. Since then a number of studies 
investigated the pathogenic potential of quartz and showed that the inflammatory 
potential ascribes to undissociated SiOH on the surface of quartz interacting via H-
bonding with cell membrane components (Ghiazza et al., 2011). Modification of the 
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surface with aluminium lactate significantly reduced ability of quartz to generate 
hydroxyl-radicals and showed reduced inflammogenicity (Schins et al., 2002). 
 
Asbestos is another major hazardous particle in occupational exposure settings and 
its use dates back to approximately 2500 B.C when anthophyllite was used as a 
reinforcement in clay utensils and pottery (Virta, 2002). Exploitation of asbestos 
fibres on an industrial scale began in the early nineteenth century in Italy and 
expanded throughout the world with Canada, South Africa and USSR being the 
major producing countries. Asbestos has a wide range of applications due to their 
fire-proof and insulating properties in building and construction materials including 
ships, roofing, bricks and asphalt as well as textiles. During World War II asbestos 
was used in a range of military applications for thermal insulation and fire protection 
which led to an increase in production. The growth of asbestos industry reached a 
maximum in the late 1960s with worldwide production of 5 million tons but was 
brought to a halt in the early 1970s due to the growing opposition to the use of 
asbestos fibre in response to an epidemic of disease caused by exposure to it. By the 
year 2000 the world production level had decreased to 2 million tons (Virta, 2002). 
The first written report addressing the link between asbestos exposure and disease 
appeared in the British Medical Journal in 1924 by William Cooke (Cooke, 1924).  
This was a single case report of pneumoconiotic fibrosis (asbestosis) of the lungs in a 
worker in the asbestos industry. In 1925 the term asbestosis was first mentioned by 
Thomas Oliver and in the early 1930s a survey of occupational exposure to asbestos 
dust confirmed the relation between inhalation of asbestos and fatal asbestosis 
(Bartrip, 2004). In 1933 Home Office officials in Britain implemented asbestos 
industry regulations to control asbestos dust in workplaces; however these 
regulations were widely neglected by other countries. At the time silicosis was 
recognised as a major dust hazard and the regulations for dust measurement and 
control of silica in workplace were adapted for asbestos. In the 1960s several 
additional important connections were made linking exposure to asbestos with other 
disease including lung cancer and mesothelioma (Tweedale, 2002). A study by 
Wagner et al. highlighted that 28 out of 33 histologically proven mesothelioma cases 
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were identified in association with the asbestos fields in north western cape province, 
South Africa (Wagner et al., 1960). This relationship was strengthened by the fact 
that no such neoplasm was observed in 10000 lung examination from patients not 
subjected to asbestos exposure (Wagner et al., 1960). Subsequently it was shown that 
disease development was not restricted only to workers in asbestos industries, but it 
occurred also in insulation worker, in users of asbestos products and in individuals 
residing near asbestos factories. Finally the topic attracted media attention and led to 
law suits claiming compensation which resulted in the virtual demise of the asbestos 
industry and eventually the banning of asbestos in most Western countries. The 
mass-based standard first used for regulating exposure in workplaces was recognised 
to be deficient and in 1958 the Asbestos Research Council set the standard for 
asbestos fibre sampling and counting to be number-based and quantifying all 
airborne structures with a length of 5-100 µm with an aspect ratio of 3:1. This 
standard was chosen ‘somewhat arbitrarily and was intended to allow a margin of 
safety below the limits of 10-20 µm for pathogenic fibres’ (Walton, 1982). In 1968 
the British Occupational Hygiene Society set a standard for air contaminants and 
measurement methods and included the definitions for ‘fibres’ as stated by the 
Asbestos Research Council in their regulation (Ogden, 2003) (Asbestosis Research 
Council, 1968); this forms the current worldwide WHO standard for measuring 
airborne fibre number in workplaces which counts all airborne fibres longer than 5 
µm, thinner than 3 µm and with an aspect ratio greater than 3:1. 
 
1.4.2 Structure of asbestos 
Asbestos fibres are silicate minerals and classified into two categories, serpentine 
and amphiboles regarding their basic building blocks. Asbestos fibres have a basic 
silicate tetrahedral building block which occurs as double chains (Si4O11)
-6
 in 
amphiboles or in sheets (Si4O10)
-4
 in serpentine asbestos. Chrysotile, a hydrated 
magnesium silicate, is the only asbestiform mineral of the serpentine group and has a 
fibrillar, wavy, thread-like appearance and are extremely thin with an average 
diameter of 25 nanometers of a unit fibre with aggregations of chrysotile fibres up to 
100 µm. The length of the fibres ranges from fractions of millimetres to several 
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centimetres. The stochiometric chemical composition of chrysotile asbestos is given 
as Mg3Si2O5(OH)4 however several mineral contaminates are present, including 
brucite as the most common.  
Amphibole minerals consist of five asbestiform fibres including amosite (grunerite), 
crocidolite (riebeckite), tremolite, anthophyllite, and actinolite – of these only the 
first 3 are commercially mined and used. Compared to chrysotile asbestos, the 
amphibole fibres are straight and needle shaped. Their composition varies depending 
on the complexity of the environment but can be represented as  
A0-1, B 2C5D8O22 (OH, O, F, Cl)2 
where  A= Na, K 
B= Na, Ca, Mg, Fe
2+





, Ti, Mg, Mn, Cr 
D= Si, Al 
Adapted from (Virta, 2002).  
Crocidolite and amosite are hydrated silicates of iron and magnesium, are the most 
important amphibole asbestos fibres and together with chrysotile were industrially 
exploited to a significant degree (Virta, 2002).  
 
1.4.3 Asbestos related diseases  
1.4.3.1 Asbestosis 
Asbestosis is defined as a bilateral diffuse interstitial fibrosis in the peripheral lung at 
the sites of asbestos fibre deposition. The clinical signs of asbestosis are similar to 
that of idiopathic interstitial fibrosis (Mossman and Churg, 1998) however 
differential diagnosis can be made due to the presence of asbestos or ferruginous 
bodies, fibres surrounded by an iron-protein coating. Epidemiologic studies on the 
incidence of asbestosis showed that a minimum exposure dose of approximately 25 
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to 100 fibres per ml per year are required for the development of the disease. The 
latency period of the disease can be as short as 5.2 years after extremely high 
exposure and up to 20.2 years at lower exposure levels (Mossman and Churg, 1998).   
The alveolar type I and type II epithelial cells play a major role in the development 
of pulmonary fibrosis. Epithelial cell proliferation is a natural repair mechanism after 
injury which, if uncontrolled, can result in fibrogenesis and carcinogenesis. 
Molecular changes in the early response protooncogenes, c-fos, c-jun and c-myc after 
asbestos exposure are involved in epithelial cell proliferation (Janssen et al., 1994). 
Other important proliferative signals include tumour necrosis factor α (TNF-α), 
prostaglandins and monocyte chemotactic protein 1 (MCP-1) (Chapman, 2011).  
Epithelial cells have been shown to undergo epithelial-to-mesenchymal transition 
characterised by the downregulation of E-cadherin, loss of cell-cell contacts, actin 
reorganization and expression of α-smooth muscle actin after asbestos exposure with 
mitogen-activated protein kinase (MAPK) and extracellular-signal related kinase 
(Erk) being the main signalling pathway (Tamminen et al., 2012). Survival of 
mesenchymal cells (fibroblasts and myofibroblasts) determines the severity of the 
disease and is a key factor in determining the progress of a fibrotic response after 
toxic injury to the lung. Resistance to apoptosis is mediated by a number of growth 
factors and cytokine receptor expression including tumour growth factor-1β (TGF-
β1), platelet derived growth factor (PDGF), connective tissue growth factor (CTGF) 
and receptor expression of interleukine 4 (IL-4), IL-13 and CC-chemokine ligand 
(CCL2) (Bonner, 2010).The phenotype of myofibroblasts is further determined by 
the T-helper 1 (Th1) or T-helper 2 (Th2) microenvironment, whereby interferon γ 
(IFN-γ) and IFN-β produced by Th1 cells leads to resolution of fibrosis via growth 
arrest and cell death (Bonner, 2010). The Th2 microenvironment in contrast leads to 
myoblast survival and matrix production via TGF-β1, IL-13 and platelet-derived 




1.4.3.2 Lung cancer 
The first relation between asbestos exposure and lung cancer was reported in 1935 by 
Gloyne, and Lynch and Smith (reported in (Wikeley, 1992)). Since these tumours are 
histologically indistinguishable from those caused by other factors known to cause 
lung cancer, such as cigarette smoke, the exact incidence of lung cancer related 
solely to asbestos is unknown. An epidemiologic study showed that asbestos is a 
lung carcinogen because of its fibrogenicity (Hughes and Weill, 1991) and therefore 
asbestosis may be a necessary precursor to asbestos-related lung cancer (Nurminen 
and Tossavainen, 1994).  Molecular pathways involved in malignant transformation 
of lung epithelial cells are similar to pathways linked to pulmonary fibrosis including 
TNF-α mediated activation of nuclear-factor NF-κB, epidermal growth factor 
receptor (EGFR) signalling and activation of c-jun and c-fos leading to cell 
proliferation and transformation via activator-protein (AP)-1 dependent genes 
(Heintz et al., 2010).  
 
1.4.3.3 Pleural effusion and pleural plaques 
Pleural effusion is a build-up of pleural fluid due to an imbalance of influx and efflux 
of fluid in the pleural space (Owens and Milligan, 1995). Benign asbestos pleural 
effusion develops between 5 to 30 years after exposure to asbestos, depending on the 
exposure concentration. It can either resolve or lead to pleural thickening, however is 
not followed by the development of malignancy (Jamrozik et al., 2011).  
Pleural plaques are areas of hyaline fibrosis predominantly on the parietal pleura. 
They consist of acellular bundles of collagen with asbestos fibres enclosed in these 
areas and have a white and shaggy  macroscopical appearance (Greillier and Astoul, 
2008). Pleural plaques are mainly asymptomatic and are not pre-cancerous nor are 





Mesothelioma is an insidious cancer of the mesothelial cells lining the pleural and 
peritoneal cavities primarily seen in conjunction with asbestos exposure. Other 
causes for mesothelioma are rare but include exposure to erionite, a non- asbestos 
fibrous form of zeolite, radiation and simian virus (SV) 40 (Rascoe et al., 2012; 
Comar et al., 2012). Mesothelioma has a long latency period with clinical symptoms 
usually developing 20 to 40 years after exposure. A study by Peto et al. predicts a 
peak in mesothelioma incidence in Britain to be in the year 2020 with a number of 
2700 to 3300 deaths per annum dating back to exposures in the 1960’s and 1970’ s 
(Peto et al., 1995). Mesothelioma is classified into various stages depending on its 
severity. T1a is a tumour limited to the parietal pleura whereas T1b tumours effect 
the parietal and visceral pleura (Mueller, 2002). The most severe version of 
mesothelioma is classified under T4 with spreading of the tumour to mediastinal 
organs, the spine, inner surface of the pericardium and destruction of the ribs 
(Mueller, 2002).  
Extensive research has been performed investigating the molecular pathogenesis of 
malignant mesothelioma to identify potential target for therapeutics.   TGF-β1 is 
associated with the development of various tumours and has been shown to be 
markedly suppressed in asbestos induced tumorigenic cells (Wen et al., 2011). 
Therefore, TGF-β1 suppression could be a potential target for therapeutics by 
preventing rogression via the PI3K/Akt signalling pathway (Wen et al., 2011).  
Studies on the role of microRNAs (miRNA) in regulating multiple genes in 
malignant mesothelioma have identified mRNA-34b/c as playing a major role in 
pleural mesothelioma pathogenesis (Kubo et al., 2011). Epigenetic silencing of 
miRNA-34b/c as seen in tumours was linked to proliferation, migration and invasion 
and over-expression of miRNA-34b/c induced anti-tumour effect such as cell cycle 
arrest and apoptosis (Kubo et al., 2011).  
Other key molecular factors aberrant in mesothelioma include vascular endothelial 
growth factor (VEGF), epidermal growth factor receptor (EGFR) and Wnt pathway 
(Lee et al., 2007). VEGF is involved in angiogenesis, growth, metastasis and is a 
potent tumour inducer. It is seven-fold up-regulated in the serum of malignant 
51 
 
mesothelioma patients were it plays an important role in mesothelial cell 
transformation (Kumar-Singh et al., 1999) (Rascoe et al., 2012). Overexpression of 
IL-6 in tumours was linked to the increased expression of VEGF via the signal 
transducer and activator of transcription 3 (STAT3) pathway (Adachi et al., 2006). 
Epidermal growth factor receptor (EGFR) and its ligand transforming growth factor 
α (TGF-α) show over-expression in cancer leading to cell proliferation, 
differentiation and survival (Lee et al., 2007). Successful clinical trials have been 
performed on cytotoxic drugs to evaluate the anti-tumour activity of VEGF and 
EGFR inhibitors (Kindler, 2004). Chromosomal alterations, especially p53 and pRb 
are common in malignancies. In malignant mesothelioma the p53 and pRb alleles 
remain intact however allele loss is seen in 1p, 3p21, 6q, 9p21, 15q11-15 and 22q 
(Zucali et al., 2011). Loss of the 9p21 chromosome band results in the loss of the 
INK4a/ARF locus which encodes the proteins p16INK4a and p14ARF (Lee et al., 
2007). Both proteins are essential regulators for tumour suppressor pathways and 
apoptosis regulation (Prins et al., 1998), which explains the unresponsiveness of 
mesothelioma treatment with drugs inducing apoptosis (Zucali et al., 2011). Loss of 
the proteins p16INK4a and p14ARF is linked to mutation in the gene 
neurofibromatosis type 2 gene (NF2) on chromosome 22q12, which is seen in nearly 
100% of all mesothelioma patients (Cheng et al., 1999). An in vivo study on wild-
type and heterozygote mutation of the NF2 gene in mice exposed to crocidolite 
asbestos fibres showed that NF2 gene mutation is involved in mesothelioma 
oncogenisis (Fleury-Feith et al., 2003). 
Treatment of malignant mesothelioma is extremely difficult since a number of 
genetic mutations accumulate over the years of disease development and progression. 
Current therapies including surgery, chemotherapy and radiotherapy led to very little 
improvement in the patient’s survival rate. However, new therapeutic approaches 
including immunotherapy and gene therapy of wild type (wt)-p53 gene delivery  in 
the pleura space in the early stages of mesothelioma demonstrated promising results 




1.5 Fibre pathogenicity paradigm 
Fibre toxicology is a sub-discipline of particle toxicology addressing the specialised 
nature of fibre effects. Studies on natural occurring fibres like asbestos, erionite and 
zeolite as well as man-made fibres like synthetic vitreous fibre (SVF) and refractory 
ceramic fibre (RCF1) have resulted in the fibre pathogenicity paradigm (FPP) 
(Donaldson, 2009). It was borne out of 25 years of research and has proven to be the 
most robust structure-activity relationship in particle toxicology (Donaldson et al., 
2010). The FPP can be split into 3 main criteria, namely fibre dimensions, 
biopersistence and surface reactivity.  
 
1.5.1 Dose 
As in all branches of toxicology the dose is the most important factor driving a 
toxicological response as stated already by Paracelsus in  his famous quotation “All 
things are poison and nothing is without poison; only the dose makes that a thing is 
no poison”. A recent comprehensive review we discussed in detail the biologically 
effective dose (BED) in toxicology, focusing on nanotoxicology and high aspect 
ratio nanoparticles including nanofibres (Donaldson et al., 2012). The BED is a term 
describing the actual component of the total dose that drives adverse effects or in 
other words “the entity within any mass dose of particles that drives a critical 
pathophysiogically relevant form of toxicity in tissue” (Donaldson et al., 2012). In 
fibre toxicology, fibre dimension including length and diameter, and biopersistent are 
the accepted components used to describe the BED which are summarised in the 
fibre pathogenicity paradigm.  
 
1.5.2 Fibre dimension  
Fibre dimensions have been identified as one of the major determinants in particle 
toxicology. The width of a fibre determines the aerodynamic diameter which further 
governs the side of deposition of a fibre in the respiratory tract as discussed in 
chapter 1.3.2 (Ellison, 1993).  
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The first indication of the importance of fibre length in the development of 
respiratory disease in relation to asbestos exposure was reported by Beger in 1933 
(quoted by (Holt, 1957)) who showed that asbestos fibres with a length of 25-109 µm 
were found in a patient who died on asbestosis. A series of animal inhalation studies 
and studies on lung material from asbestosis cases were performed to investigate the 
length fraction of asbestos fibres responsible for asbestosis (KNOX and BEATTIE, 
1954; VORWALD et al., 1951). The inhalation models indicated a fibre length of 
20-50 µm were necessary to cause peribronchiloar fibrosis whereas human asbestosis 
cases showed that fibres up to 15 µm caused severe. An extensive study by Stanton 
& Wrench in 1972 investigated the role of fibre length, diameter and composition of 
a range of fibrous materials including asbestos, fibrous glass and aluminium oxide on 
experimental pleural mesothelioma in rats. This study concluded that carcinogenicity 
was related to fibres with a length between 10 to 80 µm with a diameter below 2.5 
µm (Stanton, 1973; Stanton and Wrench, 1972). Physiochemical properties of the 
fibre samples had no influence on the carcinogenicity outcome. In 1986 the ‘Stanton’ 
fibre threshold for pathogenic fibres of ≥ 10 µm had to be corrected according to the 
growing knowledge on asbestos fibre length and mesothelioma incidences in humans 
(Timbrell, 1983) and rats (Davis et al., 1986). Timbrell showed that asbestos fibres 
form the Northwest Cape in Africa had virtually no fibres greater than 10 µm 
however numerous mesothelioma cases had been reported (Timbrell, 1983). In vivo 
inhalation studies in rats showed that long fibre amosite with a size distribution of 
30% >5 µm and 10% > 10 µm produced carcinomas in rats (Davis et al., 1986). 
These studies led to the conclusion that “the critical fibres for mesothelioma 
induction have lengths between 5 and 10 µm”, whereby “fibres shorter than 5 µm 
appear to be ineffective, while an appreciable fraction longer than 10 µm appears to 
be unnecessary” (Lippmann, 1993). In 1997 the WHO included in their regulation of 
airborne dust the definition of fibres as particles with a diameter < 3µm and a length 
> 5 µm with an aspect ratio of 3:1, a definition which originated from the Asbestos 
Research Council meeting in 1958 (Asbestosis Research Council, 1968). 
There are various proposed mechanism by which fibre length influences the 
development of lung and pleural diseases. The predominant mechanism is length 
dependent retention of longer fibres in the lung caused by inefficient clearance by 
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alveolar macrophages. Due to the aerodynamic properties of fibres as discussed in 
chapter 1.3.2, they bypass the normal clearance mechanism of the lung, which would 
restrict the deposition of foreign particles in the lower respiratory tract to a size 
fraction that can be phagocytosed by alveolar macrophages. Fibres, exceeding the 
maximal length for complete phagocytosis by macrophages, can cause ‘frustrated 
phagocytosis’, a term used to describe incomplete uptake of particles by cells as 
shown in Figure 1-4.   
 
Figure 1-4: Diagrammatic representation of short fibre complete phagocytosis and 
long fibre –mediated frustrated phagocytosis. Short fibres can be fully phagocytosed 
by macrophages whereas long fibres are too long to be fully taken up leading to an 
unclosed membrane and leakage of cell content.  
  
The retention of longer fibres in the lung is well documented. Coin et al. performed a 
study measuring the average fibre length of chrysotile asbestos over time retained in 
the peripheral and central regions in the lung after inhalation exposure and concluded 
that the average length of retained fibres increased over time with fibres ≥ 16 µm 
clearing very slowly (Coin et al., 1992). Another study by Searl et al. confirmed the 
hypothesis that short fibres are cleared by cells from the lower regions of the lung 
and longer fibres (> 20 µm) are retained (Searl et al., 1999).  
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In addition to the selective retention of longer fibres in the lung due to failed 
macrophage clearance, retention of longer fibres in the pleural and peritoneal space 
after translocation from the lung has also been reported (Moalli et al., 1987; Murphy 
et al., 2011). Clearance of fibres from the pleural- and peritoneal space is via the 
passive lymphatic flow through stomata, as discussed in chapter 1.2.1. Stomatal 
openings range from 2-8 µm and act as a sieve, preventing efficient clearance of 
fibres exceeding the size of the stomata.  First evidence of the selective retention of 
asbestos fibres in the peritoneal caviety was given by Moalli et al. (Moalli et al., 
1987). After intraperitoneal injections of short and long asbestos fibres, shorter fibres 
(90.6% ≤ 2µm) were readily cleared after 6 hours through the stomatal opening in 
the diaphragm whereas longer fibres (60.3% ≥ 2 µm) were retained at the lymphatic 
stomata (Moalli et al., 1987).  
Phagocytosis of foreign material by macrophages leads to the generation of an 
oxidative or respiratory burst through which the invading pathogens are killed. 
Reactive oxygen species (ROS) are produced within the phago-lysosome by the 
multi-subunit NADPH-dependent phagocytic oxidase, whereby electrons are pumped 





can spontaneously undergo dismutation in a pH and concentration 
dependent manner to form H2O2 and O2. In the case of frustrated phagocytosis, 
release of ROS extracellularly, into the surrounding tissue, can occur with potential 
harmful effects (Bergstrand, 1990).   
In recent years in-depth investigation of the mechanism of asbestos induced 
inflammation has led to a better understanding of the molecular pathways involved in 
frustrated phagocytosis. The NALP3 inflammasome has been identified as a key 
player in asbestos induced inflammation (Hornung et al., 2008; Hornung and Latz, 
2010; Yang et al., 2010; Dostert et al., 2008). The NALP3 inflammasome, 
alternatively named NLRP3, is a member of the nucleotide-binding oligomerisation 
domain (NOD)-like receptors (NLRs) containing a pyrin domain 3 (NALP3) 
complex and consists of the adaptor protein, apoptosis-associated speck-like protein 
containing a C-terminal caspase recruitment domain (ASC) and the effector cystein 
protease caspase 1 (Tschopp and Schroder, 2010). ASC is alternatively named 
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PYCARD. Oligomerization of the NALP3 inflammasome and pro-caspase 1 
clustering results in the auto-activation of caspase 1 and cleavage of pro-IL-1β to 
mature IL-1β (Tschopp and Schroder, 2010).A diverse range of pathogens, 
environmental and endogenously derived molecules can lead to the formation and 
activation of the NALP3 inflammasome, which potentially modulates innate immune 
functions.  Among these are extracellular ATP (Petrilli et al., 2007; Mariathasan et 
al., 2006), viral RNA, whole viruses and fungi (Allen et al., 2009; Gross et al., 2009), 
pore forming toxins (Mariathasan et al., 2006) and particulates. Activation of the 
NALP3 inflammasome was reported after islet amyloid polypeptide (Masters et al., 
2010), asbestos (Dostert et al., 2008), silica and monosodium urate crystals (MSU) 
(Martinon et al., 2006) exposure but not with diesel exhaust particles or cigarette 
smoke (Dostert et al., 2008), which strengthen the conclusion that the crystalline 
structure of the particles and frustrated phagocytosis are the driving factors for the 
observed response. In contrast to these reports, NALP3 activation has also been 
observed after exposure to nanosized CB (Reisetter et al., 2011), nano-sized TiO2 




Figure 1-5: Diagrammatic representation of the NALP3 inflammasome activation by 
asbestos fibres. Frustrated phagocytosis of asbestos fibres by macrophages leads to 
the activation of NADPH oxidase and the generation of ROS, which was shown to be 
a mechanism for NALP3 inflammasome activation. Figure reprinted with permission 
from Science AAAS(O'Neill, 2008). 
 
The activation of the NALP3 inflammasome is a two-step process whereby induction 
of pro-IL-1β in response to TLR, NLR, IL-1 or TNFα stimulation is a separate first 
step required for NALP3 signalling and release of IL-1β (Bauernfeind et al., 2011). 
The NALP3 inflammasome can be activated via various different mechanisms. The 
efflux of potassium from the cells via the P2X7 channel has been shown to be 
required for NALP3 activation (Petrilli et al., 2007).  A further mechanism is 
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lysosomal rupture due to the phagocytosis of crystalline or particulate structures and 
subsequent release of cathepsin B (Tschopp and Schroder, 2010). A third proposed 
model is the activation via ROS, however it is not known whether ROS can directly 
be sensed by the NALP3 inflammasome (Bryant and Fitzgerald, 2009). Dostert et al. 
performed a in-depth study demonstrating NALP3 inflammasome activation after 
asbestos and silica exposure in vitro and in vivo, which could be blocked by using 
NALP3, ASC and caspase-1 knockdown mice (Dostert et al., 2008).   The relation of 
IL-1β expression with the NALP3 inflammasome after asbestos exposure was further 
confirmed using potassium efflux inhibitors, ROS inhibitors and blockage of 
phagocytosis leading to a significant decrease of IL-1β expression (Dostert et al., 
2008). Another study by Hornung et al. confirmed these results showing NALP3 
activation to silica crystals and aluminium salt in conjunction with lysosomal 
destabilisation (Hornung et al., 2008).  
So far, the activation and mechanism of NALP3 inflammasome has been studied 
mainly in macrophages. A recent study was focusing on the role of the 
inflammasome in neutrophils and showed a pivotal role of NALP3 in facilitating IL-
1β cytokine release (Mankan et al., 2012). In addition, a study by Peeters et al. 
showed the activation of the NALP3 inflammasome by crystalline silica in human 
lung epithelial cells and identified a crucial link between inflammasome inactivation 
and blunted fibroblast proliferation (Peeters et al., 2013). The NALP3 inflammasome 
activation and chronic activation of IL-1β, which is directly relevant to fibroblast 
proliferation and fibrogenesis describes an important link between acute and chronic 




It has been widely accepted that biopersistence plays a major role in the pathological 
response to inhaled fibres since it determines the dissolution/ breakage of long fibres 
and their clearance rate. It is at the level of long fibres that biopersistence can be seen 
to be most important since they represent the pathologically-relevant length fraction.  
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A long fibre that is non-biopersistent will undergo weakening and breakage and can 
subsequently be phagocytosed by alveolar macrophages and cleared. Biopersistent 
long fibres on the other hand will accumulate due to incomplete phagocytosis and 
clearance resulting in a pathological response. Chrysotile asbestos has been shown to 
be less pathogenic compared to amphibole asbestos due to its less biopersistent 
chemical composition (Bernstein and Hoskins, 2006).  The outer coating of 
chrysotile fibres is a rolled sheet composed of magnesium silicate and an external 
brucite layer which is soluble in the lung surfactant leaving the crystalline structure 
of silica to be readily attacked by acid within the phagolysosome when phagocytosed 
by macrophages (Bernstein and Hoskins, 2006).  This process leads to destabilization 
of the chrysotile structure and ultimately its fragmentation into smaller fragments. In 
contrast, the double chain of silica tetrahedra in amphibole asbestos fibres provides 
tensile strength which is highly influenced by the iron content making them strong 
and durable (Virta, 2002). Studies have shown that amphibole asbestos fibres, mainly 
amosite, do not dissolve in vivo or in vitro at pH ranges that might be plausibly 
encountered in biological systems (Searl et al., 1999; Hesterberg et al., 1997).  An 
extensive study was performed by Searl et al. comparing biopersistence and 
durability of nine mineral fibre types in rat lungs over a 12 month period (Searl et al., 
1999). The studies on the clearance over the 12 month period showed that, for 
amosite, RCF-2 and RCF-4, the biopersistence increased with fibre length (Searl et 
al., 1999). For non-biopersistent fibres, man-made vitreous fibres, MMVF-10 and 
MMVF-22 the persistence decreased with increased fibre length showing the 
breakage/dissolution of longer fibres (Searl et al., 1999). In addition, in vitro 
durability studies were performed over a 12 month period whereby the same fibre 
samples were incubated in a pH 4.6 solution.  The results obtained from in vitro 
durability studies paralleled the in vivo studies (Searl et al., 1999).  
Extensive research was performed on p-aramid, a man-made organic fibre, first 
commercialised in 1970, which has fibril lengths up to 100 µm (Donaldson, 2009). 
P-aramid is a long chain synthetic polyamide used as advanced composite and in 
fabrics, body armour, etc and was manufactured in high quantities. Even though the 
fibres of p-aramid are long and respirable, inhalation exposure studies showed that 
these fibres have limited pathogenicity and fibrogenicity due to their non-
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biopersistence with dissolution and shortening of longer fibrils into shorter fragments 
(Bellmann et al., 2000; Kelly et al., 1993).  
Until recently research on the biopersistence of nanofibres focused on naturally 
occurring fibres as well as man-made synthetic vitreous and polyamide fibres. In 
recent years research into the biopersistence of carbonaceous nanomaterials, 
including fibrous carbon nanotubes (CNT) and graphene platelets attracted attention 
due to the increased production of these materials. The first study on the durability of 
CNT was performed by Osmond-McLeod comparing four different types of CNT, 
including single-walled as well as multi-walled CNT (SWCNT/MWCNT) to X607, a 
non-durable glass wool, long fibre amosite asbestos and long fibre chrysotile  
(Osmond-McLeod et al., 2011). Fibres were incubated in Gambles solution, a 
simulated biological fluid at a pH of 4.5 representing the acidic milieu within 
phagosomes, for up to 24 weeks and weight loss as well as length distribution and 
structural changes were recorded. Three out of four CNT tested showed nearly 100 
% durability similar to that of amosite asbestos (Osmond-McLeod et al., 2011).  In 
addition to the durability study, recent investigations have shown that carbon 
nanomaterials, including graphene oxide and oxidized carbon nanotubes, are 
degraded by oxidase enzymes including horseradish peroxidase and neutrophil 
myeloperoxidase (hMPO) in vitro and in vivo (Kagan et al., 2010; Graham et al., 
1999; Kotchey et al., 2011; Shvedova et al., 2012) causing them to exhibit less 
inflammatory potential in vivo.  
 
1.5.4 Surface reactivity 
As mentioned above, studies on the toxicity of fibres, exhibiting entirely different 
chemical compositions, led to the conclusion that length and biopersistence are the 
dominating criteria in predicting the severity of fibre pathogenicities. However, not 
all long, biopersistent fibres show an equal degree of pathogenicity which is due to 
their difference in chemical composition, especially surface characteristics. At the 
end of the 1970s environmental exposure to erionite, a naturally occurring fibrous 
mineral, was found to be related  to very high incidences of pleural mesothelioma in 
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Cappadocia, a region in Turkey where erionite was present in homes (Temel and 
Gundogdu, 1996).  Erionite is a fine fibrous wool-like crystal and is a hydrated 
aluminosilicate minerals. It has similar morphology to amphibole asbestos however 
different chemical and physical properties and a 20 times larger internal surface 
compared to crocidolite asbestos (Metintas et al., 1999). The drastically increased 
surface-area- to –volume ratio could account for the enhanced pathogenicity.  
It is known that these naturally occurring fibres possess a highly reactive surface due 
to their high iron content which is involved in iron-mediated redox chemistry and 
subsequently oxidative stress (Kamp et al., 1992).  
Two mechanisms can lead to the production of reactive oxygen species (ROS) by 
asbestos. Firstly, the associated iron cations can promote the formation of highly 
reactive hydroxyl free radical (HO
•
) from hydrogen peroxide (H2O2) via the Fenton 
reaction (1) (Turci et al., 2011).  
Fe
2+







Biological reducing agents such as superoxide can reduce ferric iron (Fe
3+
) back to 
ferrous iron (Fe
2+
) which can further catalyze the formation of HO
•
 from H2O2 via 







 + O2 (2) 
Further reaction catalyzed by iron include alkoxyl radicals from organic 
hydroperoxides and ferryl (FeO
2+
) (Kamp and Weitzman, 1999).  
The production of ROS can cause oxidation and nitrosylation of proteins and DNA 
either by direct addition of HO
• 
to the DNA or by hydrogen abstraction (Byrnes, 
1996). The second mechanism by which asbestos induce ROS is via stimulation of 
macrophages and neutrophils and their release of O2
-
 and H2O2 catalyzed by iron 
(Kamp and Weitzman, 1999). There is strong evidence that this increase in ROS 
mediated by the iron content is linked to apoptosis, inflammation and proliferation 




1.6 Inflammation in relation to inhaled particles  
1.6.1 Lung inflammation 
Inflammation is seen acutely and chronically in lungs exposed to harmful dusts and 
fibres and inflammation is a pathobiological process that leads to pathological 
change associated with particle exposure including fibrosis, airway inflammation and 
lung cancer. For these reasons inflammation is commonly studied as a way to 
identify harmful particles and to understand the features of particles that drive 
pathogenicity, the biologically effective dose. The cellular dynamics of the lung 
response to inhaled particles has been subject to intensive investigations in an 
attempt to identify the key mediators of the inflammatory response. From dust 
exposure experiments potent agents such as complement fragments C5a, 
prostaglandins, leukotrienes and other lipid mediators have been identified to act as 
chemoattractants and activators for macrophages and neutrophils (Finkelstein and 
Barrett, 2000). Alveolar macrophages whose evolved function is to take up deposited 
particles play a major role in the initiation of a pulmonary response to inhaled 
particles by up-regulating expression of a number of pro-inflammatory and pro-
fibrotic cytokines. Among these, IL-1β and TNF-α have been identified as important 
mediators in the recruitment of neutrophils, lymphocytes, and macrophages. In 
addition, via cytokine growth factors, they induce fibroblast proliferation and 
granuloma formation as well as the release of acute phase proteins (Finkelstein and 
Barrett, 2000; Ohtsuka et al., 1995; Mohr et al., 1991; Piguet et al., 1993). Other 
cytokines involved in the recruitment of inflammatory cells are macrophage 
inflammatory protein 1 and 2 (MIP-1 α and MIP-2), which were shown to be 
upregulated after intratracheal installation of silica and titanium dioxide (Driscoll et 
al., 1993). In addition to the secretion of chemokines and cytokines by macrophages, 
direct interaction of epithelial type II cells with particles stimulates epithelial cells to 
produce inflammatory mediators such as granulocyte-macrophage colony-
stimulating factor (GM-CSF), TGF-β, IFN, IL-8, MIP-2 and RANTES (Finkelstein 
and Barrett, 2000).  
Intracellular signalling pathways leading to the activation of the above mentioned 
inflammatory mediators have been extensively studied, and the molecular pathways 
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leading to an acute inflammatory response in the lung are dependent on the type of 
particle exposure and a complex mixture of various pathways are involved. A well 
understood signalling pathway in lung inflammation is that of the endotoxin 
lipopolysaccaride (LPS). LPS stimulation is initiated by binding to LPS binding 
protein (LBP) which facilitates the association between LPS and CD14. CD14 
facilitates further the transfer of LPS to the TLR4/MD-2 receptor complex (Lu et al., 
2008). TLR4 undergoes oligomerization and recruits the TIR (Toll-interleukin-1 
receptor) domain which is an adaptor protein for MyD88 (myeloid differentiation 
primary response gene 88). MyD88 recruits and activates IL-1 receptor-associated 
kinase-4 (IRAK-4) and TRAF6 (TNF receptor-associated factor 6) as well as the 
transcription factors  NF-κB, AP-1 and IRF-5 further downstream leading to 
proinflammatory cytokine expression (Lu et al., 2008). TLR4 oligomerization via 
LPS can also stimulate a MyD88 independent pathway via TRIF (TIR domain-
containing adaptor inducing IFN-β) signalling which induces type I interferons by 
recruiting TRAF3 and RIP1 (receptor-interacting protein 1) to activate transcription 
factor IRF3, as well as NF-κB and AP-1 (Lu et al., 2008).  
The activation of the MAP kinase pathways has also been linked to asbestos and 
silica exposure (Tamminen et al., 2012; Heintz et al., 2010; Rimal et al., 2005). The 
extracellular signal related kinase (ERK1/2) pathway is the best characterised 
pathway in asbestos induced lung inflammation as well as mesothelioma (Heintz et 
al., 2010) and has also been shown to be activated ROS from ultrafine particulate 
matter (Weissenberg et al., 2010). The ERK pathway controls the expression and 
transcriptional activity of Fos and c-jun family members of the activator protein 
(AP)-1 transcription factor regulating genes for cell proliferation, transformation, 
migration, protein metabolism and immune response (Heintz et al., 2010). Similar 
signalling pathways activated in epithelial cells after asbestos exposure leading to 
lung cancer have been identified in pleural inflammation and the development of 




1.6.2 Inflammation in the pleural cavity  
The onset of inflammation in the pleural space by either bacterial endotoxin, asbestos 
or other stimuli is characterised by an extensive influx of leukocytes from the  
vascular compartment (Mutsaers, 2004). The influx of leukocyteleukocytes requires 
a chemotactic gradient to the site of inflammation which is either generated by 
activated mesothelial cells or by residing macrophages in the pleural space. 
Expression of chemokines such as IL-8 and MCP-1 play a significant role in the 
chemotactic activity and are elevated in mesothelial cells after activation by LPS, IL-
1β and TNF-α (Antony et al., 1995). Particulate stimuli such as talc and asbestos are 
also potent inducers in MCP-1 and IL-8 expression in pleural mesothelial cells and 
enhance intracellular adhesion molecule-1 (ICAM-1) expression (Nasreen et al., 
1998; Tanaka et al., 2000). Other cell adhesion molecules expressed in activated 
mesothelial cells are vascular cellular adhesion molecule (VCAM-1), E-cadherin, N-
cadherin, CD49a, CD49b and CD29 (Mutsaers, 2004). Increased expression of 
ICAM-1 on mesothelial cells leads to transmigration of leukocyteleukocytes via 
interaction with β2 integrin family receptors (Zeillemaker et al., 1996). IL-6 has also 
been shown to play an important role in pleural inflammation, as IL-6 knockout mice 
exhibit reduced polymorphonuclear leukocyte (PMN) migration and inflammation 
compared to wild type mice after intrapleural injection of carrageenan, a 
polysaccharide extracted from red seaweed (Cuzzocrea et al., 1999). IL-6 expression 
leads to additional expression of TNF-α and IL-1β, key cytokines in pleural 
inflammation expressed by activated resident macrophages in the pleural space 
(Frode et al., 2001). Little is known about the role of resident pleural macrophages in 
the initiation of inflammation and orchestration of PMN recruitment. A study by 
Cailhier et al. indicated that residential macrophages and their cytokines TNF-α, IL-
6, MIP-2 and IL-10 are essential for the recruitment of PMN (Cailhier et al., 2006). 
A recent study by Murphy et al. investigated the pro-inflammatory responses of 
macrophages and mesothelial cells in vitro after CNT treatment and showed that 
CNT resulted in a significant release of IL-1β, TNF-α, IL-6 and IL-8 from 
macrophages but not mesothelial cells (Murphy et al., 2012b). However, pro-
inflammatory mediators released by macrophages after CNT treatment led to an 
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significant increase in cytokine production of mesothelial cells (Murphy et al., 
2012b). 
Acute inflammation, release of cytokines and chemokines as well as production of 
mutagenic reactive oxygen species is known to be directly linked to the chronic 
inflammation and carcinogenesis caused by asbestos (Dai and Churg, 2001; Dostert 
et al., 2008; Nagai and Toyokuni, 2010; Unfried et al., 2002). It is also known that 
asbestos is cytotoxic to mesothelial cells via an apoptotic pathway; however, 
apoptosis is counterintuitive for a cell that is in the process of transformation. More 
recent studies by Yang et al. investigating the form of mesothelial cell death after 
asbestos exposure showed that mesothelial cells undergo programmed necrosis 
which is linked to carcinogenenis (Yang et al., 2010).  In pleural inflammation ROS 
production, nitric oxide (NO) and reactive nitrogen species (NO·) production by 
mesothelial cells is seen in response to cytokines, bacteria and asbestos with 
concomitant increase in  anti-oxidant gene expression (Mutsaers, 2004).  A massive 
oxidative and nitrosative stress can cause poly (ADP ribose) polymerase (PARP) 
overactivation, depletion of ATP and promotion of cell necrosis (Virag and Szabo, 
2002). PARP is a DNA nick-sensor enzyme that contributes to DNA repair, however 
during necrosis, PARP overreaction promotes the translocation of high-mobility 
group box (HMGB)-1 from the nucleus to the cytosol and the extracellular space 
which triggers an inflammatory response (Ditsworth et al., 2007). HMGB-1 is a 
damage-associated molecular pattern (DAMP) which, when released into the 
extracellular space activates adaptive immunity and initiates tissue repair programs 
(Bianchi and Manfredi, 2007).  During exposure of human mesothelial cells to 
asbestos fibres, HMGB-1 translocates from the nucleus to the extracellular space 
where it triggers TNF-α release by macrophages, which protects human mesothelial 
cells from undergoing apoptosis and leads to chronic inflammation and potentially 





Due to the unique properties of matter in the nanosize scale, research in developing 
new nanomaterials is proceeding remarkably fast and nanomaterials are being 
incorporated into a wide variety of consumer products.  A material can be defined as 
a nanomaterial if at least one dimension is less than 100 nm and more specifically, on 
the 18
th
 of October 2011 the European Comission adopted the recommendations on 
the definition of a nanomaterial to “A natural, incidental or manufactured material 
containing particles, in an unbound state or as an aggregate or as an agglomerate 
and where, for 50 % or more of the particles in the number size distribution, one or 
more external dimensions is in the size range 1 nm - 100 nm” (European 
Commission, 2012). According to the structure and nanoscale dimension of the 
material it can be further split into 3 different categories. One dimension nanoscale 
materials are referred to as nano-layers, -films or surfaces whereas two dimensional 
nanoscale materials are categorised as nanotubes, nanowires and nanorods; the third 
category consists of nanoparticles, which are nanoscale in all three dimensions 
(ISO/TS 27687, 2008).  
 
1.7.1 High aspect ratio nanomaterials 
The definition of a high aspect ratio in general terms describes the proportional 
relationship between the width and the height of an object. In terms of fibrous 
nanomaterials, the aspect ratio is determined by the ratio between the fibre length, 
which can be up to millimetre and its diameter, which is in the nanometer range. At 
present, fibrous high aspect ratio nanomaterials (HARN) include nanotubes, 
nanowires and nanorods which can be composed of various different elements and 
exhibit a large surface area (Figure 1-6). A new form of nanomaterial, also 
classifiable under the term ‘high aspect ratio’ are nanoplatelets made of graphene 
(Figure 1.5). Graphene nanoplatelets (GP) are completely different in their shape 
compared to the conventional fibrous HARN by exhibiting a planar geometry. 
Therefore the aspect ratio of a plate-like GP is determined by the diameter of the 




Figure 1-6: Images and characteristics of the different types of HARN. Gold 
Nanorod image was kindly provided by (Sharma et al., 2009). 
 
1.7.1.1 Fibrous HARN 
The terms nanowire and nanorod are used interchangeably in literature and the 
definition of these terms is still somewhat vague. The distinguishing feature between 
nanowires and nanorods is their length. Nanowires can be up to millimetres in length 
whereas each dimension of nanorods is within 100 nm.  Therefore the standard 
aspect ratio of nanorods is 3-5 in comparison to the aspect ratio of nanowires which 
can be greater than 1000. Another term used in the literature for HARN is nanofibres 
which are occasionally used as an umbrella term for nanowires and nanotubes. Best 
known and most industrially utilised of all HARN are carbon nanotubes (CNT) 
which are long, thin cylindrical structures comprising single or multiple layers of 
concentric graphene sheets.  CNT have been optimised for a huge range of 
applications by derivatisation of the surface with a range of chemical moities. 
Carbon, packed in the graphenic structure of CNT exhibits exceptional properties 
from electrical and thermal conductivity to tensile strength and rigidity. The 
development and optimization of CNT for a huge range of applications, from 
electronics to structural engineering has been a feature of the developing 
nanotechnologies industry (Aitken et al., 2006). There are a number of methods 
employed in the synthesis of CNT (Awasthi et al., 2005) however the advantages in 
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the production of non-carbon nanotubes, nanowires and nanorods over CNT could 
include controllability of length, diameter, geometry, surface functionality and purity 
during the production process. Various techniques have been developed to synthesise 
nanowires and nanorods based on different methods (e.g. evaporation-condensation, 
dissolution-condensation, vapour- liquid- solid), but the template-based approaches 
have proved the most versatile.  Dependent on the material under use, different 
template- based synthesis methods can be utilised (Cao and Liu, 2008). For 
electrically conductive materials, the electrochemical deposition method is used and 
various nanowires and nanorods have been synthesised using this method, including 
metals such as Au, Ni, Co, Fe and Pb as well as semiconductors, conductive 
polymers and oxides.  Other template-based synthesis methods are electrophoretic 
deposition from colloidal dispersion and template filling. A wide range of HARN has 
been produced using electrophoretic deposition method including polycrystalline 
oxides like ZnO, TiO2 and SiO2 (Cao and Liu, 2008). 
The applications of nanofibres range from electronic devices, aerospace, automotive, 
sporting goods, textiles to tools for biology and medicine (Li and Tay, 2011; Prina-
Mello et al., 2006; Uskokovic et al., 2012; futuremarketsinc.com, 2012). The 
application chart in Figure 1-7 summarises the number of nanotubes companies 




Figure 1-7: Application chart showing the number of nanotube companies 
worldwide targeting particular end user market. From Future Markets, Inc 2011 
(futuremarketsinc.com, 2012). 
 
With regard to nanomedicine applications, carbon nanotubes in particular have been 
identified for a number of potential uses including imaging, enhancement of bone 
growth and targeting and delivery of drugs (Pascu et al., 2010; Sahithi et al., 2010; 
Liang and Chen, 2010). Sharma et al. studied the neuroprotective efficacy of 
compounds attached to nanowires in comparison to normal compound delivery and 
reported an enhanced beneficial effect of the nanowire-drug delivered compound 
(Sharma et al., 2010). Uskokovic et al. showed that nanowire-coated microparticles 
are efficient transepithelial drug delivery devices due to their lager surface area 
compared to spherical counterparts (Uskokovic et al., 2012). Ceramic nanoparticles 
have drawn special attention in the fields of drug delivery, imaging, sensing and 
thermotherapy due to their biocompatibility, simple preparation and ease of surface 
modification. Additionally silica nanotubes combined with iron oxide seem to be a 
promising tool for image-guided drug delivery (Chen et al., 2012). The tubular shape 
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permits loading of large amounts of the desired molecule, whereas the outer surface 
can be modified using for example polyethylenglycol or targeting moieties (Son et 
al., 2006).  
Year–by–year there is a near exponential increase in publications based on 
nanomaterials as well as a considerable expansion in the market potential. According 
to the data summarised in a recent report by ‘Bcc Research-Market Forecasting’, the 
global market for nanotechnology was valued at nearly $ 20.1 billion in 2011 with an 
annual growth rate of 18.7% (bccresearch.com, 2012). A search in Pubmed was 
performed to show the increase in the number of publications on the topics ‘carbon 
nanotubes’, ‘nanoparticles’  and ‘nanofibre’, ‘nanotube’, ‘nanowire’, ‘nanorod’, 
which are summarised under HARN excluding CNT (Figure 1-8). The number of 
HARN-related publications rose from 23 in the year 2000 to 5133 in the year 2012 
(Figure 1.7).  
 
Figure 1-8: Number of publications on the topics of nanoparticles, high aspect ratio 
nanoparticles, excluding carbon nanotubes, and carbon nanotubes as well as the 
number of publications on the toxicity of nanomaterials. The graph shows the 
increase in the number of publications on the main three categories of nanomaterials 
from 2000 to 20012. HARN in this graph include nanofibres, nanowires, nanorods 
and nanotubes made of materials other than carbon. These data are based on 
publications in the PubMed database. The search in the database was performed 
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using the ‘advanced search option’ and ‘limits’ to specify the date range of 
publications in each field. Number of publication was revealed using the search 
terms ‘carbon nanotubes’ and ‘nanoparticles’. HARN data was obtain by summing 
the number of hits from ‘nanofibres’, ‘nanowires’, ‘nanorods’ and ‘nanotubes’ using 
the ‘Search Builder option NOT’ to exclude CNTs. Insert shows the number of 
publications on nanoparticles/HARN in relation to the papers on their toxicity. CNT: 
Carbon nanotube; HARN: High aspect ratio nanoparticle. 
 
The increasing growth of the HARN industry suggests considerable potential for 
human exposure to airborne HARN as these materials are handled in workplace 
during industrial preparation and use. However despite rapid growth in the 
publications reporting the development, optimization and potential applications of 
various HARN, the number of publications based on toxicity studies of HARN 
makes up only 5.6% of all publications. These data illustrate quite clearly the 
worrying mismatch between the increases in research focused on the development 
and use of HARN versus research concerned with potential health effects to exposure 
to HARN. 
 
1.7.1.2 Planar HARN/ Graphene Nanoplatelets 
Graphene is the youngest in the family of carbon nanomaterials being first isolated in 
2004 by Andre Geim and Konstantine Novoselov by a somewhat unconventional 
method of using adhesive tape upon graphite, and stripping of a single layer of 
graphene (Geim and Novoselov, 2007).  Graphene is a single layer of carbon packed 
in a hexagonal (honeycomb) lattice. The carbon atoms are covalently connected to 
three other carbon atoms with a distance of 0.142 nm resulting in a sp
2
 bonding 




Figure 1-9: Honeycomb lattice of graphene. Adapted from a public domain image by 
AlexanderAIUS. 
 
Graphene exhibits remarkable mechanical and electrical properties that make the 
material suitable for a number of applications. As stated by the Nobel Prize 
committee, ‘a hammock made of graphene would be strong enough to support a 4 kg 
cat, with the hammock weighing only 0.77mg’ and has a breaking strength of ~40 
N/m (Van, 2011; Geim and Novoselov, 2007). In regards to electrical conductivity, 
the hexagonal symmetry arrangement of the atoms in graphene allow the structure to 
conduct electricity much more efficient than silicon and can therefore act as a future 
replacement for versatile silicon in microchips (Van, 2011). The exceptional 
properties of graphene are reflected in the number of patents issued and papers 
published in 2010, being 400 and 3000 respectively. In addition, the European Union 
is giving 1,000 million euro funding for a 10 year coordination action on graphene, 
and the United Kingdom as well as South Korea are investing £ 50 million and $ 350 
million, respectively in a new commercialization hub.   
In the light of the increased production of graphene materials in recent years, it is of 
utmost importance to determine the potential hazard of the material and exposure of 
the workforce in manufacturing industries to determine the risk associated with 




1.7.1.3 Toxicology of HARN 
HARN have useful and novel electro-physical properties which resulted in an 
increased production compared to other nanoscale materials, as a consequence of 
which, there is increasing potential for inhalation exposure.  In light of the adverse 
effects of asbestos, some of which can be classified as high aspect ratio nanoparticle, 
albeit natural in origin the increasing production of HARN has triggered concern 
that, if HARN are inhaled into the lungs they may behave like asbestos. Exposure to 
asbestos fibres caused a worldwide epidemic of disease, although not all fibres that 
can be breathed into the lungs are as pathogenic as asbestos and the different forms 
of asbestos are not equally pathogenic. Therefore, if we can fully understand what 
features render a fibre pathogenic then we have the potential to develop HARN that 
are safe-by–design. 
Regarding the unique geometry of nanoplatelets, their platelet-like structure, atomic 
thinness, extreme aspect ratio and extended lateral dimensions, nanoplatelets could 
pose a potential risk in relation to inhalation exposure similar to that seen with 
fibrous HARN, including asbestos fibres.  
The term nanotoxicology was first mentioned by Robert Service in the Science 
journal in 2004, raising the awareness that the different properties of nanomaterials 
compared to their bulk form “makes their potential health and environmental effects 
maddeningly difficult to predict” (Service, 2004). Donaldson et al. fully described 
the context of nanotoxicology within particle toxicology and set out major concerns 
raised by this new area in an Editorial in Occupational and Environmental Medicine 
in the same year (Donaldson and Tran, 2004; Donaldson et al., 2004).  
A number of studies have been performed since then to evaluate the toxicological 
potential/risk of nanomaterials by identifying their hazard and assessing the exposure 
levels (Oberdorster et al., 2005). Figure 1-10 summarizes the key questions that need 




Figure 1-10: Risk assessment of nanomaterials. Hazard identification and exposure 
assessment are required in order to formulate exposure standards. Reproduced and 
adapted from (Oberdorster et al., 2005). NP= nanoparticle. 
 
1.7.1.4 Hazard of HARN 
The aim of the present thesis is to identify the potential hazard of HARN in relation 
to asbestos fibres. The basis of this comparison is the morphological similarity 
between HARN and asbestos fibres, both, in terms of length as well as diameter. 
From asbestos exposure history we know that the lung as well as the 
pleural/peritoneal cavity are the target sites for disease development. Therefore 
investigation of the adverse health effects of HARN should be directed towards these 
sites.  
The first direct comparison between HARN and asbestos fibres in their ability to 
cause granuloma formation in the peritoneal cavity via the route of direct 
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intraperitoneal injection was performed by Poland et al. (Poland et al., 2008).  The 
study was comparing different forms of CNT, including two tangled CNT in the size 
range of 1-20 µm and two long fibrous CNT, with a mean length of 13 µm and up to 
56 µm, to short and long amosite asbestos fibres (SFA/LFA) and nanoparticulate 
carbon black (CB) (Poland et al., 2008). This study demonstrated for the first time 
that CNT show asbestos-like length-dependent pathogenicity, whereby long CNT led 
to a substantial inflammatory response in the peritoneal space and granuloma 
formation on the diaphragm up to 7 days similar to the response observed after 
exposure to LFA fibres (Poland et al., 2008). No inflammatory response was 
measured after intraperitoneal injections of short/tangled CNT and SFA (Poland et 
al., 2008). At the same time a study by Takagi et al. reported the ability of MWCNT 
to induce mesothelioma in the peritoneal space after direct administration in p53+/- 
mice (Takagi et al., 2008). However this study received strong criticism due to the 
unrealistic high dose of 3 mg/ml that was used in this study leading to artifactual 
responses and questionable interpretation of the observed histological interpretation 
of mesothelioma (Donaldson et al., 2008).  
In 2005 a study by Muller et al. investigated the respiratory toxicity of multi-wall 
CNT (MWCNT) (5.6 µm mean length) and ground MWCNT (0.7 µm mean length) 
in rats after intratracheal administration at a dose of 0.5, 2 and 5 mg up to 2 month 
post exposure (Muller et al., 2005). Due to a uniform dispersion of ground MWCNT, 
a fibrotic response was observed in the lung parenchyma whereas insufficient 
dispersion of non-ground MWCNT produced collagen-rich granulomas only in the 
bronchial lumen but not in the lung parenchyma (Muller et al., 2005). The observed 
toxicological effects of short/ground MWCNT in this study have been further 
examined by Fenoglio et al. (Fenoglio et al., 2008) showing that the structural 
surface defects, metals and oxygenated functionalities in the ground MWCNT 
sample governed the toxic potential of these CNTs. By reduction of oxygenated 
carbon functionalities and reduction of metallic oxides the toxic effect of short CNT 
could be eliminated (Fenoglio et al., 2008). To further test the hypothesis that 
MWCNT with defects have higher carcinogenic activity, MWCNT with and without 
defect were instilled into the peritoneal cavity of rats and the incidence of 
mesothelioma development was measured and compared to crocidolite asbestos 
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(Muller et al., 2009). No carcinogenic response was measured and no difference in 
the rate of mesothelioma was observed between the two MWCNT groups (Muller et 
al., 2009). These results can be explained by the shortness of the samples used and 
the clearance mechanisms from the peritoneal space with the efficient clearance of 
shorter fibres through stomata from the peritoneal space (Moalli et al., 1987; Poland 
et al., 2008).  
Another study investigating the length dependent effect of CNT in the peritoneal 
space used ultrashort and full-length single-walled CNT (SWCNT) concluded that 
large aggregates of CNTs (> 10 µm) induce granuloma formation likely through a 
frustrated phagocytosis mechanism whereas smaller aggregates of SWCNT (< 10 
µm) were sufficiently engulfed by phagocytes without granuloma formation 
(Kolosnjaj-Tabi et al., 2010).  
So far, the studies reporting CNT toxicity focused on the peritoneal space as a 
surrogate for the more relevant pleural space in relation to mesothelioma 
development. Murphy et al. developed a technique for direct pleural installation to 
study the effects of short and long CNT in the pleural cavity (Murphy et al., 2011). 
The CNT panel used by Murphy et al. was the same as used by Poland et al. to 
directly compare the inflammatory response in the pleural space to that observed in 
the peritoneal space (Murphy et al., 2011; Poland et al., 2008). The results showed 
that the adverse effects reported in the peritoneal space were equivalent to the ones in 
the pleural space, whereby only long CNT as well as LFA resulted in extensive 
formation of granulomatous lesions on the parietal pleura mesothelial cell layer 
(Murphy et al., 2011).  
The knowledge of the toxicity of CNT in a compact or particulate form increased 
extensively over the recent years reporting various pathological responses ranging 
from sustained elevations of neutrophils and collagen deposition in the lung 
(Pauluhn, 2010; Murphy et al., 2012a), DNA damage malignant transformation of 
epithelial cells (Yamashita et al., 2010) and tumourgenisis (Wang et al., 2011a) as 
well as in vitro studies investigating the inflammatory mediators and signalling 
pathways involved in CNT toxicity (Brown et al., 2007; Pacurari et al., 2008). In 
vitro studies on the alteration of molecular pathways in normal and malignant human 
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mesothelial cells after SWCNT exposure showed an activation of PARP, AP-1, NF-
κB, p38, and Akt as well as enhanced DNA damage and increased cell death which 
indicates asbestos-like molecular changes (Pacurari et al., 2008). An advanced 3-D 
cell culture model has been developed to study granuloma formation of macrophages 
in vitro after CNT treatment showing a correlation between the high aspect ratio of 
CNT and granuloma formation (Sanchez et al., 2011). 
The hazard assessment of HARN has been so far concentrated on CNT, due to their 
extensive market growth compared to other forms of HARN. However, as shown in 
Figure 1-8 HARN other than CNT underwent a substantial growth in use in the last 3 
years measured as the number of publications. Therefore investigation of the 
toxicological potential of other forms of HARN is essential and aids the overall 
understanding of the biological effective dose of HARN. However, hardly any 
publications can be found on the toxicity of HARN other than CNT. Hamilton et al. 
demonstrated increased pathogenic potential of long titanium dioxide (TiO2) 
nanowires compared to their shorter (< 5 µm) counterpart (Hamilton et al., 2009). In 
this study long TiO2 nanowires elicited inflammation via the NALP3 inflammasome 
which was linked to lysosomal breakdown and release of cathepsin B (Hamilton et 
al., 2009). Another study by Poland et al. looked into the differential response of 
short (< 5 µm) and long (> 20 µm) nickel nanowires (NiNW) in the lung and the 
peritoneal cavity after aspiration exposure and direct intrapleural injection, 
respectively (Poland et al., 2012). The inflammatory response to NiNW in the 
peritoneal cavity was similar to that seen after CNT exposure, with a marked 
inflammation only after long NiNW exposure (Poland et al., 2012). The response in 
the lung had a similar pattern, showing extensive granuloma formation and collagen 
deposition in the lung after long NiNW exposure (Poland et al., 2012).  
The first study on the hazard identification of multilayered graphene nanoplatelets 
was reported in 2010 by Zhang et al. (Zhang et al., 2010). Neural cytotoxicity of 
multi-layered graphene and SWCNT was tested in Phaeochromocytoma-derived 
PC12 cells, leading to the conclusion that shape plays the primary role in induction 
of cytotoxicity, whereby graphene treated cells showed higher levels of oxidative 
stress compared to SWCNT (Zhang et al., 2010). Graphene toxicity was further 
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studied on bacteria, showing anti-bacterial activity of reduced graphene nanowalls 
(Akhavan and Ghaderi, 2010) and on mice via intravenous administration of 
PEGylated graphene resulting in minimal toxicity at a tested dose of 20 mg/kg (Yang 
et al., 2011) as well as via direct administration into the lungs of graphene and 
graphene oxide demonstrating that oxidation of graphene is a major contributor to 
pulmonary toxicity (Duch et al., 2011).  
 
1.7.1.5 Dose/Exposure  
The use of a relevant/realistic dose for in vitro and in vivo toxicological studies on 
the hazard of nanomaterials is essential to perform dose-response assessment for 
real-world exposure scenarios (Oberdorster et al., 2005). In the case of aspiration-
type delivery to the respiratory tract, a relatively high bolus is delivered to the lung 
within a few seconds in a very high dose-rate. In  real-world inhalation exposure 
scenarios in occupational and environmental settings, a much lower dose is deposited 
over a prolonged time. A study was performed by Shvedova et al. to directly 
compare inhalation studies versus aspiration studies of single-walled carbon 
nanotubes in mice and showed that both ways of administration resulted in very 
similar responses (Shvedova et al., 2008). Aspiration experiments are therefore of 
value as proof of principle studies which can be used for extrapolation to inhalation 
studies. Dosimetry chosen for in vitro studies in relation to the respiratory tract is 
often based on ‘hot spots’ areas at bifurcations of the respiratory tract, which can 
receive massive doses, being hundred times higher than the average dose for the 
whole airway as calculated by Balashazy et al. (Balashazy et al., 2003). However, 
deposition enhancement greatly depends on the size of the particle as well as the 
patch size or area of deposition which has to be considered for nanoparticle 
dosimetry in vitro. As demonstrated by Oberdoerster et al. studies in 96 well plates 
with a total area of ~0.4 cm
2
 only experience an enhancement factor of 2 and alveolar 
epithelial cells do not experience any enhanced deposition (Oberdorster, 2010).  
Up to now relatively little information is available on the exposure level of 
nanomaterials, especially HARN in workplace settings. In regards to CNT exposure, 
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various different methods have been used to measure exposure concentration 
including condensation particle counters (CPC), optical particle counters (OPC) and 
scanning mobility particle sizers (SMPS). These techniques however do not 
distinguish between particle type and morphology and are therefore limiting for 
measurement of fibres concentration in the workplace. A recent study on the 
occupational exposure assessment in carbon nanotube and nanofibre primary and 
secondary manufacturers used a filter-based sampling method to perform a structure 
count analysis by transmission electron microscopy to assess exposure (Dahm et al., 
2012). The vast majority of samples collected in this study were below the NIOSH 
recommended exposure limit for CNT in workplace, which is 7 µg/m
3
 (Dahm et al., 
2012). In two secondary manufacturing facilities, in which samples were collected 
during dry powder handling such as mixing and weighing, the concentration 
measured was above the proposed exposure limit (Dahm et al., 2012).  
 
1.7.1.6 Risk characterisation and management 
As shown in diagram 1.9 hazard identification and exposure assessment are essential 
to perform risk characterisation to subsequently formulate occupational exposure 
limits to minimize exposure to hazardous substances in the workplace, however for 
most nanomaterials occupational exposure limits are not available (Kuempel et al., 
2012). The NIOSH centre for disease control and prevention developed a 
recommended exposure limit for CNT and carbon nanofibres based on subchronic 
and short-term animal studies investigating pulmonary inflammation and fibrosis 
(NIOSH, 2010). Extrapolation of the data to humans has been performed by 
accounting for species differences in the alveolar lung surface area and exposure 
concentration have been calculated for a working lifetime resulting in a upper limit 
of quantitation of 7 µg/m
3







Scope and Aims of the Thesis 
The aim of this thesis was to investigate the biologically effective dose of HARN in 
the lung and the pleural space and evaluate their pathogenicity in relation to the fibre 
pathogenicity paradigm. 
1) Investigate the validity of the fibre pathogenicity paradigm to various forms of 
HARN, other than CNT, which meet the fibre criteria. 
2) Identify the threshold length for fibre-induced pleural and pulmonary 
inflammation. 
3) Examine HARN/cell interaction in vivo and in vitro and mechanism of 
inflammation.  










Chapter 2: Materials and Methods 
2.1 Acknowledgement 
The silver nanowire samples were synthesis and provided by Seashell Technology, 
San Diego, USA with input from Dr James R. Glass, Dr Janet C. Dickerson and Dr 
David A. Schultz. Nickel nanowire synthesis was performed by Dr  Adriele Prina-
Mello and Dr Fiona Byrne, Centre for Research on Adaptive Nanostructures and 
Nanodevices (CRANN), Trinity College Dublin. ICP-MS and size distribution of the 
nickel nanowires and pH measurements of the AgNW and nickel nanowires was 
performed by Dr Adriele Prina-Mello and Dr Dania Movia. Measurement of the 
proteome profile in BMMs after AgNW treatment was performed by Tanya 
Chernova as part of a formal collaboration between the ELEGI Colt laboratories and 
the MRC Toxicology Unit, Leicester. Chemical oxidation of GP was performed by 
Dr Colin Campbell, School of Chemistry, The University of Edinburgh. 
 
2.2 Particles  
2.2.1 Silver nanowire panel 
In order to evaluate the threshold length for fibre induced pathogenicity, a panel of 
nanowires and control fibres was assembled. Silver nanowires consisted of five 
different, distinct length categories, abbreviated in the text as AgNW3, AgNW5, 
AgNW10, AgNW14 and AgNW28 according to their mean length in micrometre (μm). 
The AgNW panel were provided by Seashell Technology 
(http://www.seashelltech.com; California, USA) in isopropanol at a concentration of 
30 mg/ml. They were synthesized using a polyol process as described in US patent 
number 7,922,787 B2 issued to Seashell Technology, San Diego. In brief, the polyol 
method is a solution based method whereby the polyol, e.g. ethylene glycol serves as 
a reducing agent that reduces a silver compound, mainly AgNO3 to metallic silver 
(Wang and Dickerson, 2011). The silver compound can be any source of silver that 
produces silver metal when reduced.  







(Zhu et al., 2011) 
When the concentration of silver atoms has reached a high saturation level, 
nucleation is initiated and growth of silver nanostructures begins. An organic 
protective agent, e.g. poly vinyl pyrrolidone (PVP) is used to shield nanostructures 
from each other to avoid aggregation (Wang and Dickerson, 2011). The silver metal 
that is formed produces various types of silver nanostructures, depending on the 
reaction conditions used. Additionally, the ratio between the concentrations of the 
organic protective agent to the concentration of the silver solution can affect the 
types of nanostructures formed (Wang and Dickerson, 2011).  
However, synthesis of AgNW and reaction conditions to obtain different lengths did 
not affect the chemical composition of the different lengths of AgNW. 
 
2.2.2 Control nanofibre panel 
Nickel nanowires (NiNW) in two different length classes, short (4 µm/NiNW4) and 
long (20 µm/NiNW20) and short (2 µm/NT2) and long (13 µm/NT13 and 36 µm/NT36) 
multi-walled carbon nanotubes (MWCNT) were used as alternative forms of HARN.  
NiNW were fabricated by electrochemical template synthesis at Trinity College 
Dublin (Ireland) as previously reported by Byrne et al. (Byrne et al., 2009) and 
Prina-Mello et al. (Prina-Mello et al., 2006). In brief, a three electron cell with a 
platinum counter electrode, a Ag/AgCl reference electrode and working electrode 
which consisted of a alumina membranes with 200 nm parallel pores was used for 
electrochemical template synthesis of the NiNW (Byrne et al., 2009). Deposition of 
metallic nickel into the pores via reduction of nickel ions resulted in the growth of 
NiNW (Byrne et al., 2009). The surface of these wires was coated with a layer of 
nickel oxide which is approximately of 3-4 nm thick, which acts as protective layer 
against the chemical dissolution (Prina-Mello et al., 2006). The different length of 
NW was achieved by altering the time of deposition. Size distribution data was 
obtained by scanning electron microscope (SEM, Carl Zeiss Ultra Plus, UK) 
performed by Dr Fiona Byrne.  
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The panel of MWCNT used in this project have been characterised previously by Dr 
Craig A. Poland (Institute of Occupational Medicine, Edinburgh, UK) and Dr Fiona 
Murphy (University of Leicester, UK) and reported in (Murphy et al., 2011; Poland 
et al., 2008). The MWCNT were produced by catalytic vapour discharge and were 
purchased from Nanostructured and Amorphous Materials, Inc. (NT2) and Mitsui & 
Co. Ltd. in Japan (NT13). The NT36 sample was produced in The Nanoscience Centre 
at the University of Cambridge. 
Mixed length amosite asbestos enriched for long fibres (100% fibres ≥5 µm, 50.3% 
fibres >15 μm, 35.2% fibres >20 μm), hereafter referred to as long fibre asbestos 
(LFA), shortened amosite asbestos (SFA; 3.1% fibres ≥5 μm) (Donaldson et al. 
1989) were used to link the response to asbestos pathogenicity. Both LFA and SFA 
were created from the same batch of South African amosite (Davis et al., 1986) 
obtained from the Manville Corporation (USA). SFA was prepared by grinding long 
fibres in a ceramic ball mill, and the resulting fibre preparation sedimented in water. 
The process of ball milling, used to shorten the LFA to make the SFA was associated 
with small changes in the iron chemistry (Graham et al. 1999; Tomatis et al. 2010). 
SFA contained a consistent fraction of non-fibrous particles based on the definition 
of a fibre by the WHO  i.e., longer than 5 µm, thinner than 3 µm and with as aspect 
ratio greater than 3:1 (WHO, 1997).  
 
2.2.3 Compact particle control 
Material particulate control panel consisted of Ag-nanoparticle (AgP), Ni-
nanoparticle (NiNP) and nanoparticle carbon black (CB). AgPs with a diameter of 35 
nm, a purity of 99,5% and a specific surface area of 30–50 m
2
/g and NiNPs with a 
diameter of 80 nm were purchased from Nanostructured & Amporphous Materials, 
Inc. Carbon Black (Printex 90®) was provided by Evonik Degussa GmbH in 
Germany. It was used as an amorphous carbon particle control.  
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2.2.4 Graphene Nanoplatelets 
The graphene nanoplatelets grade 2 (GP) used in this project were purchased from 
cheaptubes.com.  A chemical exfoliation process was used to retrieve GP, whereby 
natural graphite flakes and an acid are sonicated over time (Geng et al., 2009). GP 
had a surface area of about 100 m²/g, a density of ~2.0 g/cm
3
, an average thickness of 
approximately 10 nm and an average diameter of 5 µm based on manufacturers 
description. Each GP consisted of several sheets of graphene as determined by SEM 
and are therefore classified as few-layer graphene.   
 
2.2.5 Dispersion 
Particles were suspended in cell culture medium containing 0.5% bovine serum 
albumin (BSA; Sigma-Aldrich, Poole, UK) for in vitro experiments or sterile 0.9% 
saline (PAA Laboratories Ltd., UK) containing 0.5% bovine serum albumin for in 
vivo experiments. A particle stock concentration of 1 mg/ml was prepared. To ensure 
the carrier-solution of AgNWs, isopropanol, did not contribute to the observed 
response, the vehicle control solution contained isopropanol in the same 
concentration as in the AgNW solution used for in vivo and in vitro experiments. 
AgNW showed a uniform dispersion in both suspensions after brief vortex without 
further sonication. NT, CB and GP were dispersed by sonication in an ultra-
sonicating water bath at 230V, 50Hz, 350W (FB11002, Fisherbrand, Thermo Fisher 
Scientific, Inc., MA, USA) for 1 hour (LFA, SFA, NiNW, AgP and NiNP ), 2 hours 
(NT and CB) and 6 hours (GP) to break up aggregates. All suspensions were 
prepared fresh before each experiment.  
 
2.2.6 Light microscopy 
The length distribution of AgNWs and GP were determined using light microscopy. 
Whilst the limit of resolution of light microscopy would normally preclude the 
visualisation of 120 nm diameter nanowires, the surface plasmon resonance 
properties of AgNW means that they have a strong scattering cross section allowing 
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for sub 100 nm nanoparticles to be easily visualized with a conventional microscope 
(Schrand et al., 2010).  
For light microscopy images a concentration of 50 µg/ml of particles was used to 
demonstrate the dispersion of the materials. Ten µl of particles (50 µg/ml) suspended 
in 0.5 % bovine serum albumin (BSA; Sigma-Aldrich, Poole, UK)/saline were mixed 
with 10 µl of glycerol (Sigma-Aldrich, Poole, UK) to reduce the flow of the 
particles. The suspension was placed on glass slide and covered with a glass 
coverslip and sealed (Murphy et al., 2011). Images were captured at x100 
magnification using QCapture Pro software (Media Cybernetics). For AgNW length 
distribution 100 fibres from each batch were measured according to their length by 
using a graticule and by using measurement software (Image-Pro Plus; Media 
Cybernetics Inc., MD, USA). The length distribution was plotted as percentage fibre 
per length category and percentage of fibre greater than length. For GP size 
distribution 300 GP/GP-aggregates were measured according to their projected area 
diameter by using a graticule. The size was plotted per length category. 
 
2.2.7 Scanning electron microscopy 
Physical characterisation of CB and GP was determined by scanning electron 
microscopy (SEM). CB and GP were dispersed in 0.1% BSA (heat-shocked 
fractionate) (Sigma-Aldrich, Poole, UK)/saline at a concentration 5 µg/ml by 
ultrsonication. The suspension was filtered onto an Isopore™ membrane filter 
(Millipore), dried and gold sputter coated. Scanning electron microscopy was carried 
out using a Hitachi S-2600N digital scanning electron microscope (Oxford 
Instruments, Oxfordshire, UK). Preparation of particles samples for SEM was 
performed by Steven Mitchell (The University of Edinburgh). 
 
2.2.8 Backscatter SEM 
Physical characterisation of AgNW was determined by backscatter scanning electron 
microscopy (BSEM). See details for BSEM in chapter 2.3.17. For BSEM, 5 µg/ml 
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AgNW in saline suspension was filtered onto an Isopore™ membrane filter 
(Millipore), dried and rotary-coated with about 8 nm of carbon in an Edwards 306A 
vacuum coating system (Edwards High Vacuum, Crawley, UK). Backscatter SEM of 
carbon-coated specimens was carried out using a Hitachi 4700 II field emission SEM 
(Hitachi High-Tech, Maidenhead, UK) at a beam accelerating voltage of 10 kV and a 
working distance of about 8 mm. Preparation of particle samples for BSEM was 
performed by Steven Mitchell (The University of Edinburgh). 
 
2.2.9 Electron paramagnetic resonance 
Electron paramagnetic resonance (EPR) was used to detect oxygen-centred free 
radical generation from the particles in the absence of cells. EPR technique is based 
on the change in electromagnetic energy level of an unpaired electron spin by 
applying a magnetic field. The spin trap 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-
piperidine hydrochloride (Tempone-H, Alexis Biochemicals, San Diego, CA) was 
used to detect peroxynitrite, superoxide and peroxyl radicals via the oxidation of 
hyrdoxylamines from Tempone-H by superoxide to form stable nitroxide radicals 
(Dikalov et al., 1997; Rosen et al., 1982). In the Tempone-H assay no addition of 
H2O2 is necessary to start the reaction, compared to using DMPO as a spin trap (Lu et 
al., 2009). All AgNW including controls (AgP, SFA, LFA) were measured at a 
concentration of 100 µg/ml in Hanks Balanced Salt Solution (HBSS) (Sigma-
Aldrich, Poole, UK). AgP, SFA and LFA were sonicated for 1 hour prior to addition 
of Tempone-H.  
CB and GP were diluted to a final concentration of 50 µg/ml in HBSS and sonicated 
for 1 hour. HBSS and 1 mM Pyrogallol (benzene-1,2,3-triol) (Sigma), a known 
superoxide generator were diluted in HBSS and used as negative and positive 
controls, respectively. Tempone-H was added to the samples and controls to give a 
final concentration of 1 mM. EPR spectra were measured after 60 minutes incubation 
at 37°C using the following instrumental conditions: Microwave frequency: 9.39 
GHz, Magnetic field: 3355 G, sweep width: 55 G, sweep time 30 seconds number of 
passes- 1; modulation amplitude- 1500 mG; receiver gain- 1E1; phase 180 ; 
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microwave frequency- 9,30-9,55 GHz (Miller et al., 2009). Intensity values of the 
highest spectra peak were recorded and graphed against each other (arbitrary units). 
 
2.2.10 ICP-MS Analysis 
For quantification of contaminating metals the supernatant of 50 µg/ml (AgP and 
AgNW samples) and 1 mg/ml (CB and GP) were analysed using the technique of 
inductively-coupled mass spectrometry (ICP-MS). The particles suspensions were 
made up in 0.5% BSA/saline to be consistent with experimental conditions. 
Supernatant was collected from each sample, after overnight mixing, by 
centrifugation at 13 000 rpm for 30 min. Samples were analysed by ICP-MS using an 
Agilent 7500ce (with octopole reaction system), employing an rf forward power of 
1540 W and reflected power of 1 W, with argon gas flows of 0.82 L min
-1
 and 0.2 L 
min
-1
 for carrier and makeup flows, respectively. Sample solutions were taken up 
into the Micro mist nebuliser by peristaltic pump at a rate of 0.06 rps (approximately 
1.2 mL min
-1
).  The gas flow for Helium mode was 6.5 mL min
-1
.  Skimmer and 
sample cones were made of nickel. The instrument was operated in spectrum multi-
tune acquisition mode and five replicate runs per sample were employed.  Each mass 




































Zn were further analysed in Helium mode to 
remove any polyatomic interferences. ICP-MS measurement and analysis was 
performed by Dr Lorna Eades (School of GeoSciences, The University of 
Edinburgh). 
 
2.2.11 Endotoxin contamination 
The levels of gram-negative bacteria endotoxin in all particle suspensions were 
evaluated by the Limulus Amoebocyte Lysate (LAL) assay (Lonza, Walkersville, 
MD) according to manufacturer’s description using supernatant of the particle 
suspensions to avoid interference of particles with the assay. A 1 mg/ml solution was 
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prepared in certified endotoxin free LAL reagent water (Lonza, Walkersville, MD) 
and mixed for 24 hour prior to ultracentrifugation (13,000 g). In brief, the assay is 
based on an enzymatic reaction of a clottable protein in the presence of endotoxin in 
the circulation of amebocytes of Limulus polyphemus whereby gram-negative 
bacterial endotoxin catalyzes the activation of a proenzyme in LAL (Young et al., 
1972). The rate of activation is proportional to the amount of endotoxin in the sample 
which is measured photometrically. Quantitative analysis of the endotoxin 
concentration in particles samples was performed using a comparison against a 
standard curve of known concentration of endotoxin in the range of 0.1-1 EU/ml.  
 
2.2.12 Dissolution of nanowires 
Dissolution of AgNW and NiNW was measured via the change in pH compared to 
vehicle control across a 24 h exposure. Russell RL060P Portable pH Meter (Thermo 
Electron Corporation, USA) + Semi-micro with a Pellon junction microelectrode 
(VWR, Ireland) was used for pH measurements. Sodium chloride topical irrigation 
sterile solution (sodium chloride 0.9 % w/w) (Johnson & Johnson, UK) was used as a 
control and for NW dilutions. NW solution was prepared by adding stock NWs 
solution to saline (final NWs concentration: 50 µg/mL) into a clean, dry eppendorf 
(1.5 mL). pH measurements were repeated every 2 hours for 24 hours (n=3). 
Measurements were carried out under the same environmental conditions (21 degree 
Celsius, RH =64 %). A linear fitting on the averaged data of each NW and solution 
measured were applied. The linear fitting associated to the saline pH variations was 
compared to those of the NWs solutions. This data allowed identifying time-
dependent pH variations. pH measurements were performed by Dr Adriele Prina-




2.2.13 Calculation for equalised fibre length 
Since fibre exposure is regulated on the basis of the fibre number, we calculated the 
number of fibres per treatment for AgNW. Following equation was used for the 
calculation of nanowires per treatment.  
Length of NW (average) [µm]         l 
Diameter of NW [µm]      
Density of NW [µg/ml]       x   = ρ 





                               
Weight of NW [µg]                                                         
Dose [µg] per mouse          
Number of NW                
 
     
               
 
2.3 In vitro 
2.3.1 THP-1 monocyte cell line 
The immortalised human monocytic cell line THP-1 was used for in vitro studies.  
The THP-1 cell line is cultured from the blood of a boy with acute monocytic 
leukemia and was obtained from ATCC (Product: TIB-202) (Tsuchiya et al., 1980). 
The monocytic nature of THP-1 cells was characterised by their ability to 
phagocytose latex particles and sensitized sheep erythrocytes, lysosome production 
and the ability to restore T-lymphocyte response to Con-A (Tsuchiya et al., 1980). 
THP-1 cells were cultured in Roswell Park Memorial Institute (RPMI) media 
supplemented with 10% heat inactivated FBS, 1% penicillin/streptomycin and 1% L-
Glutamine (PAA, Austria). Prior to each treatment the cells were differentiated to 
macrophages using 10 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma) for 2 
days at 37°C in 5% CO2 atmosphere (Park et al., 2007). Differentiation of monocytes 
into macrophages was characterised by their change in size using flow cytometry as 
well as their adherence to the cell culture flask, whereas undifferentiated cells 
remained in suspension and were removed by washing. Supernatant of the cells was 
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tested for Mycoplasma infection at the start and the end of the in vitro experiments 
and no infection was detected. Mycoplasma test was performed by Dr Forbes Howie, 
Centre for Inflammation Research, Edinburgh.  
 
2.3.2 Cell culture treatment 
Prior to each treatment THP-1 cells were seeded in at a specified density in medium 
containing 10% FBS and differentiated with 10 ng/ml PMA for 48 hours. Prior to 
treatment the cells were washed with PBS and RPMI medium without serum was 
added to each well.  
 
2.3.2.1 GP in vitro study on THP-1 cells 
THP-1 cells were differentiated at a cell density of 5x10
5
/ml in 24 well plates and 
treated for 24 hour with either lipopolysaccharide (LPS) at a final concentration of 1 
µg/ml, CB at 1 µg/cm² or 5 µg/cm² and GP at a concentration range of 1 µg/cm², 5 
µg/cm² and 10 µg/cm² in cell culture media and/or media supplemented with either 
Cytochalasin D at a final concentration of 0.2 µM (Enzo Life Sciences), potassium 
chloride at a final concentration of 30 mM (Sigma) and diphenyleneiodonium 
chloride at a final concentration of 15 µM (Sigma). After the treatment the 
supernatant was centrifuged for 5 min at 2000 g, transferred, centrifuged again for 5 
min at 13000 g and used for subsequent analysis. 
 
2.3.2.2 AgNW in vitro study on THP-1 cells 
THP-1 cells were differentiated at a cell density of 5x10
5
/ml in 24 well plates prior to 
AgNW treatment. Nanofibres were uniformly dispersed in cell culture medium 
(RPMI 1640) supplemented with 1% penicillin/streptomycin and 1% L-Glutamine 
(PAA, Austria) and 0.5% bovine serum albumin (BSA; Sigma-Aldrich, Poole, UK) 
and briefly vortexed.   Cells were treated with AgNW equalised to fibre number 
since fibre exposure is regulated on the basis of the fibre number and so relative 
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potency needs to be determined on a per-fibre basis. To equalise for fibre number a 
dose of 2 µg/cm² for AgNW14 was chosen as the standard in vitro dose based on 
measurement of membrane integrity and proliferation of THP-1 cells. Based on 2 
µg/cm² for AgNW14, concentrations for the other length classes AgNW panel were 
calculated assuming that fibres thickness was constant in the different length classes 
(Table 2-1). After the treatment the supernatant was centrifuged for 5 min at 2000 g, 
transferred, centrifuged again for 5 min at 13000 g and used for subsequent analysis. 
 
Table 2-1: Calculation for the mass adjustments for equalisation of number. 
Length class 
[µm] 
Calculation to equalise for 







3 3/14 x 2 0.4 1.2x10
6
 
5 5/14 x 2 0.6 1.1x10
6
 
10 10/14 x 2 1.4 1.1x10
6
 
14 Standard 2.0 1.3x10
6
 





2.3.3 Lactate Dehydrogenase 
The conversion of lactate to pyruvate was detected using the Cytotoxicity Detection 
Lactate Dehydrogenase kit (Roche Diagnostics Ltd., Burgess Hill, UK) following the 
manufacturer’s instructions. In brief, upon damage of the plasma membrane of cells 
cytoplasmatic lactate dehydrogenase (LDH) is released into the supernatant. LDH in 




 and the oxidation of 





 to the tetrazolium salt 2-p- iodophenyl-3-p-nitrophenyl-5-phenyl 
tetrazolium chloride reducing it to formazan, which is a red compound. The amount 
of colour formed in the assay is proportional to amount of membrane damaged cells.  
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Seventy microliters of cell supernatant from THP-1 cells (see chapter 2.3.2.1 and 
2.3.2.2) and bone marrow derived macrophages (BMMs) (see chapter 2.3.11) 
exposed to the particles panel was added in triplicates to a 96 well plate (Corning, 
Amsterdam, The Netherlands). Thirty microliters of phosphor buffered saline (PBS) 
and 100 µl of LDH test reagent (diaphorase/NAD+ mixed with iodotetrazolium 
chloride and sodium lactate at a ratio of 1:45) was added to each well and incubated 
for 30 minutes at room temperature. Triton X (Sigma), a nonionic detergent, was 
used as a positive control at a concentration of 0.1% and the cells were incubated 
with Triton X for 30 min to obtain 100 % cell lysis. A microplate reader (BioTek® 
SynergyHT, Inc. VT, USA) was used to measure the optical density at 490 nm. The 
level of LDH release in the sample was expressed as a percentage of the total LDH 
released after cell lysis using Triton X (positive control) and the untreated control. 
% LDH release = 
                              
                                  
 
 
2.3.4 Alamar blue assay 
After treatment to particles as described above, adherent cells in the culture dish 
were used to measure their metabolic activity via a chemical reduction of 
AlamarBlue® (Invitrogen). Resazurin is the active ingredient in alamarBlue® which 
is a nontoxic, cell permeable compound. In metabolic active cells resazurin is 
reduced to resorufin converting the non-fluorescent blue compound to a very bright 
red fluorescent compound which can be measured photometrical. 150 μl of PBS and 
15 μl of AlamarBlue® was added to each well and incubated for 3 hours at 37°C in 
5% CO2 atmosphere. Absorbance was monitored at 570 nm and 600 nm as a 
reference wavelength (BioTek® SynergyHT, Inc. VT, USA). Data are normalized to 




2.3.5 BD™ Cytometric Bead Array Flex Set  
The supernatant of untreated THP-1 macrophages and THP-1 macrophages treated 
with 5 µg/cm² CB and GP as well as 2 µg/cm² (based on AgNW14) for AgNW 
(details on the dose used see Chapter 2.3.2.2) as described above was used to screen 
for a number of 11 cytokines important in acute inflammation and apoptosis to 
identify cytokines unregulated after treatment. The cytokine levels were measured 
using BD™ Cytometric Bead Array Flex Set. The flex set included the human 
soluble protein buffer master kit and beads number D9, A7, A9, B4, D8, D4, B9, C5, 
E6, B6 representing the cytokines TNF, IL-6, IL-8, IL-1, CCL-2 (MCP-1), CCL-5 
(Rantes), CCL-3 (MIP-1α), basic FGF, IL-13 and TGF-β.  
Twenty-five microliters of mixed capture antibodies were added to 50 µl of each 
supernatant or standard in a 96 well plate and incubated for 1 hour at room 
temperature. Detection reagent was added to each well and incubated for 2 hours at 
room temperature. After centrifugation at 1500 g for 5 min the supernatant was 
removed and wash buffer was added to each well and agitated for 5 min for 
resuspension of the beads. BD FACSArray Bioanalyzer (BD Biosciences, San Jose, 
CA) was used to measure the fluorescence intensity and FACP array software was 
used for analysis. The concentration of each cytokine was calculated using the 
standard curve and expressed as pg/ml.    
 
2.3.6 Enzyme-linked immunosorbent assay (ELISA) 
The supernatant of all treatments from chapter 2.3.2.1 was further used to measure 
the expression of IL1-β using human IL1-β/IL-1F2 DuoSet (R&D Systems Europe 
Ltd., Abingdon, UK) according to manufacturer’s description. One-hundred micro-
litre of capture antibody raised against IL1-β was incubated over night in a 96 well 
micro-titre plate. The wells were washed 3 times with 0.05% Tween-20 in PBS (pH 
7.2) and blocked using reagent diluent (1% BSA in PBS; R&D systems, Abingdon, 
UK) for 1 hour at room temperature with subsequent washing and addition of 100 µl 
test samples and standards in triplicate. After 2 hour incubation the wells were 
washed and a biotinylated detection antibody added and incubated for 2 hours. After 
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washing the wells 100 µl of horseradish peroxidase conjugated streptavidin solution 
was added. The wells were washed again and developed by adding 3,3’,5,5’ - 
tetramethylbenzidine (TMB) substrate solution (Sigma-Aldrich, Poole, UK). H2SO2 
at a concentration of 0.5 M was added after 20 min to stop the reaction by changing 
the blue byproduct to a yellow colour which can be measured using a plate reader at 
a wavelength of 450 nm. Concentration of IL1-β was calculated using an appropriate 
standard curve. 
 
2.3.7 Lysosomal membrane integrity 
Lysosomal membrane stability was assessed using acridine orange (AO), a 
lysosomotropic base which accumulates in lysosomes via proton trapping, as 
described previously (Sohaebuddin et al., 2010). The assay is based on the principle 
that AO is a metachromatic fluorophore and a lysosomotropic base which 
accumulates preferentially in the lysosomes and becomes protonated and trapped in 
the organelle (Sohaebuddin et al., 2010). Differentiated THP-1 cells were used for 
lysosomal membrane integrity studies. Prior to each treatment the cells were seeded 
and differentiated in µ-Dishes (35mm, high) (ibidi, Germany) at a density of 6x10
4 
cells/ml in 400 µl medium containing 10% FBS and 10 ng/ml PMA (Sigma) for 2 
days at 37 °C in 5 % CO2 atmosphere (Park et al., 2007). Fibres were uniformly 
dispersed in cell culture medium (RPMI 1640) supplemented with 1% 
penicillin/streptomycin and 1% L-Glutamine (PAA, Austria), 0% FBS and 0.5% 
bovine serum albumin (BSA; Sigma-Aldrich, Poole, UK, heat shock fractionated).  
The cells were then loaded with AO (5 µg/ml) in culture medium, rinsed with RPMI 
and incubated with control (SFA, LFA, Ag-P) and Ag-NW panel (5 µg/cm²). 
Additionally, sphingosine, a positive control for lysosomal rupture was included and 
used at a concentration of 10 µM (Kagedal et al., 2001). Sphingosine, a detergent is 
lysosomotropic accumulates in lysosomes via proton trapping where it exerts its 
detergent properties (Kagedal et al., 2001).  After 4 hour treatment images were 
obtained from live cells using a Leica SP5 C confocal scanning microscope at a 63x 
oil immersions objective lens (485 nm excitation, 530 nm green emission, 620 nm 
red emission). For quantitative analysis, the area of each cell and the area of 
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lysosomal red staining of each cell were selected and measured using Image-Pro Plus 
software (Media Cvbernetics Inc., MD, USA). The percentage of lysosomal staining 
per cell was calculated for 50 cells per treatment group (n=4) and expressed as % 
lysosomal staining per cell.  
 
2.3.8 Detection of reduced glutathione (GSH) as indicator of the oxidative 
status of cells 
Glutathione (GSH), a tripeptide (γ-glutamyl-cysteinyl-glycine) is the most abundant 
low-molecular-weight thiol and together with glutathione disulfide (GSSG) a major 
antioxidant present in the lung lining fluid (Wu et al., 2004). Two cytosolic enzymes, 
γ-glutamylcysteine synthetase and GSH synthetase are responsible for sequentially 
catalysing GSH from glutamate, cysteine and glycine (Wu et al., 2004). 
Approximately 90% of GSH is present in its reduced form and the ratio between 
reduced and oxidised GSH determines the antioxidative capacity of cells. The major 
roles of GSH in regards to the antioxidant mechanism are effective scavenging of 
free radicals and ROS directly and indirectly through enzymatic reactions and 
scavenging of xenobiotics via glutathione-S-transferase. The shift of the GSH/GSSG 
ratio toward an oxidizing state can activate several signalling pathways involved in 
the pathogenesis of many diseases (Wu et al., 2004). The oxidative status of 
glutathione can be detected via monobromobimane (MBB), which becomes 
fluorescent after binding nonenzymatically free thiol groups. THP-1 cells were 
seeded in 12- well plates at a density of 0.5 x 10
5
/ml in 2.5 ml medium containing 
10% FBS and differentiated as described above. Prior to treatment the cells were 
washed with PBS and 2.5 ml of 1% FBS RPMI medium was added to each well. 
Cells were treated for 4 hour with either CB or GP at 1 µg/cm² or 5 µg/cm² in cell 
media. 100 µM N-ethyl-maleimide (NEM) (Sigma-Aldrich) was used as a positive 
control for the depletion of reduced glutathione (Palmen and Evelo, 1996). NEM is 
an alkene that is reactive towards thiol groups which leads to the depletion of 
glutathione. Supernatant and cells were transferred into falcon tubes and centrifuged 
for 3 min at 1500 g. PBS was added to the pellet and centrifuged for 3 min at 1500 g 
and repeated twice. 150 µl of 50 µM  MBB (Sigma-Aldrich)  was added to the 
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pellets and incubated for 10 min at 37ºC. Controls were included in all measurements 
and comprised of untreated/unstained and untreated/stained samples as well as 
treated/unstained samples. The dye was detected using a BD LSRFortessa™ flow 
cytometer. MBB was excited by a violate laser (405nm, 50 mW) and the emission 
was detected through a 450/50 filter. FlowJo software (Tree Star Inc.) was used for 
analysing the data. Gating was based on FSC/SSC and the data is expressed as mean 
fluorescence intensity. The mean value of the blank sample was subtracted of the 
stained samples.  
 
2.3.9 Generation of bone marrow derived macrophages 
Bone marrow-derived macrophages (BMMs) were used for studies on macrophage 
migration in vitro.  BMMs were generated from 8 week old wild-type C57/Bl6 
mouse femurs and tibias. In brief, the bone marrow was flushed with PBS using a 24 
gauge needle, resuspended, passed through a cell strainer and centrifuged at 15000 
rpm for 3 min. Cells were resuspended in red blood cell lysis buffer Hybrid Max™ 
(Sigma-Aldrich, UK) for 5 min at room temperature. Cells were centrifuged, 
resuspended in DMEM (Dulbecco's Modified Eagle Medium, Life Technologies) 
containing 10% FCS, 1% penicillin/ streptomycin and 20% L929 cell media and 
plated in a 10 cm
2
 non tissue coated dish and cultured for 7 days. 
 
2.3.10 Macrophage migration assay 
Migratory ability of BMMs after AgNW treatment was measured using a 
macrophage migration assay. After 7 day differentiation BMMs were seeded in 24 
well plates at a density of 5x10
5
/ml in DMEM containing 10% FCS, 1 % penicillin/ 
streptomycin and 20% L929 cell media and culture for 2 days as a confluent 
monolayer. The medium was replaced with serum free DMEM containing 1% 
penicillin/ streptomycin. Cells were treated with AgNW equalised to fibre number. 
To equalise for fibre number a dose of 2.5 μg/cm² for AgNW14 was chosen as the 
standard in vitro dose based on measurement of membrane integrity and metabolic 
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activity for BMMs. Based on 2.5 μg/cm² for AgNW14, concentrations for the other 
length classes AgNW panel were calculated assuming that fibres thickness was 
constant in the different length classes (Table 2-2). The panel was dispersed in 0.5% 
BSA/ cell culture medium (serum free DMEM) and added to the cells.  An artificial 
wound was created by scraping with a pipette tip and the number of cells migrating 
into the wound was monitored microscopically and photographs were taken 
immediately and after 30 hour. Images were acquired through a Zeiss Axiover S100 
microscope equipped with a 30x objective lens and were captured using RS 
Photometrics CoolSnap. The number of cells migrated into the wound was counted 
and expressed as percentage compared to vehicle control. 
 
Table 2-2: Calculation for the mass adjustments for equalisation of fibre number in 
vitro for the migration assay. 
Length class 
[µm] 
Calculation to equalise for the 







3 3/14 x 2.5 0.5 1.5x10
6
 
5 5/14 x 2.5 0.9 1.5x10
6
 
14 Standard 2.5 1.6x10
6
 





2.3.11 NALP3 inflammasome study 
2.3.11.1 Cell treatment for NALP3 inflammasome study  
Murine bone marrow derived macrophages were derived from tibia and fermoral 




 mice as described in 
chapter 2.3.10. Female C57Bl/6J mice were obtained from Harlan Olac (Bicester, 




 breeding pairs were 
provided by the late Prof. Jurg Tschopp (Department of Biochemistry, University of 
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 mice can be found in Martinon et al. (Martinon et al., 2006). 
Animals were maintained according to the regulations of the European Union and the 
Irish Department of Health.  
After 7 day differentiation BMMs were seeded in 6 well plates at a density of 10
6
/ml 
in DMEM containing 10% FCS, 1% penicillin/ streptomycin and 20% L929 cell 
media and culture for 2 days as a confluent monolayer. The medium was replaced 
with serum free DMEM containing 1% penicillin/ streptomycin. Two distinct 
treatment conditions were used: 
1) Prior to treatment with the fibre panel, cells were primed with LPS at a 
concentration of 10 ng/ml for 3 hours. Cells were treated with AgNW at a range of 
doses.  For AgNW3 and AgNW14 a low (0.5 μg/cm²), medium (2.5 μg/cm²) and high 
(10 μg/cm²) dose was used. For AgNW5 a range of doses from low (0.5 μg/cm²), 
medium (1 μg/cm²), high (5 and 10 μg/cm²) was used. The concentration of LFA 
used was 100 µg/ml (~26 μg/cm²) based on a previous study (Dostert et al., 2008). 
The panel was dispersed in 0.5% BSA/ cell culture medium (DMEM, 0% FCS) and 
added to the cells.  Alum, aluminium hydroxide (Brenntag Biosector), was used as a 
positive control for NALP3 inflammasome activation and was used at a 
concentration of 100 and 200 µg/ml. BMMs were treated for 24 hours. 
2) Prior to treatment with the fibre panel, cells were primed with LPS at a 
concentration of 10 ng/ml for 12 hours. Cells were treated with AgNW and LFA 
equalised to a fibre number dose ( 
Table 2-3) which was based on 100 µg/ml LFA as reported in Dostert et al. (Dostert 
et al., 2008).  The panel was dispersed in 0.5% BSA/ cell culture medium (DMEM, 
0% FCS) and added to the cells.  Alum, aluminium hydroxide (Brenntag Biosector), 
was used as a positive control for NALP3 inflammasome activation and was used at 
a concentration of 20 µg/ml. BMMs were treated for 6 hours. This treatment was 




Table 2-3: Calculation for the mass adjustments for equalisation of fibre number in 
vitro for the NALP3 study. xDose is based on LFA as reported by Dostert et al. 
(Dostert et al., 2008). 
 
 Calculation to equalise for the same 







AgNW3 3/14 x 26 5.5 16.8x10
6
 
AgNW5 5/14 x 26 9.2 16.0x10
6
 
AgNW14 Standard- based on 100 µg/ml for LFAx 26 17.0x10
6
 
SFA Equalised to AgNW3 5.5 25.9x10
6
 




2.3.11.2 Preparation of secreted proteins in the supernatant 
After treatment of the BMMs with the AgNW panel and controls, the supernatant 
was collected and the protein content concentrated using StrataClean™ resin 
(Agilent Technologies, USA). One microliter of the resin was added per 100 µl of 
supernatant and the mixture was vortexed for 1 min. The mixture was then 
centrifuged for 1 min at 40x g and the supernatant aspirated and 25 µl of 5x Laemmli 
sample buffer was added to the pellet. The samples were then boiled for 5 min at 
99°C. 
Laemmli sample buffer: 
- 10 % (v/v) glycerol (Sigma-Aldrich) 
- 2% (w/v) sodium dodecyl sulphate (SDS) (Sigma-Aldrich) 
- 200 µg/ml bromophenol blue (Sigma-Aldrich) 
- 125 mM Tris pH 6.8 (Sigma-Aldrich) 
- 28.75 ml dH2O 
- Add 50 µl DTT (Dithiothreitol) at a final concentration of 50mM to 950 µl of 




2.3.11.3 Preparation of whole cell lysates 
All procedures were performed on ice. Cells were washed with PBS and cell lysates 
were prepared by direct lysis in 5x Laemmli sample buffer and boiled for 5 min at 
99°C.   
 
2.3.11.4 Sodium dodecyl sulphate- polyacrylamide gel electrophoresis (SDS-  
PAGE) 
Gels were prepared in a Biorad apparatus. The resolving gel was prepared and the 
stacking gel added after the resolving gel was set. The gels were placed in a Biorad 
gel running apparatus containing running buffer. The protein samples and molecular 
weight standard (Prestained Protein Marker, Broad Range (7-175 kDa); New 
England BioLabs® Inc.) were added to the gels. The gels were electrophoresed using 
a constant current at 25 mA per gel until the dye front from the sample buffer ran off 
the end of the gel. 
15 % resolving gel (15 ml): 
- 3.5 ml H2O 
- 7.5 ml 30% (v/v) Acrylamide mix (29.2% acrylamide and 0.8% N,N’-
methylene-bis-acrylamide) (UltraPure Protogel) 
- 3.8 ml 1.5M Tris-HCl (pH 8.8) 
- 150 µl 10% SDS 
- 150 µl 10% ammonium persulfate (APS) (Sigam-Aldrich) 
- 6 µl N,N,N’,N’- tetramethylethylenediamine (TEMED) (Sigma-Aldrich) 
Stacking gel (1ml): 
- 0.68 ml H2O 
- 0.17 ml 30% (v/v) Acrylamide mix (29.2% acrylamide and 0.8% N,N’-
methylene-bis-acrylamide) (UltraPure Protogel) 
- 0.13 ml 1.5 M Tris-HCl (pH 8.8) 
- 10 µl 10% SDS 
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- 10 µl 10% ammonium persulfate (APS) 
- 1 µl N,N,N’,N’- tetramethylethylenediamine (TEMED) 
- 10x SDS-PAGE running buffer: 
- 30.3 g 25 mM Tris 
- 144 g 192 mM glycine 
- 10 g 0.1% SDS 
- Make to 1 litre with dH2O 
 
2.3.11.5 Electrophoretic transfer of proteins 
The resolved proteins were transferred to an Immobilon™ polyvinylidene diflouride 
(PVDF) membrane via a wet transfer system. The membrane was soaked in methanol 
to activate it and all other components were soaked in transfer buffer. The gel was 
placed between two filter-papers each side and a sponge. The setup was filled with 
transfer buffer and a constant current of 150 mA was applied to the transfer chamber 
for 2 hours. 
10x transfer buffer: 
- 58 g 48 mM Tris 
- 29 g 39 mM glycine 
- 3.7 g 0.037% SDS 
- Make up to 1 litre with dH2O 
- Add 200 ml of methanol and 700 ml of dH2O to 100 ml to make 1x solution 
Blocking of non-specific binding sites 
The membrane was blocked in 5% (w/v) Marvel in 0.01% (v/v) Tris buffered saline 
(TBS)- Tween20® for 1 hour at room temperature to block non-specific binding 
sites. 
10x Tris buffered saline-tween (TBST): 
- 12.11 g Tris 
- 87.6g NaCL (pH 8.0) 
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- 5ml Tween-20 
- Bring up to 1 litre with dH2O 
 
2.3.11.6 Antibody probing 
Antibodies of interest were diluted 1 in 1000 in 5% (w/v) non-fat dried milk powder 
(Marvel) in 0.1% TBST. The membrane was incubated over night at 4°C with 
constant rotating. The membrane was then washed 4x in 0.1% TBST for 5 min each 
at room temperature and subsequently incubated with a secondary horse-radish 
peroxidise conjugated antibody (depending on the primary antibody) for one hour at 
room temperature. The secondary antibody was diluted 1 in 2000 in 5 % Marvel in 
0.1% TBST. After this incubation the membrane was washed 3x in 0.1% TBST for 5 
min each and a chemiluminescence substrate (20x LumiGLO® Reagent and 20x 
Peroxide) (Cell Signaling Technology®) was added and developed using Scientific 
Imaging Film.  
Antibodies used: 
- Anti-mouse IL-1β/IL-1F2 antibody, goat IgG, R&D Systems  
- Peroxidase-conjugated AffiniPure Bovine Anti-Goat IgG (H+L) (Jackson 
ImmunoResearch Laboratories, Inc.) 
- Caspase-1 p10 (M-20): sc-514, affinity purified rabbit polyclonal antibody 
(Santa Cruz Biotechnology, Inc.) 
- Peroxidase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) (Jackson 
ImmunoResearch Laboratories, Inc.) 
 
2.3.11.7 ASC complex isolation 
The activation of NALP3 inflammasome involves the recruitment of an adaptor 
protein, apoptosis-associated speck-like protein containing a CARD (ASC), which 
forms a complex to activate procaspase 1 (Taniguchi and Sagara, 2007). To 
determine the formation of the ASC complex, a protocol for ASC complex isolation 
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was obtained from Dr Rebecca Coll, Trinity College Dublin (Coll and O'Neill, 
2011b). 
Murine bone marrow derived macrophages were derived as described in chapter 
2.3.10. After 7 day differentiation BMMs were seeded in 6 well plates at a density of 
10
6
/ml in DMEM containing 10% FCS, 1% penicillin/ streptomycin and 20% L929 
cell media and culture for 2 days as a confluent monolayer. The medium was 
replaced with serum free DMEM containing 1% penicillin/ streptomycin. Prior to 
treatment with the fibre panel, cells were primed with LPS at a concentration of 10 
ng/ml for 3 hours. For the initial experiments cells were treated with AgNW5 and 
AgNW14 at 1, 5 and 10 μg/cm². For subsequent experiments, a dose of 10 μg/cm² 
was used for AgNW3,5,14 as well as SFA and LFA. Alum was used at a dose of 100 
µg/ml. The panel was dispersed in 0.5% BSA/ cell culture medium (DMEM, 0% 
FCS) and added to the cells. BMMs were treated for 6 hours. 45 minutes before end 
of the particle treatment 5 mM of ATP disodium salt (Sigma-Aldrich) was added.  
After treatment the supernatant was removed and the cells were rinsed in ice-cold 
PBS and 500 µl of ice-cold buffer was added to each well. Cells were removed using 
a cell scraper, transferred in a microcentrifuge tube and lysed by shearing gauge 
needle. 50 µl was removed for Western blot analysis, the rest was centrifuged at 330 
x g for 10 min at 4°C. The pellets were washed twice in 1 ml ice-cold PBS and 
centrifuged after each wash and respuspended in 500 µl PBS. 2 mM of 
disuccinimydyl suberate (DSS) (Thermo Scientific), prepared from a fresh stock of 
100 mM DSS equilibrated to room temperature and diluted in dry dimethyl sulfoxide 
DMSO (Sigma-Aldrich) was added to the pellet and incubated at room temperature 
for 30 min with rotation. DSS is an N-hydroxysuccinimide ester that reacts 
efficiently with primary amino groups to form stable amide bonds and therefore can 
be used to demonstrate the formation of ASC dimers and higher order oligomers in 
the cell pellet. The samples were centrifuged for 10 min at 330 x g at 4°C. The 
supernatant was discarded and the cross linked pellets were resuspended in 30 µl 




Buffer for ASC-complex isolation: 
- 20 mM Hepes-KOH, pH 7.5 
- 150 mM KCl 
- 1% NP40 (Igepal CA-630) (Sigma-Aldrich) 
- 0.1 mM Phenylmethanesulfonyl fluoride (PMSF) (Sigma-Aldrich) 
- 1 µg/ml leupeptin (Sigma-Aldrich) 
- 11.5 µg/ml aprotinin (Sigma-Aldrich) 
- 1 mM sodium orthovanadate (Na3VO4) (Sigma-Aldrich) 
Antibody for ASC-complex Western blotting: 
- ASC, pAb (AL177), from rabbit (Enzo Life Sciences) 
 
2.3.11.8 ASC confocal microscopy 
For confocal analysis of the ASC-complex formation, stably transfected ASC-CFP 
macrophages kindly gifted from Prof. Luke O’Neill, Trinity College Dublin were 
used. ASC-CFP cells were cultured at 2x10
5
/ml in DMEM supplemented with 10% 
FCS and 1% P/S on a 35 mm glass bottom culture dish the day prior to cell 
treatment. The medium was replaced with serum free DMEM containing 1% 
penicillin/ streptomycin. Prior to treatment with the fibre panel, cells were primed 
with LPS at a concentration of 10 ng/ml for 3 hours. Cells were treated with AgNWs 
at 1 μg/cm² for 6 hours. The panel was dispersed in 0.5% BSA/ cell culture medium 
(serum free DMEM) and added to the cells. 20 mins before confocal microscopy 5 
mM ATP was added for 20 mins. Imaging was performed using a 458 nm laser on an 
Olympus FluoView™ FV1000 Microscope equipped with a temperature and CO2 
controlled chamber.  
 
2.3.12 Proteome Profiler Array 
A screening of the phosphorylation sites of 46 kinases was performed to identify if a 
change in the kinase profile could be an involved in the inhibition of BMMs 
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migration in vitro after AgNW treatment. BMMs were differentiated and seeded at 
5x10
5
/ml in DMEM containing 10% FCS, 1% penicillin/ streptomycin and 20% 
L929 cell media and culture for 2 days as a confluent monolayer in a 60 mm tissue 
culture dish. The medium was replaced with serum free DMEM containing 1% 
penicillin/ streptomycin and the particle panel was added at the concentrations 
described above and treated for 30 h. The cells were rinsed with cold phosphate-
buffered saline (PBS) and immediately solubilised in lysis buffer by pipetting up and 
down and rocking the cell lysate at 4ºC for 30 min. The lysate was centrifuged at 
14,000 x g for 5 min, the supernatant was transferred into new test tubes and the 
protein concentration was measured using the bicinchoninic acid protein assay 
(Sigma-Aldrich, Poole, UK) following the manufacturer’s instructions (see chapter 
2.4.7). 500 µg of lysates were diluted and incubated with the human Phospho–
MAPK Array Kit (Proteome Profiler™, R&D Systems) as per manufacturer’s 
instructions. In brief, a nitrocellulose membrane has been spotted with capture and 
control antibodies on which the diluted cell lysate mixed with biotinylated detection 
antibodies were incubated over night. Blots were washed and developed on X-ray 
films following exposure to streptavidin-HRP and chemiluminescent reagents. 
MAPK array was performed by Dr Tanya Chernova at the MRC Toxicology Unit at 
the University of Leicester.  
 
2.3.13 Scanning Electron Microscopy 
THP-1 cells were differentiated and seeded in 24 well plates on Thermanox® Plastic 
Coverslips (NUNC™, Rochester, NY USA) at a density of 1 x 10
6
/ml. The cells 
were treated with 1 µg/cm² and 5 µg/cm² CB and GP for 4 hours days at 37°C in 5% 
CO2 atmosphere and washed 5 x with 0.1 M sodium cacodylate (pH 7.2) buffer. 
Overnight fixation was done in 3% glutaraldehyde/ 0.1 M sodium cacodylate (pH 
7.2) buffer. After fixation the cells adherent to the coverslips were washed in sodium 
cacodylate buffer, post-fixed in 1% Osmium Tetroxide in 0.1 M sodium cacodylate 
buffer for 45 min, critical point dried and gold sputter coated and viewed using a 
Hitachi S-2600N digital scanning electron microscope (Oxford Instruments, 
Oxfordshire, UK).  
108 
 
2.3.14 Transmission Electron Microscopy  
Samples for TEM on THP-1 cells after GP treatment (1 and 5 µg/cm²) were prepared 
as described for scanning electron microscopy (chapter 2.3.14). After overnight 
fixation and subsequent washing the samples were embedded in Araldite resin.  
Sections, 1 μm thick were cut on a Reichert OMU4 ultramicrotome (Leica 
Microsystems (UK) Ltd, Milton Keynes), stained with Toluidine Blue and viewed in 
a light microscope to select suitable areas for investigation.  Ultrathin sections, 60nm 
thick were cut from selected areas, stained in Uranyl Acetate and Lead Citrate then 
viewed in a Phillips CM120 Transmission electron microscope (FEI UK Ltd, 
Cambridge, England).  Images were taken on a Gatan Orius CCD camera (Gatan 
UK, Oxon, England). Samples for SEM were gold sputter coated. Preparation of the 
samples for TEM was performed by Steve Mitchell, The University of Edinburgh. 
 
2.3.15 Backscatter electron signals in SEM 
In backscatter scanning electron microscopy (BSEM) an electron beam is scattered 
across the surface of the sample by magnetic lenses. The electrons are accelerated to 
typically 10 keV and are scattered in a drop shaped region at the surface of the 
sample. Secondary electrons (SE) are emitted from the surface of the sample due to a 
collision between primary electrons and electrons within the sample. These electrons 
are low-energy electrons and penetrate only short distances about 2- 30 nm in the 
sample. Backscatter electrons are elastically scattered further inside the sample (~ 
0.1-1 µm) and are collected less efficiently then SE (Figure 2-1).  However the 
efficiency of BSE reflection is a function of the atomic number (Z) of the samples 
atoms.  Elements with high atomic number such as silver reflect or back-scatter 
electrons more strongly than the lower Z light elements (predominantly H, C, N, O, 
P) of which cells are composed. BSEM is therefore a useful way to study frustrated 
phagocytosis since it provides high-contrast detection of nanowires, allowing clear 
discrimination between the nanofibres and other cellular features.  Since the BSE 
signal from the fibres is attenuated by overlying cellular material, the method allows 
a clear distinction to be made between fibres that are, or are not, membrane-bounded, 
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and can allow detection of fully phagocytosed fibres, which would not otherwise be 
detected in an SE image, provided they are at shallow depth within the cell. This 
principle has been used widely for detection of colloidal gold markers in 
immunocytochemistry (Soligo et al., 1985; Jeffree et al., 2003).  
 
Figure 2-1: Section through a specimen illustrating the variation of electron 
scattering.  High atomic number materials have a much greater scattering close to 
the specimen surface. The incidence electrons are scattered 90° and emerge as 
backscattered electrons. Illustration adapted from (Krinsley et al., 1998). 
 
2.3.15.1 Cell culture for BSEM 
BSEM was used to study cell-nanowire interaction and frustrated phagocytosis in 
THP-1 and macrophage migration in BMMs in vitro. For the study of cell nanowire 
interactions and frustrated phagocytosis THP-1 cells and BMMs were prepared as 
described in chapter 2.3.2.2 and 2.3.10 and seeded into 24 well plates on 
Thermanox® Plastic Coverslips (NUNC™, Rochester, NY USA) at a density of 
0.5x10
6
/ml. The THP-1 cells were treated for 4 hours at a dose of 2 µg/cm² for 
AgNW14 (dose equalised for fibre number see Table 2-1) and BMMs were treated for 
30 hours at a dose of 2.5 µg/cm² for AgNW14 (dose equalised for fibre number see 
Table 2-2) at 37°C in 5% CO2 atmosphere. After the treatment they were washed 5x 
with 0.1 M sodium cacodylate (pH 7.2) buffer. Overnight fixation was done in 3% 
glutaraldehyde/ 0.1 M sodium cacodylate (pH 7.2) buffer. After fixation the cells 
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adherent to the coverslips were washed three times in sodium cacodylate buffer. 
Fixed samples were dehydrated in 50%, 70%, 90% and 100% normal grade acetones 
for 10 minutes each, then for a further two 10 minute changes in analar acetone.  
Dehydrated samples were critical point dried and mounted on SEM aluminium stubs 
and rotary-coated with about 8 nm of carbon in an Edwards 306A vacuum coating 
system (Edwards High Vacuum, Crawley, UK).  
 
2.3.15.2 BSEM on THP-1 and BMMs 
SEM of carbon-coated specimens was carried out using a Hitachi 4700 II field 
emission SEM (Hitachi High-Tech, Maidenhead, UK) at a beam accelerating voltage 
of 10 kV and a working distance of about 8 mm. SE and BSE images were taken 
simultaneously using an annular YAG crystal BSE detector and the upper SE 
detector to produce perfectly-synchronised image pairs. The two images were 
superimposed using Adobe Photoshop. The SE and BSE image were converted to 
grayscale, the BSE image was pasted into the SE image by using the layer function 
“lighten”. This newly merged image and the SE image were converted to RGB 
mode, and overlaid by pasting the red channel of the BSE image into the red channel 
of the greyscale SE image, thus colour coding in red the strong BSE signal from the 
nanowires, the SE image appearing in grey. 
 
2.3.15.3 Methodology for quantifying unphagocytosed fibres 
Image-Pro plus software (Media Cybernetics Inc., MD, USA) was used to measure 
the amount AgNW outside macrophages. The intensity of red pixels of the 
nanofibres differs if the fibre is taken up by a cell and therefore covered by a cell 
layer (lower intensity) or if the fibres is unphagocytosed (higher intensity). Using 
Image-Pro software, it was possible to specifically select the red pixel intensity of 
unphagocytosed cells which was expressed as object and area count. The number of 
objects (unphagocytosed fibres) was divided by the number of cells per image and 
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expressed as unphagocytosed fibres per cell. Approximately 100 cells per image 
were counted (n=3).    
 
2.3.16 Bright- field microscopy 
Phagocytotosis of AgNW by THP-1 cells were differentiated in a µ-dish (35mm) 
(ibidi, Germany) and treated for 4 hours at a dose of 2 µg/cm² for AgNW14 (dose 
equalised for fibre number see Table 2-1). Bright-field microscope images were 
taken using Leica confocal laser scanning microscope SP5 at a 60x oil immersion 
objective lens.  
 
2.3.17 Oxidation study on GP in vitro 
2.3.17.1 Incubation of GP with horseradish peroxidase and H2O2 
The potential of biodegradation of GP was examined in vitro using enzymatic 
oxidation of GP via horseradish peroxidase (HRP). Following protocol for HRP 
oxidation of GP was adapted from Kotchey et al. (Kotchey et al., 2011). Two 
milliliter of 0.125 wt% GP were dispersed in double distilled water and dispersed by 
sonication in an ultrasonicating water bath at 230 V, 50 Hz, 350W (FB11002, 
Fisherbrand, Thermo Fisher Scientific, Inc., MA, USA) for 2 h to break up 
aggregates. Lyophilized HRP type VI was solubilized in 1x phosphate buffered 
saline (PBS) (PAA, Austria) at 0.390 mg/ml and 4 ml were added to the GP 
dispersion and 3.5 ml of PBS for a total volume of 9.5 ml. H2O2 (Sigma Aldrich, 
Poole, UK)  was added to give a final concentration of 40 µM. For the 24 hour 
incubation time H2O2 was added every hour for 12 hours, for 1 week incubation time 
H2O2 was added daily. Controls included GP incubation with HRP (- H2O2) (control 
I) and GP incubation with H2O2 (-HRP) (control II).  
Chemical oxidation of GP was performed in a SPI Plasma Prep III plasma etcher, at 




2.3.17.2 Raman spectroscopy  
Raman spectroscopy is widely used for the characterization of carbon products since 
it is highly sensitive for symmetric covalent bonds with little or no natural dipole 
moment. As a result, Raman spectroscopy is capable of discerning slight changes in 
the structure and therefore gives information about the molecular morphology of 
carbon materials.  
In brief, Raman spectroscopy measures the difference in molecular vibrational or 
rotational energies after inelastic collision between an incident photon and a 
molecule. The laser beam with the frequency vo interacts with the molecule and 
induces an electrical dipole moment and vibration with a characteristic frequency vm. 
The molecule can interact with the laser in three different ways: 
 1.  The molecule has no Raman- active modes, it absorbs a photon and emits 
light with the same frequency vo as the excitation source. 
2.  The photon is absorbed by a Raman-active molecule, which is at the basic 
vibrational state at the time of interaction. This results in the transformation of part of 
the photon’s energy to the Raman-active mode and the resulting frequency of the 
scattered light is reduced to vo-vm, which is called Stokes frequency. 
3. The photon is absorbed by a Raman-active molecule, which is in an excited 
vibrational state at the time of interaction. The excessive energy is released and the 
molecule returns to the basic vibrational state which results in the frequency of the 
scattered light to go up to vo+vm. This is called Anti-Stokes frequency. 
The vibrational frequency corresponds to the position of a bond within the molecule 
and gives information on its orientation and can therefore be used for the detection of 
slight changes in the orientation of C-C bonds. Graphene consists of stacks of sp
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bonded planar sheets which have a characteristic spectrum with the main band at 
1582 cm
-1
, which is known as the G-band (graphite or tangential band) and at 
2700cm
-1
, which is known as G’ band. In graphene with a defective structure, 
another band, the D-band is measured at ~1350 cm
-1 
(Figure 2-2). This band is 
therefore often referred to as the disorder band or the defect band and its intensity 
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relative to the G band is used as a measure of the quality of graphene. Another 
disorder induced Raman D’-band at 1620 cm
-1
 indicates imperfect crystalline order 
(Malard et al., 2009) (Figure 2-2).  
 
Figure 2-2: Raman spectra of graphene. This spectra shows the main Raman 
features, the D, G and G’ as well as D’ bands. Figure with permission from (Malard 
et al., 2009). 
 
2.3.17.3 Raman spectroscopy on GP 
Samples for in vitro oxidation of GP via HRP and H2O2 were prepared by adding 10 
µl of GP at day 0, 1 and 7 on a quartz microscope slide and dried. All spectra were 
collected on a Renishaw inVia Raman microscope using an excitation wavelength of 
514 nm of an argon ion gas laser. Exposure time was 250/sec, laser power was used 
at 30%, and a 50x objective was used with a numerical aperture of 0.45. Samples 
were scanned from 1000 to 2000 cm
-1
 to visualize D and G bands. Spectra were 
collected with a 120 s exposure; for pristine GP a total of 20 locations were selected 
per sample. For in vitro oxidation via HRP and plasma oxidation a total of 6 
locations were selected per sample.  
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2.4 In vivo 
2.4.1 Experimental animals 
Eight to nine week old female C57Bl/6J strain mice (Harlan, UK) were used in this 
project. Animals were maintained according to the regulations of the European 




 experiments mice were 
provided by the late Prof. Jurg Tschopp (Department of Biochemistry, University of 










mice can be found in Martinon et al. (Martinon et al., 2006). Animals were 
maintained according to the regulations of the European Union and the Irish 
Department of Health.   
Mice were kept in a group size of five in standard caging with sawdust bedding 
within a pathogen-free Home Office approved facility. Mice were maintained on a 
normal 12 hour light and dark cycle. Prior to the treatment mice were kept for 7 days 
in the facility to acclimatise. The work was carried out by staff holding a valid UK 
Home Office personal licence under a Home Office approved project licence. The 
experimental unit is here described as each individual mouse rather then based per 
cage and each cage contained a vehicle control mouse. 
 
2.4.2 Pharyngeal aspiration 
The given particle dose for pharyngeal aspiration was 50 µg per mouse for graphene 
platelet study and ranged from 10.7 to 50.0 µg per mouse for the AgNW study. An 
initial dose response series was performed which comprised of the doses 5, 10, 25 
and 50 µg per mouse. The dose for the AgNW study was adjusted to reach an equal 
fibre number and calculations to reach the equal fibre number is shown in Table 2-4. 
 Mice were anesthetized with Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1 
trifluoroethane)  and the tongue was gently held in full extension while 50 µl of 
particle suspension was pipette onto the base of the tongue (Rao et al., 2003). The 
tongue was held extended until at least two breaths were complete. To stimulate 
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inhalation and to induce a gasp reflex the nasal cavities of the mice were covered. 
Mice were observed until full recovery.  
Table 2-4: Calculation for the mass adjustments for equalisation of fibre number for 
the AgNW aspiration study. 






SFA Short fibre control 10.7 50.48x10
6
 
AgNW3 3/14 x 50 10.7 32.71x10
6
 
AgNW5 5/14 x 50 17.9 31.19 x10
6
 
AgNW10 10/14 x 50 35.7 28.17 x10
6
 
AgNW14 Standard 50.0 32.76 x10
6
 




2.4.3 Intrapleural Injection  
Particle panel were prepared at a concentration of 50 µg/ml in 0.5% BSA/saline.  For 
AgNW study, VC and Ag-P were made up in 600x diluted isopropanol and 0.5 % 
BSA/saline solution. 600x diluted isopropanol was included in VC and AgP since the 
stock solution (30 mg/ml) of AgNW panel was isopropanol and diluted 600x to reach 
the final concentration. The panel was injected at a dose of 5 µg and a volume of 100 
µl per mouse into the pleural cavity of un-anaesthetised female C57BI/6 mice (aged 
8 weeks) using a sleeve over the tip of a 27G to prevent the needle to pass through 
the pleural space into the lung (Figure 2-3 II) (Murphy et al., 2011). For a dose 
response series, the dose used for AgNW3 was increased to 7.5 and 10 µg per mouse 
and the dose for AgNW5 was decreased to 1 and 2.5 µg per mouse. The animals were 
humanly restrained by scuffing to expose the site of injection, which was the right 
upper quadrant of the thorax (Figure 2-3 I and III). No anaesthetic was used during 





Figure 2-3: Intrapleural injection. I) Illustration of the intrapleural injection method. 
II) Modified needle for intrapleural injection. III) Intrapleural injection of trypan 
blue dye to illustrate the distribution of the injected volume in the pleural space as 
indicated by the white arrows.  
 
2.4.4 Broncho alveolar lavage 
Mice were sacrificed 24 hour, 1 week and 6 weeks post exposure of a single dose by 
terminal anaesthesia by injection of 0.5 ml of pentobarbitone (200 mg/ml) into the 
peritoneal cavity followed by exsanguinations via the abdominal aorta. The thoracic 
cavity was exposed via removal of the diaphragm and the right portion of the rib 
cage and cutting through the clavicle. The trachea cannulated using a 23 gauge 
needle and ligated. The lungs were lavaged three times with 800 µl of ice-cold sterile 
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saline. The first lavage was retained separately and the subsequent lavages were 
pooled and kept on ice for the entire duration of the processing.  
 
2.4.5 Pleural lavage 
Mice were euthanized at each timepoint by asphyxiation in 100% CO2. An incision 
was made into the skin of the mice at the base of the abdomen and the skin was 
removed to expose the underlying tissue. The abdominal wall was removed and the 
xiphoid process was held up to remove the ligament connecting the diaphragm and 
the liver. A small incision was made directly inferior to the xiphoid process (Figure 
2-4). The pleural space was lavaged through the incision using a Pasteur pipette with 
three 1 ml washes of sterile saline. The first wash was kept separately for further 
biochemical analysis. 
 




2.4.6 Differential cell count 
To separate the cellular fraction from the supernatant, the lavage fluid from the lung 
and the pleural was centrifuged for 5 minutes at 2000 g at 4°C in a Mistral 3000i 
centrifuge (Thermo Fisher Scientific, Inc., MA, USA). The supernatant was kept for 
LDH, total protein and cytokine analysis. The cell pellets were resuspended in 0.5ml 
of 0.1% BSA/ ssaline solution. Total cell count was performed using a 
NucleoCounter (ChemoMetec, 7 A/S, Allerød, Denmark). For differential cell count 
cells were diluted in 0.1% BSA/ saline to reach a concentration of ~ 40,000 cells per 
slide. Cyto-centrifugation was performed at 300 rpm for 3 min using Cytospin 4 
cytocentrifuge (Thermo Scientific, UK). Cells were fixed with 100% methanol and 
Diff-Quick staining was performed using Diff-Quick stainset (Dade Behring Gmbh, 
Marburg, Germany). 
  
2.4.7 Total protein measurement 
Total protein content in the supernantant was measured using the bicinchoninic acid 
(BCA) protein assay (Sigma-Aldrich, Poole, UK). The samples and a bovine serum 
albumin standard (BSA, Sigma-Aldrich, Poole, UK) in a range of 0-1000 µg/ml were 
incubated with 1 part of Cu
2+
 sulphate solution (4% w/v) and 50 parts bicinchoninic 
acid (Sigma-Aldrich, Poole, UK) for 30 min at 37°C. The protein bonds in the 




which is subsequently chelated by two molecules 
of bicinchoninic acid forming a purple coloured product. The absorbance was read at 
570 nm using Synergy HT microplate reader (BioTek Instruments, Inc VT, USA) 
and the protein concentration of the sample was established via extrapolation from 






For histological examination the lungs and heart were removed on-block and fixed 
by installation of 10% ice-cold formalin without lavage and submerged in fixative 
for a period of 4 hours prior processing. The heart was removed and the lung 
separated into individual lobes and transferred to 70% ethanol for 24 hour. The tissue 
was embedded in paraffin, sectioned and stained with H&E to show gross pathology 
and Pico-Sirius Red (PSR) to show collagen deposition. Serial images were taken at 
2.5x magnification using QCaputre Pro software (Media Cybernetics, Inc., MD, 
USA) and seamlessly re-aligned using Adobe Photoshop CS3 Version 10.0.1 (Adobe 
systems Inc.) to show the entire section of the lungs. Images at 20x magnification 
were taken to show higher magnification areas of the lung sections. 
 
2.4.8.2 Chest wall 
The whole chest was resected from the mice after lavage, washed in ice-cold saline 
and fixed for 4 hours in 10 % formalin. The lower right posterior portion of the chest 
wall was separated from the rest which had an area of approximately 10 mm x 10 
mm adjacent to the spine including the lower 6 ribs and intercostals space. According 
to Shinohara et al. (Shinohara, 1997; Shinohara, 1997) this region is rich in stomata. 
Mediastinal lymph nodes were separated from the upper thoracic cavity. The chest 
wall was excised from the surrounding tissue, dehydrated through graded alcohol 
(ethanol) and imbedded on-edge in paraffin, sectioned (4 µm) and stained with 
Haematoxylin & Eosin (H&E) and picrosirius red (PSR) for gross pathology (n=2 
per treatment for chest wall). Representative images of chest wall samples and lesion 
area were obtained by taking serial images at 10x magnification using QCapture Pro 
software (Media Cybernetics Inc., MD, USA). For SEM the tissue was prepared 
using tetroxide staining, critical point dried and gold sputter coated. SEM was carried 
out using a Hitachi S-2600N digital scanning electron microscope (Oxford 
Instruments, Oxfordshire, UK). For BSEM specimens were fixed and dehydrated as 
above and mounted on SEM aluminium stubs and rotary-coated with about 8 nm of 
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carbon in an Edwards 306A vacuum coating system (Edwards High Vacuum, 
Crawley, UK). SEM of carbon-coated specimens was carried out using a Hitachi 
4700 II field emission SEM (Hitachi High-Tech, Maidenhead, UK) at a beam 
accelerating voltage of 10 kV and a working distance of about 8 mm. SE and BSE 
images were taken simultaneously using an annular YAG crystal BSE detector and 
the upper SE detector to produce perfectly-synchronised image pairs (more detail see 
chapter 2.3.16). The steps of tetroxide staining, critical point drying and gold sputter 
coating was performed by Steve Mitchell.  
 
 
2.4.8.3 Methodology for lesion quantification 
Serial images along the chest wall section were taken at 10x magnification using 
Zeiss Axioskop microscope fitted with a Micropublisher 3.3 RTV camera using 
QCapture Pro software (media Cybernetics Inc., MD, USA). Photoshop CS3 (Adobe 
systems Inc., CA, USA) was used to seamlessly re-align the images to give a high 
resolution image of the large sections of chest wall. To quantify the lesion area per 
unit chest wall length (mm²/mm) the length of the each section along the 
mesothelium and the lesion area, identified by histology as lymphatic aggregates 
adhering to the mesothelial surface were measured using calibrated Image-Pro Plus 
software (Media Cybernetics Inc., MD, USA).  
 
2.4.8.4 Lymph nodes 
After 4 hour fixation mediastinal lymph nodes were separated from the upper 
thoracic cavity. The lymph nodes were excised from the surrounding fatty tissue, 
dehydrated through graded alcohol (ethanol) and imbedded in paraffin, sectioned (4 
µm) and stained with picrosirius red (PSR). For lymph node CB and GP burden 
quantification of four sequential sections were taken from each lymph node. Images 




2.4.9 Cytometric bead array 
The pleural lavage fluid as well as the BAL fluid from mice treated with AgNWs, 
GP and CB was used to screen for a number of 11 cytokines important in acute 
inflammation and apoptosis to identify cytokines unregulated after treatment. The 
cytokine levels were measured using BD™ Cytometric Bead Array Flex Set. The 
flex set included the human soluble protein buffer master kit and beads number A9, 
C8, B4, C4, B8, E5, B7, D8, C7, D4 representing KC, TNF, IL-6, IL-10, IL-13, IL-
1β, MCP-1, RANTES, MIP-1α, G-CSF and IL-4.  
Twenty-five microliters of mixed capture antibodies were added to 50 µl of each 
supernatant or standard in a 96 well plate and incubated for 1 hour at room 
temperature. Detection reagent was added to each well and incubated for 2 hours at 
room temperature. After centrifugation at 1500 g for 5 min the supernatant was 
removed and wash buffer was added to each well and agitated for 5 min for 
resuspension of the beads. BD FACSArray Bioanalyzer (BD Biosciences, San Jose, 
CA) was used to measure the fluorescence intensity and FACS array software was 
used for analysis. The concentration of each cytokine was calculated using the 
standard curve and expressed as pg/ml.    
 
2.4.10 Chemokine and Cytokine measurement 
Chemokines MCP-1 and MIP-1α and cytokines MIP-2 and IL-1β were measured in 
non-diluted BAL and pleural lavage fluid using a quantitative sandwich enzyme 
immunoassay technique (Quantikine kit of R&D systems). An affinity purified 
polyclonal antibody specific to the protein of interest was pre-coated onto a 
microplate. Fifty microliter of assay diluents and 50 µl of standard, control and 
samples were added per well, mixed gently for 1 min and incubated for 2 hours at 
room temperature. After 4 washes 100 µl of polyclonal antibody conjugated to 
horseradish peroxidase were added to each well and incubated for 2 hours. Wash step 
was repeated and 100 µl of substrate solution (hydrogen peroxide and 
tetramethylbenzidine) added to each well and incubated for 30 mins. After addition 
of 100 µl stop solution (hydrochloric acid) the absorbance was measured at 570 nm 
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and 450 nm using Synergy HT microplate reader (BioTek Instruments, Inc VT, 
USA). The reading at 570 nm was subtracted from 450 nm to adjust for optical 
imperfections and the sample concentration was established via extrapolation from 
the standard curve. 
 
2.4.11 Raman Spectroscopy of lung tissue 
Raman spectroscopy on lung tissue embedded in paraffin was used to measure 
oxidation of pristine GP in vivo in lung tissue after 24 hour, 1 week and 6 weeks 
aspiration exposure. For ex-vivo measurement, lung tissue embedded in paraffin was 
used to record GP oxidation. Areas of GP deposited in lung tissue were identified. 
All spectra were collected on a Renishaw inVia Raman microscope using an 
excitation wavelength of 514 nm. Samples were scanned from 1000 to 2000 cm
-1
 to 
visualize D and G bands. Spectra were collected with a 120 s exposure; for ex-vivo 
measurements and pristine GP at 0h a total of 20 locations were selected per sample.  
 
2.5 Statistical analysis 
All data was analysed using GraphPad Prism 5 (Version 5.03; GraphPad Software 
Inc. USA). Results were expressed as the mean + S.E.M. and multiple comparisons 
were analysed using one-way analysis of variance (ANOVA) with a Tukey-HSD 
method post-test and two sample comparisons were made using the Student's t-test. 
In all cases, values of P < 0.05 were considered significant. For pH measurement 
statistical analysis is measured as difference in the slope of the linear fitting of each 




Chapter 3: The threshold length for fibre induced pleural 
inflammation 
 
The following results have been published in 
Schinwald A, Murphy F, Prina-Mello A, Poland C, Byrne F, Glass J, Dickerson 
J, Schultz D, Movia D, Jeffree C, Macnee W, Donaldson K. The threshold 
length for fibre-induced acute pleural inflammation: shedding   light on the 
early events in asbestos-induced mesothelioma., Toxicological Sciences. 2012 
May 12; 128(2):461-70. 
and 
Schinwald A & Donaldson K. Use of back-scatter electron signals to visualise 
cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long 
fibres and compartmentalisation in mesothelial cells. Particle and Fibre 
Toxicology. 2012 Aug 28; 9(1):34. 
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preparation for SEM and BSEM technical assistance. Prof. Chris Jeffree was deeply 
involved in the set up of the BSEM experiments and gave specialist input in 
preparation and detection of AgNW in tissue/cells. 
 
3.2 Aims and Hypothesis 
Suspicion has been raised that high aspect ratio nanoparticles or nanofibres might 
possess asbestos-like pathogenicity. The pleural space is a specific target for disease 
in individuals exposed to asbestos and, by implication nanofibres. Pleural effects of 
fibres depend on fibre length and as previously recorded, direct exposure of the 
peritoneal  (Poland et al., 2008; Poland et al., 2012) and the pleural mesothelial
 
surfaces (Murphy et al., 2011) to a range of different length of CNTs produced 
inflammatory and fibrotic effects only with long (>10 µm) samples of CNT. 
However, the key threshold length beyond which adverse effects occur has never 
been identified up to now since all asbestos and vitreous fibre samples containing 
longer fibres are heterogeneously distributed in their length.   
Nanotechnology advantageously allows the production of nanofibres with highly 
defined length distributions which enable the in depth investigation of the threshold 
length for fibre-induced pleural inflammation.  
This study utilised this advance in nanotechnology and aimed to investigate the 
threshold length for fibre effects in the pleural space with nano-fibrous structures in 
tightly defined length categories. From the information available on fibre induced 
inflammation in the pleural space, we hypothesised that the threshold length will lie 






3.3.1 Morphology and size distribution of the fibre panel 
To assess the role of fibre length in pleural inflammation a thorough characterisation 
of the length distribution of the fibre used in the study was performed. AgNW length 
distribution was characterized by light microscopy as well as backscatter scanning 
electron microscopy (BSEM), to additionally demonstrate the diameter of the fibres 
(Figure 3-1 I and II). Light microscopy can be used to visualise AgNW even though 
they are nominally ~100 nm in diameter and below the threshold of resolution of the 
light microscope because they show surface plasmon resonance (Schrand et al., 
2008) which renders them visible by light microscope (see chapter 2.2.6). AgNW 
showed a uniform dispersion, consistent diameter and tight length distribution for 
each class as shown in Figure 3-2 and Table 3-1. The AgNW had an aspect ratio 
ranging from 50 up to 280 for AgNW5 and AgNW28, respectively and therefore 







Figure 3-1: Light microscope and BSEM images of the AgNW panel.  I) Light 
microscopy images of AgNW panel in 0.5% BSA/saline at a concentration of 50 
µg/ml. Scale bar 20 µm, insert 10 µm. II) BSEM of 5 µg/ml AgNW in saline. Insert 





Figure 3-2: Fibre length distribution of AgNW.  Length distribution of AgNWs 









Table 3-1: Characterisation of AgNW length distribution and diameter.  
 
 
For all additional nanofibres and control particles used in this study, the mean length 
is summarised in Table 3-2. Size distribution for CNT used in this study (NT2, NT13 
and NT36) was performed by Dr Craig Poland and Dr Fiona Murphy (Poland et al., 
2008; Murphy et al., 2011). The short CNT sample, NT2, consisted of extremely 
short but straight fibres whereas long CNT samples, NT13 and NT36, consisted of 
long straight fibres as defined by the WHO with a length greater than 5 µm and an 










Table 3-2: Mean length + S.E.M. and source of additional nanofibres and control 
particles. *Courtesy of Murphy et al.  (Murphy et al., 2011).  
 
The tightly defined length categories of the nanofibres used in this study, especially 
AgNWs and NiNWs allowed investigating the threshold length for fibre effects in 
the pleural space. This has been so far not been feasible since all naturally occurring 
fibres such as asbestos fibres and other man made vitreous fibres have a wide 
distribution of length.   
 
 
Figure 3-3: Nickel nanowire size distribution. Size distributions of nickel nanowire 
were carried out by measuring the lengths of at least 100 fibres under scanning 
eletron microscope. Average length for short NiNW is 4.2 + 0.9µm, average of long 
NiNW is 20.3 + 5.5µm. Size distribution was performed by Dr Adriele Prina-Mello.  
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3.3.2 Metal contamination and soluble metals 
The presence of transition metals and the release of soluble metals from the 
nanowires, have been stated as a driver for inflammation due to their ability to 
generate free radical species via redox cycling with biological reductants. Redox-
active metals are defined as those containing an unpaired electron in their d-orbital 
(Kelly and Mudway, 2006). The release of soluble metals into the aqueous extract 
(saline) of the different fibre lengths of AgNW and NiNW as well as AgP was 
measured using Inductive Coupled Plasma Mass Spectrometry (ICP-MS). The 
concentration of soluble metals was expressed as ng/g (Table 3-3 I and Table 3-4 I) 
as well as the amount (fg/g) per injected dose in the in vivo intrapleural injection 
experiment of a dose of 5 µg/mouse (Table 3-3 II and Table 3-4 II). The 
concentration of silver ions in the AgNW samples ranged from 1007 ng/g for 
AgNW14 to 1666 ng/g for AgNW5, however due to the formation of insoluble silver 
chloride the data is confounded. The concentration of soluble nickel in the samples 
was approximately 1200 ng/g. When comparing these concentrations to the soluble 
iron metal concentration in LFA, which is approximately 3200000 ng/g (Osmond-
McLeod et al., 2011) and reported to contribute to pathogenicity observed with 
asbestos (Donaldson et al., 1996), negligible amounts of contaminating metals were 













Table 3-3: Concentration of soluble metal in AgNW and AgP. I) Concentration 
(ng/g) of soluble metal associated with AgP and AgNWs in the supernatant of a 50 
µg/ml solution. II) Calculated concentration (fg) of soluble metals per injected dose 
(5 µg/mouse). 
























AgP  1123 39.03  <0.01  0.03  0.17  13.01  3.69  0.30  0.46  0.98  7.18  
AgNW
3
  925.80 1.51  <0.01  0.01  0.26  2.56  3.88  0.24  0.68  0.18  2.23  
AgNW
5
  1666 4.27  <0.01  0.04  0.19  4.30 60.62  2.31  1.46  0.16  4.98  
AgNW
10
  830.10 5.38  <0.01 0.01  0.13  2.23  6.70  0.15  0.45  0.10  0.89  
AgNW
14
  1007 2.62  <0.01 <0.01  0.17  2.65  6.93  0.29  0.32  0.31 0.44  
AgNW
28
  1078 3.72  <0.01 0.03  0.17  6.30  15.32  0.29  0.58  0.38  7.78  





























AgP 5615 195.15 <0.01 0.14 0.87 65.05 18.46 1.49 2.31 4.92 35.88 
AgNW
3
  4629 7.57 <0.01  0.02 1.28 12.81 19.41 1.20 3.42 0.92 11.16 
AgNW
5
  8330 21.36 <0.01  0.18 0.96 21.48 303.10 11.57 7.32 0.79 24.84 
AgNW
10
  4150.5 26.88 <0.01 0.06 0.67 11.17 33.52 0.76 2.26 0.47 4.48 
AgNW
14
  5035 13.08 <0.01 <0.01 0.82 13.23 34.66 1.434 1.62 1.55 2.23 
AgNW
28








Table 3-4: Concentration of soluble metal in NiNW and NiNP. I) Concentration 
(ng/g) of soluble metal associated with NiNP and NiNWs in the supernatant of a 50 
µg/ml solution. II) Calculated concentration (fg) of soluble metals per injected dose 
(5 µg/mouse). 
























NiNP  0.71 80.12 0.09 0.71 0.57 0.29 173.62 0.27 1146.1 0.18 10.51 
NiNW
4
  10.59 211.03 0.09 0.18 0.43 3.43 168.15 0.32 1197.4 0.02 6.62 
NiNW
20
  30.13 202.54 0.08 0.57 0.71 17.73 186.81 0.10 1314.4 0.23 13.25 
Values subtracted from BSA/saline sample (blank control) 
 
II)  

























NiNP  3.55 400.60 0.45 3.57 2.86 1.43 868.10 1.36 5730.5 0.89 52.55 
NiNW
4
  52.95 1055.15 0.47 0.91 2.14 17.14 840.75 1.60 5987.3 0.11 33.10 
NiNW
20
  150.65 1012.70 0.38 2.86 3.57 88.64 934.05 0.50 6572.4 1.13 66.25 
Values subtracted from BSA/saline sample (blank control) 
 
3.3.3 Dissolution measurement of AgNW and NiNW 
Biopersistence of fibres in biological fluids is a major contributing factor to their 
pathogenicity as discussed in chapter 1.5.3. Dissolution of AgP/AgNW and the 
subsequent release of silver ions into the surrounding media are hypothesised to 
contribute to the severity of inflammation seen after silver exposure. Therefore, the 
dissolution kinetics of AgNW were measured via change in pH compared to vehicle 
control across the 24 h exposure. Dissolution of AgNW occurred to a modest extent 
as shown by the almost flat slope of the curve across the 24h exposure and no 
difference in dissolution was observed between all AgNW (Figure 3-4 I). To confirm 
that the AgNW retain their shape over the 24 hour period, AgNWs were incubated 
for 24 hour in pH 5.0 saline solution and rotated during this time. Images of the 
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AgNW structure were taken before and after the incubation time and showed no 
dissolution of the fibres over 24 hour (Figure 3-4 III). 
Measurements for the kinetics of the dissolution of NiNW was modest over 24 hour 
detected using pH change measurement, compared to saline solution reference curve 
plotted below at the used concentration (Figure 3-4 II). 
 
Figure 3-4: Dissolution measurement of NW. I) Comparison between sterile saline 
solution (as baseline) and AgNW3, 5, 10, 14, 28 dispersed in sterile saline solution. 
Average value of pH and standard deviation calculated for every time point up to 
24h (interval 2 h) (n = 3). No statistical difference between Ag samples. Statistical 
significance AgNWs vs saline (p<0.01). II) Comparison between sterile saline 
solution (as baseline) and nickel nanowires long and short dispersed in sterile saline 
solution. Average value of pH and standard deviation calculated for every time point 
up to 24h (interval 2 h) (n = 3). Statistical significance saline vs NiNW p<0.01, 
NiNW long VS short (>0.05). III) Light micrograph images of AgP and AgNW at 0 
hour and 24 hour after rotation in pH 5.0 saline solution. No dissolution or change 
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in morphology was observed after 24 hour. Red arrows indicate AgP and AgNW. 
Scale bar 10 µm.  
 
3.3.4 Electron Paramagnetic Resonance 
Intrinsic release of oxygen-centred free radical by the AgNWs, AgP and SFA/LFA 
was measured via Electron paramagnetic resonance (EPR). The spin trap Tempone-H 
was used to detect superoxide and peroxyl radicals and pyrogallol was used as a 
positive control. Pyrogallol, the positive control for superoxide generation as well as 
SFA, LFA and AgNW5 produced a signal significantly greater than that of the 





















































Figure 3-5: Intrinsic free radical generation. Electron paramagnetic measurement of 
oxygen centred free radicals released by nanowires. Significance vs. vehicle control 
indicated by *p<0.05, ***p<0.0001. Data represent mean + S.E.M. of n=3. 
 
3.3.5 Acute inflammatory response to AgNW and AgP 
The aim of this study was to identify any length dependent inflammatory response in 
the pleural space to AgNWs and AgP. Five microgram of AgNW and AgP were 
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injected into the pleural space and the pleural cavity was lavaged 24 hours later. The 
acute inflammatory reaction was measured as the total cell number and total 
granulocytes (predominantly neutrophils plus a low proportion of eosinophils) in the 
lavage (Figure 3-7). There was a clear length-dependent inflammatory response to 
AgNW, with significant increase in both total cell and total granulocyte number after 
treatment with AgNW5, AgNW10, AgNW14 and AgNW28 (Figure 3-6 I, II, III). In 
contrast, neither the very short fibre, AgNW3 nor the compact nanoparticles (AgP) 
elicited a significant inflammation compared to the vehicle control (Figure 3-6). The 
length-dependent response reveals that the total granulocyte number induced was 
significantly increased (p<0.01) with AgNW5 compared to AgNW3 (Figure 3-6 III). 
Moreover, there was no significant difference in inflammatory response 
(granulocytes) as length increased between AgNW5, AgNW10 and AgNW14, 
demonstrating an all-or-nothing type of response between 3 µm fibre length and 5 to 
14 µm fibre length. This was not reflected in the total cell count, since a significant 
increase was observed between 5, 10 and 14 µm. For fibre length longer than 28 µm, 
there was a significant increase in total cell number and granulocyte cell number 
compared to AgNW5 (Figure 3-6 III). This all-or-nothing response in granulocyte 
number, observed between 3 µm and 5-14 µm  was confirmed by a dose effect series 
using 1, 2.5, 5, 7.5 and 10 µg/mouse for AgNW3 and AgNW5 (Figure 3-8 I and II). 
AgNW3 did not lead to a significant increase in inflammatory cells up to a tested 
dose of 10 µg per mouse, however AgNW5 showed a significant increase at a dose of 
2.5 µg/mouse onwards (Figure 3-8 I and II). 
In addition to the inflammatory response, the total protein concentration was 
measured in the lavage fluid as an indicator of the amount of inflammatory 
molecules present. The two longest fibres, AgNW14 and AgNW28 led to a significant 






Figure 3-6: Length dependent response to AgNW in the pleural space 24 hour post 
injection. I) Count of total cell number and total granulocyte number in relation to 
fibre length of AgNW and AgP after 24 hour treatment in female C57Bl/6 mice. The 
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influx of total cells and granuloctyes (neutrophil and eosinophil) is dependent on 
fibre length of AgNW. All length were significantly greater than AgNW3 (p<0.001). 
Significance vs. vehicle control indicated by **p<0.001, ***p<0.0001. II) Mean 
length of AgNW and AgP plotted against the total cell number.  Significant 
difference of AgNW5 vs AgNW10 (p<0.05), AgNW5 vs AgNW14 (p<0.05) and AgNW5 
vs AgNW28 (p<0.001). III) Mean length of AgNW and AgP plotted against the total 
granulocyte number. All lengths were significantly greater then AgNW3 (p<0.01-
0.001). No significant difference of AgNW5 vs AgNW10 and AgNW5 vs AgNW14, 
significant difference of AgNW5 vs AgNW28 (p<0.001). Data represent mean + 




Figure 3-7: Cytospins of the pleural lavage fluid 24 hour post injection of vehicle 
control (VC) and AgNW/AgP. Inflammatory cells are present in AgNW5-28. Scale bar 






Figure 3-8: Dose effect series for AgNW3 and AgNW5 measuring the acute 24 hour 
inflammatory response. Total cell number (I) and total granulocyte number (II) of 
AgNW5 at a dose of 1.0, 2.5 and 5.0 µg/mouse and AgNW3 at a dose of 5.0, 7.5 and 
10.0 µg/mouse. Significance versus vehicle control (0 µg/mouse), * indicates p<0.05, 
** indicates p<0.01. A) # indicates p<0.05, significance of AgNW5 (2.5 µg/mouse) vs 
AgNW3 (7.5 µg/mouse), ## indicates p<0.05, significance of AgNW5 (5 µg/mouse) vs 
AgNW3 (5.0, 7.5 µg/mouse); B) # indicates p<0.05, significance of AgNW5 (2.5 
µg/mouse) vs AgNW3 (5.0, 7.5 µg/mouse), ## indicates p<0.05, significance of 






Figure 3-9: Total protein in the lavage fluid after 24 hour intrapleural injection of 
AgNW and AgP. AgNW14 and AgNW28 led to a significant increase in the amount of 
total protein. Significance vs. vehicle control indicated by *p<0.05, ***p<0.0001. 
Data represent mean + S.E.M. of n=4. 
 
The general design of this study used equal fibre mass, therefore many more short 
fibres than long fibres were injected, yet still this greater number of short fibres in 
the dose of AgNW3 was much less inflammogenic than the fewer long fibres in the 
dose of AgNW5. Since fibre exposure is regulated in workplaces on the basis of the 
fibre number, the number of fibres per treatment was calculated for AgNW3 and 
AgNW5, the key lengths spanning the threshold value. Based on fibre number 
calculations the inflammatory response was re-expressed ‘per fibre’ and this clearly 
showed that the fibre-specific inflammatory potency of the AgNW3 fibres is 







Figure 3-10: Acute inflammatory response expressed per fibre. The inflammatory 
response was expressed per fibre. The equalisation to fibre number reinforced the 
identified threshold value. Data represent mean + S.E.M. of n=4 mice.  
 
3.3.6 Role of silver ion toxicity and soluble metals 
To preclude a role of the soluble, ionic fraction of AgNWs, additionally to the 
measurements of ionic fraction and dissolution, supernatant was collected from a 5 
µg dose of AgNW5 and AgNW14 in BSA/saline after overnight mixing and injected 
into the pleural space. This soluble fraction produced no significant inflammatory 
response in the pleural space after 24h (Figure 3-11) further confirming that soluble 










Figure 3-11: Total cell number and total granulocyte number from pleural lavage 
fluid after 24 hour treatment with supernatant (SN) of AgNW5 and AgNW14. Cell 
number shown as total cells and total granulocytes was counted from mice treated 
with the supernatant of AgNW5 and AgNW14 at 24 hour post-injection. Data 
represent mean + S.E.M. of n=3 mice.  
 
3.3.7 Acute inflammatory response to intrapleural injection a range of HARN 
The acute inflammatory response of AgNW in the pleural space after intrapleural 
injection was compared to other forms of HARN including and SFA and LFA, NT2, 
NT13 and NT36 (Murphy et al., 2011)  and NiNW4 and NiNW20 using the same 
method. Nanoparticle carbon black (CB) and nickel nanoparticle (NiNP) were 
included as material nanoparticulate controls (Table 3-2). Particulates and short 
fibres (CB, NiNP, SFA, NT2, NiNW4) produced no significant increase in total cell 
or granulocyte number 24 hour post intrapleural injection (Figure 3-12 I). In contrast 
all long fibre samples including LFA, NT13, NT36 and NiNW20 produced an 
inflammatory response (Figure 3-12 I). The amount of total protein was measured in 
SFA/LFA and NiNWs/NiNP and showed a significant increase after treatment with 




Figure 3-12: Acute inflammatory response in the pleural space 24 hour after 
treatment with all control fibres and particles. I) Total cell number and total 
granulocyte number in the lavage fluid of mice treated at a concentration of 5 
µg/mouse with the material control panel SFA, LFA, NiNP, NiNWs, CB and NTs at 
24 hour post-injection. II) Total protein measured in the lavage fluid. Significance 
versus vehicle control *** indicates p<0.001.  Data represent mean + S.E.M. of n=5 
mice. NT data from Murphy et al. 2011 (Murphy et al., 2011).  
 
3.3.8 The threshold length for pleural inflammation  
To identify the threshold length for pleural inflammation, the mean length of all 
nanofibre and control particles were plotted against the total granulocyte number 
(Figure 3-13). Particulates and short fibres (CB, Ni-P, Ag-P, NT2, AgNW3, NiNW4) 
produced no significant increase in total cell number and granulocytes 24 hour post 
intrapleural injection. In contrast all fibre samples that were 5 µm and longer 
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produced an inflammatory response (NT13, NT36, AgNW5/10/14/28, NiNW20) (Figure 
3-13). The data clearly show that the threshold length for long fibre effects in the 
pleural space is 5 µm. The difference in response to NiNW4 and AgNW5 is dramatic 
but can be explained by their size distribution curves which are illustrated in Figure 
3-13 II. Hardly any NiNW4 are longer than 5 µm, however ~40% AgNW5 are ≥5 µm 




Figure 3-13: The acute pleural response to CNT, NiNW and AgNW in various 
lengths. I) Female C57Bl/6 mice were intrapleurally instilled with 5 µg/mouse of CB 
(14nm), NT2, NT13, NT36, Ni-P, NiNW4, NiNW20, AgP (35nm), AgNW3, AgNW5, 
AgNW10, AgNW14, AgNW28, SFA and LFA.  Total granulocyte number is shown from 
pleural lavage after 24 hour post exposure. A clear length- dependent threshold 
response in the pleural space to different sources and compositions of high aspect 
ratio nanomaterials from 5 µm in length is evident;  CB/NT2/NT36 data from Murphy 
et al. (Murphy et al., 2011). Length is shown as mean. Data represent mean + S.E.M. 
of n=4 mice. II) The percentage of nanofibres per length are plotted to illustrate 
their length distribution in relation to the cut-off length for fibre induced pleural 
inflammation. 
 
3.3.9 Histology and SEM of the parietal pleura 24 hour post injection 
The mesothelial lining of the parietal pleura is uniquely sensitive to fibre exposure 
and it has been shown that pathological lesion after fibre exposure arise near stoma- 
rich regions on the parietal pleura (Shinohara, 1997) due to retention of particles that 
are too large to negotiate the stomata. To investigate the pathogenic response to 
AgNW, the surface of the parietal pleura was examined by light microscopy and by 
Scanning Electron Microscopy (SEM) at 24 hours post-exposure at the regions 
identified as being rich in stomata. In the vehicle control treated mice the 
mesothelium of the parietal pleura was a single, continuous layer of mesothelial cells 
overlaying the muscular tissue as shown in the histological sections as well as via 
SEM (Figure 3-14). Normal appearance of the mesothelial cell layer was observed 
after treatment with the panel of short fibres and particle control, Ag-P, AgNW3 and 
SFA as identified via histological sections (Figure 3-14 top row) and SEM (Figure 
3-14 bottom row). In contrast, sections of the parietal pleura from mice injected with 
LFA and AgNW5/10/14/28 showed lesions comprising of macrophages and 
granulocytes on the mesothelial cell layer at the parietal pleural surface (Figure 





Figure 3-14: Length dependent response of AgNW and control particles on the 
parietal mesothelial surface 24 hours post injection. Haematoxylin and eosin (H&E) 
histology sections (top row) and SEM images (bottom row) of VC and mice treated 
with Ag-P, AgNW3, SFA, AgNW5, AgNW10, AgNW14, AgNW28 and LFA. No alteration 
on the mesothelial surface can be seen in the mice treated with Ag-P, AgNW3 and 
SFA. Normal mesothelial cells on the parietal pleura appear either flat as seen in the 
image of VC-exposed mesothelium or in a more rounded or raised form in areas 
called the lacunar regions,  such as that seen in the  image of SFA-exposed 
mesothelium (Donaldson et al., 2010). Accumulation of inflammatory cells was 
observed on the mesothelial lining in mice treated with long AgNW (≥5 µm) and 




Figure 3-15: Length dependent response of AgNW and control particles on the 
parietal mesothelial surface 24 hour post injection. Overview of whole chest wall 
section at low magnification. Triangle indicates normal mesothelial cell layer, arrow 
indicates lesion areas of accumulated inflammatory cells and P indicates papillae or 
tongue-like structures made up of cell aggregates, which extend from the surface of 
the mesothelium.  
 
3.3.10 Frustrated phagocytosis in vivo in the lavage fluid and on the parietal 
pleura surface 24 hour post exposure  
Incomplete uptake of fibrous material by macrophages, termed frustrated 
phagocytosis has been stated as an important factor in the initiation of an 
inflammatory response after fibre exposure. The degree of phagocytosis of different 
length of AgNW in pleural macrophages was assessed in by light microscopy in 
cytospin preparations and by backscatter scanning electron microscopy (BSEM) in 
lesions on the parietal pleura. Cytospin images showed that AgNW3 and AgNW5 
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could, for the most part, be fully phagocytosed inside pleural macrophages recovered 
in the lavage fluid (Figure 3-16 I). In contrast AgNW10/14/28 led to frustrated 
phagocytosis in the pleural macrophages as indicated by incomplete uptake of the 
fibres and accumulation of multiple macrophages to phagocytose the deposited fibres 
(Figure 3-16 I). The percentage of macrophages showing frustrated phagocytosis in 
the cytospin sections of the lavage fluid was counted (Figure 3-16 II). AgNW28 was 
not counted since too few very long fibres could be seen on the cytospin preparation. 
This can be explained by physical retention of 28 µm long fibres at the side of 
injection in the pleural space, which has a thickness of approximately 7 µm in mice 





Figure 3-16: Phagocytosis of AgNW in pleural lavage fluid. I) Cytospin preparation 
of the pleural lavage fluid from mice treated with AgNW3 and AgNW5 showed 
complete phagocytosis of nanowires in pleural macrophages (nanowires indicated by 
the arrow); AgNW10 are not entirely phagocytosed, showing the ends of a nanowire 
protruding from a cell (indicated by two arrows); Frustrated phagocytosis of 
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macrophages was observed after AgNW14/28 treatment. A number of macrophages 
can be seen sharing a single fibre indicated by the arrow. All cytospin images are 
x100 magnification. Scale bar for all images 10 µm. II) Percentage of frustrated 
phagocytosis of pleural macrophages. 50 fibre- containing macrophages were 
counted in the lavage fluid from AgNW3, AgNW5, AgNW10, AgNW14 treatment. The 
percentage of macrophages showing frustrated phagocytosis (not fully enclosed 
fibres) was calculated by comparing to the number of macrophages with completely 
enclosed fibres. Macrophages from AgNW10 and AgNW14 treatment show a 
significant increase in frustrated phagocytosis compared to AgNW3 (** indicates 
p<0.01).  Data represent mean + S.E.M. of n=4 mice. AgNW28 was not counted since 
too few very long fibres could be seen on the cytospin preparation.   
 
BSEM examination was carried out on the macrophage accumulations on the parietal 
pleura samples from mice injected with AgNW3, AgNW5 and AgNW10 at 24 hour 
post intrapleural instillation in order to examine retention of AgNW in the pleural 
space and their interaction with inflammatory cell in terms of phagocytosis/ 
frustrated phagocytosis. No AgNW3 could be observed on the parietal pleura surface 
24 hour post treatments confirming that short fibres are readily cleared from the 
pleural space. In contrast to AgNW3, both AgNW5 (Figure 3-17 top row) and 
AgNW10 (Figure 3-17 bottom row) led to an aggregation of inflammatory cells on 
the surface of the parietal pleura with accumulation of nanowires within the lesion 
area (Figure 3-17 I and III). Most AgNW5 were fully phagocytosed by pleural 
macrophages (Figure 3-17 I, II and insert, star). In comparison, AgNW10 showed a 
number of fibres only partly phagocytosed and therefore leading to frustrated 
phagocytosis (Figure 3-17 II, IV white arrow). Some AgNW5 and AgNW10 were not 
taken up by macrophages as indicated by the yellow arrows (Figure 3-17 I and III). 
By looking at the surface with higher magnification unclosed membrane could be 
visualised in pleural macrophages phagocytosing AgNW10 (Figure 3-17 IV and 
insert, black arrows). Additional higher magnification images of phagocytosis of 







Figure 3-17: Images of the parietal pleura surface 24 hour post pleural instillation 
of AgNW5 and AgNW10. Overview of the lesion area on the surface of the parietal 
pleura with AgNW5 (I) and AgNW10 (III). The yellow arrow indicates a nanowire 
which is not taken up by inflammatory cells whereas the star indicates a fibre that is 
fully phagocytosed but can be visualised underneath the surface of the cell. The 
white arrow indicates nanowires which are protruding out of cells. II) This figure 
shows AgNW5 that are fully phagocytosed by pleural macrophages but can be 
visualised underneath the surface as indicated by the star. IV) AgNW10 is causing 
frustrated phagocytosis in a macrophage in the centre of the image. The unclosed 
cell membrane is indicated by the black arrows and exposed fibre surface is 
indicated by the white arrow. The cross on the lower right of the image indicates 
fibres which are largely internalised but whose tips rise vertically to penetrate the 




Figure 3-18: Merged secondary electron and backscatter electron SEM images 
lesions surface of the parietal pleura from mice treated with AgNW5 and AgNW10. 
For AgNW5, two fibres are shown which are fully phagocytosed by pleural 
macrophages (black arrows). The white arrow shows a fibre on the surface in the 
lesion area; For AgNW10, the star indicates frustrated phagocytosis of macrophages 
with AgNW10. The loci where unclosed phagosomes must be present are indicated by 
the white arrows. The black arrow shows a fibre that is shared by two cells each of 
which must have an unclosed phagosome. Scale bar is 10 µm. 
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3.3.11 Quantification of pro- inflammatory mediators in the pleural lavage fluid 
after 24 hour exposure 
To determine the inflammatory mediators present in the pleural space after AgNW 
treatment a screening of 11 cytokines and chemokines was performed from the 
pleural lavage fluid using the BD™ Cytometric Bead Array Flex Set. The cytokines 
measured in the screening included IL-4, IL-6, IL-10, IL-13, IL-1β, CCL2 (MCP-1), 
G-CSF, TNF and the chemokines measured included CCL-5 (Rantes), CCL-3 (MIP-
1α) and CXCL-1 (KC). No significant increase in the amount of the cytokines and 
chemokines was detected in the lavage fluid at any treatment; however a trend in the 
increase of CCL-2 after treatment with AgNW10/14/28 was observed (Figure 3-19 I). 
Dilution of the concentration levels of the pro-inflammatory mediators during the 
lavage fluid could be responsible for the low concentration measured in the samples. 
The concentration of CCL-2 and CCL-3, important mediators in the inflammatory 
response were further investigated by a more sensitive assay, the R&D Quantikine 
kit in the pleural lavage fluid.  For this measurement the pleural lavage fluid of 
further control particles were included, namely NT2/36 and NiNW4/20. CCL-2 showed 
increased expression after long fibre treatment including LFA, AgNW10/14/28 and 
NT36 and NiNW20, however statistical significance was only reached after AgNW28 
treatment (Figure 3-19 II). Similar pattern was observed for the detection of the 





Figure 3-19: Detection of pro-inflammatory mediators in the pleural space 24 hour 
post injection of NWs. I) The concentration of the measured cytokines IL-4, IL-6, IL-
10, IL-13, IL-1β, CCL2 (MCP-1), G-CSF, TNF and chemokines CCL-5 (Rantes), 
CCL-3 (MIP-1α) and CXCL-1 (KC) is shown after 24 hour treatment with the AgNW 
panel. No significant difference was detected. II) The concentration of the cytokine 
CCL-2 was measured via R&D Quantikine kit and showed significant increase in 
expression after treatment with AgNW28. III) The chemokine CCL-3 was measured 
via R&D Quantikine kit and showed no significant increase in expression after any 
treatment. Significance versus Vehicle control *** indicates p<0.001. Data 





3.3.12 Inflammatory response of AgNW in the pleural space at a 1 week 
timepoint 
To address the course of the response, mice were injected with a single dose of 5 µg 
AgNW and control particles and the inflammatory response was assessed at a 1 week 
time point. The acute inflammatory response had largely resolved at this time point 
although there was still a length-dependent effect detectable at AgNW14/28 (Figure 3-
20 I). The amount of total granulocytes was significantly increased with AgNW14 and 
AgNW28, however no change in total cell number was detected across all treatments 
(Figure 3-20 I). Histological sections of the chest wall at 7 days continued to show 
thickening of the sub-mesothelial cell layer in the same length-dependent pattern as 
the acute inflammation i.e. with a threshold at 5 µm (Figure 3-20 II). This pattern 
was confirmed by SEM of the parietal pleura chest wall section, whereby normal 
appearance of the mesothelial cell layer was detected after VC, Ag-P, AgNW3 and 
SFA and granulomatous regions were found on chest wall sections after treatment 

























Figure 3-20: Total cell number and total granulocyte number from pleural lavage 
fluid and H&E stained histology section of parietal pleura 1 week post exposure. I) 
Total cell number and total granulocyte number 1 week post exposure to 5 µg/mouse 
of SFA, LFA, Ag-P and AgNW panel. Significance versus Vehicle control * indicates 
p<0.05, ** indicates p<0.01, *** indicates p<0.001.  Data represent mean + S.E.M. 
of n=4 mice. II) Normal appearance of mesothelial lining after VC, Ag-P, AgNW3 
and SFA exposure but thickening of the pleural sub-mesothelial layer can be seen in 
mice exposed to AgNW5-14 and LFA as indicated by the black arrows. No thickening 
of the mesothelial cell layer could be seen after AgNW28 exposure at 1 week (not 
shown). This was most likely due to retention of these very long fibres at the site of 










Figure 3-21: Length dependent response of AgNW and control particles on the 
parietal mesothelial surface 1 week post injection. Overview of whole chest wall 
section at low magnification. Triangle indicates normal mesothelial cell layer, arrow 
indicates lesion areas of accumulated inflammatory cells and P indicates papillae or 
tongue-like structures made up of cell aggregates, which extend from the surface of 
the mesothelium. Granulomatous areas are indicated by red areas.N=2. 
 
3.3.13 Integrity of AgNW and frustrated phagocytosis in vivo on the parietal 
pleura surface 1 week post exposure 
Backscatter scanning electron microscopy (BSEM) examination was carried out on 
the macrophage accumulations on the parietal pleura samples from mice injected 
with AgNW5 and AgNW10 at 1 week post intrapleural instillation in order to examine 
the development of interaction between the mesothelial cell layer/inflammatory cells 
on the surface and the integrity of the AgNW. BSEM of parietal pleura after 1 week 
treatment with AgNW5 are shown in Figure 3-22 I, II, III and AgNW10 in Figure 
3-22 IV, V, VI. By 1 week, AgNW5 started to lose their integrity, presumably in the 
acidic conditions within a phagosome as seen in Figure 3-22 I, II indicated by the 
black arrow. Non-dissolved fibres overlying the mesothelial cell layer appear intact 
in their morphology (Figure 3-22 II, white arrow). Ghost-like structures of nanofibres 
which are covered by microvilli (Figure 3-22 II, III star) could be seen. AgNW10 
could be found either in accumulations of inflammatory cells which appeared denser 
and more granulomatous after 1 week (Figure 3-22 IV cross), or in the mesothelial 
cell layer (Figure 3-22 IV triangle). AgNW10 also started to lose integrity inside the 
phagocytic compartments of pleural macrophages (Figure 3-22 V cross). Figure 3-22 
VI shows AgNW10 partly membrane bound on the mesothelial cell layer. Direct 





Figure 3-22: Images of macrophages on the parietal pleura 1 week post pleural 
instillation of AgNW5 and AgNW10.  Lesion area showing AgNW5 (I) dissolving 
inside macrophages, as can be seen by the loss of fibre structure (black arrow) (II). 
Intact nanofibres on the mesothelial cell layer as indicated by the white arrow (II) 
and membrane bound as indicated by the star (II,III). IV) Lesion area appears 
denser and more granulomatous after 1 week treatment AgNW10 and occasional 
nanowires can be seen in these granulomatous areas as indicated by the white cross. 
Surprisingly, a large part of the nanowires were seen on and within the mesothelial 
cell layer indicated by the triangle. These nanowires appeared structurally intact 
whereas nanowires fully phagocytosed by macrophages as seen in V) indicated by 
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the cross on the right side start to dissolve under the acidic condition within a 
macrophage. On the top left of this image, a fibre is partly internalised (star) and 
partly exposed (white arrow). VI) AgNW10 which is partly membrane bound on the 
mesothelial cell layer.N=2.  
 
 
Figure 3-23: Integrity of AgNW5 at 24 hour and 1 week. Merged secondary electron 
and backscatter electron SEM images of the parietal pleura from mice treated with 
AgNW5. AgNWs appear intact in their morphology inside pleural macrophages 24 
hour post-exposure, however after 1 week dissolution can be seen, evident as a more 
diffuse and ‘ghost-like appearance of the AgNW (arrows) inside macrophages. N=2 
 
3.3.14 Compartmentalisation of nanowires into mesothelial cells 
So far, we hypothesised that after a prolonged exposure to fibres in general up to 7 
days, the instilled fibres in the pleural space would either be cleared from the pleural 
space and enter the lymphatic drainage system or be accumulated in a granulomatous 
lesion on the parietal pleura at stomata (Boutin et al., 1996). By using backscatter 
imaging, for the first time it was possible to visualise nanowires in the mesothelial 
cell layer of the parietal pleura. Both treatments, AgNW5 and AgNW10 (but not 
AgNW3 which were not observed as they had been cleared) showed nanofibres either 
on the surface of the mesothelial cells (black arrow Figure 3-24) or taken up by these 
cells (white arrow Figure 3-24 II). This is especially surprising for AgNW5, since 
pleural macrophages are able to phagocytose these fibres completely under the 
applied treatment dose, as shown in Figure 3-17 II and Figure 3-18. By comparing 
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the structure/shape of the nanowires associated with the mesothelial layer (Figure 
3-24) and within macrophages (Figure 3-22 II and V),  it can quite clearly be seen 
that the nanowires are still intact after 1 week in the mesothelial layer whereas within 
the phago-lysosome of a macrophage the fibres start to degrade and lose integrity. 
These images show evidence that not all fibres longer than 5 µm are internalised by 
macrophages during the early inflammatory reaction, and that some are 
compartmentalised into the mesothelial layer  which could lead to direct effects on 









Figure 3-24: Mesothelial surfaces of the parietal pleura 1 week post injection of 
AgNW5 and AgNW10. Mesothelial cell layer of the parietal pleura after AgNW5 (I) 
and AgNW10 (II) exposure. AgNWs can be seen on the surface of the mesothelial 
layer as indicated by the black arrow. These AgNW are also partly taken up by 
mesothelial cells as indicated by the white arrow. The morphology of the nanofibres 




3.4 Discussion  
Thus far, the polydispersity of fibre length in samples including naturally occurring 
fibres and synthetic vitreous fibres prohibited the accurate investigation of the 
toxicity of various fibre lengths. In this study, the use of defined length classes of 
nanofibres allowed to quantify the threshold length for inflammatory effects in the 
pleural space, the key site for fibre pathogenicity.  
A method of intrapleural injection of particles, previously described by Murphy et al. 
(Murphy et al., 2011) was used to measure acute inflammation in the pleural space.  
A very specific panel of AgNW in different length classes was used and 
characterised according to their length, diameter, size distribution, concentration of 
soluble metals, dissolution behaviour and generation of free radicals. In depth 
characterisation of the material was essential to be able to link the pathological 
response observed after exposure to the material characteristics. From the fibre 
length distribution measurement, it can be seen that all AgNW length classes used in 
this study displayed a very tight distribution of length around their mean length 
which allowed the investigation of fibre length in relation to pleural inflammation. 
The concentration of soluble metals was determined in order to account for their 
effects in relation to pathophysiological response observed. This is especially 
important in the context of silver and its release of silver ions which could account 
for the observed effects from silver nanowires exposure.  The role of silver ion in 
mediating a toxicological effect has been discussed extensively in the literature 
however the results are contradictory. Information about the role of Ag ion release in 
observed toxicity of silver particulates is mainly based on in vitro experiments at 
extremely high doses and cannot be correlated with in vivo observations (Johnston et 
al., 2010) and recent studies could not identify a significant health effect in in vivo 
studies after nanosilver exposure (Stebounova et al., 2011). If soluble silver was the 
explanatory factor for the pattern of inflammation after intrapleural silver nanowire 
injection, differences in the amount of soluble Ag release from the AgNWs should be 
observed. This was shown not to be the case and in fact all samples give off 
negligible amounts of silver ions or other contaminating metals in femto to pico 
grams dilutions that would not be biologically active. To confirm the integrity of the 
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AgNW fibre shape over the 24 hour exposure time, dissolution experiments were 
performed which showed a minimal extent of dissolution measured via pH change 
and no difference in morphological integrity could be detected after incubation of 
AgNW over 24 hour in a pH 5 solution. 
NiNW were used as a control fibre to account for differences in the pathological 
response in terms of composition of the fibre samples. To preclude a role of the 
soluble, ionic fraction of NiNWs in the assay, the amount of Ni released was 
measured by ICP-MS. Thus, NiNW4/20 and Ni-P were incubated with BSA/saline for 
24 h and measured. The amount of soluble nickel detected in the supernatant solution 
did not differ between the short and long fibre sample and the Ni-P control. In 
addition, soluble Ni ions from the NiNW are unlikely to play a role since previous 
studies have shown that degradation of NiNW in biological media is minimal 
(Raphael et al., 2010).  
The NiNW used in this study are covered by a 3-4 nm layer of nickel oxide (Prina-
Mello et al., 2006) which is insoluble and so would prevent dissolution of the 
underlying nickel metal surface (Raphael et al., 2010); we also previously showed 
that the soluble products from NiO NP were not inflammogenic (Cho et al., 2012) in 
the lung. Following injection into the peritoneal cavity of NiNW from the same 
source as those used in the present study, only long NiNW produced a significant 
inflammatory response and not Ni nanoparticles or short NiNW (Poland et al., 2012). 
To completely rule out the effect of soluble Ni an aqueous extract of long NiNW was 
instilled into the peritoneal cavity and did not cause inflammation. We have 
previously shown that the response of the pleura and peritoneal cavities are identical 
in terms of the response to fibre length (Poland et al., 2012; Murphy et al., 2011), 
since the response is based on retention at stomata in the mesothelial lining in both 
cases. Therefore the release of Ni ions from long NiNW cannot explain any 
differences seen in the response to NiNW in the present study. 
After careful characterisation of the AgNW samples, it was shown that the fibres 
differed only in their length distribution but were otherwise identical in composition, 
diameter and solubility. To measure the inflammatory potential of the nanofibre 
panel, intrapleural injections were performed. This method is justified on the basis 
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that a fraction of all inhaled particles and fibres that deposit in the peripheral lung 
translocate into the pleural space (Miserocchi et al., 2008; Walton, 1982; Mitchev et 
al., 2002; Mercer et al., 2010). By using the model of direct pleural instillation we 
bypassed various mechanisms of fibre clearance throughout the respiratory tract. 
However, recently rodent pharyngeal aspiration and inhalation models using CNT 
(Ryman-Rasmussen et al., 2009; Mercer et al., 2011) verified the translocation of 
inhaled CNT to subpleural region where they caused pleural inflammation. In the 
study by Ryman-Rasmussen et al. (Ryman-Rasmussen et al., 2009) MWCNTs were 
found sub-pleurally in macrophages, in sub-pleural mesenchymal cells and free in 
the collagen matrix of the sub-pleura. In the study by Mercer et al. the ‘pleural 
penetrations’ of CNT could be free fibre or fibres in macrophages (Mercer et al., 
2011). However, so far the length threshold for fibres to reach the pleural space after 
inhalation exposure in rodent model is not known. Studies investigating the 
dimensions of asbestos fibres in mesothelial tissue from mesothelioma patients 
revealed that fibres up to a length of 62 µm were found in tumour tissue, with an 
average of 4.55 µm (Suzuki and Yuen, 2002). These data show that even the longest 
AgNW used in this study could potentially reach the subpleural tissue in humans 
after inhalation exposure. Long fibres translocated to the pleural space, both free or 
inside macrophages are retained because they cannot negotiate the stomata in the 
parietal pleura, through which the efferent flow of pleural fluid passes (Donaldson et 
al., 2010). We believe that this explains the propensity of long fibres to cause pleural 
effects including mesothelioma when compact particles and short fibres do not. 
However up to this point there has been no quantitative data on the threshold length 
for retention at the parietal stomata. 
In this study, a dose of 5 µg was selected for intrapleural injection to allow 
comparison of the results with  previously published data investigating the length 
dependent effect of CNT in the pleural space (Murphy et al., 2011).   
The results from the intrapleural injection study using a range of different length of 
silver nanowires demonstrated a clear length threshold value for fibre pathogenicity 
in the pleural space of 5 µm. Significant increase in total cell number and 
granulocytes in the pleural space was observed after exposure to fibres of a length 
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including 5 µm and longer. Injecting a single dose into the pleural space, as we have 
done here, massively over-represents the number of fibres that reach the stomata 
compared to inhalation, yet there was no inflammatory effect of any of the short 
nanofibres. The fact that the huge dose and high dose rate of short fibres produced by 
instillation into the pleura proved non-inflammatory argues that the short fibres 
would be non-inflammatory to the pleura following inhalation, when the dose 
reaching the pleura and the dose-rate to the pleura would be vastly less than used 
here. To confirm this statement, a dose response series was performed whereby the 
dose of AgNW3 was increased up to 10 µg/mouse and the dose of AgNW5 was 
decreased to 1 µg/mouse. Even the highest dose of AgNW3 used did not lead to a 
significant inflammation however the lowest dose of AgNW5 showed increased 
inflammation which reached significance at a dose of 2.5 µg/mouse. As discussed 
earlier, the role of Ag ions released by AgNW might have accounted for the observed 
inflammatory response. Therefore, the supernatant of the AgNW solution was 
injected into the pleural space but not inflammatory reaction was detected. Although 
we found no difference between soluble extracts of short and long AgNWs measured 
by ICP-MS as reported above and no inflammation was detected after exposure to 
the soluble fraction of AgNW, the results may have been confounded by the 
formation of silver chloride. The issue of the potential formation of silver chloride 
from silver ions and chloride ions  raises an important question as to whether silver 
ions could ever be toxic in vivo because of their rapid removal  by formation of 
insoluble silver chloride following reaction with chloride ions, which are ubiquitous 
in biological systems. Furthermore it seems to be impossible to measure silver ion 
release from silver nanoparticles into biological media because chloride ions would 
always be present in biological media with formation of silver chloride. 
We set out to determine whether length was a unifying factor in pleural inflammation 
across a range of HARN in addition to AgNW to rule out material-specific effects 
and to further determine the length threshold for pleural inflammation. We obtained 
good support for the contention that, for acute pleural inflammation, length is the 
predominant structural explanatory variable across a range of fibrous nanomaterials 
and asbestos.   
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In addition to measuring the acute inflammatory response in the pleural space via cell 
count, the mesothelial cell layer on the parietal pleura was examined in histological 
sections and via SEM. These investigations confirmed the observed inflammatory 
response since accumulations of inflammatory cells were detected after treatment 
with fibres ≥ 5µm.  
The need for macrophages to internalise and clear fibres from the lung and the 
pleural space has long been accepted (Lehnert, 1992). In terms of clearance of long 
fibres it has been postulated that incomplete uptake of fibres, frustrated phagocytosis 
plays a major role in the development of an inflammatory milieu after exposure to 
fibres. An in vivo study performed by Oberdorster et al. assessed the clearance of 
small (~3 µm in diameter) and large (~10 µm in diameter) polystyrene microspheres 
in rat and identified minimal clearance of larger spheres after a 200 days post 
position period (Oberdorster et al., 1988). This was considered to be due to impaired 
clearance of particles when the macrophage particle load is 60% of its normal 
volume. It was recently demonstrated that frustrated phagocytosis is a major factor in 
the genesis of inflammation in the peritoneal and pleural space after deposition of 
long fibres whereby macrophages undergoing frustrated phagocytosis of the long 
fibres (Poland et al., 2008; Murphy et al., 2012b). However, so far frustrated 
phagocytosis has not been fully visualised in vivo in the pleural and the cut-off length 
below which complete internalisation of particles/fibres occurs is unknown. The use 
of a novel technique, backscatter electron microscopy allowed to distinguish between 
membrane bound fibres and unphagocytosed fibres and to visualise the interaction of 
inflammatory cells with different length of nanofibres on the parietal pleura, the site 
of fibre retention in vivo.    
Here nanofibres in tight size ranges enabled us to show that true frustrated 
phagocytosis, where fibres actually protrude from the surface of the cell, is not 
necessary for long fibre-induced inflammation in the pleural space. This is argued on 
the basis that AgNW5 caused inflammation in the pleural space but was for the most 
part phagocytosed by pleural macrophages. These results show that frustrated 
phagocytosis is not solely responsible for the onset of an inflammatory reaction in 
the pleural space after exposure to fibrous particles and that fibres around 5 µm can 
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be fully phagocytosed but nonetheless cause sufficient cellular stress to induce pro-
inflammatory effects.  
To investigate the time course of the response, a single intrapleural injection of the 
nanofibre panel was performed and the inflammation measured after a 1 week 
timepoint. The amount of inflammatory cells in the pleural lavage fluid was reduced 
compared to the 24 hour timepoint showing only a significant increase of 
granulocytes after longest fibre treatment LFA, AgNW14 and AgNW28. However, 
histology and SEM showed a similar pattern to the 24 hour data with inflammatory 
aggregates on the mesothelial cell surface after treatment with fibres ≥ 5 µm. 
Investigations of the parietal pleura revealed that nanofibres started to lose their 
integrity at the 1 week timepoint and dissolve within macrophages and start to loose 
their integrity between the 24 hour and 1 week timepoint. Intact nanofibres were 
found on the normal mesothelial cell layer after 1 week exposure. So far, we 
hypothesised that fibres, which are retained in the pleural space would be 
accumulated in lesions on the parietal pleura.  In this study the mesothelial cells did 
not seem to be pro-inflammatory in this position as they have not attracted 
leukocytes to their vicinity and so their main effect may be by direct genotoxic or 
cytotoxic effects on the mesothelial cells. A lack of direct pro-inflammatory effect of 
the nanowires on the mesothelial cells would be consistent with the study by Murphy 
et al. (Murphy et al., 2012b) on the interactions between long carbon nanotubes, 
macrophages and mesothelial cells in the genesis of inflammation. Work with long 
carbon nanotubes show that fibres interacting with macrophages cause the 
macrophages to release factors that evoke large scale production of inflammatory 
mediators by adjacent mesothelial cells (Murphy et al., 2012b). Activated 
mesothelial cells produce a number of pro-inflammatory mediators including 
prostaglandins, nitric oxide, reactive oxygen species, cytokines and growth factors. 
Prolonged release of these pro-inflammatory mediators due to retention of fibres on 
the mesothelial surface may play a role in stimulation tumour growth (Mutsaers, 
2002). Further studies have investigates the signalling pathways and aberrant 
transcriptional responses involved in mesothelial cell proliferation after asbestos 
exposure and showed an induction of c-fos and c-jun protooncogene mRNA and 
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protein in pleural mesothelial cells as well as an increase in AP-1 DNA binding 
(Heintz et al., 1993). In addition, asbestos fibres have been shown to activate EGFR 
in mesothelial cells leading to the downstream activation of ERKs involved in the 
regulation of cell survival, motility and cell transformation (Zanella et al., 1996).  
 In contrast direct interaction between carbon nanotubes and mesothelial cells in vitro 
produced very little pro-inflammatory cytokine release by the mesothelial cells 
however led to significant membrane damage at higher carbon nanotube 
concentrations at a similar extent to that seen in macrophages (Murphy et al., 2012b). 
A study by Adamson reported that exposure to long (≤ 20 µm)  crocidolite asbestos 
fibres led to increased pleural mesothelial cell proliferation in mice however no 
uptake of fibres in mesothelial cells was observed and again an indirect effect of 
mitogens released by cells in the sub-pleural lung tissues was implicated (Adamson, 
1997). Therefore nanofibres that escape macrophage phagocytosis and take up 
residence in the mesothelium may be relatively non-inflammatory but represent a 
direct genotoxic threat. The interaction of AgNW with mesothelial cells changed 
their biopersistent characteristics, since AgNW appeared intact in their shape 
compared to compartmentalisation in macrophages where dissolution is observed.  
The greater pathogenic potency of long asbestos fibres in asbestos-induced pathology 
was identified in animal studies in the first half of the 20
th
 century and with special 
reference to mesothelioma in the later studies of Stanton et al. (Stanton and Wrench, 
1972) and Davis et al (Davis et al., 1986). A mechanistic basis for the extra 
pathogenic effect of long asbestos fibres is evident in the greater retention of long 
fibres in the pleural space compared to short fibres  and the greater potency of long  
fibres in general at eliciting pro-inflammogenic effects in vivo (Poland et al., 2008) 
and in vitro (Poland et al., 2012).  The data here suggest that 5 µm, and above in 
length, are likely to be retained at the stomata where they can elicit inflammation. 
However, there is no doubt that a high enough dose of the shorter fibres would be 
inflammogenic in the pleural cavity due to artefactual aggregation into mats and clog 
in the stomata. This was shown previously by Goodglick et al. in the peritoneal 
cavity which possesses identical stomatal mechanism for fibre clearance (Goodglick 
and Kane, 1990). In the study the inflammatory response in the peritoneal cavity was 
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measured after injection of 120 µg short (24 % of fibres between 1.1-5.0 µm) and 
long (55 % of fibres between 1.1-5.0 µm) crocidolite asbestos fibres over 5 days. The 
study showed that the short fibres used in this study elicited an inflammatory 
response after the 5 day exposure due to a saturation of clearance mechanism and 
therefore accumulation of fibres, however no further examination was performed to 
investigate whether the uncleared short fibres are cytotoxic, fibrogenic, or 
carcinogenic (Goodglick and Kane, 1990).   
Naturally, for purposes of extrapolating to the human risk relating to fibre length, the 
size of human parietal pleural stomata, the site of long fibre retention, is most 
relevant. Across mammalian species there is a remarkable consistency in the reported 
size of stomata on the diaphragm or parietal pleura (Table 1-1). This suggest that the 
findings of a general threshold for fibre retention that is applicable to humans is well-
served by the mouse model described here.  One can only speculate on the events 
that follow from first retention of a long fibre at a stoma but the lodging of a long 
fibre at a stoma and recruitment of inflammatory cells to it may enhance the 
likelihood of further retention of long fibres and led eventually to effective blockage 
of the stoma. 
It is worth mentioning that the global regulation of fibres is based on a standard 
definition of a fibre as an object that has a length greater than 5 µm, a width less than 
3 µm and an aspect ratio of greater than 3:1. The 5 µm length regulatory standard 
was defined in the middle of the last century and its origin was described in 1983 by 
Walton (Walton, 1982). It is fortuitous that the length of 5 µm was chosen, albeit 
without recourse to any scientific knowledge on length-dependent parietal pleural 
retention, as a margin of safety from long fibres (10-20 µm) that were known, even 
then, to be the most pathogenic fraction (Walton, 1982).  
This study is of course a study of a short-term response, however short term response 
is rationally related to long-term pathology in the pleural space and the argument for 
this is twofold. The first is the argument of dose, by which we mean that the model 
we put forward relies on acute inflammation as both a marker of – and a response to - 
retention in the pleural space and we confirm here that short fibres transit out of the 
pleural space. So long fibres must represent the only dose that could be related to the 
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acute- but importantly also the chronic - responses seen in the pleural space to fibres. 
The second argument is based on the fact that the endpoint studied, inflammation is 
known to be directly related to fibrosis and cancer caused by asbestos through well-
understood pathways and mechanisms (Dostert et al., 2008; Dai and Churg, 2001; 
Nagai and Toyokuni, 2010; Unfried et al., 2002). 
The fact that the silver nanowires used here were not biopersistent beyond a few days 
does not detract from the relevance of the length-dependent effects demonstrated 
here. Biopersistent fibres of the same dimensions would have the same acute effect 
as silver nanowires but, in contrast, would evoke an ongoing chronic inflammatory 
response that would lead to pathological change as we have reported for long 
biopersistent multi-walled carbon nanotubes (Murphy et al., 2011). A clear link 
therefore exists between fibre length and the potential to cause acute inflammation; 
additionally there is a link between fibre biopersistence and ability for the acute 
inflammation to become chronic and a link between chronic pleural inflammation 
and the common pleural pathologies associated with asbestos exposure -pleural 
fibrosis and mesothelioma. 
Biopersistence therefore remains a key factor in determining pathogenic effects of 
long nanofibres and warrants further elucidation if the biopersistent nanofibres in 
narrowly defined length classes similar to the AgNW can be obtained. This data 
suggest that any long biopersistent fibre will be retained on the parietal pleura and is 
likely to engender chronic inflammation.  
The conclusion of the threshold length of this study is mainly based on linear straight 
single fibres. However long fibres that are tangled and agglomerated  in their overall 
morphology, as is often the case with tangled CNT, have been shown to cause less 
inflammation due to their tightly packed spherical agglomerated state (Murphy et al., 
2011; Poland et al., 2008). Therefore the aggregation state of nanofibres has to be 
considered on order to assess their toxicity. 
In summary, our data provides for the first time a quantitative threshold for 
respirable fibre length in inducing pleural inflammation using a range of nanofibres. 
The threshold length for inducing pleural inflammogenicity in a range of fibres 
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including amosite asbestos is 5 µm in the mouse which we suggest can be 
extrapolated to humans. This knowledge is a valuable addition to our understanding 
of the mechanism of asbestos–related pleural disease especially for mesothelioma 
and its relationship to fibre length. We recognise that this research was carried out in 
a mouse model and with a necessarily restricted range of nanofibres and that 
extrapolation to humans is not straightforward. Therefore, for regulatory purposes, 
we urge further research on the important issue of the threshold length for safe fibres 
as regards the mesothelioma hazard to the pleura and the role of biopersistence. From 
the present data however we may conclude that, for acute inflammation, there is 
good evidence that short fibres less than 5 µm form the basis of safer- by- design 




Chapter 4: In vitro studies on the mechanism of the length 
dependent inflammation caused by AgNW.   
 
Some of the following results have been published in 
Schinwald A & Donaldson K. Use of back-scatter electron signals to visualise 
cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long 




The study on the NALP3 inflammasome was performed at Trinity College Dublin, 





 mice were provided by Dr Ed Lavelle and Prof. Luke O’Neill. 
Protocols for the study on the NALP3 inflammsome and ASC complex formation in 





performed under the supervision and help of Dr Sinead Corr. ASC-CFP stable 
transfected cell line was obtained from Prof. Luke O’Neill.  
 
4.2 Aims and Hypothesis 
In the previous chapter we have shown that nanofibres cause a length dependent 
inflammation in the pleural space, however didn’t elicit the cellular mechanism 
leading to inflammation caused by nanofibres. 
Here, we focused on cell/nanofibre interactions in vitro to examine the ability of long 
fibres to elicit a pro-inflammatory response in macrophages derived from the human 
monocyte cell line (THP-1) and murine bone marrow derived macrophages, by direct 
exposure to AgNW.  Frustrated phagocytosis, cytokine and chemokine expression as 
well as the mechanism of the NALP3 inflammasome activation including IL-1β and 
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caspase 1 expression as well as ASC complex formation were measured as an 
indicator of the pro-inflammatory potential of AgNWs. We hypothesised that the 
length dependent inflammation seen in vivo will be reflected by a length dependent 
activation of cells in vitro.  
 
4.3 Results 
4.3.1 Membrane integrity and metabolic activity in THP-1 macrophages after 
AgNW treatment 
The in vitro experiments were based on a treatment dose which was non/low-toxic to 
THP-1 cells in culture and was adjusted for fibre length to ensure approximately the 
same fibre number for each treatment (Table 2-1). The 2 µg/cm
2 
dose based on 
AgNW14 was determined by measuring the membrane integrity via the release of 
lactate dehydrogenase (LDH) into the supernatant and cell proliferation/metabolic 
activity of the THP-1 cells after 24 hour treatment. All treatments, with exception of 
AgNW28 showed no significant increase in membrane integrity and loss of 
proliferation and metabolic activity (Figure 4-1).  
 
Figure 4-1: THP-1 membrane integrity and proliferation/metabolic activity. I) 
Measurement of membrane integrity plotted as % LDH release based on the positive 
and negative control. Only AgNW28 led to a significant release of LDH into the 
supernantant. II) Proliferation and metabolic activity was measured using 
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alamarBlue®. Cells treated with AgNW28 showed decreased proliferation. 
Significance versus vehicle control *P <0.05, **P <0.01. Data represent mean+ 
S.E.M. of n=5.  
 
4.3.2 Bright field microscopy of THP-1 cells after 4 hour exposure in vitro 
THP-1 cells were exposed to the panel of AgNWs for 4 hours and bright field images 
were taken using a 60x magnification. THP-1 cells completely phagocytose AgNW3 
(Figure 4-2 I) and AgNW5 (Figure 4-2 II). The fibres were fully taken up as indicated 
by the yellow circle. AgNW10 were mostly phagocytosed with only a small 
percentage of fibre-ends protruding out of the cells as indicated by the red arrow 
(Figure 4-2 III). Frustrated phagocytosis was observed after treatment with AgNW14 
(Figure 4-2 IV) and AgNW28 (Figure 4-2 V). In Figure 4-2 IV the black arrow 
indicates a fibre shared by two cells and another fibre only partly enclosed by the cell 






Figure 4-2: Bright-field microscope images of THP-1 cells treated with AgNWs. I) 
AgNW3 and II) AgNW5 were fully enclosed by the cell as indicated by the yellow 
circle. III) AgNW10 were mostly taken up, however a small number of fibres were not 
fully enclosed and fibre ends were protruding out of the cells as indicated by the red 
arrow. IV) AgNW14 and III) AgNW28 caused frustrated phagocytosis. Red arrows 
indicate fibres partly taken up by THP-1 cells and the black arrow indicates sharing 
of a fibre between two adjacent cells. Scale bar 20µm. Images are representative of 
an n=3. 
 
4.3.3 Characterisation of cell/nanowire interaction in vitro using BSEM 
Backscatter electron microscopy (BSEM) enabled us to visualise the interaction of 
THP-1 macrophage cells with AgNW. We mainly focused on the 
uptake/phagocytosis of the five different size categories of AgNW to identify the cut-
off value, at which frustrated phagocytosis occurs in vitro. Figure 4-3 I-V show 
differentiated THP-1 macrophages after 4 hour treatment with AgNW3 (I), AgNW5 
(II), AgNW10 (III), AgNW14 (IV) and AgNW28 (V). In Figure 4-3 I one external 
AgNW3 can be seen (white arrow) and a few AgNW3 can be seen just underneath the 
surface of a macrophage as indicated by the black arrow (Figure 4-3 I insert). After 
treatment with AgNW5, nanowires were fully taken up by macrophages as indicated 
by the white arrow (Figure 4-3 II insert).  A small proportion of cells showing 
incomplete uptake of AgNW10 fibres could be observed as indicated by the white 
arrow (Figure 4-3 III) however, most of the fibres were membrane bound 
(black/white arrow) and therefore phagocytosed by the cells. Obvious frustrated 
phagocytosis could be observed from a nanowire length of 14 µm (Figure 4-3 IV) 
and 28 µm (Figure 4-3 V). A much greater amount of AgNW was observed 
protruding through cells or shared between adjacent cells, indicating frustrated 
phagocytosis (white arrow). The number of unphagocytosed fibres per cell was 








Figure 4-3: BSE images of differentiated THP-1 cells treated for 4 hours with 
AgNW. I) AgNW3 treated macrophages showed full phagocytosis of the nanowires. 
Only one nanowire could be visualised outside a cell (white arrow) and a few 
underneath the surface indicated by the black arrow.  II) After AgNW5 treatment all 
nanowires were phagocytosed by cells after 4 hours (white arrow). III) A big 
proportion of AgNW10 appear membrane bound and therefore phagocytosed by cells 
(black/white arrow), however a few fibres could be seen protruding out of cells 
(white arrow). Frustrated phagocytosis was observed after AgNW14 (IV) and AgNW28 
(V) treatments, since most of the fibres can be seen protruding out of the cells or 
shared between cells (white arrow and insert). BSE merged image with a scale bar of 
10µm and 5µm for the inserts.Images are representative of an n=3. 
 
4.3.4 Screening of cytokines and chemokines involved in the inflammatory 
response to AgNW exposure 
To assess which cytokines/chemokines were involved in acute inflammation after 
particle exposure a cytometric bead array was performed. THP-1 macrophages were 
exposed to a dose of 2 µg/cm
2  





  and a selected panel of cytokines and chemokines; 
TNF, IL-6, IL-8, IL-1β, CCL-2 (MCP-1), CCL-5 (RANTES), CCL-3 (MIP-1α), 
basic FGF, IL-13 and TGF-β were measured. Out of this range of cytokines, CCL-2, 
CCL-3 and IL-8 were significantly increased after AgNW28 and LFA exposure with 




Figure 4-4: Screening of a panel of 10 cytokines/chemokines after exposure to AgNW 
and SFA/LFA. Three cytokines (CCL-2, IL-8 and CCL-3) out of 11 tested were 
significantly upregulated after a 24 hour exposure to AgNW28 and LFA. Shorter fibre 
treatment did not led to a significant increase in any of the cytokines measured. Data 
expressed as mean + s.e.m, n=3. (**) P < 0.01, (***) P < 0.001 compared to vehicle 
control.  
 
4.3.5 Lysosomal destabilisation in THP-1 macrophages after AgNW treatment 
Lysosomal destabilisation has been linked to the inflammogenicity of long fibres as 
well as cholesterol crystals and silica (Rajamaki et al., 2010; Palomaki et al., 2011; 
Hornung et al., 2008), in relation to activation of the NALP3 inflammasome. 
Lysosomal membrane stability was assessed in macrophages in vitro after treatment 
with AgNWs using acridine orange (AO). THP-1 macrophages were treated for 4 
hours with AgNWs and controls. After 4 hour treatment, images were obtained from 
live cells and the area of red lysosomal staining in each cell was quantitatively 
analysed. A significant decrease in lysosomal membrane integrity was observed after 
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exposure to AgNW5-28 and sphingosine, a positive control for lysosomal rupture 
(Figure 4-5 I and II). AgP and AgNW3 had similar amounts of lysosomal staining 





Figure 4-5: Loss of lysosomal integrity as a marker for inflammasome activation. I) 
Quantification of lysosomal membrane destabilisation expressed as percentage of 
lysosomal staining (AO) per cell. A significant decrease in lysosomal membrane 
integrity in THP-1 cells could be observed after exposure of AgNW5-28  at a 
concentration of 5 µg/cm² and sphingosine, a positive control for lysosomal rupture 
(*** indicates p<0.001).  Data represent mean + S.E.M. of n=4. II) Representative 
confocal microscopy images (left panel) and brightfield images (right panel) of each 
treatment to visualise loss of lysosomal membrane integrity using AO. VC, Ag-P and 
AgNW3 showed no significant decrease of lysosomal membrane integrity after 4 hour 
treatment, however AgNW5, AgNW10, AgNW14 and AgNW28 led to a significant loss of 
membrane integrity as seen by the decrease in lysosomal red staining. 
 
4.3.6 Activation and secretion of the pro-inflammatory cytokine IL-1β 
Secretion of the pro-inflammatory cytokine IL-1β has been reported in macrophages 
after exposure to various fibres such as CNTs, silica, asbestos and TiO2 (Murphy et 
al., 2012b; Hornung et al., 2008; Hamilton et al., 2009). To assess the secretion of 
IL-1β after exposure to AgNW, murine BMMs were exposed to a range of 
concentrations from 0.5 to 26 µg/cm
2
 of AgNW (see details in chapter 2.3.12.1 and 
Table 2-3). Control particles comprised of SFA (5.5 µg/cm
2
), LFA (26 µg/cm
2
) and 
aluminium hydroxide (Alum) (100 and 200 µg/ml). Prior to the treatment BMMs 
were stimulated with LPS (10 ng/ml). Western blot analysis for the detection of IL-
1β was performed at various different conditions, by changing the exposure time of 
AgNWs and controls as well as the LPS- priming time, the concentrations used for 
exposure as well as cell number used for the experiment but no consistent results 
could be obtained. The results as shown below are merely to give an indication of the 
extent of variation between results and are not representative for the whole study on 
IL-1β expression.  
The extent of pro- IL-1β and IL-1β was measured in the cell lysate and the 
supernatant (Figure 4-6 I). 24 hour exposure of BMMs to AgNW led to the 
production of active IL-1β in the cell lysate at all concentrations measured. In 
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addition, secreted IL-1β was measured in the supernatant after exposure to AgNW5 at 
10 µg/cm
2 
(H1) and AgNW14 at all concentrations. For the control fibre LFA, IL-1β 
was measured in the cell lysate and to a lesser extent in the supernatant (Figure 4-6 
I). Alum was used as a positive control for IL-1β activation and secretion which was 
shown in the supernatant (Figure 4-6 I). The experiment was repeated 6 times, 
showed however varying results in regards to the extent of mature IL-1β expression 
in the cell lysate as well as the supernatant with an n=3 showing similar results as 
shown in Figure 4-6 I. The experiment was repeated using a 6 hour exposure to 
AgNW and controls (see details for concentrations Table 2-3) but showed no 
production of active IL-1β nor secretion of IL-1β in the supernatant (Figure 4-6 II) 




 mice were used to assess the 




mice showed no production of mature IL-1β at any treatment, which was replicated 














 mice after treatment with AgNWs and controls. I) BMMs were treated for 24 hours 
with AgNW3 and AgNW14 at a low (0.5 μg/cm²), medium (2.5 μg/cm²) and high (10 
μg/cm²) dose. For AgNW5 a range of doses from low (0.5 μg/cm²), medium (1 
μg/cm²), high (5 and 10 μg/cm²) was used. The concentration of LFA used was 100 
µg/ml (~26 μg/cm²) based on a previous study (Dostert et al., 2008). Alum was used 
as a positive control for NALP3 inflammasome activation and was used at a 
concentration of 100 and 200 µg/ml. Prior to treatment with the fibre panel, cells 
were primed with LPS at a concentration of 10 ng/ml for 3 hours. Active IL-1β was 
detected in the cell lysate as well as in the supernatant after treatment with AgNWs 
and LFA. Alum showed strong secretion of IL-1β in the supernatant (n=3). II) BMMs 
were treated for 6 hours with AgNW at a dose based on fibre number (AgNW3- 5.5 
µg/cm
2
, AgNW5 9.5 µg/cm
2
, AgNW14 26 µg/cm
2
). Concentration for SFA and LFA 
was 5.5 and 26 µg/cm
2
, respectively. Alum was used at a concentration of 20 µg/ml. 
BMMs were treated for 6 hours. Prior to treatment with the fibre panel, cells were 
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primed with LPS at a concentration of 10 ng/ml for 12 hours. No production of IL-1β 




mice were treated as described for II but no production of mature IL-1β was detected 
in the cell lysate and the supernatant (n=3). 
 
4.3.7 Detection of caspase 1 
The formation of the NALP3 inflammasome leads to the activation of pro-caspase 1 
to its mature form which consequently activates pro- IL-1β to form IL-1β (Taniguchi 
and Sagara, 2007). Pro-caspase 1 and the formation of caspase 1 was detected via 
Western blotting in cell lysate and supernatant of BMMs treated with AgNWs and 
controls. Treatment conditions were the same as described above (see chapter 
2.3.12.1 and  
Table 2-3). Western blot analysis for the detection of caspase 1 was performed at 
various different conditions, by changing the exposure time of AgNWs and controls 
as well as the LPS- priming time, the concentrations used for exposure as well as cell 
number used for the experiment but no consistent results could be obtained. The 
results as shown below are merely to give an indication of the extent of variation 
between results and are not representative for the whole study on caspase 1 
expression.  
A length- and dose-dependent activation of caspase 1 was detected after AgNW and 
LFA treatment at a 24 hour timepoint, whereby AgNW3 at 10 μg/cm² (high dose) 
showed a slight increase in caspase 1 production in the cell lysate compared to VC 
(Figure 4-7 I). AgNW5 showed a dose- dependent increase with highest production 
of caspase 1 in the cell lysate at 10 μg/cm² which was similar in AgNW14 and LFA 
treated BMMs (Figure 4-7 I). In the supernatant, caspase 1 was detected only after 
treatment with Alum, in a dose-dependent manner (Figure 4-7 I). The experiment 
was repeated 6 times, showed however varying results in regards to the extent of 
mature caspase 1 expression in the cell lysate as well as the supernatant with an n=2 
showing similar results as shown in Figure 4-7 I.  At a 6 hour timepoint, alum led to 
a production of caspase 1 in the cell lysate and the supernatant (Figure 4-7 II). 
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Caspase 1 was also detected after AgNW3,5,14 treatment in the cell lysate and AgNW5 





 mice were used to assess the production of caspase 1 after treatment to 




 mice showed no production of mature caspase 1 at 












Figure 4-7: Detection of caspase 1 activation in BMMs after treatment with AgNWs 
and controls. I) BMMs were treated for 24 hours with AgNW3 and AgNW14 at a low 
(0.5 μg/cm²), medium (2.5 μg/cm²) and high (10 μg/cm²) dose. For AgNW5 a range of 
doses from low (0.5 μg/cm²), medium (1 μg/cm²), high (5 and 10 μg/cm²) was used. 
The concentration of LFA used was 100 µg/ml (~26 μg/cm²) based on a previous 
study (Dostert et al., 2008). Alum was used as a positive control for NALP3 
inflammasome activation and was used at a concentration of 100 and 200 µg/ml. 
Prior to treatment with the fibre panel, cells were primed with LPS at a 
concentration of 10 ng/ml for 3 hours. Caspase 1 was detected in the cell lysate after 
treatment with AgNWs and LFA in a dose and length dependent manner. Alum 
treatment produced strong secretion of caspase 1 in the supernatant. (n=2) II) 
BMMS were treated for 6 hour with AgNW at a dose based on fibre number (AgNW3- 
5.5 µg/cm2, AgNW5 9.5 µg/cm
2
, AgNW14 26 µg/cm
2
). Concentration for SFA and 
LFA was 5.5 and 26 µg/cm
2
, respectively. Alum was used at a concentration of 20 
µg/ml. BMMs were treated for 6 hours. Prior to treatment with the fibre panel, cells 
were primed with LPS at a concentration of 10 ng/ml for 12 hours. Production of 
caspase 1 was detected in the cell lysate and the supernatant after treatment with 
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alum. A strong band for caspase 1 was also detected for the VC in the 




mice were treated as described for II but 
no production of mature caspase 1 was detected in the cell lysate and the 
supernatant (n=3). 
 
4.3.8 ASC-complex formation 
The NALP3 inflammasome activation is described via the formation of the apoptosis 
associated Speck like protein containing a CARD (ASC) cluster together with the 
PYD domain and CARD-domain, which is responsible for the recruitment of 
procaspase 1 (Schroder and Tschopp, 2010). The formation of the ASC dimers and 
higher order oligomers was detected via Western blotting using anti-ASC antibodies 
and showed ASC oligomerisation (ASC dimer at 47.5 kDa) in BMMs after treatment 
with ATP (5 mM) and AgNW14 at a concentration of 5 µg/cm
2
 (Figure 4-8 I). For 
VC, LPS, AgNW5 at 1 (L), 5 (M) and 10 (H) µg/cm
2 
as well as AgNW14 at 1 (L) and 
10 (H) µg/cm
2
, no oligomerisation could be detected (Figure 4-8 I). Cell lysates were 
analysed and showed uniform expression of ASC in all treatments (Figure 4-8 I). The 
assay was repeated using the highest dose (10 µg/cm
2
) for AgNWs including Alum 
(100 µg/ml), LFA and SFA as a control, whereby only LFA showed ASC 
oligomerisation (Figure 4-8 II). Further repeats of the assay, were performed, showed 




Figure 4-8: Detection of the ASC complex formation via Western blotting. BMMs 
were treated with AgNW5 and AgNW14 at 1, 5 and 10 μg/cm² for 6 hours. Prior to 
treatment with the fibre panel, cells were primed with LPS at a concentration of 10 
ng/ml for 3 hours. 45 minutes before the end of the particle treatment, 5mM of ATP 
were added. ASC complex formation can be seen after treatment with ATP and 
AgNW14 at 5 μg/cm² by blotting against ASC (ASC dimer at 47.5 kDa). In the cell 
lysate, uniform ASC expression was detected.(n=1). II) BMMs were treated with a 
dose of 10 μg/cm² for AgNW3,5,14 as well as SFA and LFA for 6 hours. Alum was used 




An additional assay was employed to examine the activation of ASC oligomerisation 
by NALP3. Immortalized murine macrophages that stably express ASC-CFP were 
used to analyse the formation of ASC oligomers or ‘Specks’. In untreated cells and 
cells primed with LPS the CFP-ASC is diffuse throughout the cytosol of the cells, 
but in response with LPS and ATP (Figure 4-9) or AgNWs as well as SFA and LFA 
the CFP-ASC condensed into a large, bright Speck. 300 cells were counted for each 
treatment and analysed for the number of Specks formed but only a very small 
proportion of cells (~ 2%) showed Speck formation after AgNW and control 





Figure 4-9: Confocal microscopy to identify ASC-complex formation in a murine 
macrophage cell line stably transfected with CFP-ASC. VC cells were unstimulated 
and showed uniform dispersion of CFP-ASC throughout the cytoplasma. For all 
other treatments cells were primed for 3 hours with 10 ng/ml LPS and 1 µg/cm
2
 of 
AgNW and control fibres as well as 5 mM ATP. LPS alone showed no formation of 
Specks whereas Specks could be identified on all other treatment groups. Left hand 
side of each treatment groups shows phase contrast image and right hand image 




4.3.9 Pleural inflammation in NALP3-/- mice  
The aim of this study was to identify if the length dependent inflammatory response 





C57/Bl6. Five microgram of AgNW5 and AgNW14 were injected into the pleural 




 mice and the pleural cavity was lavaged 24 hours after the 
intrapleural injection. The acute inflammatory reaction measured as the total cell 
number and total granulocytes in the lavage. The total cell number and granulocyte 
number were significantly decreased compared to the response seen in wild type  














 mice compared to wild type mice 24 hour post injection. I) Count of total 
cell number and (II) total granulocyte number after 24 hour treatment with AgNW5 




 mice. The influx of total cells 




 mice compared 
to wild type mice but no difference was detected after AgNW14 treatment. 
Significance vs. vehicle control indicated by **p<0.001, ***p<0.0001. Significance 




 mice #p<0.05, ##p<0.001.   
 
4.4 Discussion 
In this study we focused on elucidating the mechanism of nanofibre induced 
inflammation in vitro using THP-1 macrophages and murine BMMs. We started off 
investigating the uptake efficiency of nanofibre by THP-1 macrophages. The need 
for macrophages to internalise and clear fibres from the lung and the pleural space 
has long been accepted (Lehnert, 1992). In terms of clearance of long fibres it has 
been postulated that incomplete uptake of fibres, frustrated phagocytosis plays a 
major role in the development of an inflammatory milieu after exposure to fibres. An 
extensive study has investigated the phagocytic capacity of murine bone marrow-
derived macrophages to engulf various sizes of latex beads in a range of 13 µm to 
>30 µm in diameter (Cannon and Swanson, 1992). By measuring the bead diameter 
they calculated a phagocytosis capacity of 19.8 µm, which is 1.44 times the actual 
diameter of the cell. In regard to the phagocytosis of fibres by macrophages, Ye et al. 
investigated the role of glass fibre length in TNF-α production and NF-κB activation 
in a mouse macrophage cell line and correlated and increase in both cytokine level 
and transcription factor to incomplete phagocytosis of long fibres (17 µm) whereas 
short fibres (7 µm) were fully phagocytosed and therefore had less expression of the 
measured endpoints (Ye et al., 1999). 
Here we showed that the threshold length value at which long fibres can be fully 
phagocytosed by macrophages in vitro is 14 µm, which was identified using BSEM. 
In the previous chapter we reported that in vivo inflammatory cells on the parietal 
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pleura showed incomplete uptake and frustrated phagocytosis of 10 µm fibres. There 
are a number of potential explanations for this anomalous difference between in vivo 
and in vitro length-dependent effect. Firstly the in vivo model is a pleural granuloma 
model in mice and this is very different from the in vitro situation where the cells 
human; secondly they are a cell line and thirdly they are not in the granulomatous 
milieu but are spread out singly on plastic, submerged in medium with 10% serum, a 
very abnormal environment. We conclude that investigations on frustrated 
phagocytosis and its relation to the pathological effects of fibres need to be carried 
out in vivo although future work could be focussed on trying different cell lines and 
culture conditions with the aim of finding a better in vitro model that mimics the in 
vivo findings. 
Inflammasomes are believed to be early warning systems for danger to the innate 
immune system (Bryant and Fitzgerald, 2009). It has been recently implicated that 
frustrated phagocytosis is involved in the NALP3 inflammasome activation (O'Neill, 
2008). The underlying mechanism by which frustrated phagocytosis of long fibres 
induces acute and chronic inflammation is poorly understood. Recent studies 
however identified the NALP3 inflammasome complex as an important component 
of the molecular pathway by which cells sense foreign bodies like asbestos fibres and 
initiate an inflammatory response (Hornung et al., 2008; Palomaki et al., 2011; 
Dostert et al., 2008; Winter et al., 2011). The inflammasome is a multiprotein 
complex consisting of nucleotide-binding oligomerization domain (NOD)-like 
receptors (NLR) which is activated via damage-associated molecular patterns 
(DAMPs) and forms a complex with apoptosis-associated Speck-like protein 
containing a caspase- recruiting domain (CARD) (ASC) and pro-caspase 1. 
Activation of caspase 1 leads to expression of IL-1β and IL-18, which mediate pro-
inflammatory effects (Tschopp and Schroder, 2010). The inflammasome can be 
activated via different pathways including low intracellular potassium concentration 
(Petrilli et al., 2007), reactive oxygen species produced by NALP3 activators via 
NADPH oxidase (Martinon, 2010), frustrated phagocytosis (O'Neill, 2008) and 
phagosomal/lysosomal destabilisation (Hornung et al., 2008). 
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Recently, lysosomal destabilisation has been implicated in the inflammogenicity of 
long fibres of asbestos and TiO2, as well as cholesterol crystals and silica (Rajamaki 
et al., 2010; Palomaki et al., 2011; Hornung et al., 2008), linked to activation of the 
NALP3 inflammasome. We therefore investigated the length–dependent loss of 
lysosomal membrane integrity in a macrophage cell line exposed to the different 
lengths of AgNW. Our studies showed a significant, length-dependent decrease of 
lysosomal membrane integrity at a fibre length of ≥ 5 µm, following the same pattern 
as seen in the in vivo pleura inflammation study. We interpret this to mean that 5 µm 
long nanofibres, which can be enclosed without fibre ends protruding from the cell, 
produce sufficient lysosomal stress to be pro-inflammatory even though ‘classical’ 
frustrated phagocytosis, with protruding fibre ends, did not occur. This signifies a 
potentially new mechanism for long fibre–induced inflammation for 5 µm length 
fibres that deserves further research. However, frustrated phagocytosis remains the 
likely predominant pro-inflammogenic mechanism since it would apply for all fibres 
longer than 5 µm. 
We went on to investigate if IL-1β and caspase 1, two major components of the 
NALP3 inflammasome, are upregulated in a length dependent manner after AgNW 
exposure in murine BMMs.  Mature IL-1β and caspase 1 are known to be 
upregulated after asbestos, silica and CNT exposure (Dostert et al., 2008; Hornung et 
al., 2008; Murphy et al., 2012b) via a NALP3 dependent mechanism. The results 
from our study on the expression of IL-1β and caspase 1 in BMMs after AgNW 
treatment showed no consistent results in the production of IL-1β and caspase 1, 
whereby a high degree of variability between each experiment was observed. We 
therefore cannot conclude that caspase 1 and subsequent cleavage of pro-IL-1β to 
mature IL-1β was involved in the pro-inflammatory response seen in the pleural 
space after AgNW exposure.     
The formation of the ASC complex is a necessity for the recruitment of pro-caspase 
1 and subsequent cleave of caspase 1 to its active form (Bryant and Fitzgerald, 
2009). In addition to the significance of ASC in the NALP3 inflammasome 
activation, it plays important roles in regulating innate and adaptive immune 
responses via regulating the NF-κB pathway and mitogen-activated protein kinase 
199 
 
(MAPK) activation (Hassan and Amer, 2011). We investigated the formation of the 
ASC complex after AgNW treatment using a protocol as described by Coll et al. 
(Coll and O'Neill, 2011a) based on the detection of ASC dimers and higher 
oligomers via Western blotting as well as visualising ASC formation using confocal 
microscopy. The formation of the ASC complex was observed in both assays after 
treatment of BMMs with controls and fibre panel, however the results obtained via 
Western blotting were not reproducible and too little percentage of cells showed 
Speck formation in the confocal microscopy assay to form a valid conclusion. 
Since the in vitro studies on the NALP3 inflammasome as an underlying mechanism 
in fibre-induced inflammation didn’t show convincing results, we performed a 




 mice to study the extent of 
inflammation in vivo after intrapleural injection of AgNWs. Interestingly, we 





mice however only a slight decrease but no significant change in inflammation was 
observed after treatment with AgNW14. This leads to the conclusion that the NALP3 
inflammasome is involved in the inflammation seen after fibre exposure and 
inflammation can be reduced by blocking the NALP3 inflammasome, however only 
in the case of inflammation caused by fibres that do not cause frustrated 
phagocytosis. This observation shows that the all-or-nothing response in the pleural 
space as discussed in the previous chapter, which was linked to the retention of 
longer fibres in the pleural space, can be extenuated by interfering with the NALP3 
inflammasome pathway.  
In summary, the study on the mechanism of the pro-inflammatory response to 
AgNW showed that the NALP3 inflammasome could be an underlying mechanism 
however an in depth study has to be performed to elucidate this mechanism further 







Chapter 5: The threshold length for fibre induced 
pulmonary inflammation 
 
Some of the following results have been published in 
Schinwald A, Chernova T, Donaldson K. Use of silver nanowires to determine 
thresholds for fibre length-dependent pulmonary inflammation and inhibition 




Phospho-kinase array was performed by Dr Tanya Chernova at the MRC Toxicology 
Unit in Leicester.  
5.2 Aims and Hypothesis 
Despite the knowledge that fibre length plays a crucial role in the development of 
asbestos related diseases, the threshold length for the induction of lung diseases after 
fibrous exposure is unknown.The objective of this study was to examine the 
threshold fibre length for the onset of pulmonary inflammation after aspiration 
exposure in mice to four different lengths of AgNW. We hypothesized that exposure 
to longer fibres shows a defined threshold length which will differ from the threshold 
length identified in the pleural space due to differences in the clearance mechanism 
of the lung and the pleural space. 
 The normal lung clearance mechanisms provide a defense mechanism for removing 
fibre dose and yet selective retention of longer fibres is well-documented (Coin et al., 
1996; Searl et al., 1999). For the key fraction of fibres that deposit beyond the 
ciliated airways and are slowly cleared, macrophages are the central cells involved in 
phagocytosing and transporting the fibres to the foot of the mucociliary escalator for 
clearance. We therefore hypothesized that the uptake of long fibres impairs the 
ability of macrophages to migrate whilst short fibres do not, providing a mechanism 
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for selective retention of long fibres. We addressed this hypothesis using the samples 
with different fibre length classes and assessed their effects on macrophage migration 
in an in vitro wound closure assay. 
 
5.3 Results 
5.3.1 Length dependent inflammatory response to AgNW in lung at 24 hour 
The inflammatory response to the panel of AgNW and control fibres as assessed by 
the bronchoalveolar lavage fluid (BAL) profile was measured 24 hour post 
aspiration. An initial dose response series was performed with AgNW14 at a dose of 
5, 10, 25 and 50 µg/mouse (n=2) (Figure 5-1 I, II) and SFA and LFA at a dose of 10 
and 50 µg/mouse (n=2) (Figure 5-1 III, IV). The dose of 50 µg/mouse was chosen 
since it gave a persistent inflammatory response with AgNW14 and LFA. The dose 
was adjusted so that each of the different treatments (Table 2-4) comprised of the 
same fibre number, whereby for AgNW3, AgNW5, AgNW10, AgNW14, SFA and LFA 
a dose of 10.7, 17.9, 35.7, 50.0, 10.7 and 50.0 µm, respectively was used. No change 
in total bronchoalveolar cell number was measured after exposure to equal numbers 
of the different fibre lengths compared to vehicle control (Figure 5-2 I).  However, 
the total number of granulocytes was significantly increased after exposure to 
AgNW14 (Figure 5-2 II). AgNW3-10, SFA and LFA produced no significant increase 
in granulocyte number, although the LFA produced a trend to more inflammation 
than SFA. The effect of length on inflammation was demonstrated by plotting 
AgNW length against inflammation and it is clear that the relationship is not linear 
and that there is a discernible step–increase in granulocyte recruitment at a length 
between 10 and 14 µm (Figure 5-2 III). Total amount of protein and increase in 
membrane permeability by the release of LDH was measured but showed no 




Figure 5-1: Dose response series for AgNW14, SFA and LFA in the lungs at 24 hour. 
C57/Bl6 mice were exposed to AgNW14 at a dose of 5, 10, 25 and 50 µg/mouse (I, II) 
and control particles SFA and LFA at 10 and 50 µg/mouse (III, IV) by pharyngeal 
aspiration. At 24 hour post exposure the lungs were lavaged and total cell number (I, 





Figure 5-2: Length dependent inflammatory response to AgNW in the lungs at 24 
hour. C57/Bl6 mice were exposed to AgNW and control panel by pharyngeal 
aspiration. At 24 hour post exposure the lungs were lavaged and total cell number (I) 
and total granulocyte number (II) were measured. III) The acute inflammatory 
increase was plotted against length of AgNW. Significance indicated compares 
treatment groups to vehicle control (II) and within each treatment (III), * indicates p 
< 0.05, ** indicates p < 0.001. Data represent mean + SEM of n = 4 mice. 
 
5.3.2 Histological evaluation of lung sections following treatments 
The pathology of the lung exposed to the AgNW panel and controls were examined 
24 hour after aspiration. The sections after exposure to VC, SFA and AgNW3 
showed normal histology of bronchioles, respiratory bronchioles, alveolar ducts and 
alveoli (Figure 5-3 I, II, IV). AgNW5 and AgNW10 produced minor granulomas and 
lymphocyte infiltrates and the majority of the lung histology appeared normal 
(Figure 5-3 V, VI). AgNW14 and LFA caused more extensive granuloma and 
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lymphocyte infiltrates which is consistent with the amount of total granulocytes from 
the lavage fluid (Figure 5-3 III, VII). Accumulations of nanowires inside alveolar 
macrophages were common (Figure 5-3 V, VI white arrow). AgNW14 produced the 
stronger response with more granulomatous areas compared to shorter fibres 
however this was still minor compared to the extensive interstitial thickening and 
remodelling of the alveolar spaces after LFA treatment (Figure 5-3 III, VII). 
Frustrated phagocytosis, classified as incomplete uptake of fibres by cells, was 
observed with AgNW14 and LFA. Whole lung sections stained with H&E and higher 








Figure 5-3: Lung histology 24 hour post aspiration to AgNW panel and controls. 
H&E stained lung sections at lower (left) and higher (right) magnification show 
normal alveolar structure in the vehicle control (I), SFA (II) and AgNW3 (IV) 
sections. Small accumulations of inflammatory cells were seen after AgNW5 (V) and 
AgNW10 (VI) exposure whereas a greater amount of inflammatory cell infiltration in 
the alveoli, peribronchiolar and perivascular regions were observed after LFA (III) 
and AgNW14 (VII). The white arrows indicate the areas of fibre accumulation. 
Abbreviations: al, alveolus; br, bronchiole; v, blood vessel. Representative images 





Figure 5-4: Lung pathology 24 hours post aspiration of vehicle control. Images of 
lung sections stained with H&E were realigned to show gross morphology of the 
lungs 24 hour post aspiration with vehicle control (0.5% BSA/saline). Call-outs 
stained with H&E show the normal structure of the terminal bronchioles, alveolar 




Figure 5-5: Lung pathology 24 hours post aspiration of AgNW3. Images of lung 
sections stained with H&E were realigned to show gross morphology of the lungs 24 
hour post aspiration with AgNW3. Call-outs stained with H&E show the normal 




Figure 5-6: Lung pathology 24 hours post aspiration of AgNW5. Images of lung 
sections stained with H&E were realigned to show gross morphology of the lungs 24 
hour post aspiration with AgNW5. Call-outs stained with H&E show mainly a normal 
structure of the terminal bronchioles, alveolar ducts, alveoli and alveolar septa with 




Figure 5-7: Lung pathology 24 hours post aspiration of AgNW10. Images of lung 
sections stained with H&E were realigned to show gross morphology of the lungs 24 
hour post aspiration with AgNW10. Call-outs stained with H&E show normal 
structure of the terminal bronchioles, alveolar ducts, alveoli and alveolar septa with 




Figure 5-8: Lung pathology 24 hours post aspiration of AgNW14. Images of lung 
sections stained with H&E were realigned to show gross morphology of the lungs 24 
hour post aspiration with AgNW14. Call-outs stained with H&E show small 
accumulations of cells and AgNW aggregates which are more frequent compared to 





Figure 5-9: Lung pathology 24 hours post aspiration of SFA. Images of lung sections 
stained with H&E were realigned to show gross morphology of the lungs 24 hour 
post aspiration with SFA. Call-outs stained with H&E show a normal structure of the 




Figure 5-10: Lung pathology 24 hours post aspiration of LFA. Images of lung 
sections stained with H&E were realigned to show gross morphology of the lungs 24 
hour post aspiration with LFA. Extensive granulomatous areas can be seen. Call-





5.3.3 Frustrated phagocytosis in alveolar macrophages 
The link between the extent of frustrated phagocytosis and lung inflammation was 
examined in the lavage fluid. The uptake of different length of AgNW by alveolar 
macrophages was evident in cytospin images of the broncho-alveolar lavage fluid 
(Figure 5-11). Shorter fibres including SFA, AgNW3, AgNW5 and AgNW10 could be 
completely phagocytosed by alveolar macrophages whereas LFA and AgNW14 were 
undergoing frustrated phagocytosis indicated by the sharing of fibres between 
adjacent cells (Figure 5-11). This is in agreement with frustrated phagocytosis 
observed in histological sections and the extent of inflammation seen in the lavage 





Figure 5-11: Uptake of AgNW and controls in alveolar macrophages. Cytospin 
images from the lavage fluid 24 hour post aspiration illustrates the complete uptake 
of shorter fibres including SFA, AgNW3, AgNW5 and AgNW10 whereas LFA and 
AgNW14 led to frustrated phagocytosis in alveolar macrophages. Scale bar 20 μm. 




5.3.4 Fibre- length dependent inhibition of locomotion in BMMs 
Fibres that deposit in the lower respiratory tract are cleared via macrophages, 
whereby the fibres are phagocytosed and transported to the foot of the mucociliary 
escalator for clearance. If this clearance mechanism is impaired, accumulation of the 
deposited fibre dose occurs over time. This study investigated the locomotion 
behavior of bone marrow derived mouse macrophages (BMMs) to treatment of the 
AgNW panel in an in vitro macrophage migration assay in order to aid the 
understanding of fibre-laden alveolar macrophage migration behaviour in vivo. In the 
macrophage migration assay, a wound was made into a confluent layer of cells and 
the migration of cells back into the wound was monitored. An initial dose response 
series with concentrations of 0.5, 1, 2.5 and 5 µg/cm
2
 based on fibre number for 
AgNW14 was performed to measure metabolic activity, membrane integrity and 
migratory behavior of the BMMs. The initial screening showed that a dose of 2.5 
µg/cm
2 
and below only a slight increase in membrane permeability and decrease in 







Figure 5-12: Dose response series for cell migration, membrane integrity and cell 
metabolism. I) A dose response series was performed to measure the number of cell 
migrated into the wound at concentrations of 0.5, 1, 2.5 and 5 µg/cm
2
. Data 
represent mean + SEM of n = 3. II) Metabolic activity of BMMs was assessed via the 
reduction of AlamarBlue® at an absorbance of 570 nm. At a dose of 5 µg/cm
2
 
extensive reduction in metabolic activity was measured. III) The integrity of the 
BMM cell membrane after the different concentrations of AgNW and AgP was 
measured via the release of LDH into the cell supernatant and compared to VC. At a 
dose of 5 µg/cm
2
 extensive increase in membrane permeability was measured. Initial 
screening of n=1. 
 
For subsequent measurements a dose of  2.5 µg/cm
2  
based on AgNW14 was chosen 
(see Table 2-2). As shown in Figure 5-13 I, the untreated cells migrated into and 
repopulated wounds area within 30 hour. Similar wound closure was seen after 
treatment with AgP and AgNW3 (Figure 5-13 I). A slight decrease in the 
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repopulation of the wound occurred during treatment with AgNW5 whilst BMMs 
treated with AgNW14 and AgNW28 (Figure 5-13 II) demonstrate a substantial 
decrease in the ability to migrate into the wound compared to VC. In addition to light 
microscopy images, cells were fixed after 30 hours and images taken by SEM 
(Figure 5-14). The number of cells which migrated into the wound were counted and 
expressed as percentage of migrated cells normalised to VC and this revealed that 
locomotion was significantly decreased with AgNW5, AgNW14 and AgNW28 (Figure 
5-15 I). Cytochalasin D, a positive control which causes impaired migration due to 
disruption of the actin filaments produced a decrease in locomotion comparable to 
AgNW14 (Figure 5-15 I). Differences in the rate of metabolic activity or cell death 
could not account for the inability of longer fibre-exposed macrophages to migrate 
into the wound as the treatment neither interfered with the metabolic activity 
measured via chemical reduction of Alamar Blue® (Figure 5-15 II) nor compromised 
cell membrane integrity measured as the release of lactate dehydrogenase into cell 
supernatant (Figure 5-15 III). Decrease in cell adhesion has been linked to a decrease 
in the ability of cell migration. Backscatter scanning electron microscopy (BSE) 
images confirm that treatment with AgNW did not impair the ability of cell adhesion 
and spreading (Figure 5-13 I, II bottom panel). To the contrary, extensive cell 
spreading is observed in cells treated with long fibres presumably a consequence of 
BMMs increasing the surface area involved in engulfing the fibres. Using BSE, 
nanowires and nanoparticles phagocytosed by BMMs could be visualised underneath 







Figure 5-13: Fibre-length dependent impaired migration of BMMs in a wound-
healing assay. An artificial wound was created in the BMM monolayer using a 
pipette tip and the migration of BMMs into the wound was assessed after treatment 
with VC (I), AgP (I), AgNW3 (I), AgNW5 (II), AgNW14 (II), AgNW28 (II). The dose was 
adjusted to equal fibre number and based on 2.5 μg/cm
2
 for AgNW14. Photographs 
were taken immediately and at 30 hour after creating the wound. For BSE images 
were taken at the edge of the wound. No impairment of cell adhesion and spreading 
could be observed and in fact increased cell spreading due to uptake of longer fibres 
was observed. Nanoparticles and fibres could be visualised underneath the cell 
membrane as indicated by the white arrow in the inserts which are the non-overlayed 
BSE images. Representative images are shown; similar results are obtained in 3 
independent experiments.  
 
Figure 5-14: 30 hour macrophage migration assay in BMMs. SEM images showing 
the closer of the wound after 30 hour at different treatments with AgNW. 






Figure 5-15: Inhibition of BMMs migration in a macrophage migration assay and 
cell viability. I) The number of migrated cells in the ‘wound’ region was counted and 
expressed as percentage of cells migrated into the wound normalised to VC. 
Significant reduction of migration was seen with AgNW5, AgNW14, AgNW28 and 
cytochalasin D, a positive control for actin cytoskeleton disruption. II) Metabolic 
activity of BMMs was assessed via the reduction of AlamarBlue® at an absorbance 
of 570 nm. At the dose used no significant reduction in metabolic activity was 
measured. III) The integrity of the cell membrane after the different treatments was 
measured via the release of LDH into the cell supernatant and compared to VC and 
TX, positive control. A sub-lethal dose was chosen at which none of the treatments 
led to a significant increase in cell permeability. Significance indicated compares 
treatment groups to vehicle control, * indicates p < 0.05, ** indicates p < 0.001, *** 




5.3.5 Screening for kinase phosphorylation in BMMs after AgNW treatment 
To reveal whether there was any fundamental change in the activation/metabolic 
state of the cells when they were impaired in their ability to migrate by 
phagocytosing long fibres, an initial screening of 46 kinase phosphorylation sites was 
performed. 
The phospho- kinase array showed that kinases including GSK-3 α/β, Akt (S473), β-
catenin and PLC-γ were activated on treatment with AgNW3, AgNW5 and AgNW14 
which can be explained via a general activation due to phagocytosis of particles 
(Figure 5-16 I, II). Kinases including STAT3, p53 (S392), p27 (T198), p27 (T157) 
and p70 S6 (T389) were more activated in AgNW5 and AgNW14 compared to 
AgNW3 which correlate with the loss of locomotion (Figure 5-16 I, II). Interestingly, 
the highest level of activation of the cytoplasmic tyrosine kinase Src family members 
including Src, Lck, Hck and Frg was detected in the AgNW14 treated BMM (Table 
5-1). A summary of the relative pixel intensities of all kinases can be found in the 





Figure 5-16: Phosphoproteomic analysis of BMMs exposed to AgNW. I) A phospho- 
kinase array (R&D) was performed to screen the phosphorylation state of 46 kinases 
in BMMs after treatments with AgNW3, AgNW5 and AgNW14 whereby 15 kinases 
showed an increase in phosphorylation relative to VC. II) Immunoblot analysis 
extract of kinases involved in cell migration/mobility and adhesion. Results are 
based on an initial screening (n = 1). Phospho-kinase array and analysis was 






Table 5-1: Phosphoproteomic analysis of BMMs exposed to AgNWs. A phospho- 
kinase array (R&D) was performed to screen the phosphorylation state of 46 kinases 
in BMMs after treatments with AgNW. Relative pixel density in % compared to VC is 
shown for all kinases measured (n=1).  
 VC AgNW3 AgNW5 AgNW14 
p38 a 100 74.85 159.09 121.96 
ERK 1/2 100 93.41 86.16 74.33 
JNK pan 100 107.53 82.98 86.15 
GSK -3 a/b 100 289.00 256.35 327.82 
MEK1/2 100 115.86 97.57 129.87 
MSK 1/2 100 77.77 96.81 79.48 
Akt  473 100 221.51 137.80 261.48 
mTOR 100 94.12 92.45 138.54 
CREB 100 52.64 29.99 78.01 
HPS27 100 128.64 131.60 141.17 
AMPK a2 100 175.96 105.32 140.03 
β-Catenin 100 306.22 249.12 293.51 
Chk-2 100 54.89 97.63 103.00 
Src 100 86.63 87.62 178.41 
Lyn 100 52.63 45.04 67.14 
Lck 100 43.72 32.90 171.80 
Fyn 100 51.26 57.08 104.40 
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Yes 100 50.56 72.43 108.49 
Frg 100 69.26 111.40 132.60 
Hck 100 100.07 132.39 162.50 
FAK 100 96.46 132.29 126.20 
STAT2 100 126.91 97.21 120.56 
STAT3 100 109.67 101.52 247.60 
STAT 5a 100 115.59 122.06 135.43 
STAT5 b 100 93.41 90.03 117.70 
STAT5 A/B 100 121.44 116.31 154.23 
STAT7 100 110.99 93.45 112.70 
 p53  S392 100 83.20 356.63 198.74 
p53  S 46 100 105.01 189.05 147.20 
p53   S15 100 38.12 190.13 152.74 
Akt 308 100 131.34 172.40 161.11 
p70 S6 T421/S424 100 134.21 104.95 134.33 
p70S6   T229 100 93.99 142.35 136.85 
cJun 100 107.21 141.34 160.83 
PLC-γ1 100 263.56 266.54 363.68 
Pyk -2 100 126.66 115.08 152.87 
 p27  T198 100 0.00 459.79 326.21 
p27  T157 100 107.95 480.65 363.21 
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paxillin 100 159.08 250.35 152.23 
RSK1/2/3 100 87.02 99.50 89.36 
RSK1/2 S221 S227 100 78.24 111.36 104.93 
STAT1 100 123.33 100.83 170.85 
STAT4 100 85.95 101.54 160.66 
eNOS  S1177 100 156.19 173.36 94.30 









The aim of this study was to investigate length-dependent effects of AgNW in the 
lungs.  To assess the role of fibre length in the initiation of inflammation the BAL 
profile was assessed after aspiration exposure. To assess the effect of length on 
macrophage clearance and retention of the long fibre dose we used an in vitro 
wound-healing assay. The latter study aimed to shed light onto the effects of fibre 
length on clearance of fibre-laden alveolar macrophages via migration from the 
alveolar region of the lung to the mucociliary escalator.    
Fibre dimension is a critical factor for lung diseases after inhalation exposure of 
various forms of fibrous materials as demonstrated in a number of experimental 
studies, with long fibres being more pathogenic than short ones (Davis et al., 1987; 
Davis et al., 1986; VORWALD et al., 1951). Long term inhalation studies in rat have 
been performed with amosite asbestos preparations of short (1% > 5 µm), medium 
(UICC reference fibre) and long (30% > 5 µm, 11% > 10 µm). These studies showed 
that the short fibres and the slightly longer UICC sample were low in pathogenicity 
whilst the long fibres induced extensive fibrosis and pulmonary adenomas.  This  
was in contrast to the studies performed using direct injection of the same samples of 
amosite asbestos into the peritoneal cavity which showed that UICC amosite was 
sufficiently long to cause mesothelioma in rats at the same frequency as long amosite 
fibres (Davis et al., 1986). This supports the findings of this study, that the length 
threshold for fibre effects in the lung is different to the length threshold for fibre 
effects at the mesothelial surface, the lung threshold being a higher value. Poland et 
al. demonstrated severe lung and peritoneal inflammation after aspiration exposure 
and direct intraperitoneal injection in mice of long (24 µm) nickel nanowire but only 
very mild diffuse alveolitis and mild peritoneal inflammation after exposure to short 
(4 µm) nickel nanowires (Poland et al., 2012). Similar results were obtained from 
studies on short (< 1 µm) and long (>13 µm) carbon nanotubes where a length- 
dependent inflammation in lung of mice after aspiration exposure was observed 
(Murphy et al., 2012a). 
In the previous chapter the threshold length for pleural inflammation was reported. 
This data clearly showed that fibres below 5 µm in length were non-inflammatory 
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and that fibres 5 µm in length and longer caused extensive recruitment of 
inflammatory cells to the pleural space.  
The current study addressed the lack of knowledge regarding the threshold length for 
acute pulmonary inflammation after deposition in the airspaces of the lungs. The 
pulmonary response to AgNW reported here showed a threshold length for the 
significant recruitment of inflammatory cells of 14 µm compared to the 5 µm fibre 
threshold length for pleural inflammation. The use of size categories means that the 
actual threshold could lie anywhere between 11- and 14 µm since the size category 
below, at which no inflammation was produced was 10 µm. This finding of a longer 
threshold in the lungs is consistent with previous reports implicating longer fibres in 
the development of lung carcinoma compared to mesothelioma (Davis et al., 1986). 
The different length thresholds for pulmonary versus pleural inflammation can be 
explained as a consequence of the different mechanisms of fibre clearance from the 
lung and the pleural space. Clearance of fibres from the pleural space is via 
lymphatic drainage to mediastinal lymph nodes through stomata, pores in the parietal 
pleura which are around 0.5-10 µm in diameter (Schinwald et al., 2012). Therefore a 
size-restricted clearance occurs in the pleural space leading to retention of fibres 
which cannot negotiate the stomata and subsequent recruitment of inflammatory cells 
(Murphy et al., 2011). The clearance mechanism in the lung relies on alveolar 
macrophage phagocytosis and migration to the foot of the mucociliary escalator and 
is discussed in more detail below. 
While deposition of  AgNW14 in the airspaces led to a significant increase in 
inflammatory cells in the broncho-alveolar lavage fluid (BAL), shorter fibres 
including SFA, AgNW3, AgNW5 and AgNW10 only produced a mild, non 
significant,  increase in the total granulocyte number. It was noticeable that the 
length-dependent response was not linear and showed a marked step-increase in the 
inflammation between 10 and 14 µm. Histological examination of lung sections 
showed no recruitment of inflammatory cells after exposure to SFA or AgNW3. 
Minor aggregations of inflammatory cells around terminal bronchioles and in 
alveolar airspaces were observed with AgNW5 and AgNW10 but these were more 
extensive in the AgNW14 and LFA samples showing early stages of granuloma 
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development in the terminal airways/ proximal alveolar region. The histological 
response to LFA was strongest showing extensive aggregates of inflammatory cells. 
However, the BAL fluid from LFA-exposed mice, whilst showing an increase in the 
mean number of granulocyte that was almost 4 times the mean number in the mice 
exposed to SFA did not attain significance.  Additionally, lavage from lungs exposed 
to LFA showed a smaller number of BAL granulocytes than AgNW14 and this 
contrasted with the histology data that showed more lung inflammation with LFA 
than AgNW14. The low PMN in the lavage from LFA-exposed lungs was possibly 
due to a poor return from the inflammation-congested areas of the lungs. The final 
scoring of LFA equal to AgNW14 for BAL granulocytes (Table 5-2) therefore took 
into account both the histological and lavage data to provide the best assessment of 
their relative inflammogenicity.  The lack of an inflammatory response with shorter 
AgNW, which can be considered to be equivalent to silver particles, is consistent 
with experimental studies demonstrating the minimal lung toxicity or 
inflammogenicity of nanosilver in a subacute murine and 28-day rat inhalation model 
(Stebounova et al., 2011; Ji et al., 2007). The study presented here focuses on short-
time response due to the fact that the AgNW used in this study appear not to be 
biopersistent beyond a few days as reported in chapter 3.3.13. It is highly likely that 
the same length dependent effects would be shown by wholly biopersistent fibres and 
that the inflammation would be chronic. However, the determination of the threshold 
length for long term chronic inhalation studies is of utmost importance and 
biopersistence remains a key factor in the pathogenicity of long nanofibres.  
The clearance efficiency of deposited fibres from the lower respiratory tract plays a 
major role in the development of pulmonary diseases since the retained dose, which 
is the dose accumulated in the alveolar region of the lungs after clearance accounts 
for the chronic pathogenic effects of inhaled fibres (Oberdorster, 1993).  
Fibres deposited in the conducting airways are cleared rapidly via cilia in the 
mucociliary escalator and subsequently swallowed or expectorated.  If fibres reach 
the respiratory bronchioles, alveolar ducts or alveolar sacs they are cleared slowly via 
alveolar macrophages (AM) phagocytosing the deposited fibres and transporting 
them upwards to the ciliated airways for mucociliary clearance. It has been noted in 
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many studies that there is selective retention of long biopersistent fibres of various 
sorts from the slow-clearing compartment with more effective clearance of the 
shorter fibres (Searl et al., 1999; Lippmann, 1990). 
The mechanism by which fibre-laden alveolar macrophages are drawn to the terminal 
bronchioles at the foot of the ciliated airways is obscure. Possible explanations 
include the passive transport with alveolar fluid or amoeboid movement of AM 
either by random migration or directed migration along a chemotactic gradient 
(Lehnert, 1992). Other pathways of clearance, usually only important during high 
dust exposure or disease are intra- and transcellular pathways by which fibres can 
reach lung interstitium and lymph nodes from where they subsequently may  reach 
the blood stream (Oberdorster, 1993; Holt, 1983; Miserocchi et al., 2008). A recent 
study investigated the effects of MWCNT on cell migration and adhesion of human 
dermal fibroblasts and murine fibroblasts, reporting a significant decrease in cell 
adhesion which was confirmed by the decrease of mRNA levels of important cell 
adhesion proteins FAK, fibronectin and laminin (Zhang et al., 2011). In addition 
fibroblast migration in a wound-healing assay was greatly impaired by MWCNT 
treatment and was accompanied by cytoskeletal derangement (Zhang et al., 2011), 
although it should be noted that the dose of MWCNT used in this study was 
cytotoxic to human fibroblast which could influence the adherence and migration 
properties of the cells.  
This study investigated whether fibre length has an effect on the migration behaviour 
of BMMs in vitro after fibre exposure using a wound-healing assay, a surrogate for 
in vivo clearance of fibrous material to the mucociliary escalator by AM migration. 
We used a very low dose to study effects on BMM migration, based on 2.5 µg/cm
2
 
for AgNW14 and all the other length classes were adjusted to provide the same fibre 
number. The dose used had no significant effect on cell metabolism or cell viability 
for any of the length classes, ensuring that the observed effects were not due to 
simply impaired cell viability. A clear length-dependent trend for inhibition of BMM 
cell migration was measured at fibre lengths of 5, 14 and 28 µm and at 28 µm there 
was more or less complete inhibition of motility. Presumably as a consequence of 
cell surface extension of AM during engulfment of long fibres, increased cell 
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spreading was observed and correlated with increased inhibition of migration. The 
BMMs in this study had an average diameter of 13 µm (Cannon and Swanson, 1992) 
whilst human alveolar macrophages have an average diameter of 21 µm (Krombach 
et al., 1997). Due to this difference the threshold length for clearance of fibres by 
alveolar macrophages in humans may be slightly higher. 
An initial screening of 46 kinase phosphorylation sites was performed to get a 
snapshot of the kinase activation status of fibre-treated BMMs. The following 
discussion of the kinase phosphorylation is based on an n=1 and therefore has to be 
considered with caution.  
We hypothesised that this might reveal whether there was any fundamental change in 
the activation/metabolic state of the cells when they were impaired in their ability to 
migrate by phagocytosing long fibres. The 3 µm long exposed cells act as a control 
for normal phagocytosis and when compared to the untreated kinase profile this 
showed most of the kinases (~32) remained unchanged. The kinases GSK-3 α/β, Akt 
473, β-catenin and PLC-γ showed activation in all treatment groups suggesting a link 
to normal phagocytosis.  Comparing the kinase phosphorylation profile of BMM 
exposed to 3 µm with those exposed to 5 and 14 µm should reveal differences 
associated with the long fibre-dependent loss of motility and 5 kinases out of 46 
(STAT3, p53 (S392), p27 (T198), p27 (T157) and p70 S6 (T389)) exhibited 
increased phosporylation with AgNW14  compared to AgNW3. Tyrosine kinases of 
the Src family were noticeably induced by treatment with long fibres.  These kinases 
have been implicated in intracellular signalling in macrophages influencing the 
amplitude of many pathways (Abram and Lowell, 2008). One of the Src downstream 
effectors is STAT3, a major modulator of inflammation, which is required for 
activation of macrophages (Lin and Bost, 2004).  A marked induction of STAT3 
following the AgNW14 treatment is a likely result of Src activation.  It’s worth 
mentioning that a constitutive activation of STAT3 is a common feature in many 
solid tumours (Looyenga et al., 2012), therefore persisting activation of STAT3 in a 
chronic inflammation caused by long fibres may contribute to pro-oncogenic 
changes. Macrophage motility is known to be negatively regulated by p53 (Sablina et 
al., 2003)  and the latter was induced in BMM treated with longer fibres, and might 
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have contributed to impairment of their migration. The role of p27 in regulation of 
cellular migration remains unclear, however, our finding would support the reports 
showing suppression of migration by induction of p27 (Berton et al., 2009). No 
kinases were down-regulated in the long fibre treated BMM compared to the controls 
confirming that there was no generalised loss of viability associated with failure to 
migrate.  It is reported in the literature that a number of different kinase pathways are 
involved in the migration and adhesion processes. Among these are kinases that 
showed an increase in their phosphorylation state after long fibre treatment 
(Kobayashi et al., 2006; Ip and Wong, 2012; Roger et al., 2006; Huang et al., 2003; 
Lee et al., 2009; Yoon et al., 2012; Baruzzi et al., 2008). The results from the 
screening of the phosphorylation sites was mainly performed to see if crucial cellular 
signalling processes are impaired by the treatment of AgNW  which might indicate 
that decreased cellular function, apoptosis/necrosis underlay the decrease in cell 
mobility. Our results showed that the long-fibre treatment did not negatively affect 
the cellular function of the BMMs as assessed by metabolic function, loss of 
membrane integrity or kinase profile. In fact long fibre treatment and inhibition of 
motility were associated with increased phosphorylation of some kinases involved in 
migration and adhesion. Clearly the interplay between adhesion and motility is 
complex since focal adhesion is required for motility and a more sophisticated 
analysis of mechanism underlying loss of motility with long fibre treatment is 
required. The results give an indication that cellular processes are intact in long fibre 
treated BMM and therefore that inhibition of locomotion can be best explained via a 
mechanical obstruction to motility. By this we suggest that the presence of long 
fibres inside the cells physically interferes with the necessary rearrangement of the 
cytoskeleton, membrane and other structures that are necessary for locomotion.  This 
however has to be confirmed by an in depth investigation of the molecular 






Table 5-2: Summary of the length-dependent effects of fibres in the lungs. 
 
* BAL granulocytes: <0.5 million (+); 0.5-1.0 million (++); 1–2 million (+++) 
** Lung histology subjectively scored on the basis of the severity of lung 
inflammation (see results) 
*** Frustrated phagocytosis on the basis of evaluation of cytospins for presence of 
frustrated phagocytosis 
**** Impaired migration on the basis of degree of significant impairment compared 
to control (see Figure 6A) 
***** Δ kinase phosphorylation based on subjective examination the levels of 
phosphorylation of the treated compared to the control levels of phosphorylation (see 
Figure 7). NA = not applicable. 
 
In conclusion this study has shown that there are length-dependent effects on the 
lung and on BMM summarised in Table 5-2. These show length-dependent increases 
in inflammation by BAL and severity of lung injury by histology in vivo and 
evidence of accompanying impairment of macrophage migration by BMM in vitro. 
A threshold length for acute pulmonary inflammation after pharyngeal aspiration of 
AgNW was evident between 10 and 14 µm in length. This compares with the 
previous studies on the threshold length for pleural inflammation of 5 µm, 
determined using the same panel of AgNW. The difference in thresholds can be 
explained by the differences in clearance mechanism between the lung the pleural 
space. In the pleural space clearance is through stomata (Donaldson et al., 2010) 
whilst clearance of deposited fibres from beyond the ciliated airways  is via uptake 
by AM and subsequent migration to the mucociliary escalator. Using an in vitro 
macrophage migration assay we showed that fibre length-dependent macrophage 
mobility, with a threshold for impairment at a length of 5 µm and increasing 
impairment with increasing length, until at 28 µm there was almost complete 
inhibition of motility. An explanation for the decrease in locomotion could be 
mechanical obstruction caused simply by the bulky long fibres interfering with the 
235 
 
movement process since there was no loss of viability or metabolism in the long 
fibre-treated cells and an initial screen of a number of 46 kinases showed only a 
change in 14 kinase phosphorylation sites. This study was a small-scale pilot study 
with acute inflammation and short term inhibition of migration in vitro as the 
endpoints. These results need to be confirmed in long term inhalation studies using a 
range of different nanofibres at plausible exposure concentrations before we can 








Chapter 6: Pulmonary and pleural response to graphene 
nanoplatelets 
 
Some of the following results have been published in 
Schinwald A, Murphy FA, Jones A, MacNee W, Donaldson K. Graphene-based 
nanoplatelets: a new risk to the respiratory system as a consequence of their 
unusual aerodynamic properties. ACS Nano. 2012 Jan 24;6(1):736-46. 
 
6.1 Acknowledgement 
Calculation of the aerodynamic diameter for graphene nanoplatelets (GP) was 
performed by Dr Alan Jones, Institute of Occupational Medicine, Edinburgh. Carbon 
Black (Printex 90®) was provided by Evonik Degussa GmbH in Germany. It was 
used as an amorphous carbon particle control. I thank Steve Mitchell (University of 
Edinburgh) for sample preparation for SEM, TEM and BSEM technical. 
 
6.2 Aims and Hypothesis 
Graphene, a two dimensional (2D) crystalline material comprised of a single layer of 
carbon atoms tightly packed into a honeycomb lattice has recently been identified 
(Novoselov et al., 2004) and attracted substantial scientific interest due to its unique 
intrinsic properties of graphene.  However, due to their nanoscale dimensions and 
thinness nanoplatelets could posseses a much lower aerodynamic diameter (Dae) than 
would be expected from their maximum diameter (Sanchez et al., 2012) which would 
mean that this new, emerging material could pose unusual risks to the respiratory 
system after inhalation exposure. Unintentional occupational or enviromental 
exposure to graphene-based materials during manufacturing or intentional exposure 
via biomedical applications are likely with their increasing development and use.   
The aim of this study was to determine the respirability of commercially available 
graphene platelets (GP) from the basic principles of the aerodynamic behaviour of 
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plate-shaped particles which allowed us to calculate their aerodynamic diameter and 
to assess their inflammatory potential in the lungs and the pleural space after 
aspiration exposure and intrapleural injection. We hypothesised that it was the shape 
in which the graphene was presented that was driving the activity and that respirable 
nanoparticulate carbon black (CB) would be readily cleared via alveolar 
macrophages from the airspaces and via stomata from the pleural space to the 
mediastinal lymph nodes. In contrast GP, exceeding the size for complete 
phagocytosis would be retained in the lung and, after translocation to the pleural 
space, GP would be too large to negotiate the stomata in the parietal pleura and so 
would initiate inflammation. 
 
6.3 Results 
6.3.1 Characterisation of Graphene Nanoplatelets  
For this study graphene nanoplatelet (GP) were purchased from a commercial source 
(cheaptubes.com) and characterised according to their size distribution, 
contaminating metals and generation of oxygen-centred free radicals. 
Nanoparticulate carbon black (Printex 90®) (CB) was provided by Evonik Degussa 
GmbH and used as an amorphous carbon particle control. Characteristics and 
specifications of CB and GP are summarised in Table 6-1. CB and layered (1-10 
layer) graphene nanoplatelet morphology were examined using scanning electron 
microscopy (SEM) (Table 6-1). Electron paramagnetic resonance (EPR) 
measurements were performed to determine the generation of oxygen-centred free 
radicals of CB and GP. Results were compared to one-another and to a positive 
Pyrogallol control, a spontaneous superoxide anion generator with Tempone H used 
as a spin trap. Both CB and GP caused a significant increase in free radical 
generation with GP production increased by 2-fold compared to CB (Table 6-1). EPR 
signal is based on the surface are of the particle of interest since the surface are is 
driving the oxidative properties of the material. In this case GP have a smaller 
surface are compared to CB due to aggregation of multiple layers of single GP 
sheets, however if GP exists in a single layer it could possess a much greater 
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potential of generating oxygen-centred free radicals compared to CB. For 
quantification of contaminating metals the supernatant of 1 mg/ml of each sample in 
0.5% BSA/saline was analysed using the technique of inductively-coupled mass 












Zn compared to CB, however all concentrations are negligible and not biologically 
relevant (Table 6-2).  
 
Table 6-1: Characteristics and specifications of CB and GP. Morphology of 
materials by scanning electron microscopy (SEM). SEM of GP confirms morphology 
of the platelet shape. EPR measurement to determine generation of oxygen-centred 
free radicals. Surface area of CB from Donaldson et al. (Donaldson et al., 2000). 
 
Table 6-2: Concentration (ng/g) of soluble metal associated with CB and GP in the 




6.3.2 Aerodynamics of platelet-shaped particles- calculation of the 
aerodynamic diameter 
Calculation of the aerodynamic diameter of GP was performed to determine the 
deposition of these particles in the respiratory tract. Calculation was performed by Dr 
Alan Jones at the Institute of Occupational Medicine.  
The gravitational settling speed of a particle is determined by the opposing effects of 
the gravitational force and the aerodynamic resistance.   The aerodynamic drag force 
depends on the shape and orientation of the particle with respect to its direction of 
motion.  A plate-like particle with uniform thickness may well settle under gravity 
with orientation perpendicular to its direction of motion.  If it is not a uniform 
thickness, it might behave like a spear with a weighted tip (if one edge is relatively 
heavy) or it might be stable in the perpendicular orientation if the extra weight is 
central.   
The gravitational force on a particle is determined by its volume and density.  For a 






      (1) 
where g is the gravitational acceleration. 
For a platelet particle, with thickness t, and projected area diameter dproj the 









     (2) 
The gravitational settling force is opposed by the aerodynamic resistance to the 
motion of the particle.   
For a circular plate-like particle of diameter b that is infinitely thin, the aerodynamic 
resistance when the plate is perpendicular to the direction of motion at velocity V, the 
following expression can be obtained from Fuchs et al. (Fuchs N.A., 1964) for the 
resistance to motion  
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VbFm  8      (3) 
where η is the viscosity of air.  
The above equation applies when the disc is perpendicular to the direction of motion. 
When the infinitely thin circular plate-like particle is orientated parallel to the 




     (4) 
 
Fuchs(Fuchs N.A., 1964) also notes that the formula in equation 4 has given good 
agreement with data when Oseen’s correction is introduced.  For present purposes, 
the detail of Oseen’s correction can be ignored. 
When the particle reaches an equilibrium settling velocity (Vs,), then Fm= Fg, and by 
taking the projected area diameter dproj as being approximately the same as the 









      (5) 







     (6) 
The definition of the aerodynamic equivalent diameter is the diameter of a unit 
density sphere with the same settling speed as particle; that is, if Vss = Vs then the d in 
equation 6 is the dae for the plate-like particle.  This leads directly to an expression 








    (7) 
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Using equation 7, we can estimate the aerodynamic diameter for plate-like-particles 
of given dimensions. Using this equation, we can estimate the aerodynamic diameter 
for plate-like-particles of given dimensions. The size of GP was measured using 
SEM and light microscopy images and plotted as percentage of GP per projected area 
diameter in the sample (Table 6-3). The GP consist of several sheets of graphene 
with a thickness of approximately 10 nm each, therefore their thickness increases to 
around 0.1 µm, depending on their dispersion. This information was used to calculate 
the Dae of GP used in this study and shows that they are within the size range of the 
respirable fraction (Table 6-3).  
  
Table 6-3: Size distribution of GP in the sample expressed as percentage of GP per 
projected area diameter. Aerodynamic diameter Dae of GP at various projected 
diameters and a thickness (t) of 0.1 µm.  
 
6.3.3 Acute pulmonary inflammatory response to GP  
To assess the hazard of GP to the lungs, GP were deposited in the lungs by 
pharyngeal aspiration at a dose of 50 µg per mouse. At 24 hour post exposure the 
total number of bronchoalveolar lavage (BAL) cells was increased significantly in 
GP exposed mice compared to vehicle control and mice aspirated with CB (Figure 
6-1 I). This increase in cell number was mainly due to increase in 
polymorphonuclear leukocyteleukocytes (PMN), mainly neutrophils and eosinophils 
in the lavage fluid (Figure 6-1 I). The loss of membrane integrity of cells in the BAL, 
measured via the release of LDH was also significantly increased in GP treated mice 
(Figure 6-1 II). Concentration of the pro-inflammatory cytokines MCP-1, MIP-1α, 
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MIP-2 and IL-1β were measured in the BAL fluid using a quantikine kit. All 
cytokines measured were elevated after GP treatment compared to VC and CB, 
however only MIP-1α reached a significant difference (Figure 6-1 III).  
 
Figure 6-1: Pulmonary inflammatory response to CB and GP 24 hour post 
aspiration. I) Total cell number and total granulocyte number to CB and GP in the 
lavage fluid. II) Measurement of the membrane integrity via LDH release in the 
lavage fluid. III) Concentration of the chemokines MCP-1 and MIP-1α as well as 
cytokines MIP-2 and IL-1β in BAL. Significance indicated compares treatment 
groups to vehicle control, ** indicates p < 0.001, *** indicates p < 0.0001 (n = 3). 
Data represent mean + SEM of n = 3. 
6.3.4 Histological examination of the lungs treated with GP and CB 
Lung pathology 24 hour post aspiration was examined. Histological sections of lungs 
from mice treated with VC (Figure 6-2) and CB (Figure 6-3) had a normal histology. 
Histology sections of lungs from mice treated with GP showed granulomatous 
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lesions in the bronchiole lumen and in the vicinity of terminal bronchioles in the 
alveolar region (Figure 6-4). 
 
Figure 6-2: Lung pathology 24 hour post aspiration to VC. An entire lung section 
stained with Haematoxylin & Eosin (H&E) is shown to demonstrate gross pathology 
of a VC treated mouse (0.5% BSA/saline). Normal delicate structure of the lung 
including the terminal bronchioles and alveolar septa (callout) (representative image 




Figure 6-3: Lung pathology 24 hour post aspiration to carbon black (CB). An entire 
lung section stained with Haematoxylin & Eosin (H&E) is shown to demonstrate 
gross pathology of a CB treated mouse (50 µg/mouse). For the most part, the 
structure of the lung looks similar to the VC with minimal deposition of CB within 







Figure 6-4: Lung pathology 24 hour post aspiration to graphene platelets (GP). An 
entire lung section stained with Haematoxylin & Eosin (H&E) is shown to 
demonstrate gross pathology of a GP treated mouse (50 µg/mouse). Extensive 
accumulations of inflammatory cells and GP aggregates are indentified (callout), 
mainly in the vicinity to terminal bronchioles. (representative image of an n=3). 
Scale bar insert 20 µm. 
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6.3.5 Medium term (1 week and 6 weeks) pulmonary inflammatory response 
to GP  
The chronic response to CB/GP exposure was investigated 1 week and 6 weeks 
following a single exposure.  The inflammatory response, measured in the number of 
total granulocytes decreased to a non-significant level from a 24 hour timepoint to 1 
week and 6 weeks timepoint (Figure 6-5 II). The total cell number retrieved from the 
BAL was higher in all treatments at the 6 weeks timepoint compared to 24 hour and 
1 week, however showed no significant increase (Figure 6-5 I).  
 
Figure 6-5: Inflammatory response in the lungs after 24 hour, 1 week and 6 weeks 
exposure to CB and GP. Total cell number (I) and total granulocyte number (II) after 
pharyngeal aspiration of a single dose of 50 µg of CB and GP 1 week post treatment. 
Significance indicated compares treatment groups to vehicle control, * indicates p < 




Histopathological changes in the lung sections 1 week and 6 weeks post aspiration 
were examined in lung sections stained with haematoxylin/Eosin (H&E) (left panel) 
and Picrosirius Red (PSR) (right panel) and compared to VC. One week post 
exposure, no granulomatous lesions could be observed in GP treated lung sections 
however an increased number of lymphocytes was present in the smooth muscle 
surrounding the bronchi and in the alveolar spaces (Figure 6-6 II). In CB treated lung 
sections only occasional areas of lymphocyte infiltrates could be observed (Figure 
6-6 I). No granuloma formations, infiltration of inflammatory cells or epithelial 
hyperplasia was observed in lung section of GP exposed mice at a 6 week timepoint 
(Figure 6-6 III) which is indicative of a lack of immunogenicity. Assaying for lung 
fibrosis indicated by collagen deposition was determined using PSR staining but no 
increase in collagen deposition was observed (Figure III) in association with 






Figure 6-6: Lung pathology of CB treated mice at 1 week and GP treated mice at 1 
week and 6 weeks. Histological examination showed minimal infiltration of 
lymphocytes in CB treated mice (I), which were seen in a greater extent in the GP 
treated mice after 1 week (II). At the 6 weeks timepoint minimal granulomatous 
areas were observed after GP exposure (III), even though GP aggregates were 
present in the lung sections. The right hand panel shows sections stained with Pico-
Sirius Red to illustrate collagen deposition, which was comparative to VC in all 
treatments.Representative images of n=2. 
 
6.3.6 Acute pleural response to GP after intrapleural injection 
So far no information is available on the translocation of platelet shaped particles 
from the lung to the pleural space after inhalation exposure. If translocation to the 
pleural space occurs, platelet shaped particles could behave similar to fibrous 
materials in a way that they cannot negotiate stomata which would lead to 
accumulation of GP in the pleural space. Therefore, we set out to determine the 
inflammatory potential of GP after intrapleural injection. 
The acute pleural inflammatory response was measured 24 hour after intrapleural 
injection of CB and GP. The pleural space was lavaged and a total and differential 
cell count was performed.  Mice exposed to GP showed a significant increase in total 
cell number compared to vehicle control (Figure 6-7 I) with significant increases in 
the number of PMN which mainly comprised neutrophils. Chemokine and cytokine 
protein levels in the pleural lavage fluid were measured (MCP-1, MIP-1α, MIP-2 and 
IL-1β) using a quantikine array showing that MIP-1α was significantly increased, 
however only very low concentrations were detected due to the dilution of pleural 
fluid during the lavage process (Figure 6-7 II). Based on the very low concentration 
(5 pg/ml) detected, the statistically significant value can however not be considered 
as biologically significant. Cytospin preparation of lavaged cells showed complete 
uptake of CB into pleural macrophages (Figure 6-7 III); however GP, due to their 
shape and size could not be fully phagocytosed leading to frustrated phagocytosis. 
Rosette-like formations of macrophages around GP are a characteristic indicator of 
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frustrated phagocytosis where more than one macrophage surround a large 
nanoplatelet and share the attempt to phagocytose it (Figure 6-7 III). Histological 
examination of the parietal pleura showed areas of histiocytic aggregates in mice 
treated with GP (Figure 6-7 IV). The lesion area along the mesothelium was 
measured and was significantly increased compared to VC and CB at the 24 hour 
timepoint (VC/CB=0 µm
2
/µm; GP= 19.5+ 11.6 µm
2
/µm) (n=3). GP were associated 
with inflammatory cells along the parietal pleura as shown by SEM Figure 6-7 IV 





Figure 6-7: Pleural inflammatory response to CB and GP 24 hour post treatment. I) 
Total cell number and total granulocyte number after pleural injection of 5 µg of CB 
and GP. II) Concentration of the chemokines MCP-1 and MIP-1α as well as 
cytokines IL-1β in pleural lavage. (*) P < 0.05, (***) P < 0.001 compared to vehicle 
control. Data represent mean + S.E.M. of n = 4 for I and II.III) Representative 
images of pleural macrophages from untreated mice, CB and GP. Intrapleural 
injection of GP led to the formation of rosette-like cell/particle aggregations 
indicating frustrated phagocytosis (n=4).  IV) Sections of chest wall were stained 
with both Haematoxylin & Eosin (H&E) at 24 hour post injection to identify a 
inflammatory response on the mesothelial cell layer of the parietal pleura (n=3). 
Pleural thickening can be seen after GP treatment, with an insert highlighting GP 
associated with inflammatory cells. Scale bar 100 µm, insert 20 µm. SEM 
micrographs show aggregations of inflammatory cells after GP treatment but normal 
mesothelial cell layer after VC and CB treatment (bottom panel). Scale bar 20µm. 
 
6.3.7 Chronic pleural inflammatory response to GP after intrapleural 
injection 
We further set out to determine the inflammatory response after 1 week in the pleural 
space to GP after intrapleural injection of a dose of 5 µg/mouse. The granulocyte 
response 1 week GP post exposure was decreased to a tenth compared to 24 hour 
exposure (Figure 6-8 I). The concentration of total protein in the lavage fluid was 
significantly increase in GP treated mice (Figure 6-8 II). Continuous thickening of 
the parietal pleura was present after 1 week exposure to GP (Figure 6-8 III). 
Inflammatory cells with associated GP were present along the parietal pleura (Figure 
6-8 III insert). These areas of inflammatory cells appeared denser and granulomatous 
on SEM micrographs at a 1 week timepoint compared to 24 hour (n=3) (Figure 6-8 





Figure 6-8: Inflammatory response in the pleural space after 1 week exposure to CB 
and GP. I) Total cell number and total granulocyte number after 1 week exposure to 
CB and GP in the lavage fluid. II) Measurement of the total protein concentration in 
the lavage fluid. (*) P < 0.05, (**) P < 0.01 compared to vehicle control. Data 
represent mean + S.E.M. of n = 4 for I and II.III) H&E stained parietal pleura 
section (n=1) (top panel) and SEM (n=3) (IV) in low and high magnification 
showing aggregations of inflammatory cells and granulomatous areas on parietal 




6.3.8 Clearance of CB and GP from the pleural space in cranial mediastinal 
lymph nodes 
To investigate the clearance of injected CB and GP from the pleural space via the 
lymphatic system, the mediastinal lymph nodes were sectioned and examined for 
particle deposition. CB particles were cleared from the pleural space after direct 
pleural injection via stomata to the cranial mediastinal lymph nodes as can be seen in 
histological lymph node sections after 24 hour and 1 week (Figure 6-9 I, II). 24 hour 
after GP exposure, few particles could be found in the lymph nodes which indicated 
prolonged retention in the pleural space (Figure 6-9 I). After 1 week GP have been 
cleared from the pleural space, however the amount of clearance appears much less 
compared to CB (Figure 6-9 II).  Quantification of the GP size cleared to the lymph 
nodes could not be performed because of the difficulty to identifying individual 
platelets of GP in the sections. 
 
Figure 6-9: Clearance of CB to cranial mediastinal lymph nodes and prolonged 
retention of GP in the pleural space.  Histological sections of lymph nodes stained 
with Picrosirius red 24 hour (I) and 1 week (II) post injection. CB could be cleared 
already after 24 hour, however GP was prolonged retained in the pleural space. 





6.3.9 Translocation of GP to the pleural space after aspiration exposure 
Direct injection of GP into the pleural space doesn’t give information about 
translocation of particles from the airspaceafter inhalation exposure since it bypasses 
the natural clearance mechanism of the lungs and process of moving from the 
airspaces to the pleural space. Therefore, to identify whether GP translocate to the 
pleura following pulmonary exposure, the tissue and alveolar macrophages lying 
immediately beneath the visceral pleura were examined in histological sections after 
aspiration exposure at a dose of 50 µg/mouse. No accumulations of GP were seen 
subjacent to the visceral pleura (data not shown). Additionally the pleural space was 
lavaged and the extent of inflammation measured at the timepoints 24 hour, 1 week 
and 6 weeks. At all timepoints no significant influx of inflammatory cells into the 
pleural space was measured after treatment with CB and GP compared to vehicle 
controls (Figure 6-10 I, II). This was verified by failure to detect aggregations of 
inflammatory cells or granuloma formation by SEM examination of the mesothelial 
surface of the parietal pleura (Figure 6-10 III, IV, V). The translocation of GP was 
compared to CNT at 24 hour, 1 week and 6 week timepoint (Figure 6-10 I, II, VI) 
(CNT data with permission from (Murphy et al., 2012a), these data were produced 
prior to the experiments presented in this chapter). Aspiration of CNT led to 
translocation to the pleural space at the 6 week timepoint as measured by increase in 
the total cell number and total granulocyte number and accumulation of 
inflammatory cells on the mesothelial surface of the parietal pleura as reported in 









Figure 6-10: Inflammatory response in the pleural cavity after pulmonary exposure 
to CB, GP and CNT. The inflammatory response in the pleural cavity after CB, GP 
and CNT exposure via pharyngeal aspiration was examined. At 24 hour, 1 week and 
6 weeks post exposure the pleural cavity was lavaged and total cell number (I) and 
total granulocyte number (II) were measured. Data represent mean + S.E.M. of n = 
4. CNT data obtained with permission from Murphy et al. (Murphy et al., 2012a). 
The parietal pleura was examined by scanning electron microscopy (SEM) to identify 
lesion formation after pulmonary exposure to CB (IV) and GP (V). Normal 
mesothelium was observed in all treatments which was comparable to VC (III). VI) 
To illustrate an inflammatory response on the parietal pleura after aspiration 
exposure, SEM of parietal pleura after aspiration to 50 µg/mouse CNT at a 6 week 
timepoint is shown. Aggregates of inflammatory cells are present on the mesothelial 
surface indicating a translocation of CNT to the pleural space; this image was 
obtained with permission from Murphy et al. (Murphy et al., 2012a).  
 
6.4 Discussion 
In this study we addressed the public/occupational health hazard of GP in mouse 
lung from the point of view of aerodynamic deposition and the cellular responses in 
the lung. Although Duch et al. (Duch et al., 2011) have studied the biocompatibility 
of GP in the mouse lung from the point of view of biomedical/therapeutic application 
of GP, we believe that this study is the first to address pathogenicity of a nanoplatelet 
shaped particle. Nanoparticulate carbon black (CB) was used as a compact graphene 
nanoparticulate control and was aspirated at a mass dose found to be non-
inflammatory in previous studies (Cho et al., 2010). Carbon nanoparticulate has also 
been reported by other groups not to cause oxidative stress or DNA damage in mice 
and rats after short-term nose-only inhalation (Wessels et al., 2011). 
The atypical platelet-like shape of the GP particles attracted our attention as they 
may pose a new risk to the respiratory system after inhalation. Nanoplatelets exhibit 
specific material properties that could be important for biological interactions. 
Among these are surface area, surface chemistry and lateral dimensions. Due to their 
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platelet shape, they have an exceptionally high surface area per unit mass which is 
much greater than that of graphite and of carbon nanotubes (Pumera, 2009). The 
lateral dimensions of a material play an important role in biological interaction and 
determine the nature and consequences of cellular uptake and subsequent clearance.  
Thus far, in the field of particle toxicology the fibre pathogenicity paradigm has been 
stated as the most robust structure-activity relationship, and it has frustrated 
phagocytosis of long fibres as the centre of the pathobiological mechanism 
(Donaldson and Tran, 2004). This structure-activity relationship focuses on fibres 
that are long, thin and biopersistent, having an aerodynamic diameter that makes 
them respirable (Donaldson et al., 2011).  This structure-activity relationship 
however does not take sheet/platelet shape particles into account and therefore has to 
be reconsidered in the light of these new materials. 
To be most harmful to the respiratory system, particles require an aerodynamic 
diameter small enough to penetrate beyond the ciliated airways i.e. they need to be 
respirable.  Deposition occurs under the effects of gravitational force, aerodynamic 
resistance, interception and impaction which together determine the site of deposition 
in the lungs (Morgan and Seaton, 1984). The aerodynamic diameter is the index that 
is calculated from these parameters and determines the respirability of a particle and 
the site of deposition (Jones, 1993). Plate–shaped particles are not common in 
industry and so exposure is limited but does occur in the talc and nano-clay 
industries where there are plate-like particles (Cheng et al., 1988; Lordan et al., 
2011). However these nanotechnologies have the potential to produce a range of 
different nanoplatelet-shaped particles. In this study we calculated the aerodynamics 
of commercially available nanoplatelets by taking into consideration gravitational 
settling force and aerodynamic resistance perpendicular and parallel to motion, and 
utilised an equation derived from the tenets of aerosol physics to estimate the 
aerodynamic diameter of platelet-like particles of the dimensions evident in our GP 
sample. This demonstrated that a platelet-shaped particle with a projected area 
diameter of 25 µm and a thickness of 0.1 µm has an aerodynamic diameter of about 3 
µm, which is within the respirable size fraction of particles that deposit beyond the 
ciliated airways (Jones, 1993); These calculations are in line with the aerodynamic 
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sizes  reported recently in Sanchez et al. (Sanchez et al., 2012) which also showed 
images suggesting that GP might lead to frustrated phagocytosis in macrophages. 
Based on our determination that the GP sample used within these experiments were 
all respirable, we assessed the inflammatory potential of GP. Mice were exposed via 
pharyngeal aspiration to CB and GP for 24 hour, 1 week and 6 weeks. CB and GP 
are composed of the same material (graphene) and were both respirable but differed 
in their shape, which resulted in very different effects in the lung and the pleural 
space.  CB did not cause any inflammatory response and was comparable to vehicle 
control in all assays, whereas GP caused extensive recruitment of inflammatory cells, 
including macrophages and granulocytes into the lung and pleural space after 24 
hour exposure.  Inflammation waned 1 week post exposure but continued to be 
significantly greater in total cells and granulocyte number than the vehicle control. 
The response to GP in the lung was similar to the response seen after aspiration 
exposure of long MWCNT using the same method (Murphy et al., 2011; Porter et al., 
2010).  Our previous study on fibre shaped HARN and recent studies on CNTs 
revealed that, due to their fibre like structure which similar to asbestos show an 
asbestos like pathogenicity and raised concern that exposure to fibre shaped HARN 
may lead to mesothelioma (Poland et al., 2008). Our result show that long fibres are 
not the only extended particles with low Dae that are able to induce inflammation in 
the lung and the pleural space but that platelet like particles with a low Dae have 
similar  potency. The induction of acute and chronic inflammation is regulated by the 
release of cytokines and chemokines that invoke leukocyte recruitment. Analysis of 
BAL fluid revealed elevated levels of MCP-1, MIP-1α, MIP-1 and IL-1β after GP 
but not CB. MCP-1 and MIP-1α have been reported to contribute to the initiation and 
outcome of inflammation in the lung and in pulmonary alveolar macrophages after 
exposure to stone-wool and crocidolite asbestos (Tatrai et al., 2005).  MCP-1 has 
further been identified to play a major role in lung leukocyte infiltration (Conti and 
DiGioacchino, 2001) and serves as a marker for the diagnosis of malignant pleural 
mesothelioma (Gueugnon et al., 2011). 
In addition to short term inflammatory effects (24 hour and 1 week), the medium 
term inflammatory effects of pristine GP in the lung of mice after aspiration exposure 
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was investigated at a 6 weeks timepoint and showed no continuous inflammation, or 
granulomatous aggregations of inflammatory cells in the bronchial and alveolar 
regions, alveolar wall thickening or fibrosis.  This contrasts with carbon nanotubes, 
which did show all of these types of effect at these timepoints in mice at the same 
dose (Murphy et al., 2012a). Even though little is known so far on the pulmonary 
toxicity of GP it has been shown that the in vivo toxicity of graphene- based 
materials is closely associated with their surface characteristics as summarized in 
Yang et al.(Yang et al., 2013). Duch et al. showed that graphene oxide and 
aggregated pristine GP caused sustained pulmonary inflammation in vivo compared 
to well-dispersed pristine GP (Duch et al., 2011). The lack of pulmonary 
inflammogenicity after exposure to GP in medium term studies is in contrast to 
recent studies on pulmonary effects of CNT, which reported that CNT have the 
potential to cause severe lung fibrosis and persistent inflammation after aspiration 
exposure at a 6 week timepoint (Wang et al., 2011b; Shvedova et al., 2005; Mercer et 
al., 2011; Murphy et al., 2012a). Both CNT and GP are composed of graphene yet 
show very different effects in the lungs and so further study is warranted to elucidate 
the underlying mechanisms for differences in the inflammatory response to CNT and 
GP. 
We further went on to investigate the response of GP in the pleural space to identify 
if GP have a similar inflammatory potential compared to fibrous HARN. Significant 
pleural inflammation and accumulation of inflammatory cells along the parietal 
pleura mesothelium was measured after interapleural injection of GP at 24 hour, 
which however decreased to a tenth of the measured inflammation at a 1 week 
timepoint. The role of frustrated phagocytosis, a mechanism by which long fibres 
produce inflammation, has been examined in a number of studies (Brown et al., 
2007; Dogra and Donaldson, 1995) and has been accepted as a contributing 
mechanism to the toxic effects of long fibres. Due to the extended shape of GP, we 
hypothesised that the uptake of GP by macrophages could be impaired leading to 
frustrated phagocytosis. Examination of pleural macrophages in the lavage fluid 
showed clear signs of frustrated phagocytosis after GP exposure whereas CB was 
fully taken up. This took the form of GP incompletely enclosed by macrophages and 
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‘rosettes‘ of up to  5 or 6 macrophages surrounding a single large platelet where all 
of the macrophages are in a state of frustrated phagocytosis.  
The main mechanism by which long, fibre like particles cause harmful health effects 
in the pleura are failed clearance of longer fibres through stomata in the parietal 
pleura and subsequent retention in the pleural space and frustrated phagocytosis of 
pleural macrophages. We therefore investigated the retention of GP in the pleural 
space by examining the most caudal, posterior intercostal region of the parietal 
pleura, documented to have the highest abundance of stomata (Shinohara, 1997). 
Interstitial incorporation  of asbestos fibres and coal dust occurs in these areas and so 
they are described as potential starting points for development of mesothelioma 
(Muller et al., 2002). In support of this hypothesis extensive accumulation of 
inflammatory cells in these areas on the parietal pleura where GP were retained was 
observed.  In order to determine the clearance pathway of CB and GP, we examined 
the particle burden in cranial mediastinal lymph nodes (LN). Pleural fluid is drained 
through the parietal stomata via the lymphatic system to LN (Marco et al., 1992). CB 
was readily cleared to the mediastinal lymph nodes after 24 hour as could be seen in 
histological sections. In comparison, few GP had reached the LN after 24 hour, 
confirming retention of GP in the pleural space. After 1 week however, a higher 
number of GP could be identified in the mediastinal LN sections, which may explain 
the reduced inflammation seen 1 week after intrapleural exposure. Breakage of GP 
into smaller fragments after 1 week could explain the time- dependent clearance of 
GP to the LNs. We noted that the accumulation of GP in the LN seen at 1 week, 
whilst evident, was less than that seen 1 week after CB, suggesting that there is a 
substantial fraction of the GP dose that remains retained in the pleural space beyond 
one week.  
The direct intrapleural injection study of GP allows to measure their pathogenicity 
with the assumption that GP translocate to the pleural space. It is however not shown 
yet if GP would translocate to the pleural space after inhalation exposure in enough 
quantity that would lead to adverse effects in the pleural space. It has been shown 
that fibre-shaped CNT can translocate to the pleural space after aspiration exposure 
leading to persistent inflammation and granuloma formation at the surface of the 
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parietal pleura, similar to that seen after asbestos fibre treatment (Murphy et al., 
2012a; Mercer et al., 2010). We set out to determine if platelet shaped particles can 
translocate to the pleural space after aspiration exposure. The results showed that GP 
used in this study did not accumulate in the sub-visceral pleural tissue up to 6 weeks 
after aspiration exposure and no inflammatory response was measured in the pleural 
space up to 6 weeks post exposure. The absence of inflammation in the pleural space 
does not necessarily exclude the possibility of translocation of very small GP that are 
able to negotiate the  parietal pleural stomata from reaching the pleural space but 
being cleared (Donaldson et al., 2010). It might be argued that GP had not reached 
the pleural space by 6 weeks but would get there eventually. However translocation 
of CNT from the airspaces of mice to the pleural space has been seen at 28 days 
(Mercer et al., 2010) and 6 weeks (Murphy et al., 2012a) and so we see no reason to 
conclude that GP translocation might only begin after 6 weeks.  The difference in 
translocation behavior of CNT and GP could be explained by the structural 
morphology, whereby the fibrous structure of CNT could facilitate translocation as 
needles are more likely to penetrate cell layers (Mercer et al., 2010). In the case of 
GP, the platelet shape with its extended lateral dimension and no sharp, penetrating 
tip could inhibit translocation.  However, one limitation of this study is the use of a 
single sample of GP with a wide distribution of lateral diameter up to 25 µm.  
Collectively, our data show that large nano platelets can have a small enough Dae to 
be respirable and to deposit beyond the ciliated airways where macrophages are the 
only mode of clearance, but are too large to be completely phagocytosed by 
macrophages. They, therefore are likely to cause an inflammatory response in the 
airspaces and be retained, similar to the response seen after long asbestos and other 
long fibre-like structures (Murphy et al., 2011). If, like long fibres, they are capable 
of reaching the pleural space they will be retained there as they will be too big to 
negotiate the stomata and, with sufficient dose, they will cause pleural inflammation 
and pleural pathology over time if they are sufficiently biopersistent.  Our study 
showed however that no translocation of GP occurred up to 6 weeks post aspiration 
which could be explained by the shape of these particles. The fact that GP was not 
inflammogenic at a later timepoint, 6 weeks, has important implications for potential 
biomedical and technological applications of GP. 
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The decrease in the severity of inflammation after 1 week and 6 weeks treatment in 
the lung and the pleural space suggests degradation of GP into smaller fragments 
which could then be cleared via alveolar/pleural macrophages. In this study we focus 
on the morphology of the GP, rather than the graphene oxidation state, as regards 
pro-inflammatory effects especially frustrated phagocytosis. The argument of 
frustrated phagocytosis of GP is based on shape rather than chemistry, as does the 
argument of long fibres-elicited frustrated phagocytosis, which is an issue of fibre 
length, not composition (Donaldson et al., 2010; Donaldson, 2009). Future studies on 
different GP samples from different sources should examine the effect of surface 
chemistry/oxidation state, which might have an additional effect; however, we 




Chapter 7: Biopersistence of graphene nanoplatelets 
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7.2 Aims and hypothesis 
The studies on the time course of GP inflammogenicity in the lung after pharyngeal 
aspiration showed a decrease in inflammation at a 6 week timepoint, even though GP 
were evidently resident in the lung tissue as was clear from the inspection of the 
sections of lung. The resistance of carbon nanomaterials to biological degradation is 
a major concern for their potential in vivo toxicity but recent investigations have 
shown that carbon nanomaterials, including graphene oxide and oxidized carbon 
nanotubes, can be degraded by oxidase enzymes including horseradish peroxidase 
and neutrophil myeloperoxidase (hMPO) in vitro and in vivo (Kagan et al., 2010; 
Graham et al., 1999; Kotchey et al., 2011; Shvedova et al., 2012) causing them to 
exhibit less inflammatory potential in vivo. This study aimed to investigate the in 
vivo oxidation and degradation of pristine GP in lung tissue at 24 hour, 1 week and 6 
weeks after single aspiration exposure. The correlation between the biological effect 
study and the investigation of the material oxidation in vivo is based on the link 
between the decrease in biological effect with increased degradation of material due 
to oxidation. To aid in the interpretation of in vivo data, additional in vitro enzymatic 






7.3.1 Oxidation of GP in lung tissue 
Degradation of GP via enzymatic oxidation in lung tissue was measured using 
Raman microspectroscopy. Section of lungs embedded in paraffin blocks from mice 
exposed to GP for 24 hour, 1 week and 6 week via pharyngeal aspiration were used.  
Characteristic graphene Raman spectra were recorded from GP within the sections 
enabling us to directly probe for oxidized graphitic material; data are presented as 
average spectra from 20 locations (Figure 7-1 I, III, IV, V). Oxidation is known to 
increase the ratio of the D (1360 cm
-1
) band, which indicates disorder in sp
2
-
hybridized carbon systems to the G band (1580 cm
-1
), evaluating the stretching of C-
C bonds of graphene. Graphene spectra recorded in lung sections showed no 
significant difference between ID/IG at the different timepoints, indicating that no 
systematic oxidation had taken place over the period of 6 weeks (Figure 7-1 II). 
Spectra from lung sections also showed vibrations at 1300 cm
-1
 and 1440-1460 cm
-1
 
characteristic of paraffin wax spectra at 20°C due to the CH2 twisting band and 
overtones of the CH2 bending, respectively (Zheng and Du, 2006). Background 
spectra from the paraffin block did not interfere with the specific Raman spectra for 





Figure 7-1: Raman spectroscopy of GP in lung sections. I) Raman spectra of GP in 
lung section embedded in paraffin from mice exposed for 24 hour, 1 week and 6 
weeks to GP via pharyngeal aspiration. Characteristic D (1360 cm
-1
) and the G band 
(1580 cm
-1
) of graphene can be seen. Spectra at 1290 cm
-1
 and 1450 cm
-1
 is 
characteristic for paraffin wax. II) No statistically significant change in the ratio of 
ID/IG was measured as shown in the insert. Data represent mean of 20 spectra. 
Average and standard deviation of 20 locations from GP in lung tissue after 24 hour 
(III), 1 week (IV) and 6 weeks (V) post exposure. 
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7.3.2 Enzymatic oxidation of GP via Horseradish peroxidase 
To determine the capability of peroxidases to oxidize GP, in vitro oxidation of GP 
was studied using the enzyme horseradish peroxidase (HRP). The active site of HRP, 
Fe(III) porphyrin IX  has been reported to be analogous to leukocytic peroxidase in 
the oxidation of graphenic carbon (Kotchey et al., 2012). The suspensions with GP, 
HRP and H2O2 were left for 24 hour (H2O2 added every hour for 12 h) and 1 week 
(H2O2 added every day) at room temperature  and Raman spectra were recorded to 
measure the change in the extent of oxidation of GP via the ratio ID/IG as well as a 
disorder induced Raman D’-band at 1620 cm
-1
, indicating imperfect crystalline order 
(Malard et al., 2009). Control samples included GP without HRP and GP without 
H2O2. Between 0 hours and 24 hours the D:G ratio showed a modest increase from 
0.12:1 to 0.22:1, however the disorder induced D’-band was recorded in three out of 
six spectra for HRP+ H2O2 treated samples and was not observed in untreated 
pristine samples (Figure 7-2 I, II, IV). The spectra recorded after 1 week incubation 
with HRP were similar to the spectra recorded after 24 hour with the exception of 
one spectrum, which showed an substantial increase in D:G ratio to 0.76:1 indicating 
extensive oxidation of GP (Figure 7-2 III, IV). Raman spectra from control samples 
were similar to those from pristine GP (data not shown). All averaged spectra with 




Figure 7-2: Raman Spectroscopy of GP after horse radish peroxidise (HRP) 
treatment. Raman spectra from pristine GP (I) and GP treated with HRP and H2O2 
for 24 hours (II) and 1 week (III). Average and standard deviation of 20 locations 
(pristine) and 6 locations (HRP treatment) are shown. IV) Averaged raman spectra 
of pristine GP and GP incubated with HRP and H2O2 for 24 hour and 1 week. An 
increase in the D-band and D’-band at 1620 cm
-1
 was observed at 24 hour and 1 
week compared to pristine spectra however no significant increase in ID/IG ratio was 
measured. For the 1 week timepoint one spectrum was recorded with an increase in 
D:G ratio to 0.76:1.  
 
7.3.3 Chemical oxidation of GP via plasma ashing 
To compare the spectroscopic data of enzymatic oxidation of GP to that of a 
chemical oxidation, O2 plasma oxidation of the GP was performed. Raman spectra of 
chemical oxidized GP were recorded after 5, 10, 15, 40 and 60 min of plasma 
oxidation. An increase in the ratio of D:G band (0.12:1 (0 min), 0:22:1 (5 min), 
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0.24:1 (10 min), 0.27:1 (15 min), 0.19:1 (40 min) and 0:25:1 (60 min)) and a disorder 
induced Raman D’-band at 1620 cm
-1
 appeared indicating imperfect crystalline order 
and  increase in the degree of oxidation of the GP (Figure 7-3 I) (Malard et al., 
2009). All averaged spectra with standard deviation including plasma oxidation up to 






Figure 7-3: Raman Spectroscopy of GP after plasma ashing. Summary of raman 
spectra (I) and individual raman spectra from pristine GP (II) and chemical oxidised 
GP using oxygen plasma for 5 min (III), 10 min (IV), 15 min (V), 40 min (VI) and 60 
min (VII). Increase in D- band and disorder induced Raman D’-band at 1620 cm
-1
 




The aim of this study was to investigate the oxidation of GP in lung tissue up to 6 
weeks after pharyngeal aspiration; parallel in vitro studies using intense enzymatic 
oxidation were also carried out.  
Biopersistence is a major contributing factor to the toxicity of carbon-based materials 
and is dependent on the surface functionalization of these materials (Osmond-
McLeod et al., 2011; Liu et al., 2010). Recent studies on the degradation of oxidized 
carbon nanomaterials by Kagan and coworkers have shown that enzymatic oxidation 
in vivo and in vitro leads to the disruption of the carbon structure in highly oxidized 
graphene as well as highly oxidized SWCNT and MWCNT (Kagan et al., 2010; 
Allen et al., 2008; Kotchey et al., 2011). In these studies of enzymatic degradation, 
the carbon nanomaterials were subjected to sever chemical oxidation prior to the 
enzymatic treatment in order to facilitate peroxidase mediated degradation via the 
interaction of positively charged residues of hMPO with the carboxyl surface of the 
nanotubes. Based on these studies our aim was to examine the degree of oxidation of 
non-oxidised pristine GP in vivo up to 6 weeks in lung tissue as well as in vitro using 
horseradish peroxidase which acts as a surrogate for leukocyte peroxidase as 
previously decribed (Kotchey et al., 2011). Raman spectroscopic evaluation of 
oxidative defects in pristine GP present in lung sections in vivo revealed that GP did 
not undergo oxidative change. This is in line with results published on the 
biopersistence of pristine CNT and reduced graphene oxide, showing less effective 
biodegradation by peroxidase compared to oxididized CNT (Kagan et al., 2010; 
Kotchey et al., 2011). A possible explanation between the degradation of pristine and 
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oxidized carbonaceous nanomaterials has been stated by Kotchey et al. as being a 
lack of binding sites for enzymes on the surface of pristine CNT and GP compared to 
oxidized surfaces with its covalently attached oxygen functional groups (epoxides, 
negative charged carboxyl groups) facilitating strong interaction with enzymes 
(Kagan et al., 2010; Kotchey et al., 2011). A recent study has shown that MPO-
deficient mice show increased pulmonary inflammation and impaired clearance after 
pharyngeal aspiration of oxidized SWCNT due to impaired degradation compared to 
wild type mice (Shvedova et al., 2012). MPO is initially present in the local 
microenvironment after inhalation exposure and could also be present during long 
term inhalation exposure, however the importance of MPO in nanomaterial 
degradation is questionable since neutrophils play only a minor role in phagocytosis 
and clearance of deposited nanomaterials in the lungs, the bulk of particle clearance 
being mediated through alveolar macrophages (Lehnert and Morrow, 1985). The 
persistence of large accumulations of GP was very obvious at 6 weeks with no 
neutrophils in the lavage fluid and therefore MPO would be an unlikely factor in the 
applied experimental conditions. Therefore, a role for MPO in the dissolution, 
breakage and clearance of these particles seems most unlikely.  Studies on the 
peroxidase activity of alveolar macrophage in rats during pulmonary inflammation 
have shown that alveolar macrophages acquire peroxidase activity from multiple 
sources during pulmonary inflammation but only 0.8% of all macrophages were 
positive for cytoplasmic peroxidase in normal rats (Shellito et al., 1987). Therefore 
future studies to clarify the impact of alveolar macrophages, if any, on 
biodegradation of graphenic nanomaterials are a priority.  
In parallel with the studies on degradation of pristine GP in vivo we examined the 
potential enzymatic oxidation of GP in vitro using HRP and H2O2, as a surrogate for 
MPO as described in Kotchey et al. (Kotchey et al., 2011). No significant increase in 
ID/IG ratio was observed but another band, the D’ band, located at 1620 cm
-1
 
appeared, which is documented in literature to be linked to substantial defects in the 
graphene structure (Kudin et al., 2008; Malard et al., 2009). Additionally, the 
recording of one spectrum showing a substantial increase in the ID/IG ratio after 1 
week HRP treatment leads to the conclusion that the oxidation process may be 
intrinsically non-linear and that this introduces a large variability to the process. 
272 
 
Minimal oxidation was seen in pristine GP treated  in vitro with the peroxidase, but 
the extent of degradation was not comparable to complete dissolution of the 
graphene structure of oxidized GP after 20 days HRP H2O2 treatment reported  in 
Kotchey et al. (Kotchey et al., 2011). Therefore, the timeframe for oxidation of 
pristine graphene appears to be much longer than for oxidized graphene. This  is in 
line with the lack of oxidation we describe up to 6 weeks post exposure in vivo and 
the self-evident persistence of GP in lungs evident as large accumulations of particles 
in the histological section. However, from our study we cannot exclude the 
possibility that a small fraction of GP were being oxidized, comminuted and then 
cleared from the lungs and therefore not detected in our study. We showed that the 
absence of a biological effect of GP after a 6 weeks timepoint was not correlated 
with degradation via oxidation and subsequent clearance of the deposited GP.  
Oxidative degradation of GP in vivo does not account for the lack of inflammation at 
a 6 weeks timepoint since no change in the ID/IG ratio in the Raman spectrum 
occurred, indicating no oxidation of pristine GP up to 6 weeks in lung tissue and in 
addition large accumulations were plainly seen in lung sections. In vitro oxidation of 
GP via HRP showed only minimal oxidation of GP indicating that pristine graphenic 
nanomaterials are more biopersistent and may behave differently in vivo to their 
oxidized counterpart. This study suggests that further research is warranted into 
biodegradation of pristine and oxidised carbonaceous nanomaterials via enzymatic 




Chapter 8: Mechanism of graphene platelet inflammation 
in vitro 
 
Some of the following results have been published in 
Schinwald A, Murphy FA, Jones A, MacNee W, Donaldson K. Graphene-based 
nanoplatelets: a new risk to the respiratory system as a consequence of their 
unusual aerodynamic properties. ACS Nano. 2012 Jan 24;6(1):736-46. 
 
8.1 Aims and hypothesis 
Based on the study showing acute inflammation in the lung and the pleural space 
after GP exposure (chapter 6), the aim of this study was to elucidate the mechanism 
underlying the inflammatory response to GP in vitro.  A number of endpoints were 
examined including oxidative stress, pro-inflammatory cytokine and chemokine up 
regulation and the involvement of the NALP3 inflammasome activation. IL-1β is 
known to be up regulated after asbestos, silica and CNT exposure (Dostert et al., 
2008; Hornung et al., 2008) and has been implicated in frustrated phagocytosis and 
the NALP3 inflammasome activation (O'Neill, 2008). We hypothesised that the 
NALP3 inflammasome complex is an important component of the molecular 
pathway and underlying mechanism by which cells sense foreign bodies including 
GP. 
8.2 Results 
8.2.1 Characterisation of cell/particle interaction  
Characterisation of differentiated THP-1 macrophage cells with GP was performed 
to identify if GP are readily internalised by the cells or led to frustrated phagocytosis. 
The interaction of differentiated THP-1 cells with graphene platelets was examined 
via SEM and TEM after a 4 hour exposure at a dose of 5 µg/cm². The SEM images 
revealed that GP exceeding the size of approximately 15 µm projected diameter 
could not be fully phagocytosed by THP-1 cells and therefore led to frustrated 
274 
 
phagocytosis (Figure 8-1 I). Complete uptake of smaller GP could be imaged using 
TEM as shown in Figure 8-1 II.  
 
Figure 8-1: Cell/particle interactions to examine the uptake of GP on the surface 
using SEM and inside of the cells using TEM following 4 hour exposure to GP.  I) 
SEM showing the attempted uptake of a GP by THP-1 macrophages (M). The arrow 
indicates the lip of the unclosed phagosome showing incomplete internalisation of 
the GP producing frustrated phagocytosis (n=3). II) TEM shows that small GP (≤ 5 
µm) could be entirely internalised (arrows) (n=2).  
 
8.2.2 GP-mediated loss of membrane integrity of THP-1 macrophages and 
depletion of reduced glutathione  
Electron paramagnetic resonance (EPR) measurements were performed to determine 
the generation of oxygen-centred free radicals of CB and GP as described in chapter 
6.3.1. Results were compared to one-another and to a positive Pyrogallol control, a 
spontaneous superoxide anion generator with Tempone H (without the addition of 
H2O2) used as a spin trap. Both CB and GP caused a significant increase in free 
radical generation with GP production increased by 2-fold compared to CB (Figure 
8-2 I). 
Release of LDH was used as an indicator of cell viability and measured after 24 hour 
exposure of THP-1 macrophages to CB and GP. A concentration range of 1 µg/cm², 
5 µg/cm² and 10 µg/cm² for GP was used and concentrations of 5 µg/cm² and higher 
significantly increased LDH release whilst CB exposure at the same concentrations 
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did not (Figure 8-2 II). An explanation for the loss of membrane integrity could be 
the generation of reactive oxygen species and so the levels of free thiol groups, 
predominantly GSH, was measured as an indicator for oxidative stress, using the 
fluorescence probe, monobromobimane. After 4 hour of GP exposure the levels of 
free thiol groups was significantly lowered compared to the vehicle control (Figure 
8-2 III, IV). CB did not cause a significant change in the levels of free thiol groups.  
 
 
Figure 8-2: Determination of the generation of oxygen-centred free radicals, LDH 
release and the decrease in free thiol groups as indications of cell toxicity and 
oxidative stress.  I) A significant increase in EPR intensity was measured in the GP 
sample which was comparable to the positive control Pyrogallol. Data expressed as 
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mean + s.e.m, n=3. II) Significant release of LDH after 24 hour exposure to GP at 5 
and 10 µg/cm
2
 while CB had no significant effect on LDH.Triton X (TX) was used as 
a positive control. Data expressed as mean + s.e.m, n=5. III) Mean fluorescence 
intensity (MFI) of monobromobimane (MBB) as indicator for levels of free thiol 
groups. GP exposure significantly reduced the MFI of MBB at all concentration 
measured. N-ethyl-maleimide (NEM) was used as a  positive control Data expressed 
as mean + s.e.m, n=4. (**) p < 0.01, (***) p < 0.001 compared to vehicle control. 
FlowJo software (Tree Star Inc.) was used for analysing the data. Gating was based 
on FSC/SSC. IV) Left hand image shows a representative side-scatter plot to 
illustrate the change in ‘granularity’ after GP phagocytosis. Change in MBB 
fluorescence was detected through a 450/50 filter, showing the decrease in 
fluorescence intensity after GP treatment and NEM, the positive control.  
 
8.2.3 Activation of the NALP3 inflammasome and pro-inflammatory cytokines 
after GP exposure in vitro 
The cytokine IL-1β has been shown to be up regulated as a response to long fibre 
treatment in a number of studies. In this study we examined if IL-1β is also involved 
in the pro-inflammatory response to GP.  We measured the concentration of IL-1β in 
the supernatant of THP-1 cells exposed for 24 hours to either LPS, CB (1 and 5 
µg/cm²) or GP (1, 5 and 10 µg/cm²) by ELISA. LPS as well as all concentrations of 
GP led to a significant increase in IL-1β expression whereas CB treatment had no 
effect (Figure 8-3 I). To investigate if the attempt to phagocytose GP was involved in 
up regulating IL-1β expression, phagocytosis was inhibited via disruption of actin 
filaments using cytochalasin D at 0.2 µM. The inhibition of phagocytosis 
significantly reduced IL-1β expression at all concentrations of GP; however 
cytochalasin D had no effect on the level of IL-1β released by THP-1 cells exposed 
to LPS since its action is not dependent on phagocytic processes (Figure 8-3 I). 
Phagocytosis of large particle activators and subsequent release of IL-1β has been 
shown to be linked to the activation of the NALP3 inflammasome. Additional 
mechanisms involved in the activation of the NALP3 inflammasome are decreased 
intracellular K
+
 linked to an efflux of K
+





 via increasing extracellular K
+
 concentration to 30 mM and the 
inhibition of generation of ROS via inhibition of NADPH oxidase using diphenylene 
iodonium (DPI) at 15 µM, the expression of IL-1β was significantly reduced in both 
LPS and GP exposed cells (Figure 8-3 I). An initial screening and a dose response 
series of the concentrations used for DPI, cytochalasin D and K
+
 was previously 
performed in the lab by Dr Fiona Murphy on THP-1 cells and published in (Murphy 
et al., 2012b). To further assess which cytokines were involved in acute 
inflammation after particle exposure a cytokine bead array was performed. The 
selected panel of cytokines and chemokines was TNF, IL-6, IL-8, IL-1β, CCL-2 
(MCP-1), CCL-5 (RANTES), CCL-3 (MIP-1α), basic FGF, IL-13 and TGF-β. Out of 
this range of cytokines, MCP-1, IL-8, MIP-1α and IL-1β were all significantly 
increased after GP exposure with no effect of CB exposure on these mediators 
(Figure 8-3 II).  
 
Figure 8-3: Data providing evidence consistent with the activation of the NALP3 
inflammasome, and pro-inflammatory cytokine expression on GP, CB and LPS 
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treatment. I) IL-1β concentration in the supernatant of THP-1 cells exposed to LPS, 
CB and GP measured by ELISA. LPS (1 µg/ml) as well as GP at all concentrations 
led to a significant increase in IL-1β expression whereas CB treatment had no effect. 
Phagocytotic uptake of GP was inhibited by cytochalsin D at a concentration of 0.2 
µM which led to a significant reduction of IL-1β expression in GP exposed cells. 
This effect was not observed in LPS treated cells. IL-1β expression after LPS and GP 
exposure was significantly reduced by inhibition of K
+
 efflux (30 mM) and 
diphenylene iodonium (DPI) at 15 µM, an NADPH oxidase inhibitor. Data expressed 
as mean + s.e.m, n=4. II) Four cytokines (MCP-1, IL-8, IL-1β and MIP-1α) out of 11 
tested were significantly upregulated after a 24 hour GP exposure. CB treatment did 
not lead to a significant increase in any of the cytokines measured. Data expressed 
as mean + s.e.m, n=3. (*) P < 0.05, (**) P < 0.01, (***) P < 0.001 compared to 
vehicle control. # p < 0.05, ## p < 0.01, ### p < 0.001 compared to vehicle control.   
 
8.3 Discussion 
The objective of this study was to examine the cellular interactions that are driving 
the acute inflammatory response to GP seen in the lung and the pleural space.  
To elucidate the mechanism leading to GP-induced inflammation, cell-nanoparticle 
interaction was examined in vitro using a macrophage cell line and a number of pro-
inflammatory cytokines and chemokines were measured and the expression of IL-1β 
put in relation to the activation of the NALP3 inflammasome. 
To investigate the interaction of macrophages with GP, cells of a differentiated 
monocytic cell line, THP-1, were treated with GP and phagocytosis was examined 
using SEM and TEM. Frustrated phagocytosis could be observed in SEM images, 
showing GP only partly phagocytosed by macrophages. TEM revealed that only 
small GP (≤ 5 µm) were fully taken up. The membrane integrity of THP-1 cells after 
24 hour GP exposure was also significantly impaired in a dose dependent manner. 
We also determined the generation of oxygen-centred free radicals by GP and CB 
using EPR. CB as well as GP generated a significant amount of free radicals, and GP 
generated approximately double that produced by CB. Therefore free radicals are 
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possibly involved in the pro-inflammatory effects seen in vivo and in vitro with GP 
compared to CB, although it is not likely that intrinsic free radical activity explains 
the extra potency of GP. We went on to determine the oxidative status of THP-1 cells 
by measuring the decrease in free thiol groups, mainly reduced glutathione after CB 
and GP treatment. Glutathione/glutathione disulfide is the major redox couple in 
cells and  its tight regulation is critical in antioxidant defence and regulation of 
cellular events (Wu et al., 2004). Glutathione is the most abundant low-molecular-
weight thiol and the loss of free thiol can be measured via loss of monobromobimane 
fluorescence (Wu et al., 2004). Exposure of THP-1 cells to GP led to a significant 
decrease in free thiol groups in a dose-dependent manner. Depletion of the 
antioxidant defence system by pollutants (Kelly et al., 1996) and respirable fibres 
(Brown et al., 2000) has been shown to result in oxidative stress and the activation of 
transcription factors including NF-κB (Brown et al., 1999). NF-κB regulates the 
transcription of inflammatory genes, including IL-1β, MIP-1α and MCP-1 (Rahman 
and MacNee, 1998).  We measured a panel of acute phase cytokines involved in the 
inflammatory response after exposure of THP-1 cells to CB and GP.  Four out of 11 
different cytokines measured, MCP-1, IL-8, IL-1β and MIP-1α, were significantly 
elevated after GP exposure. The pro-inflammatory cytokine and neutrophil 
chemotaxin IL-8 has been shown to be elevated in airway epithelial cells and serum 
(Duncan et al., 2010) as well as alveolar macrophages (Broser et al., 1996)  of 
asbestos exposed individuals (Duncan et al., 2010). 
Since GP exposure led to an increased production of IL-1β, we explored the 
possibility that GP promote inflammation by activating the NALP3 inflammasome 
pathway. As described in chapter 4, the NALP3 inflammasome has been identified as 
an underlying mechanism for asbestos, silica, CNT and monosodium urate induced 
inflammation (O'Neill, 2008). We hypothesised that large particle activators like GP 
could have a similar effect as fibrous particles.  In order to delineate the GP-induced 
signalling pathway leading to inflammasome activation, IL-1β production after GP 
exposure was compared to CB and LPS induced IL-1β release in cell culture medium 
and medium supplemented with inhibitors for phagocytosis, ROS generation and 
potassium efflux.CB was previously reported to activate the NALP3 inflammasome 
pathway leading to pyroptosis and IL-1β release (Reisetter et al., 2011). In this study 
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a dose of 30 µg/cm
2
 was used, at which loss of cell membrane integrity was 
observed.  In our study CB was used at a non-cytotoxic dose of 1 and 5 µg/cm
2
 
which did not lead to an increase in IL-1β expression.  
We investigated whether phagocytosis is needed to trigger inflammasome activation 
by disrupting actin filaments via cytochalasin D (Dostert et al., 2008). Inhibition of 
phagocytosis significantly reduced IL-1β expression after GP treatment, but had no 
effect on LPS induced IL-1β production, which is not mediated via phagocytosis. We 
further provided evidence that GP activity is blocked by inhibiting efflux of K
+
, 
which is necessary of NALP3 inflammasome activation. Reduction of IL-1β 
production was also achieved by inhibition of the NADPH oxidase supporting the 
hypothesis that ROS are generated via phagocytosis of GP through the activation of 
the reduced form of NADP. More detailed and extensive studies have to be 
performed to conclude that activation of the NALP3 inflammasome is involved in 
GP induced inflammation however the preliminary results from this study provide 
evidence leading to the conclusion that activation of the NALP3 inflammasome is 




Chapter 9: Concluding remarks 
This study focused on the shape/length of HARN as the Biologically Effective Dose, 
the key entity that drives pathophysiologically relevant forms of toxicity, 
inflammation being the one that was focused on here. Advances in nanotechnology 
allow the production of a range of different nanomaterials in various shapes, 
compositions, surface modifications, charges etc. to satisfy the production and 
industrial need for consumer end products. However, in regards to toxicological 
testing, this wide spectrum of new forms of materials make it difficult to deal with, 
since conventional toxicology can’t be applied to all newly developed materials. 
Therefore, structure-toxicity relationships (STR) are urgently needed to describe the 
Biologically Effective Dose of new nanomaterials which would allow the 
identification of the toxicological potential of a nanomaterial based on the STR 
without the need of individual testing. 
The development of STR, e.g. the fibre pathogenicity paradigm (FPP), has important 
implications on the risk assessment and exposure regulation. The current Health and 
Safety Executive standard on asbestos fibre sampling is based on the definition of 
‘fibres’ developed by the British Occupational Hygiene Society in 1968, whereby 
countable fibres were defined as strutures visible by phase contrast optical 
microscopy  with a length of 5-100 µm, an aspect ratio of 3:1 and a width of < 3 µm. 
In this study we showed that, fortuitously, this arbitrarily chosen fibre-definition 
coincides exactly with the threshold length for fibre induced pleural inflammation in 
mice. If the length set in the standard had been set higher then hazardous fibres 
would not have been counted and if it had been set lower an unnecessary penalty 
could have been applied to industries to comply with an overly-rigorous standard.  
The fact that synthetic nanofibres were used in the present studies to define the 
length threshold highlights the  general relevance of the standard to the new 
generation of fibres made from novel materials by nanotechnological methods that 
are currently being synthesised or are under test for use in industry.  There is a 
distinct possibility that workforces will be exposed to some of these nanofibres in 
workplace air and hygiene will be mandatory and our data suggest that the existing 
fibre–counting standard will be adequate for these new fibres 
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The present study also introduces a new high aspect material, namely nanoplatelets 
in the form of graphene as an exemplar, which pose an unusual risk to the lungs and 
possibly the pleural space, after inhalation exposure, due to their extended lateral 
dimensions. We showed that these sheet- or platelet shaped particles with nanoscale 
thickness but extended in their other two dimensions possess a low Dae which allows 
them to be respirable and reach the lower respiratory tract. Thus they have the 
potential to cause adverse health effects and therefore warrant further investigation. 
We suggest that the extended lateral dimensions which produce the high aspect ratio 
are the driving properties in pathological response to GP. However it seems likely 
that layer thickness and the subsequent role that this plays in rigidity is a key factor 
in determining pathogenicity, and this was not investigated here. Our initial results 
showing inflammogenicity at an acute timepoint and non-inflammogenicity at 
medium timepoints have important implications in the hazard identification of GP 
following inhalation exposure and for their use in biomedical applications. 
Additionally, the biopersistence of pristine GP in vivo in lung tissue up to 6 weeks 
with no associated inflammation implies biocompatibility, which could open the way 
to applications in tissue engineering and drug delivery. 
Our in vitro studies provide preliminary information regarding the mechanism by 
which the inflammatory response to HARN was initiated. As previously reported, 
activation of the NALP3 inflammasome complex and subsequent release of IL-1β 
may be an underlying mechanism of HARN induced inflammation - however more 
research is needed to confirm this.  
The pathophysiological responses to HARN described here were based on single 
exposure via the routes of either pharyngeal aspiration or intrapleural injection at 
short and medium timepoints up to 6 weeks. Extrapolation of this data for the 
purpose of risk assessment is limited since the routes of exposure chosen are artificial 
and the data has to be confirmed by the use of more physiologically relevant 
exposure scenarios. Long term inhalation exposure studies with relevant 
concentration and repeated exposure as performed by Pauluhn et al. and Ma-Hock et 
al.  (Pauluhn, 2010; Ma-Hock et al., 2009) are required to determine if the threshold 
length for pulmonary and pleural inflammation in response to fibrous HARN and the 
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observed loss of inflammation after GP exposure, continue over a prolonged time 
and repeated exposure.   
Even though real-time exposure scenarios are necessary for the risk management of 
HARN, it has been shown that short term exposure studies via non-physiological 
routes can assist risk management as well as forming the basis for further 
investigations (Poland et al., 2008; Health and Safety Executive, 2009). 
Based on the above understanding of the probable mechanisms, we suggest that 
potential risks to humans from fibrous and platelet shaped HARN exposure could be 
minimised by a safer-by-design approach for the manufacture of HARN. This would 
involve,  where possible, producing only short fibres less than 5 µm and graphene 
platelets small enough to be phagocytosed by macrophages in order to minimise 
potential harmful effects. In addition to the ‘safe-by design’ approach, the new 
insights into the STR of HARN as presented in this study have important 
implications for nanofibre and nanoplatelet risk assessment.   
However, the specific properties of these materials in a shape exceeding the ‘safe-by-
design’ limitations may provide advantages compared to the particulate counterpart 
and HARN in the hazardous size ranges may therefore be produced. In this case strict 
criteria and counting methods should be defined to assess occupational exposure to 
HARN. Currently, to assess inhalation exposure to fibres, air is drawn through a 
filter onto which the airborne fibres fibres are deposited. The fibres are then counted 
using an optical microscopy according to a defined method; there are several variants 
of this method but the dominant approach is that published by the World Health 
Organisation. Only fibres with diameters less than 3 μm with a length greater than 5 
μm and an aspect ratio of at least 3:1 are counted. In terms of exposure assessment of 
HARN, detection methods with higher magnification than optical microscopy have 
to be used such as TEM or SEM to overcome the resolution limitation. Currently 
there is no consensus on the most appropriate approach and much more work is 
needed to routinely detect and quantify HARN.  The current regulations of 
nanomaterials in the European Union are covered by the ‘substance’ definition in 
REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals).  
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When considering the interaction between toxicology and exposure science, it is 
evident that the development of a protective but not punitive fibre standard requires a 
strong synergy between the two disciplines allowing the identification of the most 
appropriate metric and assessment criteria. Wherever possible, such synergy should 
continue and this is more and more evident when considering the challenges of 
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ratio nanoparticles to enable their safety-by-design
High aspect ratio nanoparticles: 
definitions & volume of production
Owing to the unique properties of matter in the 
nanosize scale, nanomaterials are being incor-
porated into a wide variety of consumer prod-
ucts, and research in developing new nanoma-
terials is proceeding remarkably fast. A material 
is defined as a nano-object (used here to define a 
nanoparticle as nano-object) as having one, two 
or three external dimensions in the nanoscale [1], 
(i.e., a nanoparticle is a particle with at least one 
dimension less than 100 nm). According to the 
structure and nanoscale dimension of the mate-
rial it can be further split into three different 
categories. 1D nanoscale materials are referred 
to as nano-layers, -films or -surfaces, whereas 
2D nanoscale materials are categorized as 
nanotubes, nanowires and nanorods; the third 
category consists of nano particles, which are 
nanoscale in all three dimensions. 
This article focuses on nano materials, which 
are nanoscale in 2D, particularly high aspect 
ratio (aspect ratio [AR] = length:width ratio) 
nanomaterials for which the acronym HARNs, 
signifying high aspect ratio nanoparticles, 
has been used [2]. The reason for focusing on 
HARNs in this article are:
 Their useful and novel electrophysical proper-
ties and their increasing production com-
pared with other nanoscale materials, as a 
con sequence of which there is increasing 
potential for inhalation exposure;
 Concern that, if HARNs are inhaled into the 
lungs they may behave similar to asbestos, 
some of which can be classified as HARNs, 
albeit natural in origin;
 Exposure to asbestos fibers caused a worldwide 
epidemic of disease, although not all fibers 
that can be breathed into the lungs are as 
pathogenic as asbestos and the different forms 
of asbestos are not equally pathogenic. There-
fore, if we can fully understand what features 
render a fiber pathogenic then we have the 
potential to develop HARNs that are 
safe by design.
As the name implies, HARNs have a high 
ratio of length-to-diameter, with a high sur-
face area and can be composed of a variety of 
elements and compounds; at present, HARNs 
include nanotubes, nanowires and nanorods 
(FIGURE 1). The terms nanowire and nanorod are 
used interchangeably in literature and the defi-
nition of these terms is still somewhat vague. 
The distinguishing feature between nanowires 
and nanorods is their length. Nanowires can be 
up to millimeters in length whereas each dimen-
sion of nanorods is within 100 nm. Therefore, 
the standard AR of nanorods is 3–5 in com-
parison with the AR of nanowires, which can 
High aspect ratio, or fiber-shaped, nanoparticles (HARNs) represent a growth area in nanotechnology as 
their useful properties become more apparent. Carbon nanotubes, the best known and studied of the 
HARNs are handled on an increasingly large scale, with subsequent potential for human inhalation 
exposure. Their resemblance to asbestos fibers precipitated fears that they might show the same type of 
pathology as that caused by asbestos and there is emerging evidence to support this possibility. The large 
number of other HARNs, including nanorods, nanowires and other nanofibers, require similar toxicological 
scrutiny. In this article we describe the unusual hazard associated with fibers, with special reference to 
asbestos, and address the features of fibers that dictate their pathogenicity as developed in the fiber 
pathogenicity paradigm. This paradigm is a robust structure:toxicity model that identifies thin, long, 
biopersistent fibers as the effective dose for fiber-type pathogenic effects. It is likely that HARNs will in 
general conform to the paradigm and such an understanding of the features that make fibers pathogenic 
should enable us to design safer HARNs.
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be greater than 1000. Another term used in 
the literature for HARNs is nanofibers, which 
are occasionally used as an umbrella term for 
nanowires and nanotubes. According to the 
WHO a fiber is a particle that has a maximum 
diameter of 3 µm, a minimum length of 5 µm 
and an AR greater than 3:1 [3]. Best known 
of all HARNs are carbon nanotubes (CNTs), 
which are long, thin cylindrical structures com-
prising single or multiple layers of concentric 
graphene sheets. CNTs have been optimized for 
a huge range of applications by derivatization 
of the surface with a range of chemical moi-
eties. Carbon, packed in the graphenic struc-
ture of CNTs exhibits exceptional properties 
from electrical and thermal conductivity to 
tensile strength and rigidity. The develop ment 
and optimization of CNTs for a huge range of 
applications, from use in electro nics to struc-
tural engineering, has been a feature of the 
developing n anotechnologies industry [4]. 
The advantages in the production of nano-
wires, nonCNTs and nanorods over CNTs 
could include controllability of length, diameter, 
geometry, surface functionality and purity dur-
ing the production process. Various techniques 
have been developed to synthesize nanowires 
and nanorods based on different methods (e.g., 
evaporation–condensation, dissolution–con-
densation and vapor–liquid–solid), but the 
template-based approaches have proved the most 
versatile. Dependent on the material under use, 
different template-based synthesis methods can 
be utilized [5]. For electrically conductive mate-
rials, the electrochemical deposition method is 
used and various nanowires and nanorods have 
been synthesized using this method, including 
metals such as Au, Ni, Co, Fe and Pb, as well 
as semiconductors, conductive polymers and 
oxides. Their applications range from electronic 
devices to tools for biology and medicine [6]. 
With regard to nanomedicine applications, 
CNTs in particular have been identified for a 
number of potential uses, including imaging, 
enhancement of bone growth and target ing and 
delivery of drugs [7–9]. Prina-Mello et al. pro-
duced ferromagnetic nickel nanowires with vari-
ous ARs for manipulating, identification and 
counting of living cells [10]. Sharma et al. stud-
ied the neuroprotective efficacy of compounds 
attached to nanowires in comparison with 
normal compound delivery and reported an 
enhanced beneficial effect of the nanowire–drug 
delivered compound [11]. Other template-based 
synthesis methods are electrophoretic deposition 
from colloidal dispersion and template filling. A 
wide range of HARNs has been produced using 
the electrophoretic deposition method including 





 [5]. Amongst these, ceramic nanoparticles 
have drawn special attention in the fields of drug 
delivery, imaging, sensing and thermotherapy 
due to their bio compatibility, simple prepara-
tion and ease of surface modification. In addi-
tion, silica nanotubes combined with iron oxide 
seem to be a promising tool for image-guided 
drug delivery. The tubular shape permits load-
ing of large amounts of the desired molecule, 
whereas the outer surface can be modified using, 
for example, polyethylenglycol or targeting 
moieties [12]. 
Year by year there is a near exponential 
increase in publications based on nano-
materials as well as a considerable expansion 
in market potential (TABLE 1) [13]. According to 
the data summarized in a recent report by the 
Federal Ministry of Education and Science in 
Germany, the compound annual growth rate of 
HARNs (excluding CNTs) is 30%. Even more 
out standing is the annual growth rate of sin-
gle-walled CNTs, which is 200% [101]. These 
figures correlate with the number of HARN-
related publications, which rose from 86 in the 
year 2000 to 1822 in the year 2009 (FIGURE 2). 





Figure 1. Images and characteristics of the different types of high aspect ratio nanoparticles. 
Gold nanorod image used with permission from [11].
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Comparing this number with the amount 
of publications on nanoparticles, which was 
3231 in the year 2009, the increasing impor-
tance of HARNs in nanotechnology industry 
becomes obvious. The increasing growth of the 
HARN industry suggests considerable poten-
tial for human exposure to airborne HARNs 
as these materials are handled in the work-
place during industrial preparation and use. 
However, despite rapid growth in the publica-
tions reporting the development, optimization 
and potential applications of various HARNs, 
the number of publications based on toxicity 
studies of HARNs makes up only 6% of all 
publications, whereas the proportion of toxic-
ity studies on nanoparticles is 19% out of all 
nanoparticle publications. These data illustrate 
quite clearly the worrying mismatch between 
the increases in research focused on the devel-
opment and use of HARNs versus research 
concerned with potential health effects of 
exposure to HARNs.
Table 1. Estimated market for nanoparticles.
Market segment World market volume [M$]/base year CAGR 
(%)Past Present Future
MWCNT 290/2006 650/2010 80
SWCNT 78/2006 5000/2010 200
Nanofibers (excluding CNTs) 48/2007 176/2012 825/2017 30
Metallic nanopowders (e.g., Ag) 89/2005 770/2010 53
Ceramic nanopowder (US market) 220/2006 580/2011 21
Nanotechnology in the healthcare market 
(US market)
23,000/2006 53,000/2011 18
Nanomedicine 18,000/2006 39,000/2011 17
Market growth trends and forecasts are based on information derived from relevant financial and market information, 
amongst others. 
CAGR: Compound annual growth rate; CNT: Carbon nanotube; MWCNT: Multiwalled carbon nanotube;  













































Figure 2. Number of publications on the topics of nanoparticles, high aspect ratio 
nanoparticles, excluding carbon nanotubes, and carbon nanotubes. Shows the increase in the 
number of publications on the main three categories of nanomaterials from 2000 to 2009. HARN in 
this graph include nanofibers, nanowires, nanorods and nanotubes made of materials other than 
carbon. These data are based on publications in the PubMed database. The search in the database 
was performed using the ‘advanced search option’ and ‘limits’ to specify the date range of 
publications in each field. Number of publication was revealed using the search terms ‘carbon 
nanotubes’ and ‘nanoparticles’. HARN data was obtain by summing the number of hits from 
‘nanofibers’, ‘nanowires’, ‘nanorods’ and ‘nanotubes’ using the ‘Search Builder option NOT’ to 
exclude CNTs. 
CNT: Carbon nanotube; HARN: High aspect ratio nanoparticle.
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Asbestos
Consideration of the likely adverse health effects 
arising from inhalation exposure associated with 
the use of HARNs is inevitably viewed in the 
context of the asbestos experience. Asbestos 
comprises a number of crystalline silicate miner-
als found ubiquitously in the earth’s crust, which 
was discovered to be industrially useful in the 
late nineteenth century. The subsequent min-
ing, working and incorporation of asbestos fibers 
into a vast range of consumer products gave rise 
to exposure of workers and end-users. Asbestos 
occurs as six minerals – one of the serpentine 
class (chrysotile) and five of the amphibole class 
(amosite, crocidolite, tremolite, anthophyllite 
and actinolite). Of these, only chrysotile, amosite 
and crocidolite have proved to be of significant 
industrial importance, with concomitant human 
exposure, although tremolite exposure occurs as 
a contaminant of chrysotile.
Annual world production of asbestos is cur-
rently approximately 2,000,000 tons worldwide 
with Russia as the leading producer, followed by 
China, Kazakhstan, Brazil, Canada, Zimbabwe, 
and Colombia, which together accounted for 
96% of the world production of asbestos in 2007. 
There is an important distinction to be made 
between chrysotile and the amphibole asbestos 
types in terms of chemical composition and chem-
ical stability, which is reflected in the differences 
in their pathogenic potency (discussed in the fol-
lowing paragraphs). This highlights an important 
point – namely, that not all respirable fibers are 
equally pathogenic – there is a structure:toxicity 
model termed the ‘fiber pathogenicity paradigm’ 
that predicts whether a fiber is or is not patho-
genic (described later). Notwithstanding these 
differences, all commercial forms of asbestos, 
including chrysotile, are classified as human 
carcinogens by the International Agency for 
Research on Cancer [14] and there have been 
calls for them to be banned on a global scale [15]. 
The asbestos minerals are crystalline, and con-
tain fracture planes, or weaknesses, in the crystal 
structure meaning that when the rock is stressed 
(e.g., by crushing of the ore or during mining) the 
crystal fractures into long thin fibers that can be 
released into the air. These high AR fibers, which 
can be, in the case of chrysotile fibrils, less than 
100 nm in diameter but very long, are normally 
termed fibers, but they can be seen as naturally 
occurring HARNs. Owing to their lightness and 
shape, asbestos fibers can readily become airborne 
and remain there for a protracted time. If they are 
inhaled and are thin enough, they can deposit in 
various parts of the respiratory tree, depending 
on their aerodynamic size. Once deposited in 
the lungs the accumulation of fibers can lead to a 
number of diseases principal amongst which are 
fibrosis or scarring of the lung parenchyma and 
bronchogenic carcinoma. In addition, asbestos 
exposure also causes a number of diseases in the 
pleura, including mesothelioma, pleural effusion 
and pleural fibrosis. 
The fiber pathogenicity paradigm
Most important for the HARN issue is the 
question – what are the properties of fibers that 
imbue them with pathogenicity? If we under-
stand the properties that render fibers patho-
genic or not then we can use this information to 
test or benchmark HARNs as to their likelihood 
of showing asbestos-like pathogenic behavior. 
We can also potentially utilize the paradigm to 
design safe HARNs. 
Several decades of fiber toxicology studies, 
on both asbestos and synthetic vitreous fibers 
(SVF) have resulted in the fiber pathogenicity 
paradigm, which highlighted the fiber param-
eters that dictate whether or not a fiber will 
be pathogenic when inhaled from an airborne 
respirable cloud (FIGURE 3).
These factors are width, length and bio-
persistence (FIGURE 3). It should be noted that the 
pathogenicity paradigm pertains only to the fiber 
hazard of HARNs. It does not describe the poten-
tial hazard that might occur from inhalation expo-
sure to any HARNs that is not long enough (see 
following paragraphs), in which case it is effec-
tively a particle whose toxicology is  understood in 
terms of an entirely different paradigm.
 Width
Width or diameter is the main factor that deter-
mines aerodynamic diameter, which is the prop-
erty that controls whether, or where, in the respi-
ratory tract any particle deposits. Deposition in 
the lungs is complex, resulting from the size and 
aerodynamic behavior of the fibers as they nego-
tiate the complex branching structure of the pul-
monary airways in the airstream. Aerodynamic 
diameter (D
ae
) is the measure that defines where 
in the respiratory tree any fiber deposits with the 
extra role of interception, which is a mode of 
deposition specific to fibers that results from the 
center of gravity of a fiber following the airstream 
at a bifurcation while the tip makes contact with 
the surface of the lung causing immediate depo-
sition. D
ae 
is determined predominantly by the 
width of the fiber, the aerodynamic diameter 
of any conventional fiber, composed of mate-
rial of around unit density, being approximately 
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three-times its width [16]. The lung has fast and 
effective clearance in the larger airways, where 
the mucociliary escalator traps the particles in 
mucus, which is then swept up to the mouth for 
swallowing to the gut. Beyond the ciliated air-
ways in the gas exchange regions, clearance is by 
macrophages that move around on the lung sur-
face and phago cytose or engulf the particles. The 
particle or short fiber-loaded macro phages then 
move upwards onto the mucociliary escalator 
for upward clearance to the mouth and the gut 
leading to effective clearance of particles [17] and 
short fibers [18]. This more fragile and slow clear-
ing alveolar and terminal bronchiolar compart-
ment beyond the ciliated airways where blood is 
very close to the body surface for gas exchange is 
considered to be much more sensitive to particle 
effects. This region is termed the respiratory zone 
and the aerodynamic size fraction of fibers that 
reaches this zone is termed the respirable fraction, 
and is generally considered to be the fraction of 
greatest health concern. Alveolar macrophage 
clearance from this region is highly effective for 
micron-sized particles, which are sconfined to 
the air space and can be collected by the alveo-
lar macro phages [17]. However, Semmler Behnke 
et al. have shown very different clearance/reten-
tion kinetics for nanoparticles [19]. These show 
80% interstitialization of Ir nanoparticles, which 
are re-entrained over 6 months back on to the 
epithelial surface where they are cleared, prob-
ably in macrophages, resulting in only 10% 
retention after 6 months. 
 Length
Once deposited, length is the factor that deter-
mines whether a fiber can be effectively cleared 
from beyond the ciliated airways by macro-
phages and whether the attempt of macro phages 
to phagocytose the fibers leads to inflamma-
tion [20,21]. Long fibers ( 15 µm) cannot 
be engulfed and effectively phagocytosed by 
macrophages while short fibers are effectively 
cleared [18]. For some HARNs, the rigidity or 
ability to coil up into a bundle could be an 
important factor in modifying the length. In 
the process of attempting phagocytosis, the 
macrophage extends along the fiber, but can-
not close the phagosome owing to the length 
of the fiber. This situation of frustrated phago-
cytosis (FIGURE 4) leads to lysosomal instability, 
activation of the NALP inflammasome; a multi-
protein complex that modulates innate immune 
function, and chronic stimulation of the cell 
resulting in the macrophage releasing a range of 
proinflammatory molecules [22]. 
 Biopersistence
The property of retaining structural integ-
rity during residence in lung tissue is known 
a bio persistence. The concept of biopersistence 
arises from the observation that different natu-
ral and man-made fibers with the same length 
dis tribution had very different lung retention 
times following deposition in the lungs and 
those which were most biopersistent in the lungs 
had the highest fibrogenic and carcinogenic 
potential [23]. Within the lung, the less biop-
ersistent components of the fiber may wholly, 
or partially, dissolve causing them to split lon-
gitudinally, as seen with fibrils of chrysotile 
asbestos, or break transversely as in the case of 
glass fibers. This arises as a result of the fluid 
milieu of the lung leaching certain structural 
components or to the acidic environment of 
Width
Main factor in determining
aerodynamic diameter
Length
Determines whether frustrated 
phagocytosis occurs
Composition
Major factor determining biopersistence
Figure 3. Important parameters governing 





Figure 4. Frustrated phagocytosis in 
alveolar macrophages by amosite asbestos 
fibers. Image of macrophages of the NR8383 
cell line; white arrow, attempting to 
phagocytose long amosite asbestos fibers 
(white chevron). The resultant elongation of the 
cells along the fibers as they attempt, but fail, 
to completely enclose the long fiber (black 
arrows) is termed frustrated phagocytosis.
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macrophage phago lysosomes acting in the same 
way to weaken the fiber. 
The effect that dissolution may have on a 
fiber can be varied, causing surface modifica-
tion or weakening of the structure leading to 
breaks with subsequent formation of short fib-
ers, more easily cleared by macrophages (FIGURE 5). 
The influence of characteristics, such as suscep-
tibility to dissolution and breakage, was shown 
by Miller et al. using rat exposure data from 
the Colt Fiber Research Program in the UK 
and studies from the program of the Thermal 
Insulation Manufacturers Association in 
Switzerland and the USA [24]. The role of biop-
ersistence was more directly shown by Searl et al. 
by comparing the length fraction of bio persistent 
amosite asbestos against nonbio persistent man-
made vitreous fiber (MMVF)-10 between 3 days 
and 12 months postinhalation in rats. In the 
case of the MMVF-10 sample, the number of 
short fibers increased after 12 months indicating 
breakage of the long fibers supplementing the 
population of short fibers [18]. Even within the 
asbestos family of minerals there are differences 
in bio persistence. Chrysotile asbestos has been 
shown to be less biopersistent than the amphi-
bole forms of asbestos, such as crocidolite and 
tremolite. This has been attributed to the layer 
of a magnesium hydroxide or brucite between 
the silicate sheets of chrysotile, which is more 
prone to dissolution causing the layers to unravel 
and break. The importance of this was shown by 
McDonald and colleagues who analyzed post-
mortem lung tissue from Quebec chry sotile 
miners by electron microscopy for levels of dif-
ferent forms of asbestos. They found that despite 
the main exposure being to chrysotile asbestos 
with only tremolite as a minor contaminant, 
chrysotile and tremolite were found in approxi-
mately equal quantities in the lungs [25]. This 
suggests that exposure to low levels of bio-
persistent tremolite lead to a cumulative build 
up of dose, while the dissolution of chrysotile 
led to a reduction in retained dose over time. As 
a concept, exposure to a fiber with a dimension 
that allows penetration of the lung but does not 
allow clearance by macrophages leaves only one 
route of clearance, namely dissolution or break-
age. Therefore, exposure to a biopersistent fiber 
that will not dissolve or break means that it shall 
persist in the lung environment where it may 
trigger pathological effects.
 Biopersistence studies with HARNs
The only HARN that has been investigated from 
the point of view of biopersistence is the CNT. 
It would be anticipated that single-walled CNTs 
(SWCNTs) are more amenable to degradation 
than multiwalled CNTs (MWCNTs) and that 
treatments that disrupted the graphene struc-
ture of SWCNTs introducing defects, would 
also render the CNTs more easily degradable. 
This has been confirmed in recent studies by 
Kane and colleagues, who concluded that greater 
bio solubility would be seen in any SWCNTs 
following any treatment ‘that causes collateral 
damage to the tubular graphenic backbone in 
the form of neighboring active sites that pro-
vide points of attack for further oxidative deg-
radation’ [26]. Similar results were found when 
SWCNTs that have been highly oxidized by 
acid treatment and then exposed to neutrophil 
peroxidase underwent dissolution [27]. It seems 
unlikely that unoxidized/unmodified SWCNTs 
or MWCNTs that have undergone mild oxida-
tion would be rendered soluble by the general 
Exposure
Deposition









Nonbiopersistent fibers Biopersistent fibers
Figure 5. The relationship between biopersistence, clearance and the biologically effective 
dose of long fibers.
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oxidizing environment of the lungs. This is 
borne out by numerous studies where CNTs 
have been introduced into the lungs and have 
been readily visible in sections months later. 
The general issue of CNT biopersistence 
should be addressed using conventional dura-
bility (measuring solubility in vitro) or bio-
persistence (measuring change in lung burden 
over time) protocols that are available [28,29].
Mechanism of lung disease caused 
by long fibers 
The process of inflammation is the initial cell-
ular response to cell death and oxidative stress 
arising as a direct result of the accumulation 
of long fibers in tissue above a threshold dose. 
Inflammation in turn gives rise to cell injury, 
gene expression of proinflammatory molecules 
and further oxidative stress, as amply demon-
strated in cells and lungs exposed to asbestos 
and other fibers (FIGURE 6). Thus, there are at least 
two ways that oxidative stress can arise in tissue 
where fibers have deposited – directly by inter-
action between the fibers and target cell such as 
epithelial cells, and indirectly when inflamma-
tory leukocytes release oxidants that affect the 
target cells. The milieu in the lung tissue con-
taining long fibers, with cell injury genotoxicity, 
oxidative stress and proliferation, is a fertile one 
for genetic injury, mutation, fibrosis and cancer. 
A proportion of the fibers that deposit periph-
erally in the lungs translocate to the pleural 
tissues [2] (see following sections) where they 
cause a similar sequence of events leading to a 
number of unusual fiber-specific pleural diseases, 
including fibrosis, pleural effusion and mesothe-
lioma. Mesothelioma is a tumor arising on the 
parietal pleura of the chest wall, which is almost 
exclusively linked to asbestos exposure, although 
there are other agents that may occasionally 
cause this effect. Mesothelioma has become a 
major concern from exposure to respirable fibers 
since it occurs at low exposure when the other 
effects are not apparent and because of its insidi-
ous and uniformly fatal course. 
Mesothelioma & the pleural 
mesothelium as a unique target for 
fibers including HARNs
 Translocation to the pleural space
The pleural space is the space between the chest 
wall and the lungs. The entire surface of the pleu-
ral cavity is lined with a single layer of meso-
thelial cells, with the mesothelial layer covering 
the lungs known as the visceral pleural, whereas 
the mesothelial layer attached to the chest wall 
and diaphragm is referred to as the parietal 
pleura. The development of pleural pathologies 
due to inhalation of asbestos fibers would suggest 
a biologically effective dose of fibers is delivered 
to this extrapulmonary tissue. Although the 
exact mechanism of fiber translocation from the 
lungs to the pleural space is unknown, there is a 

















Proliferation, genotoxicity, ECM synthesis, cell injury, death
Fibers provoke inflammation
Figure 6. The target cell shown could be an epithelial cell in the lining of the bronchial tree 
(bronchogenic carcinoma) or a mesothelial cell in the parietal pleura (pleural 
mesothelioma) and the diagram illustrates the direct and indirect pathways by which fibers 
may cause procarcinogenic effects. 
Adapted from [57].
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particles that deposit in the distal regions of the 
lung translocate to the pleural space. A study car-
ried out by Mitchev et al. on healthy individuals 
showed the presence of ‘black spots’, benign areas 
of particle accumulation, on the parietal pleura 
in 92.7% of a cohort of 150 urban dwellers exam-
ined at autopsy [30]. A greater accumulation of 
black spots has been noted on the parietal pleural 
surface of miners reflecting their higher exposure 
levels to coal dust [31]. Black spots represent areas 
of particle accumulation where a proportion 
of inhaled particles reaching the pleural space 
become interstitialized in the parietal pleura of 
the chest wall as they are in the process of being 
cleared. Studies investigating the link between 
asbestos exposure and the development of pleu-
ral pathologies have also detected asbestos fibers 
retained along the parietal pleura. Dodson et al. 
reported that short (<5 µm) chrysotile fibers were 
predominantly translocated into the pleura in 
the lungs of ex-shipyard workers exposed to both 
chrysotile and amphibole asbestos fiber types [32]. 
Kohyama and Suzuki also reported an appar-
ent predilection for short fiber movement into 
the pleural space after finding large amounts 
of short chrysotile fibers in pleural tissue even 
though the fiber burden in the lung contained a 
greater percentage of amosite fibers [33]. A study 
by Boutin et al. [34], however, which compared 
the fiber burden in areas containing black spots 
to normal areas of parietal pleura, found a high 
number of long fibers particularly associated with 
the black spots, with 22% of all fibers found in 
these areas greater than 5 µm in length. They 
also showed a clear-cut concordance between the 
long amphibole asbestos fiber burden in the lung 
and the black spots of the parietal pleura, but 
not the areas of normal pleura. Heterogeneity 
of distribution of fibers within the pleural space 
can most likely account for the conflicting results 
from previous studies, which reported a prepon-
derance of short chrysotile fibers in the pleura. 
These studies suggest that both short and long 
fibers deposited in the distal alveolar regions 
of the lung follow an incompletely elucidated 
route of particle clearance from the lung to the 
pleural space.
No published study has as yet reported the 
translocation of HARN fibers to the pleural 
space after administration into the lung; how-
ever, recently a study by Ryman-Rasmussen 
et al. [35] reported the deposition of inhaled short 
CNTs throughout the lungs and directly adja-
cent to the visceral pleura, wholly consistent with 
the notion that CNTs can reach the distal lung 
and the pleura. From the current understanding 
of particle/fiber movement from the lungs it is 
entirely probable that subpleurally deposited 
CNTs, as reported by Ryman-Rasmussen, and 
other forms of HARNs will translocate into the 
pleural space. This suggests the more pertinent 
question to be asked regarding the toxicity of 
these new materials and their potential to cause 
a fiber-like hazard is not whether they reach the 
pleural space but how they are dealt with once 
they are there.
Clearance from the pleural space
As mentioned previously, length is a control-
ling factor governing the macrophage-mediated 
clearance of fibers from the distal alveolar regions 
of the lungs. Similarly, clearance of particles and 
fibers from the pleural space appears to also be 
length dependent. The primary mechanism of 
clearance from the pleural space is to remove 
the particles passively in the flow of pleural fluid 
out of the pleural space where it joins the lym-
phatic system [36]. Stomata or pores, approxi-
mately 3–10 µm in diameter, act as a sieve for 
drainage from the pleural space and are found in 
highest abundance in the most caudal, posterior 
intercostal spaces and to a lesser extent in the 
ventral, parasternal region [36,37]. Normally, the 
elutriating effects of the lungs serve to allow only 
particles smaller than approximately 5 µm, and 
therefore smaller than the diameter of the sto-
mata, to reach the distal lung and pleural space. 
These particles are easily cleared in the flow of 
pleural fluid where they drain to the mediastinal, 
parasternal and hilar lymph nodes [38]. However, 
this clearance mechanism appears to fail when 
high AR fibers are encountered (FIGURE 7). In con-
trast to the movement of fibers in the lung, where 
it is the diameter of the fibers rather than the 
length that is the ruling factor in fiber deposi-
tion, in the pleural space when the length of a 
fiber is greater than the diameter of the stomata, 
interception of the fiber ends with the mesothe-
lial cells surrounding the stomata will occur [2]. 
This results in blockage of the stomata, accu-
mulation of fibers at these drainage points and 
potential damage to the mesothelial cells. The 
presence of fibers in the pleural space will attract 
resident pleural macrophages, which will accu-
mulate at these areas of deposition. Similar to 
the attempts of alveolar macrophages to clear 
long fibers from the lung, pleural macrophages 
may be unable to fully engulf the fibers lead-
ing to a state of frustrated phagocytosis causing 
further inflammation, fibrosis and genotoxicity 
in the adjacent mesothelial cells in the areas of 
congestion around the stomatal entrances.
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HARNs in the pleural space
The role of length-dependent retention in the 
pleural space in the pathogenesis of disease 
needs to be considered when testing the poten-
tial of new types of HARNs to cause pleural 
disease. A study carried out recently in our labo-
ratory investigated the potential adverse reac-
tion to fiber-like MWCNTs in the pleural space, 
focusing on the response at the parietal pleura 
of the chest wall and diaphragm [Murphy et al., 
Manu script in Preparation]. A method of injection 
into the pleural space was developed to ensure 
that the dose of particles was delivered into the 
pleural cavity without injection into the lung. 
A panel of both long and short MWCNTs were 
injected directly into the pleural cavity and the 
inflammatory response in the pleural space and 
at the parietal pleura was examined at a num-
ber of time points up to 6 months postinjec-
tion. Acute inflammation followed by progres-
sive fibrosis and granuloma development was 
found only in response to the long MWCNT 
samples and the long amosite asbestos control 
with long MWCNTs visible in association 
with the granulo mas at each time point. Short 
MWCNTs failed to cause a sustained response 
with only a mild thickening of the mesothelium 
visible at day one, which had completely resolved 
by day 7.
The sustained response to the long but not 
short MWCNTs fully supports the hypothesis 
that length-dependent retention is the driving 
force behind the pathogenesis of long fibers in 
the pleural space. In particular, the retention 
of long fibers at the parietal pleura provides 
an explanation of the enhanced ability of long 
asbestos fibers to cause mesothelioma after inha-
lation compared with short fibers [39,40]. The 
operation of a similar length-dependent mecha-
nism of clearance from the peritoneal cavity (see 
following sections) also explains the markedly 
greater potential of long fibers instilled into the 
peritoneal cavity to cause mesothelioma at that 
site compared with short fibers [39].
Diameter of fibers determines whether a fiber 
will reach the distal regions of the lung and there-
fore translocate to the pleural space, whereas length 
of the fiber is the limiting factor controlling clear-
ance from the pleural space. This suggests that 
any HARNs with sufficiently small diameter and 
long length could pose a mesothelioma hazard.
Using the peritoneal cavity as a 
model of direct mesothelial exposure
When assessing the biological activity of various 
forms of fibers, the peritoneal cavity of rodents 
has often been used as a surrogate for the tho-



























Figure 7. Size-dependent clearance from the pleural space. (A) Short fibers and small carbon 
nanotube tangles that deposit subpleurally migrate to the pleural space and exit in the flow of pleural 
fluid through the stomata where they follow the lymphatic drainage to the mediastinal lymph nodes. 
(B) Long fibers and long carbon nanotubes also reach the pleural space but cannot negotiate the 
stomata and so they are retained where they cause inflammation and potentially long-term disease.
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two cavities in terms of the mesothelial lining 
and the ease of access to the peritoneal cav-
ity [41–44]. The peritoneal or abdominal cavity is 
the largest body cavity and contains the abdomi-
nal organs covered with a mesothelium, which 
is easily accessible for the introduction of fibers. 
In surface area, the peritoneal meso thelium is 
equal to that of the skin [45] and in many ways 
the peritoneal cavity is analogous to the pleural 
cavity, which is not surprising considering its 
shared origin, in the primitive mesoderm dur-
ing embryonic development. The pleural and 
peritoneal cavities differ in that the two main 
roles of the pleural cavity are to lubricate the 
movement of the lungs and provide a fluid-filled 
tight coupling between the lung surface and tho-
racic cage. There is no such coupling role for 
the peritoneal cavity, instead its primary role is 
to lubricate the motion of the organs contained 
within the abdomen and as such whilst the cav-
ity is lubricated, it is not fluid filled. The peri-
toneal cavity is lined with a mesothelium with 
a structure identical to that of the pleural, and 
indeed all mesothelial layers [46]. It also contains 
stomata that overlie lymphatic lacunae (similar 
to those seen in the pleural cavity) linking the 
cavity to the underlying diaphragmatic lymph-
atics. The diaphragm is considered the prin-
ciple route of drainage from the peritoneal cav-
ity [47–49] via the parasternal lymph trunks to the 
parasternal and mediastinal lymph nodes [48]. 
The physio logical nature of the peritoneal cav-
ity means that particles which enter the cavity 
can be rapidly removed in the liquid flow from 
the cavity through the diaphragm, or taken up 
by resident phagocytic cells. Particles that can-
not negotiate the narrow (3–12 µm) stomatal 
openings [50] are retained causing an inflamma-
tory and fibrotic response as demonstrated with 
asbestos and CNTs [51]. 
Despite the fact that the peritoneal cavity is 
a dynamic environment, with size-dependent 
routes of clearance via the stomata to out-
lying lymph nodes [52] and lined with a highly 
responsive mesothelium capable of mediating an 
inflammatory response [50], the rodent peritoneal 
assay is not without its critics. The main criti-
cism relates to the lack of physio logical relevance 
as a route of exposure. Indeed, the peritoneal 
model is not a model of inhalation exposure, 
it is simply a surrogate for the thoracic meso-
thelium, as a specific cellular target for asbestos 
carcinogenicity. Fiber length-dependent reten-
tion occurs in both the pleural space and the 
peritoneal cavity, making the latter an appropri-
ate model for clearance/retention of particulates 
in the mesothelial space. It is notable that a 
proportion of the mesotheliomas that arise in 
asbestos- exposed individuals occur in the peri-
toneal cavity and so there is exposure of the peri-
toneal mesothelium to fibers following inhalation 
and trans location, and a response that mimics 
mesothelioma formation in the pleural space [53]. 
Recently, there have been several studies using 
the peritoneal assay to investigate the in vivo 
response to CNTs. One of the first was a study 
by our own group in which the role of length 
in inflammogenicity and fibrosis was examined 
using a 50 µg intraperitoneal injection of CNTs 
of differing length and appropriate asbestos con-
trols [51]. We found that long, fiber-like CNTs 
generated a strong and persistent inflammatory 
response similar to that seen with long amosite 
asbestos fibers. Short CNTs, compact carbon 
particles and short lengths (<5 µm) of amosite 
asbestos generated no such inflammation and 
there was no evidence of retention in the perito-
neal space suggesting rapid clearance [54]. Over 
an extended period, the long CNT and asbes-
tos samples generated substantial fibrosis and 
the presence of foreign body giant cells typi-
cal of a foreign body reaction, again not seen 
with the compact particle controls. This led us 
to the conclusion that the length of the CNT 
and asbestos, in line with the structure:toxicity 
relationship, was causing length-dependent 
retention in the peritoneal cavity and subsequent 
response. This work has more recently been sup-
ported by a study by Yamashita and colleagues. 
They found that MWCNTs injected into the 
peritoneal cavity of mice generated inflamma-
tion and genetic damage, which was related to 
the length and thickness of the CNTs, although 
interestingly they did not find this the case for 
SWCNTs [55]. Again, it was this key length of 
approximately 15 µm that they found to be most 
inflammogenic in this fiber-sensitive model. The 
importance of fiber length in a model based on 
clearance and retention was demonstrated in a 
paper by Muller and colleagues [56]. They uti-
lized the peritoneal model to investigate the 
potential carcinogenicity of MWCNTs, using 
crocidolite as a positive control particle. Over 
a period of 2 years they were unable to dem-
onstrate a carcinogenic response to the CNTs 
for which, among other reasons, they cited the 
length of the CNTs as a contributing factor 
behind their negative findings. This was because 
the CNTs used were all less than 0.7 µm and 
so if singlet fibers were present then they very 
likely were rapidly cleared leaving only large, 
nonfibrous agglomerates.
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Conclusion: future research and 
designing safe HARNs 
The fiber pathogenicity paradigm is independent 
of specific chemical composition and therefore 
embraces asbestos, glass fibers and one organic 
fiber [16]. Our studies with CNTs [51] and as yet 
unpublished studies with NiO nanowires point 
towards the likelihood that all HARNs will con-
form to the general fiber pathogenicity paradigm, 
although further research is needed. This future 
research should address the general utility of the 
paradigm for a range of HARNs, including nano-
rods, nanowires and nanotubes of various com-
positions. Such studies would entail examining a 
wide range of HARNs for ability to cause length-
dependent proinflammatory effects in vitro and 
studies on length-dependent retention at the pari-
etal pleural stomata. Another major aim would be 
to provide quantitative data on biopersistence, the 
key attribute of the paradigm, for each HARN 
and to be able to relate the biopersistence data to 
pathogenic potential. Nanotechnology method-
ology could be used to address the key question 
regarding the true cut-off of length for a ‘long’ 
fiber, which is not answerable using naturally 
occurring fibers that always exist in a broad length 
distribution. The types of methodologies used to 
make HARNs are such that the HARNs can be 
manufactured in tight length distributions. By 
making HARNs in 3-µm length categories (e.g., 
-9, -12, -15, -18 and -20 µm long) these could 
be used to answer the big question – what is the 
length beyond which long fiber effects occur? 
This may amount to more than one value since 
the length beyond which frustrated phagocytosis 
occurs leading to effect in the lungs might be dif-
ferent from the length beyond which retention in 
the pleural space occurs, leading to pleural effects, 
since the length-dependent processes involved are 
quite different. 
The three properties identified by the fiber 
pathogenicity paradigm as those that determine 
the likelihood that any fiber sample will pose 
a fiber-type (asbestos-type) hazard – long, thin 
and biopersistent – form the biologically effec-
tive dose for fiber-type effects. Therefore, the 
safe design of HARNs from the point of view 
of the paradigm is relatively straightforward and 
making HARNs short, thick or non biopersistent 
will reduce their hazard. In particular, design-
ing in time-dependent programmed biodegrade-
ability would be a very desirable approach to safe 
HARN design. TABLE 2 shows the best current 
assessment of the quantiative values that would 
be used to attain safe HARNs. Of course, the 
advantages of HARNs in any industrial setting 
may well rely upon properties that accompany 
length, thinness or biopersistence, and the intrin-
sic properties of the material may also dictate 
fiber dimensions and biopersistence. There may 
well be a contradiction in the production of safe 
HARNs, if safety stipulates short, low AR par-
ticles or biodegradable ones, which will conflict 
with the technical requirements of these new 
materials. Therefore, management of the risks 
from these materials, by safe handling to mini-
mize exposure, needs to be mandatory. Where 
HARNs cannot be made safe-by-design, as in 
any industrial setting, due regard must therefore 
be paid to the size distribution and quantity of 
the airborne fibers in the workplace air.
Hygiene precautions to reduce inhalation 
exposure should be set in motion concomitant 
with the extent of the hazard identified by these 
size data and knowledge of the biopersistence 
derived empirically from biopersistence/durabil-
ity studies or from knowledge of the inherent 
properties of the material of which the fibers are 
composed. Many workplaces handle hazardous 
materials, they simply handle them in safe ways 
that minimize exposure and HARNs are no dif-
ferent. However, it is difficult at the moment to 
measure dimensions of very thin fibers in the air 
and there needs to be more research in this direc-
tion so that real-time monitoring of airborne 
nanofibers can occur in workplaces.




Width >3 µm Too thick to be respirable/cut-off for respirability in humans is 5 µm 
aerodynamic diameter; for fibers, the aerodynamics is approximately 
three-times the actual diameter
Length <5 µm Too short to cause frustrated phagocytosis/the actual value is unknown, 
but is somewhere between 10 and 20 µm
Biopersistent Undergoes rapid dissolution in 
the lungs 
Long fibers dissolve and break so are shortened and long fiber dose does 
not build-up/the actual soluble components lost will depend on the 
composition of the HARN
HARN: High aspect ratio nanoparticle; FPP: Fiber pathogenicity paradigm.
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Executive summary
High aspect ratio nanomaterials: definitions & volume of production
 High aspect ratio nanomaterials (HARNs) are a new class of material that are nanoscale and have a high length-to-width ratio 
(e.g., nanotubes, nanowires and nanorods).
 HARNs are increasingly being incorporated into a wide variety of products with a consequent increase in potential for 
inhalation exposure. 
 There is a need to match the increases in research into the development and applications of HARNs versus HARN-related safety research.
Asbestos & the fiber pathogenicity paradigm
 Inhalation exposure to asbestos and naturally occurring high aspect ratio fibers can lead to a number of diseases that affect the lungs 
(e.g., fibrosis and bronchogenic carcinoma) or the pleura (e.g., mesothelioma, pleural effusion and pleural fibrosis).
 The fiber pathogenicity paradigm is a structure/toxicity model for fibers that highlights width, length and biopersistence in dictating 
whether or not a fiber will be pathogenic upon inhalation. 
Mechanism of lung disease caused by long fibers
 Long fibers can interact directly with target cells (e.g., epithelial or mesothelial cells) causing cell death and oxidative stress or by 
provoking an inflammatory response recruiting leukocytes that will then release oxidants, cytokines and growth factors, creating a fertile 
environment for genetic injury, mutation, fibrosis and cancer.
Clearance from the pleural space
 The development of pleural pathologies is a particle response unique to fibrous particles.
 A proportion of all particles deposited in the distal lung will translocate to the pleural space but subsequent clearance from the pleural 
space is size dependent.
 Small particles and short fibers are easily cleared in fluid flow through stomata in the parietal pleural into the lymphatic system; however, 
fibers longer than the calibre of the stomatal openings cannot pass through and are retained where they may cause inflammation, 
fibrosis and genotoxicity in the adjacent mesothelial cells. This suggests that any biopersistent HARN with sufficiently small diameter and 
long length could pose a mesothelioma hazard.
 The peritoneal cavity is often used as a surrogate for the thoracic cavity when investigating the pathogenicity of fibers owing to the 
similarity of the mesothelial lining of the two cavities and the greater ease of access to the peritoneal cavity. Clearance from the 
peritoneal cavity, similar to the pleural cavity is via stomata in the diaphragm, which drain to the lymphatics.
Conclusion: future research & designing safe high aspect ratio nanomaterials
 HARNs have the potential to conform to the fiber pathogenicity paradigm and, therefore, may pose an occupational inhalation hazard.
 Identification of the link between structure and toxicity of HARNs can be exploited to design HARNs that are safer (i.e., short, thick and 
nonbiopersistent fibers). However, if these properties conflict with the technical requirements of the HARN, sufficient management of 
the risks to exposure needs to be mandatory.
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G
raphene, a two-dimensional (2D)
crystalline material comprising a sin-
gle layer of carbon atoms tightly
packed into a honeycomb lattice has re-
cently been identified1 and has attracted
substantial scientific interestdue to its unique
intrinsic properties. However, the novel
platelet-like shape has drawn our attention
to the toxicology of these emergingmaterials.
Unintentional occupational or environmental
exposure to graphene-based materials dur-
ing manufacturing or intentional exposure
via biomedical applications are likely with
their increasing development and use. Thus
far, the information on the inhalation toxi-
cityofgraphenenanoplatelets (GP) or platelet-
shaped particles in general is very limited.2
Nanoplatelets may pose an unusual risk to
the lungs and the pleural space because of
their aerodynamic properties. Deposition in
the respiratory tract is determined by the
aerodynamicdiameter (Dae) which is defined
as the diameter of a sphere of unit density
with the same terminal settling velocity as the
particle itself.3 The respiratory or pulmonary
fraction denotes the size fraction of particles,
<5 μm Dae, that deposit beyond the ciliated
airways where alveolar macrophages are the
main clearance mechanism, and is consid-
ered to pose the highest risk in health terms.
Sanchez et al. recently calculated the deposi-
tion fraction of graphene nanoplatelets with
different lateral dimensions ranging from
0.001 to 100 μm in the nasopharyngeal,
tracheobronchial, and alveolar region either
moving along or perpendicular to the polar
axis.2 This theoretical calculation revealed
that there would be substantial deposition
of suchnanoplatelets throughout the respira-
tory tract. Normally alveolar macrophages
only encounter compact particles elutriated
by transit through the ever-narrowing air-
ways of the lung, which they can fully ingest.
Fibres are a case where an “accident of
aerodynamics” means that very long fibers,
if they are thin, can penetrate to the distal
lung where macrophages fail to fully engulf
the long fibers leading to frustrated phago-
cytosis and inflammation.4 Because of their
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ken.donaldson@ed.ac.uk.
Received for review November 2, 2011




Graphene is a new nanomaterial with unusual and useful physical and chemical properties.
However, in the form of nanoplatelets this new, emergingmaterial could pose unusual risks to the
respiratory system after inhalation exposure. The graphene-based nanoplatelets used in this study
are commercially available and consist of several sheets of graphene (few-layer graphene). We
first derived the respirability of graphene nanoplatelets (GP) from the basic principles of the
aerodynamic behavior of plate-shaped particles which allowed us to calculate their aerodynamic
diameter. This showed that the nanoplatelets, which were up to 25 μm in diameter, were
respirable and so would deposit beyond the ciliated airways following inhalation. We therefore
utilized models of pharyngeal aspiration and direct intrapleural installation of GP, as well as an in
vitro model, to assess their inflammatory potential. These large but respirable GP were
inflammogenic in both the lung and the pleural space. MIP-1R, MCP-1, MIP-2, IL-8, and IL-1β
expression in the BAL, the pleural lavage, and cell culture supernatant from THP-1 macrophages
were increased with GP exposure compared to controls but not with nanoparticulate carbon black
(CB). In vitro, macrophages exposed to GP showed expression of IL-1β. This study highlights the
importance of nanoplatelet form as a driver for in vivo and in vitro inflammogenicity by virtue of
their respirable aerodynamic diameter, despite a considerable 2-dimensional size which leads to
frustrated phagocytosis when they deposit in the distal lungs and macrophages attempt to
phagocytose them. Our data suggest that nanoplatelets pose a novel nanohazard and structure-
toxicity relationship in nanoparticle toxicology.
KEYWORDS: graphene nanoplatelets . aerodynamic diameter . lung . pleura .
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nanoscale dimensions and thinness, nanoplatelets have
a much lower Dae than would be expected from their
maximum diameter.2 Attempted uptake of platelet-
shaped particles by macrophages in the alveolar region
could result in frustrated phagocytosis, inflammation,
failed clearance (leading to retention and accumulation
of an od dose) and translocation of nanoplatelets to the
pleural space.
The lung and the pleural space are key target tissues
for diseases related to fiber-shaped particles, for
example, asbestos. Exposure to asbestos fibers in
poorly regulated workplaces caused a worldwide
epidemic of a range of lung and pleural pathologies
which include lung fibrosis, lung cancer, pleural
plaques, pleural effusion, and pleural mesothelioma.5
The pleural mesothelium has proven to be uniquely
sensitive to fibers. The exact mechanism by which
long, biopersistent fiber-shaped particles cause their
harmful effects is partially understood and involves a
sequence of events including retention of long fibers
in the lung due to failed clearance by alveolar macro-
phages, frustrated phagocytosis, and recruitment
of inflammatory cells to the site of fiber reten-
tion. Following translocation to the pleura there is
retention of longer fibers at stomata at the parietal
pleura, inducing inflammation and prolonged inter-
action between fibers and mesothelial cells. These
events culminate in the development of lung and
pleural diseases after exposure to long biopersistent
fibers.6,7
Weused amodel of pharyngeal aspiration and direct
intrapleural injection7 of the GP to assess the acute
and sustained inflammatory response of the lung and
the pleural space, respectively. The approach of direct
intrapleural injection is justified on the basis that a
fraction of all inhaled particles and fibers that deposit
in the peripheral lung translocate into the pleural
space.810 We do note however that translocation of
GP from the distal lung region to the pleural space has
yet to be shown. As a compact nanoparticle control for
comparison with GP, we used nanoparticulate carbon
black (CB) which is also composed of graphene sheets
that are present as disjointed layers.11 We hypothe-
sized that it was the shape in which the graphene was
presented that was driving the activity, and that respira-
ble CB would be readily cleared via alveolar macro-
phages from the airspaces and via stomata from
the pleural space to the mediastinal lymph nodes. In
contrast, GP, exceeding the size for complete phago-
cytosis, would be retained in the lung and, after
translocation to the pleural space, would be too large
to negotiate the stomata in the parietal pleura and so
would initiate inflammation. In vitromodels were used
to elucidate the mechanism leading to inflamma-
tion after interactions between GP and macrophages.
We assessed the inflammatory potential of GP via
indicators such as frustrated phagocytosis, cytokine
release, and the involvement of the NALP3 inflamma-
some.
RESULTS
Characterization of Graphene Nanoplatelets. Characteris-
tics and specifications of CB and GP are summarized in
Table 1. Nanoparticulate carbon black (CB) and layered
(110 layer) graphene nanoplatelet (GP) morphology
were examined using scanning electron microscopy
(SEM) (Table 1). Electron paramagnetic resonance (EPR)
measurements were performed to determine the
generation of oxygen-centered free radicals of CB
andGP. Results were compared to one another and to
a positive Pyrogallol (benzene-1,2,3-triol) control, a
spontaneous superoxide anion generator with Tem-
pone H used as a spin trap. Both CB and GP caused a
significant increase in free radical generation with GP
production increased by 2-fold compared to CB
(Table 1). The concentration of soluble metals was
measured for CB and GP and showed that both
samples possess negligible amounts of soluble con-
taminating metals that would not be biologically
active (Supporting Information Table 1).
Aerodynamics of Nanoplatelets;Calculation of the Aerody-
namic Diameter. The gravitational settling speed of a
particle is determined by the opposing effects of the
gravitational force and the aerodynamic resistance.
The aerodynamic drag force depends on the shape
and orientation of the particle with respect to its
direction of motion. A plate-like particle with uniform
TABLE 1. Characteristics and Specifications of CB and GPa
aMorphology of materials by scanning electron microscopy (SEM). SEM of GP
confirms morphology of the platelet shape. EPR measurement to determine
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thickness settles under gravity with orientation per-
pendicular to its direction of motion. If it is not a
uniform thickness, it might behave like a spear with a
weighted tip (if one edge is relatively heavy) or it might
be stable in the perpendicular orientation if the extra
weight is central. By taking the gravitational force, the
aerodynamic resistance and the circular plate-like
shape of a particle into account we derived an expres-










dae = aerodynamic diameter t = platelet thickness
dproj = projected diameter F0 = unit density F = density
Using this equation, we can estimate the aerody-
namic diameter for plate-like-particles of given dimen-
sions. The size of GP was measured using SEM and light
microscopy images and plotted as percentage of GP
per projected area diameter in the sample (Tables 1
and 2). The GP consist of several sheets of graphene
with a thickness of approximately 10 nm each, there-
fore their thickness increases to around 0.1 μm, de-
pending on their dispersion. This information was used
to calculate the Dae of GP used in this study and shows
that they are within the size range of the respirable
fraction (Table 2). Full derivation of the Dae equation
can be found in the Supporting Information.
In Vivo. Acute Pulmonary Inflammatory Response to
GP. To assess the hazard of GP to the lungs, GP were
deposited in the lungs by pharyngeal aspiration at a
dose of 50 μg per mouse. At 24 h postexposure the
total number of bronchoalveolar lavage (BAL) cells was
increased significantly in GP-exposed mice compared
to vehicle control andmice aspiratedwithCB (Figure 1A).
This increase in cell number was mainly due to an
increase in polymorphonuclear leucocytes (PMN),
mainly neutrophils and eosinophils in the lavage fluid
(Figure 1A). The membrane leakage from cells in BAL
was also significantly increased in GP-treated mice
(Figure 1B). Concentration of the pro-inflammatory
cytokines MCP-1, MIP-1R, MIP-1, and IL-1β were mea-
sured in the BAL fluid. All cytokines were elevated after
GP treatment compared to VC and CB, however only
MIP-2 reached a significant difference (Figure 1C).
Histological sections of lungs from mice treated with
GP showed granulomatous lesions in the bronchiole
lumen and near the alveolar region. VC and CB had a
normal histology (Figure 1D) (see Supporting Infor-
mation for gross pathology of the entire lung sec-
tion Figure I). The response to CB/GP exposure was
investigated one week following exposure and con-
tinued to show an increased inflammatory response
to GP compared to CB and VC treated animals which
was, however, significantly less compared with re-
sponse at 24 h postaspiration (Supporting Informa-
tion, Figure II).
Acute Pleural Response to GP. The acute pleural
inflammatory response was measured 24 h after in-
trapleural injection of CB and GP. The pleural space was
lavaged and a total and differential cell count was
performed. Mice exposed to GP showed a significant
increase in total cell number compared to vehicle
control (Figure 2A) with significant increases in the
number of PMN which mainly comprised eosinophils
and neutrophils (Figure 2A). Chemokine and cytokine
protein levels in the pleural lavage fluid were measured
(MCP-1, MIP-1R, MIP-1, and IL-1β) showing that MIP-1R
was significantly increased (Figure 2B). Cytospin pre-
paration of lavaged cells showed complete uptake of
CB into pleural macrophages (Figure 2C); however, GP,
due to their shape and size, could not be fully phago-
cytosed leading to frustrated phagocytosis. Rosette-like
formations of macrophages around GP are a character-
istic indicator of frustrated phagocytosis where more
than one macrophage surround a large nanoplatelet
and share the attempt to phagocytose it (Figure 2C).
Histological examination of the parietal pleura showed
areas of histiocytic aggregates in mice treated with GP
(Figure 2D). The lesion area along the mesothelium was
measured and was significantly increased compared to
VC and CB at the 24 h time point (VC/CB = 0 μm2/μm;
GP = 19.5 ( 11.6 μm2/μm) (n = 3). GP were associated
with inflammatory cells along the parietal pleura. The
acute inflammatory response has largely resolved 1 week
after exposure as can be seen by the decrease in total
cell number to a quarter of the number found at 24 h
(Supporting Information, Figure III).
Clearance of CB and GP from the Pleural Space to
Cranial Mediastinal Lymph Nodes. CB particles were
cleared from the pleural space after direct pleural
injection via stomata to the cranial mediastinal lymph
nodes as can be seen in histological lymph node
sections after 24 h and 1 week (Figure 3A,B). Twenty-
four hours after GP exposure, a few particles could be
found in the lymph nodes which indicates prolonged
retention in the pleural space (Figure 3A). After 1 week
GP have been cleared from the pleural space; however,
the amount of clearance appears to be much less
compared to that of CB (Figure 3B). Quantification of
TABLE 2. Size Distribution of GP in the Sample Expressed
as Percentage of GP per Projected Area Diameter,
Aerodynamic Diameter Dae of GP at Various Projected
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the GP size cleared to the lymph nodes could not be
performed because of the difficulty of identifying
individual platelets of GP in the section.
In Vitro. Characterization of Cell/Particle Interaction.
The interaction of differentiated THP-1 cells with gra-
phene platelets was examined via scanning electron
microscopy (SEM) and transmission electron micro-
scopy (TEM). The SEM images revealed that GP exceed-
ing a size of approximately 15 μm projected diameter
could not be fully phagocytosed by THP-1 cells and
therefore led to frustrated phagocytosis (Figure 4A,B).
Complete uptake of smaller GP could be imaged using
TEM as shown in Figure 4B.
GP-Mediated Loss of Membrane Integrity of THP-1
Macrophages and Depletion of Reduced Glutathione.
Release of LDH was used as an indicator of cell viability
and measured after 24 h exposure of THP-1 macro-
phages toCB andGP. A concentration rangeof 1μg/cm2,
5 μg/cm2, and 10 μg/cm2 of GP was used, and con-
centrations of 5 μg/cm2 and higher significantly in-
creased LDH release while CB exposure at the same
concentrations did not (Figure 5A). An explanation
for loss of membrane integrity could be the generation
of reactive oxygen species and so the levels of free
thiol groups, predominantly GSH, were measured as an
Figure 1. Pulmonary inflammatory response to CB and GP 24 h postaspiration. (A) Total cell number and total granulocyte
number in the lavage fluid following exposure to CB and GP. (B) Measurement of the membrane leakage as LDH levels in the
lavage fluid. (C) Concentration of the chemokines MCP-1 and MIP-1R as well as cytokines MIP-1 and IL-1β in BAL. (/) P < 0.05,
(//) P < 0.01, (///) P < 0.001 compared to vehicle control. (D) Lung histology 24 h postaspiration. Ganulomatous lesion was
present in the bronchiolar lumen after GP exposure but normal lung pathology was seen in the CB treated mice which is
comparable to VC.
Figure 2. Pleural inflammatory response to CB and GP 24 h
post-treatment. (A) Total cell number and total granulocyte
number after pleural injection of 5 μg of CB and GP.
(B) Concentration of the chemokines MCP-1 and MIP-1R as
well as cytokines IL-1β in pleural lavage. (/) P < 0.05, (///)
P < 0.001 compared to vehicle control. (C) Representative
images of pleural macrophages from untreated mice and
mice treatedwith CB andGP. Intrapleural injection of GP led
to the formation of rosette-like cell/particle aggregations
indicating frustrated phagocytosis. (D) Sections of chest
wall were stained with both haematoxylin and eosin (H&E)
at 24 h postinjection to identify an inflammatory response
on the mesothelial cell layer of the parietal pleura (n = 3).
Pleural thickening can be seen after GP treatment, with an
insert highlighting GP associated with inflammatory cells.
Scale bar = 100 μm, insert = 20 μm. SEM micrographs show
aggregations of inflammatory cells after GP treatment but
normal mesothelial cell layer after VC and CB treatment
(Figure 2 bottom panels). Scale bar = 20 μm.
Figure 3. Clearance of CB to cranial mediastinal lymph
nodes and prolonged retention of GP in the pleural space.
Histological sections of lymph nodes stained with Picrosirius
red 24 h (A) and 1 week (B) postinjection. CB was cleared to
the nodes after 24 h, however GP was retained longer in the
pleural space. Scale bar = 40 μm, n = 4 mice per treatment
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indicator for oxidative stress, using the fluorescence
probe, monobromobimane. After 4 h of GP exposure
the levels of free thiol groups were significantly lowered
compared to the vehicle control (Figure 5B). CB did cause
a significant change in the levels of free thiol groups.
Activation of the NALP3 Inflammasome and Pro-
inflammatory Cytokines after GP Exposure in Vitro. We
measured the concentration of IL-1β in the super-
natant of THP-1 cells exposed for 24 h to either LPS,
CB (1 and 5 μg/cm2), or GP (1, 5, and 10 μg/cm2). LPS as
well as all concentrations of GP lead to a significant
increase in IL-1β expression, whereas CB treatment had
no effect (Figure 6A). To investigate if the attempt to
phagocytose GP was involved in upregulating IL-1β
expression, phagocytosis was inhibited via disruption
of actin filaments using cytochalasin D. The inhibition
of phagocytosis significantly reduced IL-1 β expression
at all concentrations of GP; however, cytochalasin D
had no effect on the level of IL-1 β released by THP-1
cells exposed to LPS since its action is not dependent
on phagocytic processes (Figure 6A). Additional mech-
anisms involved in the activation of the NALP3 inflam-
masome are decreased intracellular Kþ linked to an
efflux of Kþ and generation of ROS. By blocking the
efflux of Kþ via increasing extracellular Kþ concentra-
tion and the inhibition of generation of ROS via inhibi-
tion of NADPH oxidase using DPI, the expression of
IL-1β was significantly reduced in both LPS and GP
exposed cells (Figure 6A). To further assess which
cytokines were involved in acute inflammation after
particle exposure, a cytokine bead array was performed.
The selected panel of cytokines was TNF, IL-6, IL-8, IL-1β,
MCP-1, RANTES, MIP-1R, basic FGF, IL-13 and TGF-β.
MCP-1, IL-1, MIP-1R, and IL-1β were all significantly
increased after GP exposure with no effect of CB ex-
posure on these cytokines (Figure 6B).
DISCUSSION
Although Duch et al.12 have studied the biocompat-
ibility of GP in the mouse lung from the point of view
of biomedical/therapeutic application of GP, we be-
lieve that ours is the first peer-reviewed publication to
address the public/occupational health hazard of GP in
rat lung from the point of view of aerodynamic deposi-
tion and the cellular responses in lung. We further
elucidate the mechanism leading to GP-induced in-
flammation, using in vitro methods and a macrophage
cell line. Nanoparticulate carbon black (CB) was used as
a compact graphene nanoparticulate control and was
aspirated at a mass dose found to be noninflammatory
in previous studies.13
Figure 5. Determination of LDH release and the decrease in
free thiol groups as indications of cell toxicity and oxidative
stress. (A) Significant release of LDH after 24 h exposure to
GP while CB had no significant effect on LDH. Data were
expressed as mean ( s.e.m, n = 5. (B) Mean fluorescence
intensity (MFI) of monobromobimane (MBB) as indicator for
levels of free thiol groups. GP exposure significantly re-
duced the MFI of MBB at all concentrations measured. Data
were expressed as mean ( s.e.m, n = 4. (//) P < 0.01, (///)
P < 0.001 compared to vehicle control.
Figure 6. Data providing evidence consistent with activa-
tion of the Nalp3 inflammasome, and pro-inflammatory
cytokine expression on GP, CB, and LPS treatment. (A) IL-
1β concentration in the supernatant of THP-1 cells exposed
to LPS, CB, and GP. LPS (1 μg/mL) as well as GP at all
concentrations led to a significant increase in IL-1β expres-
sion, whereas CB treatment had no effect. Phagocytotic
uptake of GP was inhibited by cytochalsin D which led to a
significant reduction of IL-1β expression in GP exposed
cells. This effect was not observed in LPS treated cells. IL-
1β expression after LPS and GP exposure was significantly
reduced by inhibition of Kþ efflux and diphenylene iodo-
nium (DPI), an NADPH oxidase inhibitor. Data were ex-
pressed as mean ( s.e.m, n = 4. (B) Four cytokines (MCP-1,
IL-8, IL-1β and MIP-1R) out of 11 tested were significantly
upregulated after a 24 h GP exposure. CB treatment did not
lead to a significant increase in any of the cytokines
measured. Data were expressed as mean ( s.e.m, n = 3.
(/) P<0.05, (//) P<0.01, (///) P<0.001 compared to vehicle
control. (#) p < 0.05, (##) p < 0.01, (###) p < 0.001 compared
to vehicle control.
Figure 4. Cell/particle interactions to examine the uptake of
GP on the surface using SEM and inside of the cells using
TEM following 4 h exposure to GP. (A) SEM and (B) TEM of
GP-exposed THP-1 cells. (A) SEM showing the attempted
uptake of a GP by THP-1 macrophages (M). The arrow
indicates the lip of the unclosed phagosome showing
incomplete internalization of the GP producing frustrated
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The atypical platelet-like shape of the GP particles
attracted our attention as they may pose a new risk to
the respiratory system after inhalation. Nanoplatelets
exhibit specific material properties that could be im-
portant for biological interactions. Among these are
surface area, surface chemistry, and lateral dimensions.
Owing to their platelet shape, they have an excep-
tionally high surface area per unit mass which is much
greater than that of graphite and of carbon nano-
tubes.14 The lateral dimensions of a material play an
important role in biological interaction and determine
the nature and consequences of cellular uptake and
subsequent clearance.
Thus far, in the field of particle toxicology, the fiber
pathogenicity paradigm has been stated as the most
robust structureactivity relationship, and it has frus-
trated phagocytosis of long fibers as the center of the
pathobiological mechanism.15 This structureactivity
relationship focuses on fibers that are long, thin, and
biopersistent, having an aerodynamic diameter that
makes them respirable.16 This structureactivity rela-
tionship however does not take sheet/platelet shape
particles into account and therefore has to be recon-
sidered in the light of these new materials.
To be most harmful to the respiratory system, par-
ticles require an aerodynamic diameter small enough
to penetrate beyond the ciliated airways, that is, they
need to be respirable. Deposition occurs under the
effects of gravitational force, aerodynamic resistance,
interception, and impaction which together determine
the site of deposition in the lungs.17 The aerodynamic
diameter is the index that is calculated from these
parameters and determines the respirability of a par-
ticle and the site of deposition.3 Plate-shaped particles
are not common in industry, and so exposure is limited,
but does occur in the talc and nanoclay industries
where there are plate-like particles.18,19 However the
nanotechnologies have the potential to produce a
range of different nanoplatelet-shaped particles. In this
study we calculated the aerodynamics of commercially
available nanoplatelets by taking into consideration
the gravitational settling force and aerodynamic resis-
tance perpendicular and parallel to motion, and uti-
lized an equation derived from the tenets of aerosol
physics to estimate the aerodynamic diameter of
platelet-like particles of the dimensions evident in
our GP sample. This demonstrated that a platelet-
shaped particle with a projected area diameter of
25 μm and a thickness of 0.1 μm has an aerodynamic
diameter of about 3 μm, which is within the respirable
size fraction of particles that deposit beyond the
ciliated airways. These calculations are in line with
the aerodynamic sizes reported recently in Sanchez
et al.2 which also showed images suggesting that GP
might lead to frustrated phagocytosis in macrophages.
On the basis of our determination that the GP
samples used within these experiments were all
respirable, we assessed the inflammatory potential of
GP. Mice were exposed via pharyngeal aspiration and
pleural injection to CB and GP for 24 h and 1 week. CB
and GP are composed of the same material, graphene,
and were both respirable but differed in their shape,
which resulted in very different effects in the lung and
the pleural space. CB did not cause any inflammatory
response and was comparable to vehicle control in all
assays, whereas GP caused extensive recruitment of
inflammatory cells, including macrophages and gran-
ulocytes into the lung and pleural space after 24 h
exposure. Inflammation waned 1 week post-exposure
but continued to be significantly greater in total cells
and granulocyte number than the vehicle control. The
response to GP in the lung and the pleural space was
similar to the response seen after aspiration exposure
and intrapleural injection of long MWCNT using
the same method.7,20 Recent studies revealed that
long CNT, due to their fiber-like structure similar to
asbestos show an asbestos like pathogenicity and
raised concern that exposure to CNT may lead to
mesothelioma.21 Our results show that long fibers are
not the only extended particles with low Dae that are
able to induce inflammation in the lung and the pleural
space, but that platelet like particles with a low Dae
have similar potency. The induction of acute and
chronic inflammation is regulated by the release of
cytokines and chemokines that invoke leukocyte re-
cruitment. Analysis of BAL and pleural lavage fluid
revealed elevated levels of MCP-1, MIP-1R, IL-8, and
IL-1β after GP but not CB.MCP-1 andMIP-1R have been
reported to contribute to the initiation and outcome
of inflammation in the lung and in pulmonary alveolar
macrophages after exposure to stone-wool and
crocidolite asbestos.22 MCP-1 has further been identi-
fied to play a major role in lung leukocyte infiltration23
and serves as a marker for the diagnosis of malignant
pleural mesothelioma.24
The main mechanisms by which long, fiberlike par-
ticles cause harmful health effects in the pleura are the
failed clearance of longer fibers through stomata in the
parietal pleura and subsequent retention in the pleural
space, frustrated phagocytosis of pleural macro-
phages, and the involvement of the NALP3 inflam-
masome.25 We therefore investigated the retention of
GP in the pleural space by examining the most caudal,
posterior intercostal region of the parietal pleura,
documented to have the highest abundance of
stomata.7,26 Interstitial incorporation of asbestos fibers
and coal dust occurs in these areas and so they are
described as potential starting points for the develop-
ment of mesothelioma.11 In support of this hypothesis
we observed extensive accumulation of inflammatory
cells in these areas on the parietal pleura where GP
were retained. To determine the clearance pathway of
CB and GP, we examined the particle burden in cranial
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through the parietal stomata via the lymphatic system
to LN.7,27 CB was readily cleared to the mediastinal
lymph nodes after 24 h as could be seen in histological
sections. In comparison, few GP had reached the LN
after 24 h, confirming retention of GP in the pleural
space. After 1 week however, a higher number of GP
could be identified in the mediastinal LN sections,
which may explain the reduced inflammation seen
1 week after intrapleural exposure. Brakeage of GP into
smaller fragments after 1 week could explain the time-
dependent clearance of GP to the LNs. We noted that
the accumulation of GP in the LN seen at 1 week, while
evident, was less than that seen 1 week after CB,
suggesting that there is a substantial fraction of the
GP dose that remains retained in the pleural space
beyond one week.
The role of frustrated phagocytosis, a mechanism by
which long fibers produce inflammation, has been
examined in a number of studies28,29 and has been
accepted as a contributing mechanism to the toxic
effects of long fibers. Due to the extended shape of GP,
we hypothesized that the uptake of GP by macro-
phages could be impaired leading to frustrated phago-
cytosis. Examination of pleural macrophages in the
lavage fluid showed clear signs of frustrated phagocy-
tosis after GP exposure, whereas CB was fully taken up.
This took the form of GP incompletely enclosed by
macrophages and “rosettes” of up to five or six macro-
phages surrounding a single large platelet where
all of the macrophages are in a state of frustrated
phagocytosis.
To further investigate the interaction of macro-
phages with GP, we treated cells of a differentiated
monocytic cell line, THP-1, with GP and examined
phagocytosis using scanning electron microscopy
(SEM) and transmission electron microscopy (TEM).
Frustrated phagocytosis could be observed in SEM
images, showing GP only partly phagocytosed by
macrophages. TEM revealed that only small GP
(e5 μm) were fully taken up. The membrane integrity
of THP-1 cells after 24 h GP exposure was also signifi-
cantly impaired in a dose-dependent manner. We also
determined the generation of oxygen-centered free
radicals by GP and CB using EPR. CB as well as GP
generated a significant amount of free radicals, and
GP generated approximately double that produced by
CB. Therefore free radicals are possibly involved in the
pro-inflammatory effects seen in vivo and in vitro with
GP compared to CB, although it is not likely that
intrinsic free radical activity explains the extra potency
of GP. We went on to determine the oxidative status of
THP-1 cells by measuring the decrease in free thiol
groups, mainly reduced glutathione after CB and
GP treatment. Glutathione/glutathione disulfide is the
major redox couple in cells, and its tight regulation
is critical in antioxidant defense and regulation of
cellular events.30 Glutathione is the most abundant
low-molecular-weight thiol, and the loss of free thiol
can be measured via loss of monobromobimane
fluorescence.30 Exposure of THP-1 cells to GP lead to
a significant decrease in free thiol groups in a dose-
dependent manner. Depletion of the antioxidant de-
fense systemby pollutants31 and respirable fibers32 has
been shown to result in oxidative stress and the
activation of transcription factors including NF-κB.33
NF-κB regulates the transcription of inflammatory
genes, including IL-1β, MIP-1R, and MCP-1.34 We mea-
sured a panel of acute-phase cytokines involved in the
inflammatory response after exposure of THP-1 cells to
CB and GP; 4 out of 11 different cytokines measured,
MCP-1, IL-8, IL-1β and MIP-1R, were significantly ele-
vated after GP exposure. The pro-inflammatory cyto-
kine and neutrophil chemotaxin IL-8 has been shown
to be elevated in airway epithelial cells and serum35 as
well as alveolar macrophages36 of asbestos-exposed
individuals.35 IL-1β is known to be upregulated after
asbestos, silica, and CNT exposure37,38 and has been
implicated in frustrated phagocytosis and the NALP3
inflammasome activation.39 The underlying mecha-
nism by which frustrated phagocytosis of long fibers
induces acute and chronic inflammation is poorly
understood. Recent studies however identified the
NALP3 inflammasome complex as an important com-
ponent of the molecular pathway by which cells
sense foreign bodies like asbestos fibers and initiate
an inflammatory response. The inflammasome is a
multiprotein complex consisting of nucleotide-binding
oligomerization domain (NOD)-like receptors (NLR)
which is activated via damage-associated molecular
patterns (DAMPs) and forms a complex with apoptosis-
associated speck-like protein containing a caspase-
recruiting domain (CARD) and pro-caspase 1. Activa-
tion of caspase 1 leads to expression of IL-1β and IL-18,
which mediate pro-inflammatory effects.40 The inflam-
masome can be activated via different pathways in-
cluding low intracellular potassium concentration41,
reactive oxygen species produced by NALP3 activators
via NADPH oxidase,42 frustrated phagocytosis39 and
phagosomal destabilization.38 Since GP exposure led
to an increased production of IL-1β, we explored the
possibility that GP promote inflammation by activating
the inflammasome pathway. To delineate the GP-
induced signaling pathway leading to inflammasome
activation, IL-1β production after GP exposure was
compared to CB and LPS induced IL-1β release in cell
culture medium and medium supplemented with in-
hibitors for phagocytosis, ROS generation, and potas-
sium efflux. We investigated whether phagocytosis is
needed to trigger inflammasome activation by disrupt-
ing actin filaments via cytochalasin D.37 Inhibition of
phagocytosis significantly reduced IL-1β expression
after GP treatment, but had no effect on LPS induced
IL-1β production, which is not mediated via phagocy-
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blocked by inhibiting efflux of Kþ, which is necessary
for NALP3 inflammasome activation. Reduction of
IL-1β production was also achieved by inhibition of
the NADPH oxidase supporting the hypothesis that
ROS are generated via phagocytosis of GP through the
activation of the reduced form of NADP. We therefore
carried out limited studies which, while providing
data consistent with activation of the NALP3 inflam-
masome by GP, require more detailed and extensive
studies to confirm this impression.
Collectively, our data show that large nanoplatelets
can have a small enough Dae to be respirable and to
deposit beyond the ciliated airways where macro-
phages are the only mode of clearance, but are too
large to be completely phagocytosed bymacrophages.
They, therefore are likely to cause an inflammatory
response in the airspaces and be retained, similar to
the response seen after long asbestos and other long
fiber-like structures7 (Schinwald et al., manuscript under
submission). If, like long fibers they are capable of
reaching the pleural space, they will be retained there
as they will be too big to negotiate the stomata and,
with sufficient dose, they will cause pleural inflammation
and pleural pathology over time if they are sufficiently
biopersistent.
Our study also provides information regarding the
mechanism by which the inflammatory response to GP
was initiated using in vitromodels. Four cytokines have
been detected to be involved in the onset of inflam-
mation after GP exposure (MIP-1R, MCP-1, IL-8, and
IL-1β). While IL-1β may have been activated via the
NALP3 inflammasome complex, more research is
needed to confirm this. We further emphasized the
importance of phagocytosis and subsequent ROS gen-
eration in the activation of IL-1β release.
We mainly focused on the acute inflammatory reac-
tion in the lung and the pleural space up to 7 days and
the data showed a decrease in the severity of inflam-
mation after 7 day treatment which suggests degrada-
tion of GP into smaller fragments which could then be
cleared via alveolar/pleural macrophages. A study of
the chronic effects of GP exposure, preferably after
inhalation exposure is warranted to investigate bio-
persistence and effects after inhalation compared to
the instillationmodels used here. In this studywe focus
on themorphology of theGP, rather than the graphene
oxidation state, in regards to pro-inflammatory effects
especially frustrated phagocytosis. The argument of
frustrated phagocytosis of GP is based on shape rather
than chemistry, as is the argument of long fibers-
elicited frustrated phagocytosis, which is an issue of
fiber length, not composition6,43 Future studies on
different GP samples from different sources should
examine the effect of the surface chemistry/oxidation
state, which might have an additional effect; however,
we consider that any such effect will be in addition to
the shape effect.
CONCLUSION
This study highlights the importance of particle
shape as a driver for in vivo and in vitro toxicity and
introduces a new shape that may pose an unusual risk
to the lungs and the pleural space after inhalation
exposure. We suggest that sheet/platelet-shaped par-
ticles with nanoscale thickness can be very large in two
dimensions but possess a low Dae. Thus they have the
potential to cause adverse health effects and therefore
warrant further investigation. We further suggest that
lateral dimensions are the driving properties in patho-
logical response to GP and that these also requiremore
research. It also seems likely that layer thickness and
the subsequent role that this plays in rigidity is a key
factor but was not investigated here. On the basis of
the above understanding of the probablemechanisms,
we suggest that potential risks to humans from gra-
phene platelet exposure could be minimized by man-
ufacturing graphene platelets small enough to be
phagocytosed by macrophages. Our initial data also
suggest that the GP are not fully biopersistent, and
clear slowly to the mediastinal lymph nodes. Further
work is needed to determine the extent of GP bioper-
sistence and its impact on pathogenicity.
MATERIAL AND METHODS
Characterization of Nanoparticle Carbon Black (CB) and Graphene
Nanoplatelets (GP). Carbon Black (Printex 90) was provided by
Evonik Degussa GmbH in Germany. It was used as an amor-
phous carbon particle control. Graphene nanoplatelets grade 2
(GP) produced by chemical exfoliation were purchased from
cheaptubes.com. GP have a surface area of about 100 m2/g, a
density of ∼2.0 g/cm3, an average thickness of approximately
10 nm and an average diameter of 5 μm based on manufac-
turers description. One of the GP consists of several sheets of
graphene, and GP are therefore classified as few-layer gra-
phene. Physical characteristics were determined using light
microscopy and scanning electronmicroscopy (SEM). The levels
of endotoxin in the sample suspension were evaluated by
the Limuluss Amoebocyte Lysate assay (Lonza) according to
manufacturer's description using supernatant of CB and GP
suspension to avoid interference of particles with the assay. No
endotoxin level were detected in the samples. CB and GP stock
solution was prepared at 1 mg/mL in 0.5% BSA/saline for in vivo
work or cell culture medium without FBS for in vitro work and
dispersed by sonication in an ultrasonicating water bath at
230 V, 50 Hz, 350W (FB11002, Fisherbrand, Thermo Fisher Scientific,
Inc., MA, USA) for 6 h to break up aggregates.
Scanning Electron Microscopy of CB and GP. CB and GP were
dispersed in 0.1% BSA (heat-shocked fractionate) (Sigma-Aldrich,
Poole, UK)/saline at a concentration 50 μg/mL by ultrsonication.
The suspension was filtered onto an Isopore membrane filter
(Millipore), dried, and gold sputter coated. Scanning electron
microscopy was carried out using a Hitachi S-2600N digital scan-
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Light Microscopy of CB and GP. For light microscopy images a
concentration of 50 μg/mL was used to demonstrate the
dispersion of the materials. A 10 μL aliquot of CB or GP solution
were mixed with 10 μL of glycerol (Sigma-Aldrich, Poole, UK) to
reduce the motion of the GP. The suspension was placed on
glass slide and covered with a glass coverslip and sealed.7
Images were captured at 100 magnification using QCapture
Pro software (Media Cybernetics). A total of 300 GP/GP-aggre-
gates were measured according to their projected area dia-
meter by using a graticule. The size was plotted per length
category.
Electron Paramagnetic Resonance. CB and GP were diluted to a
final concentration of 50 μg/mL in Hanks Balanced Salt Solution
(HBSS) (Sigma-Aldrich, Poole, UK) and sonicated for 1 h. HBSS
and 1 mM Pyrogallol (Sigma), a known superoxide generator
were diluted in Hanks buffer and used as negative and positive
controls, respectively. Peroxynitrite, superoxide, and peroxyl
radical release were detected using spin trap Tempone-H
(Alexis Biochemicals, San Diego, CA). Tempone-H was added
to the samples and controls to give a final concentration of
1 mM. EPR spectra were measured after 60 min incubation at
37 C using the following instrumental conditions: Microwave
frequency, 9.39 GHz, magnetic field, 3355 G; sweep width, 55 G;
sweep time, 30 s; number of passes, 1; modulation amplitude,
1500 mG; receiver gain, 1E1; phase, 180; microwave frequency,
9.30 9.55 GHz. Intensity values of the highest spectra peak
were recorded and graphed against each other (arbitrary units).
ICP MS Analysis. For quantification of contaminating metals,
the supernatant of 1 mg/mL of each sample were analyzed
using the technique of inductively coupled mass spectrometry
(ICP MS). The CB and GP suspension wasmade up in 0.5% BSA/
saline to be consistent with experimental conditions. Super-
natant was collected from a 1 mg/mL solution of each sample,
after overnight mixing, by centrifugation at 13 000 rpm for 30
min. Samples were analyzed by ICP MS using an Agilent
7500ce (with octopole reaction system), employing an rf for-
ward power of 1540 W and reflected power of 1 W, with argon
gas flows of 0.82 L min 1 and 0.2 L min 1 for carrier and makeup
flows, respectively. Sample solutions were taken up into the
micromist nebulizer by peristaltic pump at a rate of 0.06 rps
(approximately 1.2 mL min 1). The gas flow for the helium
mode was 6.5 mL min 1. Skimmer and sample cones were
made of nickel. The instrument was operated in spectrum
multitune acquisition mode, and five replicate runs per sample
were employed. Each mass was analyzed in fully quant mode
(three points per unit mass). 107Ag, 27Al, 111Cd, 59Co, 52Cr, 63Cu,
56Fe, 55Mn, 60Ni, 208Pb, and 64Znwere analyzed in “nogas”mode
then 56Fe, 60Ni, 52Cr, 63Cu, and 66Zn were further analyzed in
helium mode to remove any polyatomic interferences.
In Vivo. Experimental Animals. Nine week old female C57BL/
6 strain mice (Harlan, UK) were used in this study. Mice were
kept in a group size of five in standard caging with sawdust
bedding within a pathogen-free Home Office approved facility.
Mice were maintained on a normal 12 h light and dark cycle.
Prior to the treatment mice were kept for 7 days in the facility to
acclimatize. The work was carried out by staff holding a valid
UKHomeOffice personal license under a HomeOffice approved
project license.
Pharyngeal Aspiration and Broncho-Alveolar Lavage. The
given particle dose for pharyngeal aspiration was 50 μg per
mouse of CB and GP in 0.5% BSA/saline. Vehicle control was
0.5% BSA/saline. Mice were anesthetized with isoflurane and
the tongue was gently held in full extension while 50 μL of
particle suspension was pipet onto the base of the tongue.44
The tongue was held extended until at least two breaths were
complete. To stimulate inhalation and to induce a gasp reflex
the nasal cavities of themicewere covered. Mice were observed
until full recovery.
Mice were sacrificed 24 h and 1 week postexposure of a
single dose by terminal anesthesia by injection of 0.5 mL of
pentobarbitone (200 mg/mL) into the peritoneal cavity fol-
lowed by exsanguinations via the abdominal aorta. After the
pleural cavity was lavaged (see Intrapleural Injection and Pleural
Lavage section) the thoracic cavitywas exposed and the trachea
cannulated using a 23 gaugeneedle and ligated. The lungswere
lavaged three times with 800 μL of ice-cold sterile saline. The
first lavage was retained separately and the subsequent lavages
were pooled.
Intrapleural Injection and Pleural Lavage. Samples were
prepared by ultrasonication as described and injected into the
pleural cavity of female C57BI/6 mice (aged 8 weeks) using a
sleeve over the tip of a 27G to prevent the needle to pass
through the pleural space into the lung. The concentration of
each treatment was 50 μg/mL which equates to a single dose of
5 μg per mouse and an injected volume of 100 μL per mouse.
Mice were euthanized after 24 h (n = 6) and 7 days (n = 4) by
asphyxiation in 100% CO2. The pleural space was lavaged with
three 1 mL washes of sterile saline and kept on ice.
Differential Cell Count/Total Protein and Lactate Dehydroge-
nase Measurement. To separate the cellular fraction from the
supernatant the lavage fluid from BAL and pleural lavage was
centrifuged for 5 min at 2000g at 4 C in a Mistral 3000i
centrifuge (Thermo Fisher Scientific, Inc., MA, USA). Total cell
count was performed using a NucleoCounter (ChemoMetec,
7 A/S, Allerød, Denmark) and cyto-centrifugation with following
Diff-Quik staining using Diff-Quik stainset (Dade Behring Gmbh,
Marburg, Germany) were prepared for differential cell counts. In
the supernatant, membrane integrity using the Cytotoxicity
Detection Lactate Dehydrogenase kit (Roche Diagnostics Ltd.,
Burgess Hill, UK) and protein content using the bicinchoninic
acid (BCA) protein assay (Sigma-Aldrich, Poole, UK) were mea-
sured following the manufacturer's instructions.
Dissection of Lung, Diaphragm and Chest Wall. For histolog-
ical examination the lungs and heart were removed on-block
and fixed by installation of 10% ice-cold formalin without
foregoing lavage and submerged in fixative for a period of
4 h prior to processing. The heart was removed and the lung
separated into individual lobes and transferred to 70% ethanol
for 24 h. The tissue was embedded in paraffin, sectioned and
stained with H&E to show gross pathology and Pico-Sirius Red
(PSR) to show collagen deposition. Serial images were taken at
2.5magnification using QCaputre Pro software (Media Cyber-
netics, Inc., MD, USA) and seamlessly realigned using Adobe
Phtotoshop CS3, version 10.0.1 (Adobe Systems Inc.) to show
the entire section of the lungs. Images at 20 magnification
were taken to show higher maginification areas of the lung
sections.
The diaphragm and the lower right posterior portion of the
chest wall, approximately an area of 1 cm  0.5 cm along the
spine was cut out from themice after lavage, washed in ice-cold
saline, and fixed for 4 h in 30% formalin. The tissue was excised
from the surrounding tissue and either embedded in paraffin,
sectioned, and stained with haematoxylin and eosin (H&E) for
gross pathology or prepared for scanning electron microscopy
(SEM).
Methodology for Lesion Quantification. Images from chest
wall section were taken at 10 magnification using QCapture
Pro software (media Cybernetics Inc., MD, USA). Photoshop CS3
(Adobe systems Inc., CA, USA) was used to seamlessly realign
the images to give a high resolution image of the large sections
of chest wall. To quantify the lesion area per unit chest wall
length (mm2/mm), the length of the each section along the
mesothelium and the lesion area was measured using cali-
brated Image-Pro Plus software (Media Cybernetics Inc., MD,
USA).
Scanning Electron Microscopy. Scanning electron micro-
scopy was carried out using a Hitachi S-2600N digital scanning
electron microscope (Oxford Instruments, Oxfordshire, UK).
Tissue was prepared using tetroxide staining, critical-point
dried, and gold sputter coated.
Chemokine and Cytokine Measurement. Chemokines MCP-1
and MIP-1R and cytokines MIP-2 and IL-1β were measured in
nondiluted BAL and pleural lavage fluid following the manu-
facturers' instructions (Quantikine kit of R&D systems).
In Vitro. Cell Culture. The immortalized human monocytic
cell line THP-1 was used for in vitro studies. THP-1 cells were
cultured in RPMI media supplemented with 10% heat inacti-
vated FBS, 1% penicillin/streptomycin and 1% L-glutamine
(PAA, Austria). Prior to each treatment the cells were differen-
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13-acetate (PMA) (Sigma) for 2 days at 37 C in 5% CO2 atm as
previously described.45
Measurement of Membrane Integrity. The conversion of
lactate to pyruvate was detected using the Cytotoxicity
Detection Lactate Dehydrogenase kit (Roche Diagnostics Ltd.,
Burgess Hill, UK) following the manufacturer's instructions. THP-1
cells were seeded in 24-well plates at a density of 1 106/mL in
500 μL medium containing 10% FBS and differentiated as
described above. Prior to treatment the cells were washed with
PBS and 500 μL of 1%FBS RPMImediumwas added to eachwell.
Cells were treated for 24 h with either lipopolysaccharide at a
final concentration of 1 μg/mL, NPCB at 1 μg/cm2 or 5 μg/cm2
and GP at a concentration range of 1 μg/cm2, 5 μg/cm2, and
10 μg/cm2 in cell media and media supplemented with either
cytochalasin D at a concentration of 0.2 μM (Enzo Life Sciences),
potassium chloride at 30 mM (Sigma), and diphenyleneiodo-
nium chloride at 15 μM (Sigma). Triton X (0.1%, Sigma) was used
as a positive control, and the cells were incubated with Triton X
for 30min. After the treatment the supernatant was centrifuged
for 5 min at 2000g, transferred, centrifuged again for 5 min at
13000g and used for activity assay according to manufacturer's
instructions. A microplate reader (BioTek SynergyHT) was used
to measure the optical density at 490 nm. Results are given as
the mean ( sem of five independent experiments.
Cytokine Bead Array. The supernatant of untreated cells and
cells treated with 5 μg/cm2 CB and GP in medium was used to
screen for 11 cytokines important in acute inflammation and
apoptosis to identify cytokines unregulated after treatment. The
cytokine levels were measured using a BD Cytometric Bead
Array Flex Set. The flex set included the human soluble protein
buffer master kit and bead numbers D9, A7, A9, B4, D8, D4, B9,
C5, E6, B6 representing the cytokines TNF, IL-6, IL-8, IL-1, MCP-1,
Rantes, MIP-1R, basic FGF, IL-13 and TGF-β.
Twenty-five microliters of mixed capture antibodies were
added to 50 μL of each supernatant or standard in a 96 well
plate and incubated for 1 h at room temperature. Detection
reagent was added to each well and incubated for 2 h at room
temperature. After centrifugation at 1500g for 5 min the super-
natant was removed and wash buffer was added to each well
and agitated for 5 min for resuspension of the beads. BD
FACSArray Bioanalyzer was used to measure the fluorescence
intensity and FACP array software was used for analysis. The
concentration of each cytokine was calculated using the stan-
dard curve and expressed as pg/mL. Results are given as the
mean ( sem of three independent experiments.
ELISA. The supernatant of all treatment groups (including
supplemented media) was further used to measure the expres-
sion of IL1-β using human IL1-β/IL-1F2 DuoSet (R&D Systems
Europe Ltd., Abingdon, UK) according to manufacturer's de-
scription. Results are given as the mean ( sem of five indepen-
dent experiments.
Detection of Reduced Glutathione (GSH) as Indicator of the
Oxidative Status of Cells. The oxidative status of glutathione can
be detected via monobromobimane (MBB), which becomes
fluorescence after binding nonenzymatically free thiol group of
GSH. THP-1 cells were seeded in 12- well plates at a density of
0.5  105/mL in 2.5 mL medium containing 10% FBS and
differentiated as described above. Prior to treatment the cells
were washed with PBS, and 2.5mL of 1% FBS RPMImediumwas
added to each well. Cells were treated for 4 h with either NPCB
or GP at 1 μg/cm2 or 5 μg/cm2 in cell media. N-Ethyl-maleimide
(NEM) (100 μM, Sigma-Aldrich) was used as a negative, deple-
tion of reduced glutathione. Supernatant and cells were trans-
ferred into falcon tubes and centrifuged for 3 min at 1500g.
PBS was added to the pellet and centrifuged for 3 min at 1500g
and repeated twice. A 150 μL portion of 50 μM monobromobi-
mane (MBB) (Sigma-Aldrich) was added to the pellets and
incubated for 10 min at 37 C. Controls were included in all
measurements and comprised untreated/unstained and un-
treated/stained samples as well as treated/unstained samples.
The dye was detected using a BD LSRFortessa flow cytometer.
MBB was excited by a violet laser (405 nm, 50 mW) and
the emission was detected through a 455/40 filter. FlowJo
software (Tree Star Inc.) was used for analyzing the data. Gating
was based on FCS/SCS and the data is expressed as mean
fluorescence intensity. The mean value of the blank sample was
subtracted from the stained samples. Results are given as the
mean ( sem of four independent experiments.
Scanning/Transmission Electron Microscopy. THP-1 cells
were differentiated as described above and seeded in 24 well
plates on Thermanox Plastic Coverslips (NUNC, Rochester, NY
USA) at a density of 1  106/mL. The cells were treated with
1 μg/cm2 and 5 μg/cm2 NPCB and GP for 4 days at 37 C in 5%
CO2 atm and washed 5with 0.1 M sodium cacodylate (pH 7.2)
buffer. Overnight fixation was done in 3% glutaraldehyde/0.1 M
sodium cacodylate (pH 7.2) buffer. After fixation the cells
adherent to the coverslips were washed in sodium cacodylate
buffer, postfixed in 1% osmium tetroxide in 0.1 M sodium
cacodylate buffer for 45 min, critical-point dried, and gold
sputter coated.
Samples for TEM were embedded in Araldite resin. Sections
1 μm thick were cut on a Reichert OMU4 ultramicrotome (Leica
Microsystems (UK) Ltd., Milton Keynes), stained with Toluidine
Blue and viewed in a lightmicroscope to select suitable areas for
investigation. Ultrathin sections, 60 nm thick were cut from
selected areas, stained in uranyl acetate and lead citrate then
viewed in a Phillips CM120 transmission electron microscope
(FEI UK Ltd., Cambridge, England). Images were taken on a
Gatan Orius CCD camera (Gatan UK, Oxon, England). Samples
for SEM were gold sputter coated and viewed using a Hitachi
S-2600N digital scanning electron microscope (Oxford Instru-
ments, Oxfordshire, UK).
Statistical Analysis. All data are shown as the mean ( sem,
and these were analyzed using one-way analysis of variance
(ANOVA). Multiple comparison were analyzed using the Tukey-
HSD method and in all cases, values of P < 0.05 were consider
significant. (GraphPad InStat Software Inc., CA, USA).
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For quantification of contaminating metals the supernatant of 1 mg/ml of each sample in 
0.5% BSA/saline were analysed using the technique of inductively-coupled mass 













compared to CB, however all concentrations are negligible and not biologically relevant 
(Table I).  
 
Table I. Concentration (ng/g) of soluble metal associated with CB and GP in the supernatant 
of a 1 mg/ml solution.  
 
Aerodynamics of platelet-shaped particles 
The gravitational settling speed of a particle is determined by the opposing effects of the 
gravitational force and the aerodynamic resistance.   The aerodynamic drag force depends 
on the shape and orientation of the particle with respect to its direction of motion.  A plate-
like particle with uniform thickness may well settle under gravity with orientation 
perpendicular to its direction of motion.  If it is not a uniform thickness, it might behave like 
a spear with a weighted tip (if one edge is relatively heavy) or it might be stable in the 
perpendicular orientation if the extra weight is central.   
The gravitational force on a particle is determined by its volume and density.  For a spherical 









=      (1) 
Where  g is the gravitational acceleration. 
For a platelet particle, with thickness t, and projected area diameter dproj the equivalent 









=     (2) 
The gravitational settling force is opposed by the aerodynamic resistance to the motion of 
the particle.   
For a circular plate-like particle of diameter b that is infinitely thin, the aerodynamic 
resistance when the plate is perpendicular to the direction of motion at velocity V, the 
following expression can be obtained from Fuchs et al. 
1
 for the resistance to motion  
VbFm ×××-= h8      (3) 
Where η is the viscosity of air.  
The above equation applies when the disc is perpendicular to the direction of motion. 
When the infinitely thin circular plate-like particle is orientated parallel to the direction of 








 also notes that the formula in equation 4 has given good agreement with data when 




When the particle reaches an equilibrium settling velocity (Vs,), then Fm= Fg, and by taking 
the projected area diameter dproj as being approximately the same as the diameter of the 









=      (5) 







     (6) 
The definition of the aerodynamic equivalent diameter is the diameter of a unit density 
sphere with the same settling speed as particle; that is, if Vss = Vs then the d in equation 6 is 
the dae for the plate-like particle.  This leads directly to an expression for the aerodynamic 
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Using equation 7, we can estimate the aerodynamic diameter for plate-like-particles of 












In vivo  
Acute pulmonary inflammatory response to GP  
 
 
Figure I. Lung pathology 24 hour post aspiration. The effect of 50 µg CB and GP aspiration is 
demonstrated 24 hour post aspiration. Each panel shows an entire lung section stained with 
Haematoxylin & Eosin (H&E) to demonstrate gross pathology. CB lung has normal pathology 
however in the lung of GP treated mice granulomatous areas are present (n=3).  
 
Chronic pulmonary inflammatory response to GP  
To assess the chronic inflammation to the lungs, CB and GP were aspirated into the lungs at 
a single dose of 50 µg per mouse. After 1 week post GP exposure, the granulocyte number 
continued to be significantly elevated (Fig. IIA) but was decreased compared to the 24 hour 
response. CB did not lead to an significant increase in total cell number or PMN (Fig. IIA). No 
granulomatous lesions could be observed in GP treated lung sections however an increased 
number of lymphocytes was present in the smooth muscle surrounding the bronchi and in 
the alveolar spaces (Fig. IIB). In CB treated lung sections only occasional areas of lymphocyte 































Figure II Inflammatory response in the lungs after 1 week exposure to CB and GP. A. Total 
cell number and total granulocyte number after pharyngeal aspiration of a single dose of 50 
µg of CB and GP 1 week post treatment. B. Histological examination showed infiltration of 
lymphocytes in CB and GP treated mice, with a greater extent in the GP.  Sections were 






Chronic pleural inflammatory response to GP  
The granulocyte response to 1 week GP exposure after intrapleural injection was decreased 
to a tenth compared to 24 hour exposure (Fig. IIIA). The concentration of total protein in the 
lavage fluid was significantly increase in GP treated mice (Fig. IIIB). Continuous thickening of 
the parietal pleura was present after 1 week exposure to GP (Fig. IIIC).  Inflammatory cells 
with associated GP were present along the parietal pleura.  These areas of inflammatory 
cells appeared denser and granulomatous on SEM micrographs (n=3) (Fig. IIIC bottom 


















































Figure III Inflammatory response in the pleural space after 1 week exposure to CB and GP. A. 
Total cell number and total granulocyte number after 1 week exposure to CB and GP in the 
lavage fluid. B. Measurement of the total protein concentration in the lavage fluid.  Single 
asterisk (*) indicates p < 0.05, double asterisk (**) indicates p < 0.01 compared to vehicle 
control. C. H&E stained parietal pleura section (n=1) (top panel) and SEM (n=3) (bottom 
panel) in low and high magnification showing aggregations of inflammatory cells and 
granulomatous areas on parietal pleural 1 week post GP exposure.    
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The mechanism of pleural inflammation by long
carbon nanotubes: interaction of long fibres with
macrophages stimulates them to amplify pro-
inflammatory responses in mesothelial cells
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Abstract
Carbon nanotubes (CNT) are high aspect ratio nanoparticles with diameters in the nanometre range but lengths
extending up to hundreds of microns. The structural similarities between CNT and asbestos have raised concern
that they may pose a similar inhalation hazard. Recently CNT have been shown to elicit a length-dependent,
asbestos-like inflammatory response in the pleural cavity of mice, where long fibres caused inflammation but short
fibres did not. However the cellular mechanisms governing this response have yet to be elucidated. This study
examined the in vitro effects of a range of CNT for their ability to stimulate the release of the acute phase
cytokines; IL-1b, TNFa, IL-6 and the chemokine, IL-8 from both Met5a mesothelial cells and THP-1 macrophages.
Results showed that direct exposure to CNT resulted in significant cytokine release from the macrophages but not
mesothelial cells. This pro-inflammatory response was length dependent but modest and was shown to be a result
of frustrated phagocytosis. Furthermore the indirect actions of the CNT were examined by treating the mesothelial
cells with conditioned media from CNT-treated macrophages. This resulted in a dramatic amplification of the
cytokine release from the mesothelial cells, a response which could be attenuated by inhibition of phagocytosis
during the initial macrophage CNT treatments. We therefore hypothesise that long fibres elicit an inflammatory
response in the pleural cavity via frustrated phagocytosis in pleural macrophages. The activated macrophages then
stimulate an amplified pro-inflammatory cytokine response from the adjacent pleural mesothelial cells. This
mechanism for producing a pro-inflammatory environment in the pleural space exposed to long CNT has
implications for the general understanding of fibre-related pleural disease and design of safe nanofibres.
Keywords: Carbon nanotubes, Pleura, Mesothelioma, Asbestos, Inflammation
Background
Carbon nanotubes (CNT) are high aspect ratio nanopar-
ticles comprising single (SWCNT) or concentrically
stacked multiwalled (MWCNT) graphene sheets rolled
seamlessly into a cylinder. Their high aspect-ratio and
novel properties make CNT a useful industrial material
and has led to their incorporation into a wide variety of
consumer products. However, as the applications of
CNT continue to grow, so too does the potential for
occupational inhalation exposure with obvious potential
hazards for worker health [1]. The structural similarities
between CNT and asbestos have raised particular con-
cern regarding the potential pathogenicity of CNT in
the lung and serosal cavities, specifically the pleural and
peritoneal spaces, which are key target tissues for asbes-
tos-related disease [2].
Carbon nanotubes have been found to cause a range of
pathogenic effects, oxidative stress [3] inflammation and
NLRP3 inflammasome activation [4], fibrosis [5,6] and
genotoxicity [7].
The mesothelial lining of the pleural cavity has long
been known to be particularly sensitive to asbestos
exposure producing pleural effusion, pleural plaques and
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fibrosis [8]. Cancer arising in the mesothelial cells lining
both the peritoneal and pleural cavities, mesothelioma,
is a response almost unique to fibrous particles. The
exact mechanisms leading to fibre-induced mesothe-
lioma formation are unknown although fibre dimensions
[9-11], biopersistence [12], the generation of reactive
oxygen species (ROS) [13] and inflammation [14] have
all been implicated. Due to its uniformly poor prognosis,
mesothelioma is the disease of most concern when con-
templating the potential toxicity of new high aspect
ratio nanoparticles; pleural plaques and effusion are also
a consequence of long fibre dose in the pleural space.
The ability of fibres to induce an inflammatory response
in the pleura has been considered to be a key mechan-
ism in the production of mesothelioma and other
pleural pathology[15,16]. A length dependent inflamma-
tory response, similar to that seen with asbestos, has
been reported for CNT and other high aspect ratio
nanomaterials (HARN) in a number of studies using the
peritoneal cavity as a model of mesothelium exposure
[17,18] and more recently in a study conducted by the
present authors investigating the response to CNT
instilled into the pleural cavity [19]. The length-depen-
dent response in the pleural cavity was characterised by
an initial acute inflammatory reaction as indicated by an
influx of granulocytes and an increase in protein con-
centration in the lavage fluid [19]. The length-dependent
response to CNT in vivo was attributed to the fibre
length-restricted clearance mechanisms from the pleural
space through stomata in the parietal pleura leading to
specific retention of long fibres while short fibres are
efficiently cleared [19]. Nevertheless the detailed interac-
tions between the CNT and pleural mesothelial cells
and macrophages at these points of retention are
unknown and are the focus of the present study.
Inhaled fibres that reach the pleural space will encounter
mesothelial cells lining the pleural cavity and also resident
pleural macrophages. Mesothelial cells, historically
thought of as barrier cells that provide a lubricated surface
that locks the parietal pleura to the visceral pleura allow-
ing for lung movements, are now also known to play a
prominent role in the initiation, perpetuation and resolu-
tion of inflammation in the pleural cavity [20]. During
injury or infection, mesothelial cells can respond by pro-
ducing a spectrum of pro- and anti-inflammatory cyto-
kines and chemokines, growth factors, oxidants,
extracellular matrix molecules and mediators of the com-
plement cascade [20]. Macrophages are also present in the
pleural space and can play a role in host defence and
immuno-inflammatory responses [21]. The primary func-
tion of professional phagocytes such as pleural macro-
phages is to ingest foreign material that may pose a threat
to the body and so pleural macrophages are likely to play
a key role in the removal of inhaled particles and fibres
that are retained in the pleural space. We therefore
hypothesised that the response of the mesothelial cells and
macrophages upon exposure to CNT or other fibres will
be crucial in the pathogenesis of fibre-related pleural
inflammation and therefore in subsequent pleural disease.
Here, we aim to use in vitro methods to elucidate the
relative roles of the macrophages and mesothelial cells in
driving the inflammatory response to long fibres. Long
and short CNT samples were examined in an effort to
infer whether the response to the CNT was length-
dependent, as is the case in the inflammatory response in
the pleural space in vivo [19]. Using the same panel of
CNT as described by Murphy et al. [19] we examined the
ability of long and short CNT to elicit pro-inflammatory
responses in both a human non-transformed mesothelial
cell line (Met5A), and macrophages derived from the
human monocyte cell line (THP-1) as a surrogate for
pleural macrophages, by direct exposure to CNT. The
release of TNFa, IL-6, IL-8 and IL-1b; acute phase pro-
inflammatory cytokines was measured as an indicator of
the pro-inflammatory potential of the CNT panel. In
addition we hypothesized that the inflammatory response
could be driven by cross-talk between the macrophages
and mesothelial cells and so we also examined the effect
of conditioned media from CNT-treated macrophages on
the mesothelial pro-inflammatory response.
Results
Effect of direct exposure to CNT panel on mesothelial cell
and macrophage viability
Mesothelial cell viability, as measured by trypan blue
exclusion assay, was examined after 24 hour exposure to
the CNT panel over a dose range from 5 to 50 μg/cm2. A
significant loss of cell viability was seen only in response
to NTlong1 (20 μg/cm
2) and NTlong2 (20 ug/cm
2, 50 μg/
cm2) (Figure 1A). This loss of cell viability coincided with
an increase in supernatant LDH levels in Met5A cultures
treated with NTlong1 and NTlong2 at the two highest doses
only (Figure 1B). Exposure of macrophages (THP-1) to all
the members of the CNT panel caused a significant
increase in supernatant LDH only at the higher doses
(Figure 1C). Trypan blue exclusion assay could not be car-
ried out on THP-1 cells exposed to CNT as macrophages
clumped together during the treatments making accurate
assessment of the cellular viability by this method impossi-
ble. Based on these data a sub-lethal dose of 5 μg/cm2 was
selected for treatments of both Met5A and THP-1 cells
for the subsequent activation studies.
Effects of direct exposure to the CNT panel on pro-
inflammatory cytokine release from mesothelial cells
In order to investigate the effect CNT might have on
mesothelial cell activation we assayed, using a cytometric
bead array system, the concentration of a number of
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pro-inflammatory cytokines present in Met5A cell super-
natants following direct exposure to the CNT panel for
24 hours (Figure 2A). No member of the CNT panel had
an effect on the supernatant concentrations of IL-1b, IL-6,
IL-8 or TNFa in Met5A cultures compared to LPS, a posi-
tive control to activate cells, which caused a significant
increase in the concentration of all four cytokines.
Effects of direct exposure to the CNT panel on pro-
inflammatory cytokine release from macrophages
In order to investigate the impact of CNT phagocytosis on
macrophage activation, we measured the concentration of
IL-1b, IL-6, IL-8 and TNFa present in the THP-1 cells
supernatants following exposure to the CNT panel (Figure
2B). Only the CNT samples containing long fibres- NTlong1
and NTlong2 caused a significant increase in IL-1b and IL-6
concentrations compared to untreated cells. NTlong1 also
induced a significant increase in IL-8 concentration; how-
ever no increase was seen with NTlong2. NTlong2 did appear
to elevate the concentration of TNFa, but this elevation
was not statistically significant. No increase in cytokine
concentration was seen after exposure to NPCB, NTshort,
NTtang1 or NTtang2.
Role of frustrated phagocytosis in length-dependent IL-1b
release from macrophage
The appearance of the THP-1 cells after 24 hour treat-
ment with the CNT panel at a dose of 5 μg/cm2 is shown
in Figure 3 as Diffquik stained light micrograph images
(A-G) or as scanning electron micrograph figures (H - K).
Normal cells are shown in Figure 3D and 3H. NPCB and
the short CNT samples; NTshort, NTtang1 and NTtang2
appear to be easily taken up by the macrophages as they
are seen as accumulations of black particles within the
cells (Figure 3A, B, E and 3F) but were not visible on the
cell surface in SEM images confirming that they had been
effectively phagocytosed (Figure 3I and 3J). NTlong1 and
NTlong2 were not completely taken up by the cells which
showed the classic features of frustrated phagocytosis with
fibrous CNT extended from the cell surfaces (Figure 3G
and 3K) or a single long fibre could be shared by more
than one cell (Figure C). This state of frustrated phagocy-
tosis appeared more extensive in cells treated with the
longer NTlong2 sample. We selected one cytokine, IL-1b,
to test the hypothesis that the length-dependent pro-
inflammatory effects were due to frustrated phagocytosis
of long fibres. THP-1 cells were co-incubated with the
NTlong1 and NTlong2 samples and an inhibitor of phagocy-
tosis (cytochalasin D) and the release of IL-1b was mea-
sured by ELISA (Figure 4). Cytochalasin D, a potent
inhibitor of actin polymerisation, prevented the uptake of
the long CNT by the THP-1 cells (Figure 4A) and inhib-
ited the increase in IL-1b concentration caused by expo-
sure to NTlong1 and NTlong2 in a dose-dependent pattern.
However it had no effect on the IL-1b concentrations
caused by LPS, which does not require phagocytosis to eli-
cit a pro-inflammatory response. Measurements of super-
natant LDH levels showed there was no loss of cell
viability due to cytochalasin D treatments (Figure 4B).
Effect of conditioned media from CNT-exposed
macrophages on mesothelial cell viability
In order to test the hypothesis that CNT that reach the
pleural space stimulate mesothelial cells indirectly via the
release of cytokines from particle-activated macrophages,
we used conditioned media from CNT-exposed THP-1
Figure 1 The effect of the CNT panel on cell viability. The
viability of mesothelial cells was measured by trypan blue exclusion
(A) and LDH release (B) after a 24 hour exposure to the CNT panel,
UT indicates untreated control. LDH release was also used as an
indicator of cell viability of macrophages at 24 hours after CNT
treatment (C). Data expressed as a mean ± sem, n = 3. Significance
versus vehicle control *** indicates p < 0.001.
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Figure 2 The effect of the direct exposure to the CNT panel on cytokine release from mesothelial cells and macrophages. No increase
in the levels of IL-1b, IL-6, IL-8 or TNFa was detected after mesothelial cells were exposed to the CNT panel. However significant increases in IL-
1b and IL-6 and IL-8 were seen in macrophages treated to long CNT samples only. UT indicates untreated control Data expressed as a mean ±
sem, n = 3.
Murphy et al. Particle and Fibre Toxicology 2012, 9:8
http://www.particleandfibretoxicology.com/content/9/1/8
Page 4 of 15
cells to treat Met5A cells and measured the concentra-
tions of pro-inflammatory cytokines in the Met5A super-
natant (Figure 5A).
No increase in LDH release from the Met5A cells
treated with the conditioned media confirm the treat-
ments did not caused a loss of membrane integrity and
therefore cell viability (Figure 5B).
Effect of conditioned media from CNT-exposed
macrophages on mesothelial cell production of pro-
inflammatory cytokines
Whilst direct exposure of Met5A cells to the CNT panel
had not caused any increases in IL-1b, treatment with
conditioned media from THP-1 cells exposed to LPS,
NTlong1 or NTlong2 resulted in approximately two-fold
Figure 3 Uptake of CNT by macrophages. Light micrographs (A-G) of THP-1 cells untreated (D) or treated with the CNT panel. NPCB (A),
NTshort (E), NTtang1 (B) and NTtang2 (F) appear as aggregates within the cells (white arrows). However NTlong1 (C) and NTlong2 (G) appear to be
protruding from the cells (white arrows). Scale bar indicates 20 μm. SEM images (H-K) show an untreated THP-1 cell (H) and THP-1 cells
treated with NPCB (I), NTshort (J) and NTlong2 (K). No particles can be seen associated with the cell surface or protruding from the cells in I or
J however the fibre from the NTlong2 (K) sample appear on the surface of the cells and also protruding from the cell. Scale bar indicates
10 μm.
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increase in IL-1b concentration compared with the com-
bined total from both cell types exposed directly as
shown by the horizontal lines on the bars (Figure 6A).
Media from THP-1 cells exposed to the NTlong1 and
NTlong2 samples also had a significant effect on the pro-
duction of IL-6, IL-8 and TNFa by Met5A (Figure 6B-D).
The potentiation of Met5A activation was most pro-
nounced when Met5A had been exposed to NTlong2-
exposed THP-1 media which resulted in a 20-fold, 30-fold
and 6-fold increase in the concentrations of IL-6, IL-8 and
TNFa respectively, when compared with the combined
total from each cell type exposed directly. Conditioned
media from NTlong1 treated THP-1 cells also caused a sig-
nificant increase in the production of IL-6, IL-8 and TNFa
from Met5A cells albeit to a lesser extent. Exposure to
media from THP-1 cells treated with NPCB, NTshort,
NTtang1 or NTtang2 did not have any effect on the produc-
tion of the pro-inflammatory cytokines; IL-1b, IL-6, IL-8
or TNFa, by Met5A cells.
The levels of IL-1b and IL-6 released from Met5A
cells treated with the conditioned media from THP-1
cells treated with NTlong2 was attenuated when the
THP-1 cells were co-exposed to NTlong2 and cytochala-
sin D to prevent phagocytosis (Figure 7).
Iron content
The iron content of the CNT samples is given in the
Additional file 1.
Interference of CNT in the assays
We precluded interference of CNT in the assays used
here and the evidence is present in the Additional file 1.
Discussion
We previously reported that long CNT but not short CNT
were capable of causing inflammation in the peritoneal
[17] and pleural spaces [19]. Whilst retention of the long
fibres at stomata represent the key initiating step the cellu-
lar mechanism, especially the interaction between macro-
phages and mesothelial cells, leading to inflammation was
not elucidated. The present study addressed three hypoth-
eses as to the mechanism by which CNT cause pro-
inflammatory effects in the pleural cavity. These three
hypotheses centred on the major cells of the pleural cavity,
mesothelial cells and macrophages, are outlined in dia-
grammatic form in Figure 8. The refractoriness of the
Figure 4 Inhibition of IL-1b release from long CNT-treated macrophages. (A) Example images of macrophages treated with NTlong2 with or
without cytochalasin D. Cytochalasin D inhibits the attempted uptake of long fibres by the macrophages. (B) Cytochalasin D caused a dose-
dependent inhibition of IL-1b release from macrophages treated with NTlong1 and NTlong2 but not LPS. Significance versus 0 μM cytochalasin D
within each treatment group *** indicates p < 0.001. A loss of cell viability in the presence of cytochalasin D was not detected by LDH release.
Data expressed as mean ± sem, n = 3.
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mesothelial cells to long CNT effects and the existing lit-
erature describing how conditioned media from macro-
phages treated with particles greatly amplify the pro-
inflammatory responses of epithelial cells [22] and
endothelial cells [23] led us to discount the alternative
hypothesis, that products released by mesothelial cells
could stimulate amplifying pro-inflammatory responses in
the macrophages. Whilst mesothelial cells did prove
refractory, in terms of cytokine release, to direct exposure
to long and short CNT, macrophages exposed to long
fibre CNT samples did release significant quantities of
pro-inflammatory cytokines. When the supernatant from
the long fibre-exposed macrophages was added to
mesothelial cells it stimulated the mesothelial cells to
release substantial quantities of cytokines that were much
greater than those produced by the macrophages in
response to long CNT or the mesothelial cells exposed to
long CNT (Summarised in Table 1) or the sum of these
two. Therefore the pro-inflammatory milieu generated by
macrophages in response to long fibre CNT samples was a
potent activator of mesothelial cells and caused a dramatic
amplification of cytokine production by the mesothelial
cells. Supernatants were centrifuged at 13,000 rpm for 5
minutes to remove any CNT and this procedure produced
a black pellet and a clear supernatant. When the clear
supernatant was added to the target mesothelial cells, in
contrast to the direct treatment with CNT where black
CNT were readily visible inside the cells, no particles were
visible in or on the cells. It is not possible to preclude the
presence of very small amounts of CNT but these would
be trace amounts well below the threshold of effect.
The mechanism and outcome of phagocytosis of long
CNT differs from that of short CNT or NPCB, in that
phagocytosis proceeds initially but the macrophage can-
not effectively enclose the extended structure of a long
fibre culminating in the phenomenon of ‘frustrated pha-
gocytosis’ [24]. The uptake of long fibres by macro-
phages and the subsequent pro-inflammatory response
from the mesothelial cells exposed to their supernatant
could be attenuated by inhibiting the phagocytosis of
the long fibres by macrophages during the initial treat-
ments using the microfilament poison Cytochalasin D;
this confirms that the process of frustrated phagocytosis
is is the key one that leads to inflammation in the case
of the long fibre CNT. The macrophage response to
LPS, which does not require microfilament-mediated
Figure 5 The effect of conditioned media from CNT-exposed macrophages on mesothelial cell viability. (A) Schematic diagram
representing the conditioned media experimental procedure. THP-1 cells were treated with CNT suspensions for 24 hours, supernatant was
removed and centrifuged to remove any suspended CNT, conditioned media was added to the Met5A cells for 24 hours after which cell viability
and production of cytokines was measured. Cell viability of mesothelial cells was measured by LDH release (B) but no cell death was detected.
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uptake into cells by phagocytosis, was not attenuated by
the addition of cytochalasin D highlighting the necessity
of particle uptake and the role of frustrated phagocytosis
in the pro-inflammatory reaction produced in response
to CNT exposure. Our results suggest that indirect acti-
vation of mesothelial cells by pro-inflammatory cyto-
kines elaborated from longCNT-exposed macrophages is
a key initiating event in the development of pleural
inflammation and disease.
Previous studies have described that long, needle-like
CNT and asbestos activated the NLRP3 inflammasome
Figure 6 The effect of conditioned media on cytokine release
from cells. IL-1b, IL-6, IL-8 and TNFa supernatant levels were
measured 24 hours after mesothelial cells were exposed to media
from CNT-treated macrophages. A length-dependent increase in
concentration was observed for each of the cytokines. The black
horizontal lines on the graph indicate the level of cytokine
expressed by the THP-1 cells which is still present in the
conditioned media. Data expressed as mean ± sem, n = 3.
Significance versus vehicle control *** indicates p < 0.001.
Figure 7 The effect of conditioned media from macrophages
co-exposed to NTlong2 and cytochalasin D on mesothelial
production of IL-1b and IL-6. A significant reduction in the levels
of IL-1b and IL-6 release from mesothelial cells exposed to
conditioned media from macrophages treated with NTlong2 and
cytochalasin D was observed compared to mesothelial cells treated
with conditioned media from macrophages treated with NTlong2
alone. Data expressed as mean ± sem, n = 3. Significance versus
vehicle control *** indicates p < 0.001.
Figure 8 Potential mechanisms of the long fibre-mediated
inflammatory response. The following three potential mechanisms
by which CNT cause inflammation in the pleural space were
explored in this study. (A) Long fibres interact with the pleural
macrophages producing cytokines that directly elicit an
inflammatory response. (B) Long fibres interact directly with
mesothelial cells with the subsequent factors released leading to
granulocyte influx. (C) Long fibres interact with macrophages
inducing the release of cytokines which stimulate the mesothelial
cells, amplifying the inflammatory response. As initial results showed
no response from the mesothelial cells to direct exposure to CNT,
the effect of factors released from CNT-exposed mesothelial cells on
macrophages was not examined.
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and secretion of IL-1b from LPS-primed human macro-
phages [25] whilst our macrophages were not primed
with LPS. In our study the THP-1 cells had been differ-
entiated with PMA [26]which gives then a phenotype
similar to resting monocyte-derived macrophages.
A proportion of all particles and fibres that deposit in
the distal regions of the lung will translocate into the
pleural cavity thereby facilitating direct interactions
between them and the patrolling macrophages of the
pleural space and the mesothelial cells lining it [24].
According to Mercer et al. [34]CNT that reach the distal
lung are likely to be predominantly present inside alveo-
lar macrophages. However CNT in the immediate sub-
pleural site, whilst a low proportion of all CNT, were all
in tissue i.e. not in macrophages [27]. Therefore the CNT
in the pleural space may be taken there inside alveolar
macrophages, whilst the non-phagocytosed CNT that
reach the pleural space from the sub-pleural tissue may
be taken up by pleural macrophages. Research is needed
to better understand the secretory profile of pleural
macrophages or alveolar macrophages containing CNT
in the pleural space. Mesothelial cells are reported to be
uniquely sensitive to asbestos fibres with direct exposure
in vitro inducing death [28,29], inflammatory mediator
production [28], oxidative stress [30] and genotoxicity
[39,40]. Although the potential pathogenicity of CNT has
been tested in a variety of lung-derived cell types with
responses including inflammation [33] and oxidative
stress [34] reported, there is a paucity of data concerning
the direct effects of CNT on mesothelial cells. Pacurari et
al. examined the direct effects of SWCNT and MWCNT
on normal and malignant mesothelial cells and reported
a decrease in cell viability, activation of pro-inflammatory
transcription factors and pro-inflammatory MAPK path-
way activation [35,36]. However these effects were very
modest and seen at 5-10 times the dose used in the pre-
sent paper. There was also ongoing PARP activation sug-
gesting that the cells were also undergoing apoptosis,
making this data difficult to interpret as to the true role
of direct pro-inflammatory effects of CNT on mesothelial
cells at plausible doses. In contrast, within the present
study we found mesothelial cell cytotoxicity only at the
highest exposures used in preliminary studies but no evi-
dence of pro-inflammatory responses after exposure of
mesothelial cells to a low sub-lethal dose (5 μg/cm2) of
the panel of CNT. The inflammatory response to CNT
after direct injection into the pleural space in vivo, char-
acterised by an influx of inflammatory granulocytes [19],
would undoubtedly require the actions of acute phase
cytokines such as IL-1b, TNFa, IL-6 and IL-8. The
inability of CNT to directly stimulate the production of
such cytokines in mesothelial cells in vitro would suggest
the interactions between CNT and mesothelial cells are
not directly responsible for the initiation of inflammation.
In contrast to the findings with mesothelial cells, expo-
sure of macrophages to the CNT panel resulted in the
induction of modest length-dependent pro-inflammatory
responses. This was evident when only the long fibre-
containing samples (NTlong1 and NTlong2) induced the
production of the acute phase cytokines IL-1b and IL-6.
The lack of response to the short CNT samples and par-
ticulate graphite in the form of NPCB suggest that the
pro-inflammatory response to CNT in the pleural space
is solely dependent on length. Length is a controlling fac-
tor in the clearance of fibres from the pleura where only
long fibres are selectively retained for sufficient time to
actually become involved in interactions with macro-
phages at stomatal openings [19]. Any fibre that exceeds
a maximum length for macrophage uptake will result in
frustrated phagocytosis, a state where the macrophages
are unable to fully engulf long fibres resulting in the
release of oxidants and pro-inflammatory signals [24].
Frustrated phagocytosis has long been known to play an
important role in asbestos effects [24,37] and has also
been implicated more recently in the inflammatory
responses to long CNT elicited from macrophages in
vitro [38] and in vivo [17] and long TiO2 nanofibres [39].
Brown et al. reported an increase in the production of
TNFa and a concurrent increase of ROS by macrophages
in response to CNT and showed that this response was
specifically related to the length of the CNT fibres [38].
The presence of macrophages undergoing frustrated pha-
gocytosis in the peritoneal lavage fluid of mice exposed
to long CNT was noted by Poland et al. who suggested
that this macrophage-mediated response may be playing
a role in the inflammation [17]. Here, using a panel of
CNT similarly defined by length we showed the length-
dependent release of a number of pro-inflammatory
Table 1 Summary of cytokine release from cells
IL-1b IL-6 IL-8 TNFa
NTshort NTlong2 NTshort NTlong2 NTshort NTlong2 NTshort NTlong2
Mesothelial cells (pg/m) 205 ± 26 153 ± 17 340 ± 11 347 + 2 392 ± 15 458 ± 16 15 ± 2 10 ± 3
Macrophages (pg/ml) 296 ± 23 506 ± 34 128 ± 39 380 + 8 286 ± 8 403 ± 4 6 ± 2 350 ± 200
Mesothelial cells +
conditioned media (pg/ml)
293 ± 2 1012 ± 59 214 ± 8 8479 + 3640 121 ± 29 12130 ± 2254 14 ± 4 2029 ± 328
The cytokine release for the three treatment groups are compared side by side using one short CNT (NTshort) and one long CNT (NTlong2) as exemplars
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cytokines from macrophages exposed to the long fibre
CNT samples only. Frustrated phagocytosis of TiO2
nanobelts longer than 15 μm was demonstrated by
Hamilton et al. who also described the mechanism by
which the inability of macrophages to completely enclose
long fibres lead to pro-inflammatory responses via lyso-
somal destabilisation and NALP3 inflammasome activa-
tion [39]. The NALP3 inflammasome controls the
maturation and release of IL-1b from activated cells [40]
and activation of the NALP3 inflammasome via lysoso-
mal destabilisation and the release of the lysosomal
enzyme cathepsin B was reported in response to macro-
phage uptake of crystalline silica particles [41]. The acti-
vation of the NALP3 inflammasome by long CNT has
also recently been demonstrated by Palomaki et al. in pri-
mary macrophages primed with LPS who, also reported a
role for the P2X7 receptor and its downstream tyrosine
kinases, Src and Syk, in the activation of the NALP3
inflammasome in response to ‘rigid, needle-like material’
[42]. The induction of NALP3 via frustrated phagocytosis
of long CNT is in keeping with studies examining the
inflammatory response to asbestos and other fibrous par-
ticles which have also demonstrated the importance of
the NALP3-mediated inflammatory response to particles
and fibres in vivo. Inhibition or knock-out studies of key
components of the NALP3 inflammasome prior to
administration of asbestos fibres [43], silica [41,43,44] or
MSU [41] crystals into the lungs of mice have all shown
an attenuated inflammatory response compared to wild-
type controls. The role for NALP3 in the activation of an
inflammatory response suggests that direct interaction
between macrophages and long fibres is the initiating
mechanism for the development of long fibre-related
inflammation and subsequent disease. Mesothelial cells
are well equipped to participate in the initiation and reso-
lution of inflammation. Secretion of chemokines by sti-
mulated mesothelial cells promotes directed migration of
granulocytes which can lead to influx of inflammatory
cells from the vasculature into the serosal space [45].
Mesothelial cells have been shown to be directly stimu-
lated to produce a range of pro-inflammatory mediators
including cytokines, chemokines, growth factors and oxi-
dants in response to bacterial endotoxin and asbestos but
have also been shown to be highly responsive to factors
secreted by macrophages [20]. Previous studies with
PM10 and diesel soot have also shown that fixed cells-
epithelial cells and endothelial cells respectively, show
much greater responses to particle-free conditioned
media from macrophages treated with particles than to
direct treatment with the particles [22,23]. Similarly, in
the present study a greatly amplified mesothelial pro-
inflammatory response was conferred by the particle-free
conditioned medium of long CNT-exposed macrophages.
The role of cross-talk between macrophages and
mesothelial cells in amplifying inflammation has been
demonstrated previously by Betjes et al. when peritoneal
mesothelial cells were shown to produce high levels of
IL-8 in response to conditioned media from macrophages
treated with the bacteria Staphylococcus epidermidis, but
not to the bacteria themselves [46]. IL-1b and TNFa also
mimicked induction of the mesothelial IL-8 response and
the response to the conditioned media was blocked by
the addition of anti-IL-1b and anti-TNFa antibodies [46].
The pro-inflammatory effect of the supernatant from
macrophages exposed to the long CNT samples described
here was similarly attenuated by inhibiting release of IL-1b
by blocking phagocytosis with cytochalasin D highlighting
the importance of phagocytosis in eliciting secretion of
cytokines that drive the pro-inflammatory effects on the
mesothelial cells. The acute inflammatory response seen
in the pleural space after the injection of long CNT is
characterised by the rapid influx of granulocytes into the
pleural cavity [19]. The data suggest that it is a release of
high levels of mesothelial IL-8 or KC, the mouse analogue
of IL-8 in response to stimulatory factors released from
macrophages attempting to phagocytose long CNT fibres
that explains the inflammatory cell influx in vivo. Taking
these 3 studies together [22,23,46] TNFa and IL-1b are
the most likely candidate cytokines released by macro-
phages undergoing frustrated phagocytosis of long CNT
that drive the pro-inflammatory effects in the mesothelial
cells seen in our studies.
The mesothelial response to macrophage stimulation is
also important in tissue repair. Macrophages were
recruited in large numbers to the pleural space following
long CNT deposition there [19]. Macrophages have been
shown to stimulate mesothelial cell proliferation in
response to injury in vivo with the rate of serosal healing
dependent on the number of macrophages present [47]
and also the macrophage-mediated release of cytokines
such as TNFa [48]. Our data suggest that macrophages
exposed to long CNT in the pleural space will have simi-
lar mitogenic effects on mesothelial cells which may lead
to disregulated growth patterns.
The cross-talk between macrophages and mesothelial
cells is known to be important in the normal inflamma-
tory processes in the serosal cavities but, if disregulated,
may also help to promote the development of mesothe-
lioma. The precise mechanism that leads to mesothe-
lioma development in the presence of fibres is unknown
but a role for chronic inflammation in response to
retained biopersistent fibres has been postulated [15].
Exposure of normal human mesothelial cells to asbestos
fibres in vitro has not been shown to lead to cell transfor-
mation even though phenotypic changes such as chromo-
somal changes and extended lifespan were observed
[31,32]. However Wang et al. [49] carried out a study
examining the effect on mesothelial cells of erionite, a
Murphy et al. Particle and Fibre Toxicology 2012, 9:8
http://www.particleandfibretoxicology.com/content/9/1/8
Page 10 of 15
naturally occurring long biopersistent fibre which causes
mesothelioma in man and rodents following inhalation
[50-52]. In this study, treatment of mesothelial cells with
erionite in combination with pro-inflammatory cytokines
highlighted a potential role for an inflammatory environ-
ment in the transformation of mesothelial cells [49].
While erionite alone had no effect on cell transformation,
both IL-1b and TNFa could stimulate formation of
transformed cells as identified by their anchorage-inde-
pendent growth in soft agar. While the cytokines could
induce the formation of tumorigenic colonies alone the
effect was more potent in the presence of the erionite
fibres [49]. TNFa has also been shown by Yang et al. to
inhibit asbestos-induced cell death by activating the NF-
B signalling pathway in mesothelial cells [53]. The
TNFa-mediated resistance to the cytotoxicity may pro-
mote tumour formation by increasing the pool of
mesothelial cells with fibre-mediated genomic damage in
the inflammogenic environment which evade normal cell
death. This suggests that inflammation and inflammatory
cytokines may play an important role in mesothelioma.
Here we showed that mesothelial cells exposed to a cock-
tail of cytokines and other mediators produced by macro-
phages treated with long CNT amplify and propagate the
inflammatory response thereby likely contributing to dis-
ease development in the pleural space.
A recent paper [54] has focused on the diameter of CNT
and claimed that MWCNTs ~50 nm diameter showed
mesothelial cell membrane piercing and cytotoxicity in
vitro and subsequent inflammogenicity; in contrast CNT
with a diameter of ~150 nm or ~2-20 nm were less
inflammogenic. We found no support for this diameter
hypothesis - the samples with least activity (short or
tangled CNT) had diameters of 14.8, 10.4 and 84.9 nm
respectively whilst the most active (the long CNT) was
165 nm diameter, quite close to the 150 nm diameter
found to have no activity in the Nagai study [54].
Iron has been implicated in CNT activity via it’s ability
to cause oxidative stress [55,56]. However the levels of
iron in our sample showed no relationship with activity
in any of the assays; in particular the long CNT which
had the most activity, had least iron.
Although we deal here solely with inflammation as a
factor in fibre pathogenicity and mesothelioma produc-
tion there are other effects of long fibres on mesothelial
cells such as clastogenic and genotoxic ones that are
important in themselves and possibly in concert with
inflammation in leading to mesothelioma [54,57].
Conclusion
In summary, the data presented in this study describe a
mechanism for the initiation of a long fibre mediated
inflammatory response in the pleural space via fru-
strated phagocytosis. Only long fibres are retained in the
pleural space and we have shown firstly that the incom-
plete phagocytosis of long CNT by macrophages, but
not mesothelial cells, elicits a modest pro-inflammatory
cytokine response. Secondly we show that the superna-
tant from macrophages exposed to long fibres produces
a much-amplified pro-inflammatory response in target
mesothelial cells. This amplified mesothelial cell
response to macrophage products was attenuated by
inhibition of macrophage phagocytosis, of long fibres
confirming a role for frustrated phagocytosis. This study
furthers our understanding of the role of macrophage/
mesothelial cross-talk as a mechanism underlying the
generation of a length-dependent inflammatory response
to CNT in the pleural space. In addition, this in vitro
model may prove useful for in vitro toxicity screening of
the large number of new high aspect ratio nanofibres




The panel of particles investigated consisted of 5 different
samples of multiwalled CNT and nano-particle carbon
black (NPCB) as was used previously in Murphy et al.
[19] (Table 2). The NTlong1 sample (Mitsui & Co. Ltd.,
Japan) was produced by catalytic chemical vapour synth-
esis using the floating reaction method. The NTlong2 sam-
ple was produced in an academic research laboratory (Dr
Ian Kinloch, University of Manchester) using catalytic
vapour discharge (CVD) method using a ferrocene-
toluene feedstock to grow nanotubes from iron catalysts
held on a silica plate. These nanotubes grew aligned as
mats, meaning they were straight and un-entangled. The
nanotubes were harvested from the mats using a razor
blade, with some residual iron remaining within the
nanotubes. We also included one commercially available
short straight CNT (NTshort; Nanoamor Inc., TX, USA)
and two curled and tangled nanotubes of different
lengths (NTtang1 which was cut to form predominantly
short NT fibres and the original length NT sample
(NTtang2); NanoLab, Inc., MA, USA). These were pro-
duced by CVD with an iron and ceramic oxide (alumino-
silicate) catalyst support which was removed using HCl
and Hydrofluoric acid treatment. Trace metals and endo-
toxin levels previously tested and reported in Poland
et al. [17] were low and thus not considered to play a role
in these studies.
CNT suspensions
CNT were suspended in RPMI-1640 media (PAA
Laboratories Ltd., UK) containing 0.5% bovine serum
albumin (BSA; Sigma-Aldrich, Poole, UK) at a concentra-
tion of 500 μg/ml and dispersed by sonication at 230 V,
50 Hz, 350 W for 2 hours in an ultrasonic bath
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(FB11002, Fisherbrand, Thermo Fisher Scientific, Inc.,
MA, USA). Suspensions were prepared freshly each day
and used immediately upon removal from the ultrasonic
bath.
Cell culture and treatment
The immortalised human mesothelial cell lineMet5A, and
the monocytic cell line THP-1 were obtained from the
American Type Culture Collection (ATCC) and main-
tained at sub-culture in RPMI-1640 supplemented with
10% foetal calf serum (PAA Laboratories Ltd., UK) at 37°C
and 4% CO2. Prior to experimentation Met5A cells were
seeded in 24-well plates (Corning, Amsterdam, The Neth-
erlands) at a concentration of 2.5 × 105 cells/well and
allowed to adhere for 24 hours. THP-1 monocytic cells
(2.5 × 105 cells/well) were differentiated into macrophages
with 10 ng/ml phorbol 12-myristate 13-acetate (PMA;
Sigma-Aldrich, Poole, UK) in 24-well plates for 48 hours.
Prior to the treatment of both cell types the media was
replaced with RPMI media containing 0% FCS, 1% penicil-
lin/streptomycin and 1% L-Glutamate. Cells were treated
with the CNT panel for 24 hours using a range of doses to
determine cell viability, 5 μg/cm2 was chosen as a sub-
lethal dose for subsequent activation studies. Cytochalasin
D (Enzo Life Science) was used to co-treat THP-1 cells
along with NTlong1, NTlong2, or LPS. Light microscopy
images of THP-1 cells treated with the panel of CNT were
captured at ×40 magnification using QCapture Pro soft-
ware (Media Cybernetics, MD, USA). For the conditioned
media treatments THP-1 cells were treated with the CNT
panel (5 μg/cm2) for 24 hours, supernatant was removed
and centrifuged at 13,000 rpm for 5 minutes to remove
any CNT. Conditioned media was added to the Met5A
cells for 24 hours.
Scanning electron microscopy
THP-1 cells were grown on Thermonox coverslips (Nunc,
Roskilde, Denmark) and treated with NPCB, NTshort or
NTlong2 for 24 hours. Cells were fixed with 10% Formalin
and were stained with osmium tetroxide prior to critical
point drying, mounted and gold sputter coated before
examination by scanning electron microscopy (SEM)
using an Hitachi S-2600 N digital scanning electron
microscope (Oxford Instruments, Oxfordshire, UK).
Trypan blue exclusion assay
Met5A cells were plated as above before treatment with
the particle panel for 24 hours at doses ranging from 5-
50 μg/cm2. The cell supernatant was removed and kept
for LDH measurements, cells were washed once with
PBS and incubated with 0.4% trypan blue (Sigma-Aldrich,
Poole, UK) for 5 minutes. Excess trypan blue was
removed and cells washed with PBS. Dead cells, as indi-
cated by incorporation of the trypan blue dye, were
counted and calculated as a percentage of total cells.
Lactate dehydrogenase assay
One hundred microlitres of cell supernatant from Met5A
and THP-1 cells exposed to the CNT panel at doses ran-
ging from 5-50 μg/cm2 or LPS (1 μg/ml) was added in tri-
plicate to a 96 well plate (Corning, Amsterdam, The
Netherlands) and 100 μl of the LDH test reagent (diaphor-
ase/NAD + mixed with iodotetrazolium chloride and
sodium lactate at a ratio of 1:45) added to each well. Cells
treated with 0.1% Triton-X were used as a positive control
for 100% cell lysis. Following a 30 minute incubation per-
iod the absorbance of each well at 490 nm wavelength was
established using a Synergy HT microplate reader (BioTek
Instruments, Inc. VT, USA).
Cytokine bead array
The media levels of IL-1b, IL-6, IL-8 and TNFa were mea-
sured after direct exposure of the mesothelial cells and
macrophages to the CNT panel and exposure of the
mesothelial cells to the conditioned media from CNT-
treated macrophages by cytokine bead array (BD CBA
Flex Set, BD Biosciences, San Jose, CA). Briefly, 25 μl of
the mixed capture antibodies were added along with 50 μl
of the supernatant samples and standards to each well of a
96-well plate and incubated at room temperature for one
hour. Twenty-five microlitres of the mixed PE detection
reagent was added to each well and incubated at room
temperature for two hours. The plate was centrifuged at
1500 rpm for 5 minutes and the supernatant completely
Table 2 Characteristics of the particle panel














Diameter (nm) 14 25.7 ± 1.6 14.84 ± 0.05 10.40 ± 0.32 84.89 ±
1.9
165.02 ± 4.68
Length (μm) - 1-2 1-5 5-20 Mean 13 Mean 36
% fibre greater than
15 μm
‡ ‡ ‡ ‡ 24.04 84.26
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removed. One hundred and fifty microlitres of the wash
buffer was added to each well. The plate was agitated for 5
minutes to resuspend the beads before the samples were
analyzed using the BD FACSArray Bioanalyzer (BD Bios-
ciences, San Jose, CA). Results were analysed using FCAP
array software and sample concentrations of each cytokine
were established via extrapolation from the appropriate
recombinant protein standard curve.
ELISA
The media levels of IL-1b and IL-6 after macrophage inhi-
bition studies was established using ELISA DuoSet kits
(R&D systems, Abingdon, UK) specific to each analyte of
interest. Ninety-six well microtitre plates were incubated
overnight at 4°C with 100 μl of coating antibody raised
against IL-1b or IL-6. The plates were washed 3 times
with 0.05% Tween-20 in phosphate buffered saline (PBS;
pH 7.2) and blocked using reagent diluent (1% BSA in
PBS; R&D systems, Abingdon, UK) for 1 hour (room tem-
perature) prior to further washing and addition of test
samples/standards in triplicate. After 2 hrs the plates were
washed and a biotinylated detection antibody added to
each well followed by a further 2 hr incubation, followed
by washing and the addition of HRP conjugated Streptavi-
din. The plates were washed and developed using a TMB
substrate solution (Sigma-Aldrich, Poole, UK). The subse-
quent reaction was stopped with 0.5 M H2SO4, resulting
in a yellow colour, and read at 450 nm. Sample concentra-
tions of IL-1b, IL-6 were established via extrapolation
from the appropriate recombinant protein standard curve.
Statistical analysis
All data are shown as the mean + s.e.m. and these were
analysed using one-way analysis of variance (ANOVA).
Multiple comparisons were analysed using the Tukey-
HSD method, with values of P < 0.05 considered statisti-
cally significant (Instat, Graphpad Software Inc., CA,
USA).
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Excluding CNT interference in the assay 
 
We checked the potential of the CNT samples used here to interfere with assays where elements of 
the assay  might adsorb to the particle surface. To  test for an effect in the LDH assay Met5A cells 
were lysed  (100% LDH release) and incubated with 50mg/cm
2
 long/short  CNT or media control and 
LDH assessed.. No difference was seen between the LDH levels  in samples incubated with  the 
media control or the CNT samples (Supplementary Figure 1).  The Trypan blue assay is not amenable 
to adsorption artefact since the blueness of cell is estimated by eye and, cells were not sufficiently 
highly loaded that the blue staining was obscured. In  addition, the similarity in results between the 
Trypan Blue assay and the LDH assay with only the long CNT proving to have statistically significant 
cytotoxicity supports the contention that the cytotoxicity assays  are not affected by adsorption.  In 
order for adsorption artefact to  explain the difference between NT long and NTshort in cytokine 
assays the NTshort  would  need to  adsorb 3 - 6 times more cytokine per unit mass  than the NTlong. 
We chose IL-8 as an examplar cytokine and diluted it  to 500 pg/ml and dispersed NT long and NT 
short at 5mg/ml, the only dose used in these studies; these were  then incubated overnight  and IL-8 
measured.  There was no significant difference in the levels of IL-8 between untreated IL-8 and IL-8 
treated with either long or short CNT (Supplementary Figure 2).  
We conclude that interference of CNT in assays cannot explain any of the differential effects seen 
between  long and short CNT in this study. 
 
Iron content 
The soluble iron content of  the samples here has been previously published [1] and were as follows 
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Suspicion has been raised that high aspect ratio nanoparticles 
or nanobers might possess asbestos-like pathogenicity. The pleu-
ral space is a specic target for disease in individuals exposed to 
asbestos and by implication of nanobers. Pleural effects of bers 
depends on ber length, but the key threshold length beyond which 
adverse effects occur has never been identied till now because all 
asbestos and vitreous ber samples are heterogeneously distrib-
uted in their length. Nanotechnology advantageously allows for 
highly dened length distribution of synthetically engineered b-
ers that enable for in-depth investigation of this threshold length. 
We utilized the ability to prepare silver nanobers of ve dened 
length classes to demonstrate a threshold ber length for acute 
pleural inammation. Nickel nanobers and carbon nanotubes 
were then used to strengthen the relationship between ber length 
and pleural inammation. A method of intrapleural injection of 
nanobers in female C57Bl/6 strain mice was used to deliver the 
ber dose, and we then assessed the acute pleural inammatory 
response. Chest wall sections were examined by light and scanning 
electron microscopy to identify areas of lesion; furthermore, cell–
nanowires interaction on the mesothelial surface of the parietal 
pleura in vivo was investigated. Our results showed a clear thresh-
old effect, demonstrating that bers beyond 4 µm in length are 
pathogenic to the pleura. The identication of the threshold length 
for nanober-induced pathogenicity in the pleura has important 
implications for understanding the structure–toxicity relationship 
for asbestos-induced mesothelioma and consequent risk assess-
ment with the aim to contribute to the engineering of synthetic 
nanobers by the adoption of a benign-by-design approach.
Key Words:  silver nanowires; asbestos; pleural inammation; 
HARN; ber threshold; risk assessment.
Asbestos caused and continues to cause a pandemic of lung 
and pleural disease due to inhalation of airborne respirable 
!bers, which reach the most peripheral parts of the lungs 
producing !brosis and lung cancer and enter the pleura causing 
!brosis and mesothelioma (Delgermaa et  al., 2011; Heintz 
et  al., 2010; Mossman et  al., 2011). Because of these risks, 
asbestos has been banned in most Western countries but, due to 
exposure in the past and the long lag time to diagnosis, there is 
a substantial number of ongoing deaths from mesothelioma per 
year in countries that used asbestos industrially. High aspect 
ratio nanomaterials (HARN) are characterized by their high 
ratio of length to width, are nanoscale in two dimensions, may 
be made from a wide range of elements and compounds, and fall 
either into the category of nanotubes, nanowires, or nanorods 
(Donaldson et al., 2011). Chrysotile asbestos !brils, which are 
commonly less than 100 nm in diameter, ful!ll the criteria for a 
HARN, albeit a naturally occurring example. The !brous shape 
brings advantages over compact nanoparticulate counterparts 
for certain industrial applications, and the intrinsic size, 
shape, and properties of metal nanoparticles can be tailored 
and !ne tuned with great precision (Wiley et al., 2005). The 
increasing use of HARN in the nanotechnology industries 
inevitably implies increased risk of exposure of workers during 
manufacturing processes. This has attracted the attention of 
risk assessors and toxicologists due to the similarities between 
asbestos and HARN, with mesothelioma being a major focus 
of concern.
We previously recorded that direct exposure of the perito-
neal (Poland et al., 2008) and the pleural mesothelial surfaces 
(Murphy et  al., 2011) produced in#ammatory and !brotic 
effects only with long (>10 µm) samples of carbon nanotubes 
(CNTs), a manufactured nano!ber that is in ever-higher pro-
duction. Crucially, this length-dependent effect is also seen 
with asbestos !bers in the induction of mesothelioma, lung 
cancer, and !brosis in rats (Davis et al., 1986). These studies 
clearly imply that long, straight CNT should be risk managed 
like asbestos (British Standards Institution, 2007).
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A ber pathogenicity paradigm has been developed based 
on toxicology studies with asbestos and other natural and 
man-made bers (Donaldson et  al., 2009, 2011). In 1996, 
Kane summarized parameters that render a brous material 
pathogenic, that is, biopersistence, dimensions (length, width), 
chemical composition, and surface reactivity. The parietal 
pleura is the key site of retention of long, biopersistent bers, 
and the pleura is a site where ber-specic pathology, including 
pleural effusion and the mesothelioma, is initiated (Donaldson 
et al., 1989, 2010). Studies investigating the role of the length 
of asbestos and other bers in vitro and in vivo in the devel-
opment of pleural disease led to the overwhelming conclusion 
that longer bers (> approximately 8 µm) are more pathogenic 
than shorter bers (Davis et al., 1986; Davis and Jones, 1988; 
Dodson et al., 2003; Heintz et al., 2010). Although ber length 
is accepted as the major contributing factor to ber pathogen-
icity, the length threshold value at which long-ber effects 
occur in the pleura is unknown.
In the present study, we utilized the technical advances of 
nanotechnology to produce nanobrous structures in tightly 
dened length categories to investigate the threshold length for 
ber effects in the pleural space.
MATERIALS AND METHODS
Particle panel. The panel of nanowires consisted of ve different 
lengths of silver nanowires (AgNWs) (www.seashelltech.com), abbreviated 











to their mean length in micrometer (μm). The AgNW panel was provided in 
isopropanol at a concentration of 30 mg/ml. They were synthesized using a 
polyol process as described in U.S. patent number 7,922,787 B2 issued to 
Seashell Technology, San Diego, CA. Synthesis of AgNW and reaction con-
ditions to obtain different lengths did not affect the chemical composition 
of the different nanowires. Sizing of the nanowire length was performed by 
light microscopy (100× magnication using QCaptur objective) (n = 100) 
(Table  1 and Supplementary gs. 1A–C). Mixed length amosite asbestos 
enriched for long bers (100% bers ≥ 5 µm, 50.3% bers > 15 μm, and 
35.2% bers > 20 μm), hereafter referred to as long ber asbestos (LFA), 
and shortened amosite asbestos (SFA; 3.1% bers ≥ 5  μm) (Donaldson 
et al., 1989) were used to link the response to asbestos pathogenicity. Both 
LFA and SFA were created from the same batch of South African amosite 
(Davis et al., 1986) obtained from the Manville Corporation, United States. 
SFA was prepared by grinding long bers in a ceramic ball mill, and the 
resulting ber preparation sedimented in water. The process of ball milling 
used to shorten the LFA to make the SFA was associated with small changes 
in the iron chemistry (Graham et al. 1999; Tomatis et al. 2010). SFA con-
tained a consistent fraction of nonbrous particles based on the denition 
of a ber by the WHO (1997) (i.e., longer than 5 µm, thinner than 3 µm, 





) nickel nanowires (NiNWs) and short (2 µm/NT
2
) 
and long (13  µm/NT
13
 and 36  µm/NT
36
) multiwalled CNTs (MWCNTs) 
were used (see Supplementary table 1 and Supplementary g. 2) as alterna-
tive forms of HARN. (NiNWs) were fabricated by electrochemical tem-
plate synthesis at Trinity College (TCD, Ireland) as previously reported 
by Byrne et al. (2009) and Poland et al. (forthcoming) (see Supplementary 
table 1). The surface of these wires is coated with a layer of nickel oxide, 
which is approximately of 3–4 nm thickness, which act as protective layer 
against the chemical dissolution (Prina-Mello et al., 2006). Material par-
ticulate control panel consisted of Ag-nanoparticle (Ag-P), Ni-nanoparticle 
(Ni-P), nanoparticle carbon black (NPCB) as reported in Supplementary 
table  1. Nanowires were tested for the presence of bacterial endotoxins 
using a Limulus Amebocyte Lysate test (Lonza Group, Switzerland), but no 
endotoxin was detectable (detection limit < 10pg/ml). To test the endotoxin 
levels, supernatant of the AgNW and NiNW solutions were used to avoid 
interference of AgNW or NiNW with the assay.
Experimental animals. Nine-week-old female C57Bl/6 strain mice 
(Harlan, U.K.) were used in this study. Mice were kept in a group size of ve 
in standard caging with sawdust bedding within a pathogen-free Home Ofce 
approved facility. Mice were maintained on a normal 12-h light and dark cycle. 
Prior to the treatment, mice were kept for 7 days in the facility to acclimatize. 
The work was carried out by staff holding a valid U.K. Home Ofce personal 
licence under a Home Ofce approved project licence.
TABLE 1











Mean length (µm) 3 5 10 14 28
% ber per length category (µm)
0.5–1.5 6 2 0 0 0
1.5–2.5 39 7 0 2 0
2.5–3.5 53 22 2 2 0
3.5–4.5 2 14 0 0 0
4.5–5.5 12 3 0 0
5.5–6.5 40 9 0 0
6.5–7.5 2 4 2 0
7.5–8.5 1 4 2 0
8.5–9.5 24 23 0
9.5–10.5 14 14 0
10.5–15.5 34 17 22





Diameter (nm, mean ± SEM) 115 ± 3 118 ± 3 128 ± 2 121 ± 3 120 ± 4















































Intrapleural injection and lavage. Samples were prepared in 0.5% bovine 
serum albumin (BSA; Sigma-Aldrich, Poole, U.K.)/saline and injected into the 
pleural cavity of unanesthetized female C57BI/6 mice at a dose of 5 µg per 
mouse and an injection volume of 100 µl per mouse. The site of injection was 
the right upper quadrant of the thorax. Mice were euthanized after 24 h and 1 
week (n = 4) by asphyxiation in 100% CO
2
. The pleural space was lavaged with 
three 1-ml washes of sterile saline. Cellular fraction and lavage !uid were sepa-
rated by centrifugation. Total cell count was performed using a NucleoCounter 
(ChemoMetec, 7 A/S, Allerød, Denmark), and cyto-centrifugation followed by 
Diff-Quik staining using Diff-Quik stainset (Dade Behring GmbH, Marburg, 
Germany) were performed for differential cell counts. Images of lavaged cells 
were taken using QCapture Pro (Media Cybernetics Inc., Bethesda, MD).
Dissection. After 24-h and 1-week exposure, the lower right posterior 
portion of the chest wall was resected from the mice after lavage, washed in 
ice-cold saline, and "xed for 4 h in 30% formalin. The resected chest wall 
was an area of approximately 10 mm × 10 mm adjacent to the spine includ-
ing the lower six ribs and intercostal space and, according to Shinohara et al.
(1997), resulted to be rich in stomata. The chest wall was excised from the 
surrounding tissue, embedded on edge in paraf"n, sectioned, and stained with 
hematoxylin and eosin for gross pathology (n = 2 per treatment for chest wall). 
Representative images of chest wall samples and lesion area were obtained by 
taking serial images at 10× magni"cation using QCapture Pro software (Media 
Cybernetics Inc.).
Scanning electron microscopy and backscatter secondary electron micros-
copy. Specimens were "xed and dehydrated as above, mounted on scanning 
electron microscopy (SEM) aluminum stubs, and rotary coated with about 8 nm 
of carbon in an Edwards 306A vacuum coating system (Edwards High Vacuum, 
Crawley, U.K.).
SEM of carbon-coated specimens was carried out using a Hitachi 4700 II 
"eld emission SEM (Hitachi High-Tech, Maidenhead, U.K.) at a beam accel-
erating voltage of 10 kV and a working distance of about 8 mm. Secondary 
electron (SE) and backscatter secondary electron (BSE) images were taken 
simultaneously using an annular YAG crystal BSE detector and the upper SE 
detector to produce perfectly synchronized image pairs. The two images were 
superimposed using Adobe Photoshop (Adobe Systems Incorporated, San Jose, 
CA) by layering the BSE image with the grayscale SE image using the Lighten 
function and pasting this image into the red channel of the SE image after 
conversion to RGB, thus color coding in red the strong BSE signal from the 
nanowires and the SE image appearing in gray.
Statistics. All data are shown as the mean ± SEM and these were analyzed 
using one-way analysis of variance. Multiple comparisons were analyzed using 
Tukey’s honestly signi"cant difference method and in all cases, values of p < 0.05 
were considerably signi"cant (GraphPad InStat Software Inc., La Jolla, CA).
RESULTS
Characteristics of the Particle Panel
AgNWs were characterized by SEM and light microscopy 
and showed a uniform dispersion in diameter and tight length 
distribution for each class (Table 1 and Supplementary "g. 1). 
Dissolution of AgNW was measured via change in pH compared 
with that of vehicle control across the 24-h exposure. No 
signi"cant change in dissolution of AgNW occurred as shown 
by the almost !at slope of the curve across the 24-h exposure, 
and no difference in dissolution was observed between all 
AgNW lengths (Supplementary "g. S3A).
In addition to the AgNW panel, a range of nano"ber con-
trols were used in this study including short (2  µm/NT
2
) 










) NiNWs. The CNT samples have 
been previously characterized by Murphy et  al. (2011), 
whereas NiNWs were characterized according to their 
length distribution and diameter as previously described by 
Poland et al. (forthcoming) and Byrne et al. (2009), respect-
ively. A modest extent of NiNW dissolution over 24 h was 
detected using pH change measurement; this is possible due 
to the saline solution degradation as shown by its reference 
curve (Supplementary "g. 3B).
Silver nanoparticulate (35 nm/Ag-P), NPCB, and Ni-P were 
included as material nanoparticulate controls. Well-characterized 
mixed length amosite asbestos enriched for long "bers and SFA 
(see Supplementary Information) were used as long (> 10 µm) 
and short pathogenic "ber control.
Acute In"ammatory Response to Intrapleural Injection of 
Silver Nano#bers and Controls
The pleural cavity was lavaged 24 h after intrapleural 
injection, and the acute in!ammatory reaction measured 
as the total cell number and total granulocytes (predomi-
nantly neutrophils plus a low proportion of eosinophils) in 
the lavage. There was a clear length-dependent in!amma-
tory response to AgNW, with signi"cant increases in both 
total cell and total granulocyte number after treatment with 
AgNW that were 5 µm and longer (Figs. 1B and 1C) and LFA 
(Fig. 1D). In contrast, neither the very short "bers (AgNW
3
 
and SFA) nor the compact nanoparticles (Ag-P) elicited a 
signi"cant in!ammation (Figs. 1B–D). The length-dependent 
response reveals that the total granulocyte number induced 





 (Fig. 1C). Moreover, there was no sig-
ni"cant difference in in!ammatory response (granulocytes) 







demonstrating an all-or-nothing type of response beyond the 
5 µm length. For AgNW
28
, there was a signi"cant increase 
in total cell number and granulocyte cell number compared 
with AgNW
5
 (Figs. 1B and 1C). This all-or-nothing response 





(see Supplementary "gs. 4A and 4B). AgNW
3
 did not lead 
to a signi"cant increase in in!ammatory cells up to a tested 
dose of 10 µg per mouse.
The general design of this study used equal "ber mass; there-
fore, many more short "bers than long "bers were injected, yet 
still this greater number of short "bers in the dose of AgNW
3
 
was much less in!ammogenic than the fewer long "bers in 
the dose of AgNW
5
. Because "ber exposure is regulated in 
workplaces on the basis of the "ber number, we calculated the 





key lengths spanning the threshold value (see Supplementary 
materials and methods). Based on "ber number calculations, 
we reexpressed the in!ammatory response ‘per "ber,’ and this 















































clearly showed that the ber-specic inammatory potency of 
the AgNW
3
 bers is negligible compared with the marked spe-
cic inammogenicity of AgNW
5
 bers (Fig. 1E).
Light Microscopy and SEM of Parietal Pleura Surface
The pathogenic response to AgNW by the surface of the parietal 
pleura was examined by light microscopy and by SEM at 24-h 
postexposure. The pleural surface layer was a continuous normal 
mesothelium after intrapleural injection of vehicle control, SFA, 
Ag-P, and AgNW
3
 (Figs. 2A–D). In contrast, sections of the 
parietal pleura from mice injected with LFA and AgNW
5/10/14/28
 
showed large lesions comprising macrophages and granulocytes 
at the pleural surface (Figs. 2E–I and Supplementary g. 5).
In!ammatory Response After 7-Day Exposure
To address the course of the response, a 7-day time point was 
assessed at the 5-µg dose. The acute inammatory response had 
largely resolved at this time point, although there was still a 
length-dependent effect detectable at AgNW
14/28
 (Supplementary 
g. 6A). Histological sections of the chest wall at 7 days con-
tinued to show thickening of the submesothelial cell layer in the 
same length-dependent pattern as the acute inammation, that 
is, with a threshold at 5 µm (see Supplementary g. 6B). BSE 
microscopy of in vivo biopersistence and light microscopy of 
in vitro durability showed that AgNWs retain their structural 
integrity over the 1-day time point but are not biopersistent over 
a protracted time (Fig. 3 and Supplementary g. 7).
Phagocytosis of AgNW in Pleural Lavage Fluid and in 
Lesions on the Parietal Pleura
The degree of phagocytosis of different lengths of AgNW in 
pleural macrophages was assessed by light microscopy in cytospin 





 could, for the most part, be fully phagocytosed inside 
pleural macrophages recovered in the lavage uid (Fig. 3B) and 
in lesions on the parietal pleura imaged by BSE (Fig. 3F) at 1 day. 
In contrast, AgNW
10/14/28
 lead to frustrated phagocytosis in the 
pleural macrophages (Figs. 3C–E and 3G, Supplementary g. 8). 
FIG. 1. Illustration of pleural injection and length-dependent response to AgNW in the pleural space 24 h postinjection. (A) Illustration of pleural injection 
showing a modied needle with a sleeve penetrating the chest wall into the pleural space to deliver the dose of nanobers (Murphy et al., 2011). (B) Count of 
total cell number in relation to ber length of AgNW after 24-h treatment in female C57Bl/6 mice. All lengths were signicantly greater than AgNW
3
 (p < 0.001). 












 (p < 0.001) is observed. Data represent 
mean ± SEM of n = 4 mice. (C) Total granulocyte count from pleural lavage 24 h postinjection of AgNW in female C57Bl/6 mice. The inux of total granulocytes 
(neutrophil and eosinophil) is dependent on ber length of AgNW. All lengths were signicantly greater then AgNW
3













 (p < 0.001). (D) Total 
cells and total granulocytes were counted in lavage uid of mice treated with SFA, LFA, and AgNW panel. (E) Acute inammatory response expressed per ber. 
Equalization to ber number reinforced the identied threshold value. Data represent mean ± SEM of n = 4 mice.















































In addition, the presence of AgNW on the chest wall of mice 
treated with AgNW
3
 was assessed, and no AgNW
3
 could be found 
on the parietal pleura using BSE; hence, we assume that they were 
readily cleared from the pleural space after 24 h.
Role of Silver Ion Toxicity and Soluble Metals
We determined the release of soluble silver into saline for the 
different !ber lengths using inductively coupled plasma mass 
spectrometry, but these data are confounded by the formation 
FIG. 2. Length-dependent response of AgNW on the parietal mesothelial surface 24 h postinjection. Hematoxylin and eosin histology sections and SEM 
images of VC (A), mice treated with Ag-P (B), AgNW
3








 (H), and LFA (I). No alteration on the 
mesothelial surface can be seen in the mice treated with Ag-P, AgNW
3
, and SFA. Normal mesothelial cells on the parietal pleura appear either "at as seen in the 
image of VC-exposed mesothelium or in a more rounded or raised form in areas called the lacunar regions, such as that seen in the image of SFA-exposed meso-
thelium (Donaldson et al., 2010). Accumulation of in"ammatory cells was observed on the mesothelial lining in mice treated with long AgNW (≥ 5 µm) and LFA. 
Scale bar: black 100 µm; white 20 µm.
FIG. 3. Phagocytosis of AgNW in pleural lavage "uid and in in"ammatory cells in lesions on the parietal pleura. Cytospin preparation of the pleural lavage 
"uid from mice treated with AgNW
3
 (A) and AgNW
5
 (B) shows complete phagocytosis of nanowires in pleural macrophages (nanowires indicated by the arrow). 
(C) AgNW
10
 is not entirely phagocytosed, showing the ends of a nanowire protruding from a cell (indicated by two arrows). Frustrated phagocytosis of mac-
rophages was observed after AgNW
14/28
 treatment (D and E). A number of macrophages can be seen sharing a single !ber indicated by the arrow (F). All cytospin 
images are 100  magni!cation. Merged secondary electron and backscatter electron SEM images of the lesion’s surface on the parietal pleura from mice treated 
with AgNW
5
 (F) and AgNW
10
 (G). (F) Two !bers are shown, which are fully phagocytosed by pleural macrophages (black arrows). The white arrow shows a 
!ber on the surface in the lesion area. (G) The star indicates frustrated phagocytosis of macrophages with AgNW
10
. The loci where unclosed phagosomes must be 
present are indicated by the white arrows. The black arrow shows a !ber that is shared by two cells each of which must have an unclosed phagosome. Scale bar 
for all images 10 µm.















































of insoluble silver chloride. We also collected the soluble 
products from the AgNWs of long and short lengths into 
saline and assessed the ability to cause pleural inammation. 
Although we found no difference between soluble extracts of 
short and long AgNWs, this also may have been confounded 
by the formation of silver chloride and so these data are not 
included in this paper. The issue of the potential formation 
of silver chloride from silver ions and chloride ions raises 
an important question as to whether silver ions could ever be 
toxic in vivo because of their rapid removal by the formation 
of insoluble silver chloride following reaction with chloride 
ions, which are ubiquitous in biological systems. Furthermore, 
it seems to be impossible to measure silver ion release from 
Ag-P into biological media because chloride ions would 
always be present in biological media with the formation of 
silver chloride.
Acute In!ammatory Response to Intrapleural Injection of 
Nickel Nano"bers, CNTs and Controls
The acute inammatory response to AgNW and SFA/LFA 
in the pleural space after intrapleural injection was compared 











 using the same method. 
NPCB and Ni-P were included as material nanoparticulate 
controls (Supplementary table S1). Particulates and short "b-







no signi"cant increase in total cell number and granulocytes 
24 h after intrapleural injection (Fig. 4). In contrast, all "ber 
samples that were 5  µm and longer produced an inamma-









(Fig. 4 and Supplementary "g. 9). The data clearly show that 
the threshold length for long "ber effects in the pleural space 





is dramatic but can be explained by their size distribution 
curves, which are illustrated in Figure 4B. Hardly any NiNW
4
 
are longer than 5 µm; however, ~40% AgNW
5
 are ≥ 5 µm (see 
Supplementary "gs. 1C and 2). Further information exclud-
ing a role for soluble Ni ions can be found in Supplementary 
Information.
Size of Stomata Across Mammalian Species
To link the outcome from the mouse study to the human 
risk relating to "ber length, the size of human parietal 
pleural stomata and the site of long "ber retention are most 
relevant. We performed a literature search on the size range 
of stomata on the diaphragm or the parietal pleura of various 
species, which shows a remarkable constancy (Table  2). 
From mouse to human, the size ranges from 0.8 to 10 µm. 
This is in agreement with allometric scaling for lung cells 
in mammals ranging in size from shrews to horses (Stone 
et al., 1992), which showed no mean difference in size for 
cells such as epithelial cells across this large range of body 
mass.
DISCUSSION
In this study, the use of de"ned length classes of nano"bers 
allowed us to quantify the threshold length for inammatory 
effects in the pleural space, the key site for "ber pathogenic-
ity. A method of intrapleural injection of particles, previously 
described by Murphy et al. (2011), was used to measure acute 
inammation in the pleural space. This method is justi"ed on 
the basis that a fraction of all inhaled particles and "bers that 
deposit in the peripheral lung translocate into the pleural space 
(Mercer et al., 2010; Miserocchi et al., 2008; Mitchev et al., 
2002; Walton, 1982). A dose of 5 µg was selected to allow com-
parison of the results with previously published data investigat-
ing the length-dependent effect of CNT in the pleural space 
(Murphy et al., 2011).
We used a very speci"c panel of AgNW in different length 
classes, otherwise identical in composition, diameter, and solu-
bility. This demonstrated a clear length threshold value for "ber 
pathogenicity in the pleural space of 5 µm. Signi"cant increase 
in total cell number and granulocytes in the pleural space was 
observed after exposure to "bers of a length including 5 µm 
and longer, which could be con"rmed via histological and SEM 
examination of the parietal pleura of the chest wall. Injecting a 
single dose into the pleural space, as we have done here, mas-
sively overrepresents the number of "bers that reach the sto-
mata compared with inhalation, yet there was no inammatory 
effect of any of the short nano"bers. The fact that the huge dose 
and high dose rate of short "bers produced by instillation into 
the pleura proved noninammatory argues that the short "b-
ers would be noninammatory to the pleura following inhal-
ation, when the dose reaching the pleura and the dose rate to the 
pleura would be vastly less than used here.
In our previous study (Poland et al., 2008), we emphasized 
the role of long "ber frustrated phagocytosis but had no data on 
the exact cutoff length. Here nano"bers in tight size ranges ena-
bled us to show that true frustrated phagocytosis, where "bers 
actually protrude from the surface of the cell, is not necessary 
for long "ber-induced inammation in the pleural space. This 
is argued on the basis that AgNW
5
 caused inammation in the 
pleural space but was for the most part phagocytosed by pleural 
macrophages.
The role of Ag ion in mediating the toxic effects of com-
pact Ag-P has been discussed extensively. Information about 
the role of Ag ion release in observed toxicity of silver par-
ticulates is mainly based on in vitro experiments at extremely 
high doses and cannot be correlated with in vivo observations 
(Johnston et al., 2010). Recent studies could not identify a sig-
ni"cant health effect after nanosilver exposure in in vivo studies 
(Stebounova et al., 2011). This is consistent with the primary 
role for "ber length in the pleural pathogenicity of the AgNW 
panel used here. If soluble silver was the explanatory factor 
for the pattern of inammation after intrapleural AgNW injec-
tion, a greater amount of soluble Ag release from longer AgNW 
should be observed. This was shown not to be the case and in 















































fact all samples give off negligible amounts of silver ions or 
other contaminating metals in femto- to picogram dilutions that 
would not be biologically active.
We set out to determine whether length was a unifying factor 
in pleural toxicity across a range of HARN in addition to AgNW 
to rule out material-specic effects and to further determine the 
length threshold for pleural inammation. We obtained good 
support for the contention that, for acute pleural inammation, 
length is the predominant structural explanatory variable across 
a range of brous nanomaterials and asbestos.
The greater pathogenic potency of long asbestos bers in 
asbestos-induced pathology was identied in animal studies 
in the rst half of the 20th century and with special reference 
to mesothelioma in the later studies of Stanton and Wrench 
(1972) and Davis et al. (1986). A mechanistic basis for the extra 
pathogenic effect of long asbestos bers is evident in the greater 
retention of long bers in the lungs compared with short bers 
and the greater potency of long bers in general at eliciting 
proinammogenic effects in vivo (Poland et al., 2008) and in 
vitro (Poland et al., forthcoming). With special reference to the 
translocation of bers to the pleural space and the occurrence of 
pleural pathology, we have noted that a fraction of all deposited 
particles translocate to the pleural space (Mercer et al., 2010; 
Ryman-Rasmussen et al., 2009). By using the model of direct 
pleural instillation, we bypassed various mechanisms of ber 
clearance throughout the respiratory tract. However, recently, 
rodent pharyngeal aspiration and inhalation models using CNT 
(Mercer et al., 2011; Ryman-Rasmussen et al., 2009) veried 
the translocation of inhaled CNT to subpleural region where 
they caused pleural inammation. However, so far the length 
threshold for bers to reach the pleural space after inhalation 
exposure in rodent model is not known. Studies investigating 
the dimensions of asbestos bers in mesothelial tissue from 
mesothelioma patients revealed that bers up to a length of 
62 µm were found in tumor tissue, with an average of 4.55 µm 
(Suzuki and Yuen, 2002). These data show that even the longest 
AgNW used in this study could potentially reach the subpleural 
tissue in humans after inhalation exposure. Nanobers could 
reach the pleural space freely or in macrophages. In the study 
by Ryman-Rasmussen et  al. (2009), MWCNTs were found 
subpleurally in macrophages, in subpleural mesenchymal 
cells, and free in the collagen matrix of the subpleura. In 
the study by Mercer et  al. (2011), the “pleural penetrations” 
of CNT could be free ber or bers in macrophages. Long 
bers translocated to the pleural space, both free or inside 
macrophages, are retained because they cannot negotiate the 
stomata in the parietal pleura, through which the efferent ow 
FIG. 4. The acute pleural response to CNT, NiNW, AgNW, SFA, and LFA in various lengths. (A) Female C57Bl/6 mice were intrapleurally instilled with 5 µg/




















, SFA, and LFA. Total granulocyte 
number is shown from pleural lavage 24-hour postexposure. A clear length-dependent threshold response in the pleural space to different sources and compositions 




 data are obtained from Murphy et al. (2011). Length is shown as mean. Data 
represent mean ± SEM of n = 4 mice. (B) The percentage of nanobers per length is plotted to illustrate their length distribution in relation to the cutoff length 
for ber-induced pleural inammation.
TABLE 2
Size of Stomata Across Mammalian Species
Species Stomatal size (µm) Reference
Bat 0.8–2 Azzali (1999)
Hedgehog, gerbil, bat, 
mouse
1.8–6 Azzali (1999)
Monkey 3–8 Oya et al. (1993)
Sheep 1–3 Lai-Fook (2004)
Human 6.2 Li (1993)
Rat, mouse, rabbit,  
hamster, human
4–10 Abu-Hijleh et al. (1995)
Human 2–8 Muller et al. (2002)















































of pleural uid passes (Donaldson et  al., 2010). We believe 
that this explains the propensity of long !bers to cause pleural 
effects including mesothelioma when compact particles and 
short !bers do not. However, till this point, there has been no 
quantitative data on the threshold length for retention at the 
parietal stomata. The data here suggest that !bers of 5 µm, and 
above in length, are likely to be retained at the stomata where 
they can elicit inammation. However, we do not doubt that a 
high enough dose of the shorter !bers would be inammogenic 
in the pleural cavity due to artifactual aggregation into mats and 
clog in the stomata. This was shown previously by Kane (1996) 
in the peritoneal cavity, which possesses identical stomatal 
mechanism for !ber clearance (Goodglick and Kane, 1990).
Naturally, for purposes of extrapolating to the human risk 
relating to !ber length, the size of human parietal pleural sto-
mata and the site of long !ber retention are most relevant. 
Across mammalian species, there is a remarkable consistency 
in the reported size of stomata on the diaphragm or parietal 
pleura. Therefore, we suggest that our !ndings of a general 
threshold for !ber retention that is applicable to humans are 
well served by the mouse model described here. We can only 
speculate on the events that follow from the !rst retention of a 
long !ber at a stoma, but the lodging of a long !ber at a stoma 
and recruitment of inammatory cells to it may enhance the 
likelihood of further retention of long !bers and lead eventually 
to effective blockage of the stoma.
It has not escaped our notice that the global regulation of !b-
ers is based on a standard de!nition of a !ber as an object that 
has a length greater than 5 µm, a width less than 3 µm, and an 
aspect ratio of greater than 3:1 (WHO, 1997). The 5-µm length 
regulatory standard was de!ned in the middle of the last century, 
and its origin was described in 1982 by Walton (Walton, 1982). 
It is fortuitous that the length of 5 µm was chosen, albeit with-
out recourse to any scienti!c knowledge on length-dependent 
parietal pleural retention, as a margin of safety from long !bers 
(10–20 µm) that were known, even then, to be the most patho-
genic fraction (Walton, 1982).
Ours is of course a study of a short-term response, but we 
contend that it is rationally related to long-term pathology in the 
pleural space and the argument for this is twofold. The !rst is 
the argument of dose, by which we mean that the model we put 
forward relies on acute inammation as both a marker of, and a 
response to, retention in the pleural space and we con!rm here 
that short !bers transit out of the pleural space. So long !bers 
must represent the only dose that could be related to the acute, 
but importantly also the chronic, responses seen in the pleural 
space to !bers. The second argument is based on the endpoint 
studied: inammation is known to be directly related to !brosis 
and cancer caused by asbestos through well-understood path-
ways and mechanisms (Dai and Churg, 2001; Dostert et  al., 
2008; Nagai and Toyokuni, 2010; Unfried et al., 2002).
The fact that the AgNWs used here were not biopersistent 
beyond a few days and does not detract from the relevance of 
the length-dependent effects demonstrated here. Biopersistent 
!bers of the same dimensions would have the same acute effect as 
AgNWs but, in contrast, would evoke an ongoing chronic inam-
matory response that would lead to pathological change as we 
have reported for long, biopersistent MWCNTs (Murphy et al., 
2011). A clear link therefore exists between !ber length and the 
potential to cause acute inammation; additionally, there is a link 
between !ber biopersistence and the ability for acute inamma-
tion to become chronic and a link between chronic pleural inam-
mation and the common pleural pathologies associated with 
asbestos exposure, such as pleural !brosis and mesothelioma.
Biopersistence therefore remains a key factor in determining 
the pathogenic effects of long nano!bers and warrants further 
elucidation, if the biopersistent nano!bers in narrowly de!ned 
length classes similar to the AgNW can be obtained. Our data 
suggest that any long, biopersistent !ber will be retained on the 
parietal pleura and is likely to engender chronic inammation.
The conclusion of the threshold length of this study is mainly 
based on linear, straight, single !bers. However, long !bers that 
are tangled and agglomerated in their overall morphology, as is 
often the case with tangled CNT, have been shown to cause less 
inammation due to their tightly packed spherical agglomer-
ated state (Murphy et al., 2011; Poland et al., 2008). Therefore, 
the aggregation state of the nano!bers has to be considered to 
assess their toxicity.
In summary, our data provide for the !rst time a quantitative 
threshold for respirable !ber length in inducing pleural inam-
mation using a range of nano!bers. The threshold length for 
inducing pleural inammogenicity in a range of !bers includ-
ing amosite asbestos is 5 µm in the mouse, which we suggest 
can be extrapolated to humans. This knowledge is a valuable 
addition to our understanding of the mechanism of asbestos-
related pleural disease, especially for mesothelioma and its 
relationship to !ber length. We recognize that this research was 
carried out in a mouse model and with a necessarily restricted 
range of nano!bers and that extrapolation to humans is not 
straightforward. Therefore, for regulatory purposes, we urge 
further research on the important issue of the threshold length 
for safe !bers with regard to the mesothelioma hazard to the 
pleura and the role of biopersistence. From the present data, 
however, we may conclude that, for acute inammation, there 
is good evidence that short !bers less than 5 µm in length form 
the basis of safer-by-design nano!bers, and this has an impor-
tant implication for !ber and nano!ber risk assessment.
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Materials and Methods 
 
Light microscopy/Backscatter SEM of AgNW and fibre length count 
Whilst the limit of resolution of light microscopy would normally preclude the visualisation 
of 120 nm diameter nanowires, the surface plasmon resonance properties of silver NP mean 
that they have a strong scattering cross section allowing for sub 100 nm nanoparticles to be 
easily visualized with a conventional microscope (Schrand et al. 2010). For light microscopy 
images a concentration of 50 µg/ml of AgNW was used to demonstrate the dispersion of the 
materials at the concentration used for pleural injection (Table 1 and Fig. S1a) and to confirm 
the durability over 1 day of AgP and AgNW after rotation for 24 hour in pH 5.0 saline 
solution (Fig. S7c). Ten µl of AgNW (50 µg/ml) suspended in 0.5 % bovine serum albumin 
(BSA; Sigma-Aldrich, Poole, UK)/saline were mixed with 10 µl of glycerol (Sigma-Aldrich, 
Poole, UK) to reduce the flow of AgNW. The suspension was placed on glass slide and 
covered with a glass coverslip and sealed (Murphy et al. 2011). Images were captured at 
x100 magnification using QCapture Pro software (Media Cybernetics). From each batch 100 
fibres were measured according to their length by using a graticule and by using 
measurement software (Image-Pro Plus; Media Cybernetics Inc., MD, USA). The length 
distribution was plotted as percentage fibre per length category and percentage of fibre 
greater than length (Table 1, Fig. S1c).  
For BSEM (Fig. S1b) AgNW/saline suspension was filtered onto an Isopore™ membrane 
filter (Millipore), dried and rotary-coated with about 8 nm of carbon in an Edwards 306A 
vacuum coating system (Edwards High Vacuum, Crawley, UK). Backscatter SEM of carbon-
coated specimens was carried out using a Hitachi 4700 II field emission SEM (Hitachi High-
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Tech, Maidenhead, UK) at a beam accelerating voltage of 10 kV and a working distance of 
about 8 mm. 
 
Calculation for equalised fibre length 
Since fibre exposure is regulated on the basis of the fibre number we calculated the number 
of fibres per treatment for AgNW3 and AgNW5, the key lengths spanning the threshold value. 
 
Length of NW (average) [µm]      .00 
Diameter of NW [µm]   
Density of NW [µg/ml]   
Volume of NW [ml ]    
                                          
Weight of NW [µg]           
                                          
Dose [µg] per mouse       
Number of NW      
 
 
Length of NW (average) [µm]      .00 
Diameter of NW [µm]   
Density of NW [µg/ml]   
Volume of NW [ml ]    
                                          
Weight of NW [µg]           
                                          
Dose [µg] per mouse       






pH measurements for dissolution of NWs  
 
Russell RL060P Portable pH Meter (Thermo Electron Corporation, USA) + Semi-micro with 
a Pellon junction microelectrode (VWR, Ireland) was used for pH measurements. Sodium 
chloride topical irrigation sterile solution (sodium chloride 0.9 % w/w) (Johnson & Johnson, 
UK) was used as a control and of nanowires (NW) dilutions. NW solution was prepared by 
adding stock NWs solution to saline (final NWs concentration: 50 µg/mL) into a clean, dry 
eppendorf (1.5 mL). pH measurements were repeated every 2 hours for 24 hours (n=3). 
Measurements were carried out under the same environmental conditions (21 degree Celsius, 
RH =64 %). A linear fitting on the averaged data of each NW and solution measured were 
applied. The linear fitting associated to the saline pH variations was compared to those of the 
NWs solutions. This data allowed to identify time-dependent pH variations that are 
significant. Statistical analysis is measured as difference in the slope of the linear fitting of 
each measurement (Student’s t-test). 
Discussion: 
 
Role of Ni ion release and size distribution curve  
Soluble Ni ions from the NiNW are unlikely to play a role since previous studies have shown 
that degradation of NiNW in biological media is minimal (Raphael et al. 2010).  
Additionally, the NiNW used in this study are covered by a 3-4 nm layer of nickel oxide 
(Prina-Mello et al. 2006) which is insoluble and so would prevent dissolution of the 
underlying nickel metal surface (Raphael et al. 2010); we also previously showed that the 
soluble products from NiO NP were not inflammogenic (Cho et al. 2011) in the lung. 
Following injection into the peritoneal cavity of NiNW from the same source as those used in 
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the present study, only long NiNW produced a significant inflammatory response and not Ni 
nanoparticles or short NiNW (Poland et al. 2011). 
Furthermore, as stated in the manuscript to preclude a role of the soluble, ionic fraction of 
NiNWs in the assay, the amount of Ni released was measured by ICP-MS. Thus, NiNW4/20 
and Ni-P were incubated with BSA/saline for 24 h and measured. These were found to be in 
the picogram region or not quantifiable since below the BSA/saline threshold level (see Table 
S3A,B).  
To completely rule out the effect of soluble Ni an aqueous extract of long NiNW was instilled 
into the peritoneal cavity and did not cause inflammation. We have previously shown that the 
response of the pleura and peritoneal cavities are identical in terms of the response to fibre 
length (Poland et al. 2011)
 
(Murphy et al. 2011), since the response is based on retention at 
stomata in the mesothelial lining in both cases. Therefore the release of Ni ions from long 
NiNW does not explain greater pleural mesothelial inflammation caused by long NiNW in 
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Fig. 1. Light microscope and BSEM images of AgNW panel and size distribution. A) 
Light microscopy images of AgNW panel in 0.5% BSA/saline at a concentration of 50 µg/ml. 
Scale bar 20 µm, insert 10 µm.  B) BSEM of 5 µg/ml AgNW in saline. Insert shows the 
diameter of each AgNW sample (scale bar 500nm). C) Size distribution of AgNWs plotted as 
% greater than any length. 100 fibres were calculated for each group. 
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Table 1. Mean length ± s.e.m. and source of additional nanofibres and controls. 







Fig. 2. Nickel nanowire size distribution. Size distributions of nickel nanowire were carried 
out by measuring the lengths of at least 100 fibres under scanning eletron microscope. 
Average length for short NiNW is 4.2 ± 0.9µm, average of long NiNW is 20.3 ± 5.5µm.  
 




















































































 Fig. 3. Dissolution measurement of NW. A) Comparison between sterile saline solution (as 
baseline) and AgNW3, 5, 10, 14, 28 dispersed in sterile saline solution. Average value of pH and 
standard deviation calculated for every time point up to 24h (interval 2 h) (n = 3). No 
statistical difference between Ag samples. Statistical significance AgNWs vs saline (p<0.01). 
B) Comparison between sterile saline solution (as baseline) and nickel nanowires long and 
short dispersed in sterile saline solution. Average value of pH and standard deviation 
calculated for every time point up to 24h (interval 2 h) (n = 3). Statistical significance saline 




Fig. 4. Dose effect series for AgNW3 and AgNW5 measuring the acute 24 hour 
inflammatory response. Total cell number (A) and total granulocyte number (B) of AgNW5 
at a dose of 1.0, 2.5 and 5.0 µg/mouse and AgNW3 at a dose of 5.0, 7.5 and 10.0 µg/mouse. 
Significance versus vehicle control (0 µg/mouse), * indicates p<0.05, ** indicates p<0.01. A) 
# indicates p<0.05, significance of AgNW5 (2.5 µg/mouse) vs AgNW3 (7.5 µg/mouse), ## 
indicates p<0.05, significance of AgNW5 (5 µg/mouse) vs AgNW3 (5.0, 7.5 µg/mouse); B) # 
indicates p<0.05, significance of AgNW5 (2.5 µg/mouse) vs AgNW3 (5.0, 7.5 µg/mouse), ## 
indicates p<0.05, significance of AgNW5 (5.0 µg/mouse) vs AgNW3 (5.0 µg/mouse). Data 







Fig. 5. Length dependent response of AgNW on the parietal mesothelial surface 1 week 
post injection. Overview of whole chestwall section at low magnification. Triangle indicates 
normal mesothelial cell layer, arrow indicates lesion areas of accumulated inflammatory cells 
and P indicates papillae or tongue-like structures made up of cell aggregates, which extend 






























































Figure 6. Total cell number and total granulocyte number from pleural lavage fluid and 
H&E stained histology section of parietal pleura 1 week post exposure. A) Total cell 
number and total granulocyte number 1 week post exposure to 5 µg/mouse of SFA, LFA, Ag-
P and AgNW panel. Significance versus Vehicle control * indicates p<0.05, ** indicates 
p<0.01, *** indicates p<0.001.  Data represent mean ± s.e.m. of n=4 mice. B) Normal 
appearance of mesothelial lining after VC, Ag-P, AgNW3 and SFA exposure but thickening 
of the pleural sub-mesothelial layer can be seen in mice exposed to AgNW5-14 and LFA. No 
thickening of the mesothelial cell layer could be seen after AgNW28 exposure at 1 week. This 







Figure 7. Biopersistence/durability of AgP and AgNW. Merged secondary electron and 
backscatter electron SEM images of the parietal pleura from mice treated with AgNW5. A) 
AgNWs appear intact in their morphology inside pleural macrophages 24 hour post-exposure, 
however after 1 week (B) dissolution can be seen, evident as a more diffuse and ‘ghost-like 
appearance of the AgNW (arrows) inside macrophages. C) Light micrograph images of AgP 
and AgNW at 0 hour and 24 hour after rotation in pH 5.0 saline solution. No dissolution or 
change in morphology was observed after 24 hour. Red arrows indicate AgP and AgNW. 















































Fig. S. Percentage of frustrated phagocytosis of pleural macrophages. 50 fibre- 
containing macrophages were counted in the lavage fluid from AgNW3, AgNW5, AgNW10, 
AgNW14 treatment. The percentage of macrophages showing frustrated phagocytosis (not 
fully enclosed fibres) was calculated by comparing to the number of macrophages with 
completely enclosed fibres. Macrophages from AgNW10 and AgNW14 treatment show a 
significant increase in frustrated phagocytosis compared to AgNW3 (** indicates p<0.01).  
Data represent mean ± s.e.m. of n=4 mice. AgNW28 was not counted since too few very long 




















































Fig. 9. Total cell number from pleural lavage fluid after 24 hour. A) Total cell number in 
lavage fluid of mice treated at a concentration of 5 µg/mouse with the material control panel 
NiP, NiNWs, NPCB and NTs at 24 hour post-injection. Significance versus Vehicle control * 
indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001.  Data represent mean ± s.e.m. 
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METHODOLOGY Open Access
Use of back-scatter electron signals to visualise
cell/nanowires interactions in vitro and in vivo;
frustrated phagocytosis of long fibres in
macrophages and compartmentalisation in
mesothelial cells in vivo
Anja Schinwald and Ken Donaldson*
Abstract
Background: Frustrated phagocytosis has been stated as an important factor in the initiation of an inflammatory
response after fibre exposure. The length of fibrous structures has been linked to the potential of fibres to induce
adverse health effects for at least 40 years. However, we only recently reported for the first time the threshold
length for fibre-induced inflammation in the pleural space and we implicated frustrated phagocytosis in the
pro-inflammatory effects of long fibres. This study extends the examination of the threshold value for frustrated
phagocytosis using well-defined length classes of silver nanowires (AgNW) ranging from 3–28 μm and describes in
detail the morphology of frustrated phagocytosis using a novel technique and also describes compartmentalisation
of fibres in the pleural space.
Methods: A novel technique, backscatter scanning electron microscopy (BSE) was used to study frustrated
phagocytosis since it provides high-contrast detection of nanowires, allowing clear discrimination between the
nanofibres and other cellular features. A human monocyte-derived macrophage cell line THP-1 was used to
investigate cell-nanowire interaction in vitro and the parietal pleura, the site of fibre retention after inhalation
exposure was chosen to visualise the cell- fibre interaction in vivo after direct pleural installation of AgNWs.
Results: The length cut-off value for frustrated phagocytosis differs in vitro and in vivo. While in vitro frustrated
phagocytosis could be observed with fibres ≥14 μm, in vivo studies showed incomplete uptake at a fibre length of
≥10 μm. Recently we showed that inflammation in the pleural space after intrapleural injection of the same
nanofibre panel occurs at a length of ≥5 μm. This onset of inflammation does not correlate with the onset of
frustrated phagocytosis as shown in this study, leading to the conclusion that intermediate length fibres fully
enclosed within macrophages as well as frustrated phagocytosis are associated with a pro-inflammatory state in the
pleural space. We further showed that fibres compartmentalise in the mesothelial cells at the parietal pleura as well
as in inflammatory cells in the pleural space.
(Continued on next page)
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Conclusion: BSE is a useful way to clearly distinguish between fibres that are, or are not, membrane-bounded. Using
this method we were able to show differences in the threshold length at which frustrated phagocytosis occurred
between in vitro and in vivo models. Visualising nanowires in the pleura demonstrated at least 2 compartments – in
leukocyte aggregations and in the mesothelium - which may have consequences for long term pathology in the
pleural space including mesothelioma.
Keywords: Backscatter scanning electron microscopy (BSE), Frustrated phagocytosis, THP-1 macrophages, Pleural
macrophages, Parietal pleura mesothelium
Background
The toxicology of fibres is a sub-specialty of particle
toxicology developed in response to the asbestos experi-
ence [1] but whose tenets have been used to quantify the
hazards from vitreous fibres [2] organic fibres such as
p-aramid [3] and most recently nanofibres [4,5]. Current
understanding of the fibre hazard is based on the ‘fibre
pathogenicity paradigm’ which has predictive power and
is the most robust structure/ toxicity relationship in par-
ticle toxicology. The paradigm identifies thinness, length
and biopersistence as the 3 features that determine the
pathogenic potential of any fibre sample [5]. Thinness
determines respirability, that is the likelihood that a
fibre penetrates the respiratory tract beyond the ciliated
airways [3] where most damage is likely to occur, whilst
biopersistence determines whether the fibre will retain
its structure integrity i.e. fibrous shape, during residence
in the lung. If the fibre is composed of soluble com-
ponents that are leached from the fibre under the
conditions it encounters in vivo, then the fibre is likely
to become weakened, break and become part of the
short fibre pool. Short fibres are not pathogenic in the
fibre sense, although they may have harmful effects as
particles, whilst long fibres do cause fibre-type patho-
genicity; this length-dependent pathogenicity has been
demonstrated in numerous studies in vivo [6-8] and
in vitro [9-11].
One major arbiter of length-dependent pathogenic
effect is the alveolar macrophage and pleural macrophage
whose normal function is to phagocytose fibres and clear
them. Because of the unusual aerodynamics of fibres,
extremely long fibres penetrate and deposit beyond the
ciliated airways [3]. Macrophages that attempt to phago-
cytose long fibres cannot enclose them leading to ‘frustrated
phagocytosis’ as shown diagrammatically in Figure 1; in
contrast short fibres are fully enclosed in the phagosomes
(Figure 1).
We recently reported length-dependent effects of a
range of fibres including asbestos [8], carbon nanotubes
[12,13], silver nanowires (AgNW) [14] and nickel nano-
wires (NiNW) [11] at the peritoneal and pleural meso-
thelial surfaces. All of these fibre types appear to
comply with the fibre pathogenicity paradigm with
length-dependent effects in the pleural space as a result
of retention at stomata (3–10 μm in diameter) on the
parietal pleura and frustrated phagocytosis. These data
show persuasively that the length threshold for pleural
retention of any fibres is 5 μm and that fibre shorter
than this threshold are not retained and do not cause
inflammation [14].
Figure 1 Diagrammatic representation of short fibre complete phagocytosis and long fibre –mediated frustrated phagocytosis. Short
fibres can be fully phagocytosed by macrophages whereas long fibres are too long to be fully taken up leading to an unclosed membrane and
leakage of cell content.
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Whilst we evoked frustrated phagocytosis in the pro-
inflammatory effects, we also noted that intermediate
5 μm length fibres, were fully enclosed by macrophages
but were pro-inflammatory, as previously recorded [14].
Due to restrictions on space we could not fully explore
the morphological basis of this new effect and here we
extend these findings to fully characterise fibre length
effects particularly frustrated phagocytosis in vitro and
in vivo. We utilised the technique of backscatter electron
microscopy in particular to investigate this phenomenon.
We also describe the retention of fibres in the parietal
mesothelial layer, an anatomical region not hitherto iden-
tified a retention compartment for fibres.
Results
AgNW panel
Characteristic of the AgNW panel are summarised in
Figure 2. The images illustrate the uniform distribution
of the AgNWs with no aggregation being present. Com-
plete characterisation of the AgNW panel was described
previously by Schinwald et al. [14].
Membrane integrity and metabolic activity in the
in vitro model
The in vitro experiments were based on a treatment
dose which was non/low-toxicity to THP-1 cells in cul-
ture adjusted for each fibre length to produce approxi-
mately the same fibre number (Table 1). The 2 μg/cm2
dose based on AgNW14 was determined by measuring
the membrane integrity via the release of lactate dehydro-
genase (LDH) into the supernatant and cell proliferation
of the THP-1 cells after 24 hour treatment; however,
AgNW28 caused a significant decrease in membrane
integrity and loss of proliferation and metabolic activity
(Figure 3A,B).
Bright field microscopy of THP-1 cells after 4 hour
exposure in vitro
THP-1 cells were exposed to the panel of AgNWs for
4 hours and bright field images were taken using a
60× magnification. THP-1 cells completely phagocytose
AgNW3 (Figure 4A) and AgNW5 (Figure 4B). The fibres
were fully taken up as indicated by the yellow circle.
AgNW10 were mostly phagocytosed with only a small
percentage of fibre-ends protruding out of the cells as
indicated by the red arrow (Figure 4C). Frustrated phago-
cytosis was observed after treatment with AgNW14 and
AgNW28. In Figure 5d the black arrow indicates a fibre
shared by two cells and another fibre only partly enclosed
by the cell (red arrow Figure 4D and E).
Characterisation of Cell/Nanowire interaction in vitro
using BSE
Backscatter electron microscopy (BSE) enabled us to
visualise the interaction of THP-1 macrophage cells with
AgNW. We mainly focused on the uptake/phagocytosis
of the five different size categories of AgNW to identify
the cut-off value, at which frustrated phagocytosis occurs
in vitro. Figure 5A-E show differentiated THP-1 macro-
phages after 4 hour treatment with AgNW3 (A), AgNW5
(B), AgNW10 (C), AgNW14 (D) and AgNW28 (E). In
Figure 5A one external AgNW3 can be seen (white
arrow) and a few AgNW3 can be seen just underneath
the surface of a macrophage as indicated by the black
arrow (Figure 5A insert). After treatment with AgNW5,
nanowires were fully taken up by macrophages as indi-
cated by the white arrow (Figure 5B insert). A small pro-
portion of cells showing incomplete uptake of AgNW10
fibres could be observed as indicated by the white arrow
Figure 2 Characteristics of AgNW panel. Light microscopy images of AgNW panel in 0.5% BSA/saline. Scale bar 20 μm.




Calculation to equalise for
the same fibre number
Dose
(μg/cm2)
3 3/14 × 2 0.4
5 5/14 × 2 0.6
10 10/14 × 2 1.4
14 standard 2.0
28 28/14 × 2 4.0
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(Figure 5C) however most of the fibres were membrane
bound (black/white arrow) and therefore phagocytosed
by the cells. Obvious frustrated phagocytosis could be
observed from a nanowire length of 14 μm (Figure 5D)
and 28 μm (Figure 5E). A much greater amount of
AgNW was observed protruding through cells or shared
between adjacent cells indicating frustrated phagocytosis
(white arrow). The number of unphagocytosed fibres per
cell was quantified and significantly increased with AgNW14
(p > 0.05) and AgNW28 (p > 0.001).
In vivo
Uptake of AgNWs in pleural macrophages from pleural
lavage
In Figure 6A a macrophage is shown from a pleural lav-
age after treatment with AgNW3. The macrophage
could readily phagocytose a number of short (3 μm)
AgNWs (Figure 6A). After treatment with AgNW5
(Figure 6B), again the nanowires were fully taken up by
the pleural macrophages in the lavage fluid. However,
AgNW10 (C), AgNW14 (D) and AgNW28 (E) could not
Figure 3 THP-1 membrane integrity and proliferation/metabolic activity. A) Measurement of membrane integrity plotted as % LDH release
based and positive and negative control. Only AgNW28 lead to a significant release of LDH into the supernantant. B) Proliferation and metabolic
activity was measured using alamarBlue®. Cell treated with AgNW28 showed decreased proliferation. Significance versus vehicle control *P <0.05,
**P <0.01. Data represent mean ± s.e.m. of n = 5.
Figure 4 Bright-field microscope image of THP-1 cells treated with AgNWs. A) AgNW3 and B) AgNW5 were fully enclosed by the cell as
indicated by the yellow circle. C) AgNW10 were mostly taken up, however a small number of fibres were not fully enclosed and fibre ends were
protruding out of the cells as indicated by the red arrow. D) AgNW14 and C) AgNW28 caused frustrated phagocytosis. Red arrows indicate fibres
partly taken up by THP-1 cells and the black arrow indicates sharing of a fibre between two adjacent cells. Scale bar = 20 μm.
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be fully phagocytosed by the cells anymore, leading to
frustrated phagocytosis. Enlargement of the pleural
macrophages (Figure 6D) could be observed. Data from
the same animals as described here were utilised in
Schinwald et al. [14] where details of the inflammatory
effects accompanying these cellular changes can be
obtained.
Phagocytosis/frustrated phagocytosis in vivo on the
parietal pleura surface 24 hour post exposure
Backscatter scanning electron microscopy examination
was carried out on the macrophage accumulations on
the parietal pleura samples from mice injected with
AgNW3, AgNW5 and AgNW10 at 24 hour post intra-
pleural instillation in order to examine the develop-
ment of interaction between the mesothelial cell layer/
inflammatory cells on the surface. The dose of 5 μg per
mouse used in this study lead to a significant increase
in inflammation after treatment with AgNW5, AgNW10,
AgNW14 and AgNW28 as previously reported [14]. A dose
response was performed by increasing the dose of AgNW3
up to 10 μg which resulted in no significant increase in
inflammation. The dose of AgNW5 was decreased to 1 μg
and 2.5 μg whereby 2.5 μg continuously showed significant
inflammation [14]. AgNW3 treatment was chosen to
investigate if any short fibre were retained in the pleural
space after intrapleural injection even though no inflam-
matory response was observed. AgNW5 and AgNW10
treatments were chosen since both treatments lead to a
significant increase in pleural inflammation however dif-
fer in their interactions with pleural macrophages [14].
No AgNW3 could be observed on the parietal pleura
surface 24 hour post treatments confirming that short
fibres are readily cleared from the pleural space. In con-
trast to AgNW3, both AgNW5 and AgNW10 lead to an
aggregation of inflammatory cells on the surface of the
parietal pleura with accumulation of nanowires within
the lesion area (Figure 7A,C). Most AgNW5 were fully
phagocytosed by pleural macrophages (Figure 7A, B and
insert, stars). In comparison, AgNW10 showed a number
of fibres only partly phagocytosed and therefore leading
to frustrated phagocytosis (Figure 7C,D white arrow).
Some AgNW5 and AgNW10 were not taken up by macro-
phages as indicated by the yellow arrows (Figure 7A,C).
By looking at the surface with higher magnification
unclosed membrane could be visualised in pleural
macrophages phagocytosing AgNW10 (Figure 7D and
insert, black arrows).
Phagocytosis/frustrated phagocytosis in vivo on the
parietal pleura surface 1 week post exposure
BSEM of parietal pleura after 1 week treatment with
AgNW5 are shown in Figure 8A,B,C and AgNW10 in
Figure 8D,E,F. By 1 week, AgNW5 started to lose their
integrity, presumably in the acidic conditions within a
phagosome as seen in Figure 8A,B indicated by the black
arrow. Non-dissolved fibres overlying the mesothelial cell
layer appear intact in their morphology (Figure 8B, white
arrow). Ghost-like structures of nanofibres which are
covered by microvilli (Figure 8B,C star) could be seen.
AgNW10 could be found either in accumulations of
inflammatory cells which appeared denser and more
Figure 5 BSE images of differentiated THP-1 cells treated for
4 hours with AgNW. A) AgNW3 treated macrophages showed full
phagocytosis of the nanowires. Only one nanowire could be
visualised outside a cell (white arrow) and a few underneath the
surface indicated by the black arrow. B) After AgNW5 treatment all
nanowires were phagocytosed by cells after 4 hours (white arrow).
C) A big proportion of AgNW10 appear membrane bound and
therefore phagocytosed by cells (black/white arrow), however a few
fibres could be seen protruding out of cells (white arrow). Frustrated
phagocytosis was observed after AgNW14 (D) and AgNW28 (E)
treatments, since most of fibres can be seen protruding out of the
cells or shared between cells (white arrow and insert). BSE merged
image with a scale bar of 10 μm and 5 μm for the inserts.
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Figure 6 Representative cytospin images of lavaged cells from the pleural space after 24 hour treatment with AgNWs. A) AgNW3 inside
a pleural macrophage showing complete phagocytosis. B) Pleural macrophage with a fully phagocytosed AgNW5 (B) and AgNW10 (C). D) A
pleural macrophage with increased cell size to phagocytose AgNW14. E) Frustrated phagocytosis after AgNW28 exposure. 3 macrophages sharing
2 long fibres. All images are shown at 100x magnification with a 10 μm scale bar.
Figure 7 Images of the parietal pleura surface 24 hour post pleural instillation of AgNW5 and AgNW10. Overview of the lesion area on
the surface of the parietal pleura with AgNW5 (A) and AgNW10 (C). The yellow arrow indicates a nanowire which is not taken up by inflammatory
cells whereas the star indicates a fibre that is fully phagocytosed but can be visualised underneath the surface of the cell. The white arrow
indicates nanowires which are protruding out of cells. B) This figure shows AgNW5 that are fully phagocytosed by pleural macrophages but can
be visualised underneath the surface as indicated by the star. D) AgNW10 is causing frustrated phagocytosis in a macrophage in the centre of the
image. The unclosed cell membrane is indicated by the black arrows and exposed fibre surface is indicated by the white arrow. The cross on
the lower right of the image indicates fibres which are largely internalised but whose tips rise vertically to penetrate the cell surface adjacent
to the other long fibre.
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granulomatous after 1 week (Figure 8D cross), or in the
mesothelial cell layer (Figure 8D triangle). AgNW10 also
started to lose integrity inside the phagocytic com-
partments of pleural macrophages (Figure 8E cross).
Figure 8F shows AgNW10 partly membrane bound on
the mesothelial cell layer. Data from the same animals as
described here were utilised in Schinwald et al. [14].
Compartmentalisation of nanowires into mesothelial cells
So far, we hypothesised that after a prolonged exposure
to fibres in general up to 7 days, the instilled fibres in the
pleural space would either be cleared from the pleural
space and enter the lymphatic drainage system or be
accumulated in a granulomatous lesion on the parietal
pleura at stomata [15]. By using backscatter imaging, for
the first time it was possible to visualise nanowires in the
mesothelial cell layer of the parietal pleura. Both treat-
ments, AgNW5 and AgNW10 (but not AgNW3 which
were not observed as they had been cleared) showed
nanofibres either on the surface of the mesothelial cells
(black arrow Figure 9B) or taken up by these cells (white
arrow Figure 9A,B). This is especially surprising for
AgNW5, since pleural macrophages are able to phagocyt-
ose these fibres completely as shown in Figure 7B. By
comparing the structure/shape of the nanowires
associated with the mesothelial layer (Figure 9) and
within macrophages (Figure 8B,E), it can quite clearly be
seen that the nanowires are still intact after 1 week in the
mesothelial layer whereas within the phago-lysosome of
a macrophage the fibres start to degrade and lose integ-
rity. These images show evidence that not all fibres
longer than 5 μm are internalised by macrophages during
the early inflammatory reaction, and that some are com-
partmentalised into the mesothelial layer which could
lead to direct effects on the mesothelial cells and pleural
diseases in a later stage if they are biopersistent.
Discussion
The capacity of alveolar macrophages for phagocytosis
and clearance of particles and fibres from the lung is of
major relevance in pulmonary defence and development
of lung and pleural diseases. In this study we addressed
the length cut-off value at which frustrated phagocytosis
occurs in vitro and in vivo. We recently defined the
threshold length for inflammogenicity in the pleural space
for a range of fibres including those used here [14]. How-
ever in that paper we were unable, due to restrictions on
space, to fully explore the role of frustrated phagocytosis
nor fully describe the disposition of fibres in the pleural
space. In the present paper we were able to quantitatively
Figure 8 Images of macrophages on the parietal pleura 1 week post pleural instillation of AgNW5 and AgNW10. Lesion area showing
AgNW5 (A) dissolving inside macrophages, as can be seen by the loss of fibre structure (black arrow) (B). Intact nanofibres on the mesothelial
cell layer as indicated by the white arrow (B) and membrane bound as indicated by the star (B,C). D) Lesion area appears denser and more
granulomatous after 1 week treatment AgNW10 and occasional nanowires can be seen in these granulomatous areas as indicated by the white
cross. Surprisingly, a large part of the nanowires were seen on and within the mesothelial cell layer indicated by the triangle. These nanowires
appeared structurally intact whereas nanowires fully phagocytosed by macrophages as seen in E) indicated by the cross on the right side start to
dissolve under the acidic condition within a macrophage. On the top left of this image, a fibre is partly internalised (star) and partly exposed
(white arrow). F) AgNW10 which is partly membrane bound on the mesothelial cell layer.
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compare phagocytosis/ frustrated phagocytosis of 5 differ-
ent lengths of silver nanofibres ranging from 3–28 μm
where inflammogenicity was determined in a previous
study [14]. Thus far, the polydispersity of fibre length in
samples including naturally occurring fibres and synthetic
vitreous fibres prohibited the accurate investigation of the
toxicity of various fibre lengths. The tight length classes
of nanofibres used in this study, produced using nano-
technological methods, allowed us to perform a quantita-
tive and qualitative comparison of the role of fibre length
and frustrated phagocytosis in vitro and in vivo.
The use of a novel technique, backscatter electron mi-
croscopy allowed us to distinguish between membrane
bound fibres and unphagocytosed fibres and to visualise
the interaction of inflammatory cells with different length
of nanofibres on the parietal pleura, the site of fibre
retention in vivo.
The need for macrophages to internalise and there-
fore clear fibres from the lung and the pleural space has
long been accepted [16] but the cut-off length below
which complete internalisation of particles/fibres occurs
is unknown. An extensive study has investigated the
phagocytic capacity of murine bone marrow-derived
macrophages to engulf various sizes of latex beads in a
range of 13 μm to >30 μm in diameter [17]. By mea-
suring the bead diameter they calculated a phagocytosis
capacity of 19.8 μm, which is 1.44 times the actual diam-
eter of the cell. In regard to the phagocytosis of fibres by
macrophages, Ye et al. investigated the role of glass fibre
length in TNF-α production and NF-κB activation in a
mouse macrophage cell line and correlated and increase
in both cytokine level and transcription factor to incom-
plete phagocytosis of long fibres (17 μm) whereas short
fibres (7 μm) were fully phagocytosed and therefore had
less expression of the measured endpoints [9]. These data
correlate with our identified threshold length for fru-
strated phagocytosis in vitro, which is ≥ 14 μm.
An in vivo study performed by Oberdorster et al.
assessed the clearance of small (~3 μm in diameter) and
large (~10 μm in diameter) polystyrene microspheres in
rat and identified minimal clearance of larger spheres after
a 200 days post position period [18]. This was considered
to be due to impaired clearance of particles when the
macrophage particle load is 60% of its normal volume.
Figure 9 Mesothelial surfaces of the parietal pleura 1 week post injection of AgNW5 and AgNW10. Mesothelial cell layer of the parietal
pleura after AgNW5 (A) and AgNW10 (B) exposure. AgNWs can be seen on the surface of the mesothelial layer as indicated by the black arrow.
These AgNW are also partly taken up by mesothelial cells as indicated by the white arrow. The morphology of the nanofibres on the mesothelial
layer appears intact.
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Frustrated phagocytosis has been implicated to play a
major role in the development of an inflammatory milieu
after exposure to fibres in vitro [19,20]. We recently
demonstrated that frustrated phagocytosis is a major fac-
tor in the genesis of inflammation in the pleural space
after deposition of long fibres whereby macrophages
undergoing frustrated phagocytosis of the long fibres re-
lease factors that promote a potent pro-inflammatory
cytokine response from adjacent mesothelial cells [20]. In
addition we have demonstrated that 5 μm is the thresh-
old for pro-inflammatory effects of fibre in the pleural
space for a wide range of fibers [14]. However, so far fru-
strated phagocytosis has not been fully visualised in vivo
in the pleura and the fibre length threshold for frustrated
phagocytosis in vivo is unknown. Here we showed that
the length cut off value at which long fibres can be fully
phagocytosed by macrophages differs in vitro and in vivo.
Whereas in vitro fibres of 10 μm could be completely
phagocytosed, in vivo inflammatory cells on the parietal
pleura showed incomplete uptake and frustrated phago-
cytosis of 10 μm fibres. There are a number of potential
explanations for this anomalous difference between
in vivo and in vitro length-dependent effect. The in vivo
model is a pleural granuloma in mice and this is very dif-
ferent from the in vitro situation. Firstly the cells used
in vitro are human cells, secondly they are a cell line and
thirdly they are not in the granulomatous milieu but are
spread out singly on plastic, submerged in medium with
10% serum, a very abnormal environment. We conclude
that investigations on frustrated phagocytosis and its re-
lation to the pathological effects of fibres need to be car-
ried out in vivo although future work could be focussed
on trying different cell lines and culture conditions with
the aim of finding a better in vitro model that mimics the
in vivo findings.
Interestingly, pleural injection of AgNW5 lead to sig-
nificant inflammation in the pleural space [14] but was
not associated with frustrated phagocytosis in vivo. These
results show that frustrated phagocytosis is not solely
responsible for the onset of an inflammatory reaction in
the pleural space after exposure to fibrous particles and
that fibres around 5 μm can be fully phagocytosed but
nonetheless cause sufficient cellular stress to induce pro-
inflammatory effects (Figure 10).
In this study we focused on the interaction of macro-
phages with nanofibres, however, our investigations of
the parietal pleura revealed that intact nanofibres can
also be found on the normal mesothelial cell layer after
1 week exposure. So far, we hypothesised that fibres,
which are retained in the pleural space would be accu-
mulated in lesions on the parietal pleura. In our study
the mesothelial cells do not seem to be pro-inflammatory
in this position as they have not attracted leukocytes to
their vicinity and so their main effect may be by direct
Figure 10 Length categories of frustrated phagocytosis and pleural inflammation and diagrammatic representation of frustrated
phagocytosis. A) Summary of frustrated phagocytosis and pleural inflammation in vitro and in vivo. B) Diagrammatic representations of the
length-dependent effects seen at the level of the macrophage in granulomas on the parietal pleura after instillation of fibres. These suggest that
fibres 3 μm and shorter can be phagocytosed with no inflammation and cleared from the pleural space. Fibres 5 μm long can be entirely
enclosed but are associated with inflammation whilst 10 μm fibres clearly cause frustrated phagocytosis and inflammation.
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genotoxic or cytotoxic effects on the mesothelial cells.
A lack of direct pro-inflammatory effect of the nanowires
on the mesothelial cells would be consistent with our
recent study on the interactions between long carbon
nanotubes, macrophages and mesothelial cells in the
genesis of inflammation. Work with long carbon nano-
tubes show that fibres interacting with macrophages
cause the macrophages to release factors that evoke large
scale production of inflammatory mediators by adjacent
mesothelial cells [20]. Activated mesothelial cells pro-
duce a number of pro-inflammatory mediators including
prostaglandins, nitric oxide, reactive oxygen species,
cytokines and growth factors. Prolonged release of these
pro-inflammatory mediators due to retention of fibres
on the mesothelial surface may play a role in stimulation
of tumour growth [21]. In contrast direct interaction
between carbon nanotubes and mesothelial cells in vitro
produced very little pro-inflammatory cytokine release
by the mesothelial cells but did lead to significant mem-
brane damage at higher carbon nanotube concentrations
at a similar extent to that seen in macrophages [20].
A study by Adamson reported that exposure to long
(≤20 μm) crocidolite asbestos fibres lead to increased
pleural mesothelial cell proliferation in mice but no
uptake of fibres in mesothelial cells was observed and
again an indirect effect of mitogens released by cells in
the sub-pleural lung tissues was implicated [22].
Therefore nanofibres that escape macrophage phago-
cytosis and take up residence in the mesothelium may be
relatively non-inflammatory but represent a direct geno-
toxic threat. The interaction of AgNW with mesothelial
cells changed their biopersistent characteristics, since
AgNW appeared intact in their shape compared to com-
partmentalisation in macrophages where dissolution is
observed. Silver ion measurements may not be helpful in
clarifying AgNW persistence either in vivo or in vitro to
the complexity of interpreting the data due to silver
chloride formation as discussed in Schinwald et al. [14].
Our findings suggest therefore the threshold length of
5 μm is a threshold for retention of fibres that has at least
2 sequels:- 1) inflammation in the pleural space ; 2) com-
partmentalisation and localisation of such fibres to the
mesothelial layer.
Conclusion
The use of backscatter scanning electron microscopy
enabled us to identifying frustrated phagocytosis in vitro
and in vivo using metal-based nanofibre samples without
the further need of nanofibre modification including
radio labelling or fluorescence labelling to visualise their
interaction with cells and tissue. The images and data
provided in this study show a clear cut-off value for fru-
strated phagocytosis in vitro and in vivo (Figure 10). We
could visualise the interaction of nanowires with pleural
inflammatory cells in vivo and revealed that frustrated
phagocytosis is not the only factor for the onset of
pleural inflammation and 5 μm fibres can be fully
enclosed but are still associated with inflammation as
previously described [14]. The contrast between the
in vitro and in vivo finding for the length threshold for
frustrated phagocytosis suggest that THP-1 macrophages
do not provide a good model for the length dependent
phagocytic events that occur in vivo in the murine
pleural space. More research may provide a better
in vitro model that mimics the in vivo effects. We also
visualised the interaction of mesothelial cells with nanofi-
bres and described a novel compartmentalisation of them
in mesothelial cells which appeared to show different
biopersistence characteristics compared to compartmen-
talisation in macrophages. However this needs to be
confirmed by more quantitative studies rather than the
merely descriptive data that are presented here.
Materials and methods
Backscatter electron signals by scanning electron
microscopy
Elements with high atomic number (Z) such as silver
reflect or back-scatter electrons more strongly than the
lower Z light elements (predominantly H, C, N, O, P) of
which cells are composed. Back-scattered electron im-
aging (BSE) is therefore a useful way to study frustrated
phagocytosis since it provides high-contrast detection of
nanowires, allowing clear discrimination between the
nanofibres and other cellular features. Since the BSE sig-
nal from the fibres is attenuated by overlying cellular ma-
terial, the method allows a clear distinction to be made
between fibres that are, or are not, membrane-bounded,
and can allow detection of fully phagocytosed fibres,
which would not otherwise be detected in an SE image,
provided they are at shallow depth within the cell.
This principle has been used widely for detection of
colloidal gold markers in immunocytochemistry [23,24].
Fibre panel and size distribution
The fibre panel consisted of five distinct length classes of
silver nanowires, hereafter referred to as AgNW3, AgNW5,
AgNW10, AgNW14 and AgNW28 whereby the subscript
numbers indicate the average length of the nanowires.
AgNW length diameter, contamination, soluble metal
content, endotoxin level and dispertion was characterised
as described previously by Schinwald et al. [14] (Figure 2).
The samples were kindly provided by Seashell Technol-
ogy, San Diego and synthesised using a polyol process as
decribed in the US patent number 7,922,787 B2.
For light microscopy images 1 mg/ml of AgNWs were dis-
persed in 0.5% bovine serum albumin (BSA; Sigma-Aldrich,
Poole, UK) and 10 μl of suspension was mixed in equal
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volume of glycerol (Sigma-Aldrich, Poole, UK) to reduce the
flow of AgNW. The suspension was placed on a glass slide,
covered with coverslip and images taken using QCapture
Pro software (Media Cybernetics).
In vitro study
In vitro macrophages exposed to fibres of different lengths
Cell culture The immortalised human monocytic cell
line THP1 was used for in vitro studies. Cells were cul-
tured in RPMI media supplemented with 10% heat inacti-
vated FBS, 1% penicillin/streptomycin and 1% L-Glutamine
(PAA, Austria). Prior to each treatment the cells were
seeded in 24-well plates at a density of 0.5*106/ml in
500 μl medium containing 10% FBS and 10 ng/ml phor-
bol 12-myristate 13-acetate (PMA) (Sigma) for 2 days
at 37°C in 5% CO2 atmosphere [25]. Fibres were uni-
formly dispersed in cell culture medium (RPMI 1640)
supplemented with 1% penicillin/streptomycin and 1%
L-Glutamine (PAA, Austria) and 0.5% bovine serum
albumin (BSA; Sigma-Aldrich, Poole, UK) and briefly
vortexed. Cells were treated with AgNW equalised to
fibre number since fibre exposure is regulated on the
basis of the fibre number and so relative potency needs
to be determined on a per-fibre basis. To equalise for
fibre number a dose of 2 μg/cm2 for AgNW14 was chosen
as the standard in vitro dose based on previous mea-
surement of membrane integrity and proliferation. Based
on 2 μg/cm2 for AgNW14, concentrations for the other
length classes AgNW panel were calculated assuming
that fibres thickness was constant in the different length
classes (Table 1).
Measurement of membrane integrity and proliferation
of THP-1
Cells were seeded at a concentration of 0.5*106 cells/ml
and treated for 24 hours as described above. TritonX
(Sigma) was used as a positive control for cell death and
was added at a final concentration of 0.1% for 30 mins.
After the treatment supernatant was centrifuged for 5 mins
at 2000 rpm, transferred and centrifuged again for 5 mins
at 13000 rpm. The conversion of lactate to pyruvate was
detected using the Cytotoxicity Detection Lactate De-
hydrogenase kit (Roche Diagnostics Ltd., Burgess Hill,
UK) following the manufacturer’s instructions. A micro-
plate reader (BioTek® SynergyHT) was used to measure
the optical density at 490 nm. Results are given as the
mean ± SEM of 5 independent experiments.
Cells in the culture dish were used to measure their
proliferation and metabolic activity via a chemical reduc-
tion of AlamarBlue® (Invitrogen). 150 μl of PBS and 15 μl
of AlamarBlue® was added to each well and incubated for
3 hours at 37°C in 5% CO2 atmosphere. Absorbance was
monitored at 570 nm and 600 nm as a reference wave-
length. Data are normalized to 600 nm value. Results are
given as the mean ± SEM of 5 independent experiments.
Preparation for BSE
THP-1 cells were differentiated as described above and
seeded into 24 well plates on Thermanox® Plastic Cover-
slips (NUNC™, Rochester, NY USA) at a density of
0.5*106/ml. The cells were treated for 4 hours using con-
centration as described above at 37°C in 5% CO2 atmos-
phere. After the treatment they were washed 5× with
0.1 M sodium cacodylate (pH 7.2) buffer. Overnight fix-
ation was done in 3% glutaraldehyde/ 0.1 M sodium
cacodylate (pH 7.2) buffer. After fixation the cells adher-
ent to the coverslips were washed three times in sodium
cacodylate buffer.
Bright field microscopy
THP-1 cells were differentiated as described above in a
μ-dish (35 mm) (ibidi, Germany) and treated for 4 hours
as described above. Brightfield microscope images were
taken using Leica confocal laser scanning microscope
SP5 at a 60× oil immersion objective lens.
In vivo study
Intra pleural injection of fibres
Fibres were uniformly dispersed in 0.5% bovine serum al-
bumin (BSA; Sigma-Aldrich, Poole, UK)/saline at a con-
centration of 50 μg/ml which equates a dose of 5 μg per
mouse and injected into the pleural cavity of female
C57BI/6 mice (aged 8 weeks) at a volume of 100 μl per
mouse as described previously by Schinwald et al. [14].
We used a sleeve close to the tip of a 27 G needle to pre-
vent it penetrating beyond the pleural space into the lung
[13]. Mice were euthanized after 24 hours (n = 4) and
7 days (n = 4) by asphyxiation in 100% CO2.
Lavage of pleural space
The pleural space was lavaged with three 1 ml washes of
sterile saline and kept on ice. To separate the cellular
fraction from the supernatant the lavage fluid was centri-
fuged for 5 minutes at 2000 rpm at 4°C in a Mistral 3000i
centrifuge (Thermo Fisher Scientific, Inc., MA, USA).
Cyto-centrifugation with following Diff-Quik staining
using Diff-Quik stainset (Dade Behring Gmbh, Marburg,
Germany) were prepared for visualising uptake of fibres
in pleural macrophages.
Preparation parietal pleura for BSE
Tissue dissection
The lower right posterior portion of the chest wall,
approximately an area of 1 cm × 0.5 cm along the spine
was cut out from the mice after lavage, washed in ice-
cold saline and fixed for 4 hours in 30% formalin. The
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tissue was excised from the surrounding tissue and fixed
with 3% glutaraldehyde in 0.1 M Sodium Cacodylate buf-
fer (pH 7.3) for 3 hours then washed in three 10 minute
changes of 0.1 M Sodium Cacodylate buffer.
Cell and tissue preparation for BSE
Fixed samples were dehydrated in 50%, 70%, 90% and
100% normal grade acetones for 10 minutes each, then
for a further two 10-minute changes in analar acetone.
Dehydrated samples were critical point dried and mounted
on SEM aliminium stubs and rotary-coated with about
8 nm of carbon in an Edwards 306A vacuum coating sys-
tem (Edwards High Vacuum, Crawley, UK).
BSE
SEM of carbon-coated specimens was carried out using
a Hitachi 4700 II field emission SEM (Hitachi High-
Tech, Maidenhead, UK) at a beam accelerating voltage
of 10 kV and a working distance of about 8 mm. Sec-
ondary electron (SE) and BSE images were taken simul-
taneously using an annular YAG crystal BSE detector
and the upper SE detector to produce perfectly-
synchronised image pairs. The two images were super-
imposed using Adobe Photoshop. The SE and BSE
image were converted to grayscale, the BSE image was
pasted into the SE image by using the layer function
“lighten”. This newly merged image and the SE image
were converted to RGB mode, and overlayed by pasting
the red channel of the BSE image into the red channel
of the greyscale SE image, thus colour coding in red
the strong BSE signal from the nanowires, the SE image
appearing in grey.
Methodology for quantifying unphagocytosed fibres
Image-Pro plus software (Media Cybernetics Inc., MD,
USA) was used to measure the amount AgNW outside
macrophages. The intensity of red pixels of the nanofi-
bres differs if the fibre is taken up by a cell and therefore
covered by a cell layer (lower intensity) or if the fibres is
unphagocytosed (higher intensity). Using Image-Pro soft-
ware, it was possible to specifically select the red pixel
intensity of unphagocytosed cells which was expressed as
object and area count. The number of objects (unphago-
cytosed fibres) was divided by the number of cells per
image and expressed as unphagocytosed fibres per cell.
Approximately 100 cells per image were counted (n = 3).
Statistical analysis
All data are shown as the mean ± s.e.m. and these were
analysed using one-way analysis of variance (ANOVA).
Multiple comparison were analysed using Tukey-HSD
method and in all cases (GraphPad InStat Software Inc.,
CA, USA).
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CONS P EC TU S
I n all branches of toxicology, the biologically effective dose (BED) is thefraction of the total dose of a toxin that actually drives any toxic effect.
Knowledge of the BED has a number of applications including in building
structureactivity relationships, the selection of metrics, the design of safe
particles, and the determination of when a nanoparticle (NP) can be
considered to be “new” for regulatory purposes. In particle toxicology,
we define the BED as “the entity within any dose of particles in tissue that
drives a critical pathophysiogically relevant form of toxicity (e.g., oxidative
stress, inflammation, genotoxicity, or proliferation) or a process that leads
to it.”
In conventional chemical toxicology, researchers generally use the mass
as the metric to describe dose (such as mass per unit tissue or cells in culture)
because of its convenience. Concentration, calculated from mass, may also
figure in any description of dose. In the case of a nanoparticle dose, researchers use either themass or the surface area. Themass of
nanoparticles is not the only driver of their activity: the surfaces of insoluble particles interact with biological systems, and soluble
nanoparticles can release factors that interact with these systems. Nanoparticle shape can modify activity.
In this Account, we describe the current knowledge of the BED as it pertains to different NP types. Soluble toxins released by
NPs represent one potential indicator of BED for wholly or partially soluble NPs composed of copper or zinc. Rapid dissolution of
these NPs into their toxic ions in the acidic environment of the macrophage phagolysosome causes those ions to accumulate, which
leads to lysosome destabilization and inflammation. In contrast, soluble NPs that release low toxicity ions, such as magnesium
oxide NPs, are not inflammogenic. For insoluble NPs, ζ potential can serve as a BED measurement because the exposure of the
particle surface to the acidic milieu of the phagolysosome and interactions with the lysosomal membrane can compromise the
integrity of the NPs. Researchers have explored oxidative potential of NPs most extensively as an indicator of the BED: the ability
of an NP to cause oxidative stress in cells is a key factor in determining cell toxicity, inflammogenicity, and oxidative DNA adduct
formation. Finally we discuss BEDs for high aspect ratio nanoparticles because long fibers or nanoplatelets can cause inflammation
and further effects. These consequences arise from the paradoxically small aerodynamic diameter of fibers or thin platelets. As a
result, these NPs can deposit beyond the ciliated airways where their extended dimensions prevent them from being fully
phagocytosed by macrophages, leading to frustrated phagocytosis. Although knowledge is accumulating on the BED for NPs,
many questions and challenges remain in understanding and utilizing this important nanotoxicological parameter.
In conventional chemical toxicology, the mass is the metric
generally used to describe dose (e.g., mass per unit tissue or
cells in culture) because of its convenience, although con-
centration, calculated from mass, may also figure in any
description of dose. In the case of nanoparticles, themass or
the surface area dose is used. However, nanoparticles are
unlikely to have their effect as a consequence simply of
their mass since the quantity that interacts with the biolog-
ical system is the surface for insoluble particles or any
soluble factors released in the case of soluble particles
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and may be modified by shape. Our aim here is to describe
current knowledge on the biologically effective dose (BED)
as it pertains to different nanoparticle (NP) types. Soluble
toxins released by NPs represent a potential BED for wholly
or partially soluble NPs such as copper or zinc NPs. Rapid
dissolution into ions in the acidic milieu of the macrophage
phagolysosome leads to accumulation of the toxic ions,
which causes lysosome destabilization leading to inflamma-
tion. In contrast, soluble NPs that release low toxicity ions,
such as magnesium oxide NPs, are not inflammogenic
because the ions that are released are low in toxicity. The
ζ potential is a BED for insoluble NPs because the charge on
the surface of the particle can be exposed in the acidicmilieu
of the phagolysosome, interactingwith the lysosomalmem-
brane leading to loss of integrity. The oxidative potential of
NPs remains one of the BED that has been most explored,
and the ability ofNPs to cause oxidative stress in cells is a key
factor in determining cell toxicity, inflammogenicity, and
oxidative DNA adduct formation. The final BED discussed
here is high aspect ratio, where long fibers or nanoplatelets
cause inflammation and its consequences. This arises as a
consequence of the paradoxically small aerodynamic di-
ameter of fibers or thin platelets, enabling them to deposit
beyond the ciliated airways where their extended dimensions
prevents them being fully phagocytosed by macrophages,
leading to frustrated phagocytosis. While knowledge is accu-
mulating on theBED, there is still a great deal of research yet to
bedoneandchallenges faced inutilizing this important param-
eter, possibly the most important one for nanotoxicology.
The Biologically Effective Dose (BED) in
Toxicology
Dose is central to toxicology, and the concept of dose for
particles can actually be consideredmore deeply in terms of
what is driving the response. Specifically, particles while
often measured in terms of mass do not exert their effect
as a consequence simply of their mass. The term used to
describe the actual component of the total dose that drives
adverse effects is the biologically effective dose (BED). We
here define the particle BED as “the entity within any mass
dose of particles that drives a critical pathophysiogically
relevant form of toxicity in tissue”, for example, inflamma-
tion, genotoxicity, or cellular proliferation. The BED is useful
concept for several reasons (Figure 1 and Table 1). Any given
particle sample might have more than one BED such as the
presence of polyaromatic hydrocarbons (PAHs) as well as
reactive transition metals in PM10, and indeed, the BED
might drive more than one response, for example, a local
response at the portal of entry and amore distal response in
a target organ that it affects directly by translocation or
indirectly by release of mediators at the portal of entry.
Therefore in considering any BED, we need to define the
response of interest and in terms of this Account, we confine
ourselves to inflammation as the response of interest since it
has multiple roles to play in particle-induced health effects
and pathology.
It is notable that, despite knowledge of the BED and the
obvious benefit of measuring the BED as a better guide for
risk management, neither the quartz nor fiber BED, which
are known, is themetric used in exposuremeasurement/risk
assessment; themass and fiber number are themetrics used
for quartz and fibers respectively. The reason behind this
simply reflects the challenges in measurement of particle
exposure other than mass, particularly using real-time mea-
surement systems. While there are improvements in this
area, such as being able to measure surface area (often
based on algorithms rather than direct measurement), cer-
tain factors such as particle reactivity or biopersistence
are unlikely to ever be integrated into real-time exposure
metrics.
At the level of individual cells, the BED of various nano-
particles (NP) is becoming better understood as discussed
below. The BED is synonymous with particle physicochem-
ical characteristics that are relevant for structure/toxicity
(activity) relationships (STR). This is because structures de-
fined in STRs drive the response and therefore are ideally the
FIGURE 1. The uses and importance of the biologically effective dose.
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BED for a specific pathophysiologically relevant response(s).
The BED therefore is crucial and can be useful in a number of
ways (Figure 1) that aid hazard identification, risk manage-
ment, predictive toxicology (i.e., in silico approaches), and
benign-by-design to allow the informed development of
safer nanomaterials. More detailed examples of these uses
are given in Table 1.
Retention Compartments Where the BED Is
Applied
It is informative to consider where the BED is applied. The
lung is a complex organ, and the delivery of a particle dose is
a complex interplay related to the anatomy of the lung, the
flowof air, and the aerodynamic size and composition of the
particles, all of which govern how much and where an
inhaled dose of particles deposits in the lung. A major part
of the “ineffective” dose is the fraction that is cleared by
mechanical clearance (Figure 2A) to leave the retained dose.
The retained dose distributes into various compartments
over time where residence can be transient or more long-
lived. Classically the clearance from the airways, propelled
by the mucociliary escalator, is much faster than clearance
from beyond the ciliated airways, which depends onmacro-
phage action. Depending on the particle in question and its
BED, there can be an effect in these compartments that
contributes to pathogenicity. While low toxicity particles
generally cause minimal effects at plausible doses, patho-
genic particles can have various pro-inflammatory, mito-
genic, genotoxic, or other pathophysiogically relevant
effects. The compartments are shown in Figure 2B, and the
FIGURE2. (A) The retaineddose shownas the deposited doseminus the dose that ismechanically cleared and (B) the sequestration compartments in
the lungswhere the retained particle dose (black dots) can be found:-( I) alveolarmacrophages; (II) interstitium in terminal airways; (III) epithelial cells;
(IV) the parietal pleura; (V) mediastinal lymph nodes. In addition, if lesions arise, particles can be trapped in the developing lesions.
TABLE 1. Details on How the BED Can Be Used for Hazard Identification, Risk Management, Predictive Toxicology, and Benign-by-Design
use of BED rationale
hazard identification the BED allows prediction of the types of hazard outcome, for example, a highly oxidative particle is likely to cause oxidative
DNA adducts; a fiber-shaped nanoparticle may pose a mesothelioma hazard
risk management since the BED drives the adverse effect, measuring the BED as the exposuremetricmost closelymeasures the harmful exposure
and so would allow the most effective risk management
predictive toxicology determining the BED and its potency using toxicological approaches allows prediction of the type of hazard (hazard
identification) and likely potency in causing pathogenic effects
benign-by-design knowledge of the BEDallows particles designers a structural target that theymay address to produce a safer, less harmful particle
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effects of the particle BED in these compartments give
responses that provide the pathological nuances that are
seen with different particles and that we would anticipate
with different NPs.
Biologically Effective Doses of Nanoparticles
The BED, as discussed above, gets to the heart of how any
particle dose drives response. Within any mass dose of
particles that elicits a toxic response, there must be one or
more entities that are the actual drivers, and these, by
definition, are the BED(s). They can take the form of one or
more physicochemical characteristics associated with the
particles and can be soluble or ionic species released from
the particle or characteristics integral to the particle surface
or the particle shape. Below we outline exemplar BEDs that
have been described for various nanoparticle types.
Soluble Toxins Released from NPs. Some NPs will un-
dergo a degree of solubility (ionization) in biological fluids.
Using metal oxide NPs, we have seen measurable but
limited solubility in water or neutral conditions1 (Figure 3).
However, in the acidic conditions typical of phagolysosomes
and lysosomes, NPs show variable solubility (Figure 3);
copper oxide NPs, magnesium oxide NPs, and zinc oxide
NPs showed rapid, complete dissolution in acid conditions
(pH 5.5), while other NPs showed minimal dissolution
(Figure 3).
The neutral-soluble fraction may be important for parti-
cles bathed in lung-lining fluid or the fluid of the interstitium,
which have a pH around neutrality. For example, the con-
centration of soluble ions from the nickel oxide NP, zinc
oxide NP, and copper oxide NP suspensions in neutral saline
ranged from 5 to 12 ppm.
Treatment of the alveolar type II epithelial cell line, A549
with the neutral-soluble fraction of zinc oxide NPs and
copper oxide NPs increased interleukin (IL)-8 via activator
protein (AP)-1 or nuclear factor κB (NF-κB) activation while
that with nickel oxide NPs did not. Chelation of ions in the
neutral-soluble fraction of zinc oxide NPs and copper oxide
NPs abolished the effect demonstrating the role of the ions
as the BED for the inflammatory reaction in these cells, and
in a rat lung instillationmodel, low concentrations of neutral-
soluble fractions had a role in recruiting neutrophils to the
lung.2
The acid-soluble fraction is relevant because of the com-
partmentation of particles into macrophage phagolyso-
somes, which typically have a pH of around 5.5 and
dissolution commonly occurs much faster in this acidic
environment. For example, zinc oxide NPs produced an
acute eosinophilic inflammation in a rat instillation model,2
and instillation of the relevant concentration of soluble zinc
ions produced the same magnitude of eosinophilic inflam-
mation as the whole NP, suggesting that the BED for eosin-
ophil recruitment was zinc ions and not the NP per se. On
the other hand, despite being highly soluble at pH 5.5,
magnesium oxide NPs did not elicit inflammation in the rat
instillation model.1 This is because Mg2þ is a nontoxic ion
and may even protect against cell injury.3 Therefore, the
relative toxicity of the compositional ions of high-solubility
NPs is the principal parameter dictating the toxicity of these
NPs and its toxic ions can be the BED (Figure 4).
In addition to degree of solubility impacting on the BED,
solubility also is a factor in biopersistence. Dissolution to
harmless ions is likely to be nonharmful since there is no
FIGURE 3. Solubility (%) of a panel of metal/metal-oxide NPs in
Gamble's solution at pH 7.4 and 5.5; data are shown as mean; all SEM
were <10% of the mean. Same composition NPs from different sources
are labeled with a and b subscripts such as CeO2NPa and CeO2NPb.
Solubility testwas carried out three times. Datawere redrawn from ref 1.
FIGURE 4. The mode of action of high-solubility NPs composed of
material that ionizes to toxic ions in causing inflammation. High-
solubility NPs deposit in the neutral environment of the lung lining and
first develop a corona from the lung surfactant into which they deposit.
They are then taken up intomacrophage phagolysosomes, which have
an acidic pH. In the acidic phagolysosomal milieu, dissolution to toxic
ions is greatly accelerated compared with dissolution rate at neutrality
and the toxic ions accumulate to a high concentration. This causes
lysosomal membrane destabilization and inflammation. See ref 1 for
more details.
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build-up of particles; however, dissolution to harmful ions
would lead to pathogenic effects. The consequences of slow
or partial dissolution are more difficult to predict and would
depend on the toxicity of the ions and of the residuumof the
particle that is retained.
ζ-Potential. The electric potential created between the
charged groups associated with the surface of a particle and
the suspension medium is the ζ potential (ζP) and provides
information concerning the surface charge of particles. The
ζP, as might be anticipated, shows dynamic changes de-
pending on the pH of the medium and the adsorption of
protein to form the corona.4 Subsequentlymostmetal oxide
NPs have a negative ζP in PBS (pH 7.4), a predominantly
positive ζP in acidic physiological saline (pH 5.6) (ζPacid), and
a slightly negative ζP when there is a corona of proteins
(ζPsurfactant‑corona) or lung lining fluid. The basis for advancing
ζP as a BED is that when NPs are phagocytosed by alveolar
macrophages the proteolytic enzymes and acidic pH
(pH5.6)5 found in the phagolysosomemay strip off the corona
and reveal the naked surface of the particle4 restoring the
precoronal ζPacid. If the restored ζPacid of the NP has a high
positive value, it has the potential to bind to and damage
membranes, as shown by ability to lyse erythrocyte mem-
branes as a model membrane target (Figure 5).
We suggest that the same type of enhanced interaction
between NPswith a high positive ζPacid and the internal face
of the lysosomal membrane could cause destabilization of
the lysosomes, which can trigger inflammation or cell death
(Figure 6).
Thus the ζPacid represents a BED for some NPs, and this is
supported by the finding that the ζPacid of metal/metal-
oxide NPs showed a linear correlation with the ability of a
range of NP samples to cause acute lung inflammation. This
was shown by instilling a panel of metal/metal oxide NPs
into rat lungs at equal surface area dose and plotting the
ζPacid with the extent of the inflammation.
4 There was a
clear threshold ζPacid level triggering both inflammation
(Figure 7) and the membranolytic effect (Figure 6) that was
around þ12 mV4 (Figure 7). Therefore for some NPs the
ζPacid represents the BED, but this may be quite site-specific
since it requires an acidic and hydrolytic environment such
as the macrophage phagolysosome for its full expression.
Oxidative Potential. Throughout the particle toxicology
literature, there are numerous instances where pathogenic
particles possess oxidative potential and cause their effects
via the final common pathway of oxidative stress. For
example, in the case of quartz, the elicitation of oxidative
stress and the formation of damaging hydrogen bonds
between the silanol groups at the quartz surface and the
cellmembrane is a keydriver of oxidative stress andensuing
FIGURE 5. Effect of the ζPacid value on the ability of any NP sample to
cause lysis of erythrocyte membranes. Redrawn from ref 4.
FIGURE 6. The hypothesized mechanism of inflammation caused by
low solubility, high ζPacid NPs. The high ζPacid of NP is changed to
ζPsurfactant-corona. This corona, however, can be digested by the enzymes
and the acidic conditions of lysosomal fluid, which can restore the high
ζPacid, which is inflammogenic via destabilization of lysosomal mem-
brane. Redrawn from ref 4.
FIGURE7. Relationship between ζPacid and lung inflammogenicity. Plot
of ζPacid versus percentage of total granulocytes in the BAL. NPs having
negative ζPacid were not associated with inflammation but NPs having
positive ζPacid had a significant linear correlation with the percentage
of total granulocytes in the BAL (Pearson correlation test, R2 = 0.86,
p=0.0009, 95%confidence interval=0.64 0.99.Usedwith permission
from ref 4. Copyright 2012 Society of Toxicology.
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inflammation.6 It should however be noted that in some
cells nonoxidative pro-inflammatory mechanisms also
prevail.7 In some studies, NP oxidative activity measured
directly by chemicalmethods canbe related to their ability to
cause inflammation,8 but other studies have not found this
simple relationship9
Taking another example of a different NP, the generation
of oxidative stress in cells by exposure to carbon nanotubes
has been described by several research groups.10 The oxi-
dative potential of carbon nanotubes has been ascribed to
the transition metal catalysts remaining after production,
which can be a source of free radicals.11 {However for longer
fibers of carbon nanotubes, the length of the fibers and not
iron is the BED (see below).}
Nel and co-workers12suggested a hierarchy of response
to particle-induced oxidative stress. Within this model, the
normal physiological levels of oxidative stress are dealt with
by the cell by gene expression for antioxidants but inter-
mediate levels of oxidative stress may cause a more severe
responses such as inflammation (e.g., via activation of
NF-κB), while high levels of oxidative stress cause cell death
(Figure 8).
As shown in Figure 8, several BEDs can have oxidative
potential and so exert their effect through oxidative stress.
Examples include phagocytosis of long fibers driving the
release of superoxide radicals due to activation of the
NADPH oxidase system.13 Another example of BED driving
oxidative stress is the photocatalytic activity of titanium
dioxide under UV light.
High Aspect Ratio Particles . Nanofibers. The geo-
metric shape/structure of particles has long been accepted
as a crucial factor in enhancing toxicity. The role of fiber
length/aspect ratio first became apparent because of asbes-
tos, which caused a worldwide epidemic of lung cancer and
fibrosis, as well as pleural diseases such as mesothelioma,
pleural fibrosis, and pleural plaques. The correlation of
adverse health effects and fiber structure is a robust structure
toxicity relationship encapsulated in the fiber pathogenicity
paradigm (FPP), which defines the features that define the fiber
BED14 (Figure 9).
Particles/fibers that deposit beyond the ciliated airways
are cleared via alveolar macrophages, and this relies on
complete phagocytic uptake. However longer fibers cannot
readily be completely taken up by macrophages, which
results in frustrated phagocytosis (Figure 10). This incom-
plete or frustrated phagocytosis is pro-inflammatory14 as
shown in Figure 11.
As well as being pro-inflammatory, the sheer bulk of a
long fiber(s) inside a macrophage is likely to be an obstacle
to the normal process of motility leading to accumulation of
longer fibers in the lower respiratory tract,15 recruitment of
inflammatory cells, secretion of pro-inflammatorymediators,
and generation of reactive oxygen species (see below)14
The clearance rate of longer fibers is also impacted by the
biopersistence of the deposited fibers. Nonbiopersistent
long fibers can break into smaller fragments and be cleared
via macrophages whereas biopersistent long fibers remain
in the lower respiratory tract, and some may translocate to
the pleural space surrounding the lungs.14 The generality of
the translocation of particles and fibers from the lungs to the
pleural space has been demonstrated, and liquid and parti-
cles in the pleural spacedrain tomediastinal lymphnodes by
drainage through stomata on the parietal pleura.14 With a
diameter <10 μm,16 the parietal pleura therefore acts like a
sieve, retaining longer fibers at the parietal pleura where
they can cause pathogenic responses. There is therefore a
good mechanistic basis for biopersistent long fibers as the
BED of long fibers for pleural responses.
The similarities between asbestos and manufactured
nanofibers, including nanotubes, -rods, and -wires, has en-
gendered concern as to their potential to cause similar
hazards. Following initial data supporting the hypothesis
that nanofibers conformed to the FPP in the peritoneal
cavity,17 we went on to test for length-dependent fiber
pathogenicity after direct exposure of the mesothelial lining
of the pleural space using a panel of high aspect ratio
FIGURE 8. The relationship of biologically effective dose to the driving of oxidative stress and graded cellular responses. Adapted from ref 22.
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nanoparticles (HARN) samples.18 Only long nanofibers and
long asbestos fibers elicited sustained inflammation in the
pleural space and extensive lesion formation and fibrosis
along the parietal pleura. These studies support the conten-
tion that long, biopersistent nanofibers represent theBED for
this type of nanomaterial. Most recently, we have addressed
the threshold fiber length for the onset of fiber pathogenicity
in the pleural space using silver nanowires and nickel oxide
nanowires with tightly sized length categories. After direct
intrapleural injection, wewere able to identify a clear cutoff
value of 5 μm for acute long fiber effects in the pleural
space.19 We are therefore able to further delineate
the nanofiber BED as biopersistent fibers longer then
5 μm.18
Nanoplatelets.Recently high aspect ratiomaterialsmade
of graphene in the form of nanoplatelets are attracting
substantial scientific interest. Like fibers, the platelet shape
could pose unusual risk to the lungs and the pleural space
after inhalation due to their aerodynamic properties. Very
thin sheets with a high aspect can have a low aerodynamic
diameter (Dae) compared with their geometric size. The
respirable size for humans cuts off at around an Dae of
5 μm.20 We calculated the aerodynamic diameter of a com-
mercial form of graphene nanoplatelets (GNPs), which could
be up to 30 μm across, and we found the 30 μm diameter
nanoplatelets to possess an Dae of 3.3 μm, well inside the
respirable range (Table 2). Such a particle can therefore
deposit beyond the ciliated airways where the macro-
phages will fail to fully engulf them, producing frustrated
phagocytosis21 and inflammation. We reported that
respirable-sized but physically large and extended graphene
nanoplatelets were able to cause inflammation in the lung
and the pleural space after pharyngeal aspiration and direct
intrapleural injection.21 The inflammatory response was
accompanied by frustrated phagocytosis of pulmonary
and pleural macrophage observeable in vitro (Figure 12),
and macrophage cells treated with respirable GNPs in
vitro produced increased cytokine levels compared with a
FIGURE 9. The three structural elements that determine the toxicity of fibers; see text for details.
FIGURE 10. Macrophages that have phagocytosed short nickel nano-
wires (S-NiNW, upper image) and long nickel nanowires (L-NiNW, lower
image). With short nanowires, the fibers can be clearly seen completely
enclosed within the cell (upper image, white arrow) while the phago-
cytosis of long fibers produces the classical picture of frustrated
phagocytosis with the fiber protruding from the cell surface
(lower image, black arrow). Image modified from ref 23.
FIGURE 11. Pro-inflammatory effects, as production of the cytokine
IL-1β by THP-1 macrophages exposed to vehicle, long or short nickel
nanowires, or nickel nanoparticles. Note the clear specific effect of the
long nanowires in stimulating IL-1β release.
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nanoparticle carbon black control (Figure 13). Thus, for
nanoplatelets, large extended thin particles with Dae are a
BED.
Collectively our data with nanofibers and nanoplatelets
highlights the shape of high aspect nanomaterials as a BED,
the driver for in vivo toxicity. Both nanofibers and nanoplate-
lets with nanoscale diameter or thickness can be very large in
one or two dimensions but possess a low Dae, which allows
them to deposit in the lower respiratory tract. Therefore the
fibrous and platelet habit can be seen as key BEDs if the
material of which they are composed is biopersistent.
Benefits and Challenges of the BED. Despite the accu-
mulated knowledge regarding the various BEDs that NPs
possess and their roles in driving pathological processes,
their remain major gaps and challenges in their use. In any
single type of NP numerous factors may contribute to the
BED making for a compound BED that could be the sum of
particle shape, composition, soluble toxins, etc. Furthermore
different BEDs may also impact on different pathways with
differing potencies andmay also be affected by aggregation
in air and potential disaggregation in the lungs. As a
hypothetical example, a long thin nanofiber may have a
BED as a consequence of high aspect, but if it is composed of
a reactive material, it may have ζ potential type BED and
may also release soluble ions that have a soluble ion type of
BED. Adoption of a metric based on such a complex BED
seems to pose almost insuperable difficulties and so merely
knowing theBED, if the BED is compoundand complex, does
not necessarily offer a solution to the issue of basing the
metric on the BED.However someparticles are likely to have
a single BED, for example, surface area in the low-toxicity,
low-solubility materials, and these pose a clearer target.
Conclusion
Knowledge of the BED is of great value for a variety of
reasons in considering the hazard of any nanoparticle
(Figure 1). By considering a particle not just as a single entity,
but as a sumor sums of the attributes that drive toxicological
response in a biological systems, one can understand the
root drivers of toxicity, which opens the way to a number of
key applications (Figure 1). Data is continuing to accumulate
on the nanoparticle hazard and with increased knowledge
of the toxicological profile/biological interactions of nano-
particles and the physicochemical properties, nanoparticles
maybe grouped into categorieswith a similar BED for hazard
evaluation purposes. Other potential BEDs have been listed,21
but firm evidence for their role in toxicological processes and
the development of adverse effects and disease remain to be
demonstrated. Other BEDs no doubt will become apparent as
more data accumulates, but we do not consider that there will
be a very large number, just as the variety of BEDs for
conventional pathological particles is quite limited.
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Abstract
Background: The objective of this study was to examine the threshold fibre length for the onset of pulmonary
inflammation after aspiration exposure in mice to four different lengths of silver nanowires (AgNW). We further
examined the effect of fibre length on macrophage locomotion in an in vitro wound healing assay. We
hypothesised that exposure to longer fibres causes both increased inflammation and restricted mobility leading to
impaired clearance of long fibres from the lower respiratory tract to the mucociliary escalator in vivo.
Methods: Nine week old female C57BL/6 strain mice were exposed to AgNW and controls via pharyngeal
aspiration. The dose used in this study was equalised to fibre number and based on 50 μg/ mouse for AgNW14.
To examine macrophage migration in vitro a wound healing assay was used. An artificial wound was created in a
confluent layer of bone marrow derived macrophages by scraping with a pipette tip and the number of cells
migrating into the wound was monitored microscopically. The dose was equalised for fibre number and based on
2.5 μg/cm2 for AgNW14.
Results: Aspiration of AgNW resulted in a length dependent inflammatory response in the lungs with threshold at
a fibre length of 14 μm. Shorter fibres including 3, 5 and 10 μm elicited no significant inflammation. Macrophage
locomotion was also restricted in a length dependent manner whereby AgNW in the length of ≥5 μm resulted in
impaired motility in the wound closure assay.
Conclusion: We demonstrated a 14 μm cut-off length for fibre-induced pulmonary inflammation after aspiration
exposure and an in vitro threshold for inhibition of macrophage locomotion of 5 μm. We previously reported a
threshold length of 5 μm for fibre-induced pleural inflammation. This difference in pulmonary and pleural
fibre- induced inflammation may be explained by differences in clearance mechanism of deposited fibres from the
airspaces compared to the pleural space. Inhibition of macrophage migration at long fibre lengths could account
for their well-documented long term retention in the lungs compared to short fibres. Knowledge of the threshold
length for acute pulmonary inflammation contributes to hazard identification of nanofibres.
Keywords: Asbestos fibre, Silver nanofibres, Aspiration, Clearance, Migration
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Background
The determinants of the pathogenicity of fibrous mate-
rials include fibre diameter, length and biopersistence
which form the basis of the fibre pathogenicity para-
digm (FPP) [1]. Studies on asbestos fibres, synthetic
vitreous fibres and nanofibres have shown that they all
may pose a significant health hazard when inhaled dur-
ing their manufacture and/or use [2-5]. These various
different fibrous materials possess considerable differ-
ences in their pathogenicity in keeping with the FPP
[6]. It has been accepted for many years that fibre
length plays a crucial role in the development of asbes-
tos related diseases. For example Davis et al. performed
a number of experiments investigating the pathogen-
icity of various length and compositions of asbestos
fibres via the routes of inhalation and intraperitoneal
injection [7,8]. The inhalation studies showed that
fibres with a significant proportion (~11%) of fibres >
10 μm caused widespread pulmonary fibrosis and can-
cer whereas shorter fibres (less than 5 μm) and UICC
amosite (intermediate length) caused less fibrosis or
carcinogenesis. However, the UICC amosite fibres and
long asbestos fibres had similar potency in causing
mesothelioma whilst virtually no carcinogenicity was
seen with short fibres [8]. This study showed for the
first time a difference in the fibre lengths required for
the induction of lung diseases and the lengths for peri-
toneal mesothelioma and by analogy pleural mesotheli-
oma. However, the precise threshold lengths for both
lung and peritoneal pathology after fibre exposure were
unknown at the time. In a recent study we determined
the threshold length for fibre-induced pathogenicity in
the pleura [9] as being 5 μm, using distinct length
classes of silver nanowires (AgNW). The aim of the
current study was to determine the threshold length
for fibre-induced lung inflammation by comparing the
pulmonary inflammatory response to the same panel of
different length classes of AgNW after their deposition
in the airspaces of the lungs.
The normal lung clearance mechanisms provide a de-
fence mechanism for removing fibre dose and yet se-
lective retention of longer fibres is well-documented
[10,11]. For the key fraction of fibres that deposit be-
yond the ciliated airways and are slowly cleared,
macrophage are the central cells involved in phagocyt-
osing and transporting the fibres to the foot of the
mucociliary escalator for clearance. We therefore
hypothesised that the uptake of long fibres impairs the
ability of macrophages to migrate whilst short fibres do
not, providing a mechanism for selective retention of
long fibres. We addressed this hypothesis using the
samples with different fibre length classes and assessed
their effects on macrophage migration in an in vitro
wound closure assay.
Results
Length dependent inflammatory response to AgNW in
lung at 24 hour
The panel of AgNW used for pharyngeal aspiration is
represented in Figure 1. The inflammatory response to
the panel of AgNW and control fibres as assessed by the
bronchoalveolar lavage fluid (BAL) profile was measured
24 hour post aspiration. An initial dose response series
was performed with AgNW14 at a dose of 5, 10, 25 and
Figure 1 Characteristics of AgNW panel. Representative images of the AgNW (1 mg/ml) and their mean length (μm), percentage of
fibre≥ 5 μm and average diameter (nm). Scale bar: 10 μm.
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50 μg/mouse (n = 2) and SFA and LFA at a dose of 10
and 50 μg/mouse (n = 2) (data not shown). The dose of
50 μg/mouse was chosen since it gave a persistent in-
flammatory response with AgNW14 and LFA. The dose
was adjusted so that each of the different treatments
(Table 1) comprised the similar fibre number. No change
in total bronchoalveolar cell number was measured after
exposure to equal numbers of the different fibre lengths
compared to vehicle control (Figure 2A). However the total
number of granulocytes was significantly increased after ex-
posure to AgNW14 (Figure 2B). A length dependent trend
towards an increase in granulocyte number with AgNW5,
AgNW10 and LFA was observed, although this was not sig-
nificant (Figure 2B). AgNW3 and SFA produced no in-
crease in granulocyte number compared to VC (Figure 2B).
The effect of length on inflammation was demonstrated by
plotting AgNW length against inflammation and it is clear
that the relationship is not linear and that there is a dis-
cernible step–increase in granulocyte recruitment at a
length between 10 and 14 μm. (Figure 2C). Total amount
of protein and increase in membrane permeability by the
release of LDH was measured but showed no significant
difference between the treatments (data not shown).
Histological evaluation of lung sections following
treatments
The pathology of the lung exposed to the AgNW panel
and controls were examined 24 hour after aspiration.
The sections after exposure to VC, SFA and AgNW3
showed normal histology of bronchioles, respiratory
bronchioles, alveolar ducts and alveoli (Figures 3A, B, D
and Additional file 1: Figure S1). AgNW5 and AgNW10
produced minor granulomas and lymphocyte infiltrates
and the majority of the lung histology appeared normal.
AgNW14 and LFA caused more extensive granuloma
and lymphocyte infiltrates which is consistent with the
amount of total granulocytes from the lavage fluid
(Figure 3E, F, and Additional file 1: Figure S1). Accumu-
lations of nanowires inside alveolar macrophages were
common (Figure 3E, F white arrow and Additional file 1:
Figure S1). AgNW14 produced the strongest response
with more granulomatous areas compared to shorter
Table 1 Calculation for the mass adjustments for
equalisation of fibre number in vivo
Particle Calculation to equalise for





SFA Short fibre control 10.7 50.48*106
AgNW3 3/14 × 50 10.7 32.71*10
6
AgNW5 5/14 × 50 17.9 31.19 *10
6
AgNW10 10/14 × 50 35.7 28.17 *10
6
AgNW14 standard 50.0 32.76 *10
6
LFA* Long fibre control 50.0 8.24*106
*LFA fibre counting 164,705 fibres/μg on the basis of WHO counting criteria.
Figure 2 Length dependent inflammatory response to AgNW in the lungs at 24 hour. C57/Bl6 mice were exposed to AgNW and control
panel by pharyngeal aspiration. At 24 hour post exposure the lungs were lavaged and total cell number (A) and total granulocyte number (B)
were measured. C) The acute inflammatory increase was plotted against length of AgNW. Significance indicated compares treatment groups to
vehicle control (B) and within each treatment (C), * indicates p < 0.05, ** indicates p < 0.001. Data represent mean ± SEM of n = 4 mice.
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fibres however this was still minor compared to the
extensive interstitial thickening and remodelling of the
alveolar spaces after LFA treatment (Figure 3C, G, and
Additional file 1: Figure S1). Frustrated phagocytosis,
classified as incomplete uptake of fibres by cells [12],
was observed with AgNW14 and LFA.
Frustrated phagocytosis in alveolar macrophages
The uptake of different length of AgNW by alveolar
macrophages was evident in cytospin images of the
broncho-alveolar lavage fluid (Figure 4). Shorter fibres
including SFA, AgNW3, AgNW5 and AgNW10 could
be completely phagocytosed by alveolar macrophages
(Figure 4B, D, E) whereas LFA, and AgNW14 were under-
going frustrated phagocytosis indicated by the sharing of
fibres between adjacent cells (Figure 4C, G). This is in
agreement with frustrated phagocytosis observed in histo-
logical sections and the extent of inflammation seen in
the lavage fluid showing that frustrated phagocytosis of
nanowires correlates with increased inflammation.
Fibre-length dependent inhibition of locomotion in bone
marrow derived macrophages
As shown in Figure 5A and Additional file 1: Figure S2,
the untreated cells migrated into and repopulated wounds
area within 30 hour. Similar wound closure was seen after
treatment with silver nanoparticles (AgP) and AgNW3
(Figure 5A). A slight decrease in the closure of the wound
occurred during treatment with AgNW5 whilst BMMs
treated with AgNW14 and AgNW28 (Figure 5B) demon-
strate a substantial decrease in the ability to migrate into
the wound compared to VC. The number of cells which
Figure 3 Lung histology 24 hour post aspiration to AgNW panel and controls. H&E stained lung sections at lower (left) and higher (right)
magnification show normal alveolar structure in the vehicle control (A), SFA (B) and AgNW3 (D) sections. Small accumulations of inflammatory
cells were seen after AgNW5 (E) and AgNW10 (F) exposure whereas a greater amount of inflammatory cell infiltration in the alveoli,
peribronchiolar and perivascular regionswere observed after LFA (C) and AgNW14 (G). The white arrows are indicating the areas of fibre
accumulation. Abbreviations: al, alveolus; br, bronchiole; v, blood vessel. Representative images are shown, similar results are obtained from
2 mice.
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migrated into the wound were counted and expressed
as percentage of migrated cells normalised to VC and
this revealed that locomotion was significantly decreased
with AgNW5, AgNW14 and AgNW28 (Figure 6A). Cyto-
chalasin D, a positive control which causes impaired
migration due to disruption of the actin filaments pro-
duced a decrease in locomotion comparable to AgNW14
(Figure 6A). Differences in the rate of metabolic activity
or cell death could not account for the inability of
macrophages to migrate into the wound as the treat-
ment did not interfere with the metabolic activity mea-
sured via chemical reduction of Alamar BlueW
(Figure 6B) and had no effect on cell membrane
integrity measured as the release of lactate dehydrogen-
ase into cell supernatant (Figure 6C). Decrease in cell
adhesion has been linked to a decrease in the ability of
cell migration. Backscatter scanning electron microscopy
(BSE) images confirm that treatment with AgNW did
not impair the ability of cell adhesion and spreading
(Figure 5A,B). To the contrary, extensive cell spreading
is observed in cells treated with long fibres presumably
a consequence of BMMs increasing the surface area
involved in engulfing the fibres (Figure 5A, B). Using
BSE, nanowires and nanoparticles phagocytosed by
BMMs could be visualised underneath the membrane as
indicated by the arrow (Figure 5A, B).
Figure 4 Uptake of AgNW and controls in alveolar macrophages. Cytospin images from the lavage fluid 24 hour post aspiration illustrates
the complete uptake of shorter fibres including SFA (B), AgNW3 (D), AgNW5 (E) and AgNW10 (F) whereas LFA (C) and AgNW14 (G) lead to
frustrated phagocytosis in alveolar macrophages. Scale bar 20 μm.
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Figure 5 Fibre-length dependent impaired migration of BMMs in a wound-healing assay. A,B) An artificial wound was created in the BMM
monolayer using a pipette tip and the migration of BMMs into the wound was assessed after treatment with VC, AgP, AgNW3, AgNW5, AgNW14,
AgNW28. The dose was adjusted to fibre number and based on 2.5 μg/cm
2 for AgNW14. Photographs were taken immediately and at 30 hour
after creating the wound. For BSE images were taken at the edge of the wound. No impairment of cell adhesion and spreading could be
observed and in fact increased cell spreading due to uptake of longer fibres was observed. Nanoparticles and fibres could be visualised
underneath the cell membrane as indicated by the white arrow in the inserts which are the non-overlayed BSE images. Representative images
are shown; similar results are obtained in 3 independent experiments.
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Figure 6 Inhibition of BMMs migration in a wound-healing assay and cell viability. A) The number of cell migrated was counted and
expressed as percentage of cells migrated into the wound normalised to VC. Significant reduction of migration was seen with AgNW5, AgNW14,
AgNW28 and cytochalasin D, a positive control for actin cytoskeleton disruption. B) Metabolic activity of BMMs was assessed via the reduction of
AlamarBlueW at an absorbance of 570 nm. At the dose used no significant reduction in metabolic activity was measured. C) The integrity of the
cell membrane after the different treatments was measured via the release of LDH into the cell supernatant and compared to VC and TX, positive
control. A sub-lethal dose was chosen at which none of the treatments lead to a significant increase in cell permeability. Significance indicated
compares treatment groups to vehicle control, * indicates p < 0.05, ** indicates p < 0.001, *** indicates p < 0.0001 (n = 3). Data represent
mean ± SEM of n = 3.
Figure 7 Phosphoproteomic analysis of BMMs exposed to AgNW. A) A phospho- kinase array (R&D) was performed to screen the
phosphorylation state of 46 kinases in BMMs after treatments with AgNW3 and AgNW14 whereby 15 kinases showed an increase in
phosphorylation relative to VC. B) Immunoplot analysis extract of kinases involved in cell migration/mobility and adhesion. Results are
based on an initial screening (n = 1).
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Screening for kinase phosphorylation in BMMs after
AgNW treatment
The phospho- kinase array showed that kinases including
GSK-3 α/β, Akt (S473), β-catenin and PLC-γ were acti-
vated on treatment with both the AgNW3 and the
AgNW14 which can be explained via a general activa-
tion due to phagocytosis of particles (Figure 7A, B).
Kinases including STAT3, p53 (S392), p27 (T198),
p27 (T157) and p70 S6 (T389) were more activated
in AgNW14 compared to AgNW3 which correlate
with the loss of locomotion (Figure 7A, B). Interest-
ingly, the highest level of activation of the cytoplas-
mic tyrosine kinase Src family members including
Src, Lck, Hck and Frg was detected in the AgNW14-
treated BMM (Figure 7A, Additional file 1: Table S1).
A summary of the relative pixel intensities of all
kinases can be found in the Additional file 1: Table
S1, Figure S3.
Discussion
The aim of this study was to investigate length-
dependent effects of AgNW in the lungs. To assess the
role of fibre length in the initiation of inflammation the
BAL profile was assessed after aspiration exposure. To
assess the effect of length on macrophage clearance and
retention of the long fibre dose we used an in vitro
wound-healing assay. The latter study aimed to shed
light onto the effects of fibre length on clearance of
fibre-laden alveolar macrophages via migration from the
alveolar region of the lung to the mucociliary escalator.
Fibre dimension is a critical factor for lung diseases
after inhalation exposure of various forms of fibrous
materials as demonstrated in a number of experimental
studies, with long fibres being more pathogenic than
short ones [7,8,13,14]. We recently reported a length
threshold of 5 μm for inflammation in the pleural cavity
using the same range of tightly length –defined silver
nanowires used here [9].
Long term inhalation studies in rat have been per-
formed with amosite asbestos preparations of short
(1% > 5 μm), medium (UICC reference fibre) and long
(30% > 5 μm, 11% > 10 μm). These studies showed that
the short fibres and the slightly longer UICC sample
were low in pathogenicity whilst the long fibres induced
extensive fibrosis and pulmonary adenomas. This was in
contrast to the studies performed using direct injection
of the same samples of amosite asbestos into the peri-
toneal cavity which showed that UICC amosite was suffi-
ciently long to cause mesothelioma in rats at the same
frequency as long amosite fibres [8]. This supports find-
ings of the present study, that the length threshold for
fibre effects in the lung is different to the length thresh-
old for fibre effects at the mesothelial surface, the lung
threshold being a higher value. More recent studies on
adverse effects of nanofibres have shown a positive cor-
relation between increasing fibre length and greater lung
and pleural/peritoneal inflammation [4,15,16]. Poland
et al. showed severe lung and peritoneal inflammation
after aspiration exposure and direct intraperitoneal in-
jection in mice of long (24 μm) nickel nanowire but only
very mild diffuse alveolitis and mild peritoneal inflam-
mation after exposure to short (4 μm) nickel nanowires
[4]. Similar results were obtained from studies on short
(<1 μm) and long (>13 μm) carbon nanotubes where the
resultant pathophysiological response was compared to
short and long amosite asbestos fibres [15-17]. These
studies have shown that carbon nanotubes (CNT) in-
duce a length- dependent inflammation in the peritoneal
and pleural space of mice [15-17].
We recently investigated the threshold length for
pleural inflammation and reported that various forms of
high aspect ratio nanomaterials including amosite asbes-
tos fibres, carbon nanotubes, nickel nanowires and the
silver nanowires used here, showed a clear length thresh-
old of 5 μm for initiation of an inflammatory response in
the pleural space after direct intrapleural injection [9].
The data clearly showed that fibres below 5 μm in length
were non-inflammatory and that fibres 5 μm in length
and longer caused extensive recruitment of inflamma-
tory cells [9,18] to the pleural space.
The current study addressed the lack of knowledge
regarding the threshold length for acute pulmonary in-
flammation after deposition in the airspaces of the lungs.
The pulmonary response to AgNW reported here
showed a threshold length for the significant recruit-
ment of inflammatory cells of 14 μm compared to the
5 μm fibre threshold length for pleural inflammation
[9,18]. The use of size categories means that the actual
threshold could lie anywhere between 11- and 14 μm
since the size category below, at which no inflammation
was produced was 10 μm. Our finding of a longer
threshold in the lungs is consistent with previous reports
implicating longer fibres in the development of lung car-
cinoma compared to mesothelioma [8,9]. The different
length thresholds for pulmonary versus pleural inflam-
mation can be explained as a consequence of the differ-
ent mechanisms of fibre clearance from the lung and the
pleural/ space. Clearance of fibres from the pleural space
is via lymphatic drainage to mediastinal lymph nodes
through stomata, pores in the parietal pleura which are
around 0.5–10 μm in diameter [9]. Therefore a size-
restricted clearance occurs in the pleural space leading
to a retention of fibres which cannot negotiate the sto-
mata and subsequent recruitment of inflammatory cells
[15]. The clearance mechanism in the lung relies on al-
veolar macrophage phagocytosis and migration to the
foot of the mucociliary escalator and is discussed in
more detail below.
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While deposition of AgNW14 in the airspaces lead to a
significant increase in inflammatory cells in the
broncho-alveolar lavage fluid (BAL), shorter fibres in-
cluding SFA, AgNW3, AgNW5 and AgNW10 only pro-
duced a mild, non significant, increase in the total
granulocyte number. It was noticeable that the length-
dependent response was not linear and showed a
marked step-increase in the inflammation between 10
and 14 μm. Histological examination of lung sections
showed no recruitment of inflammatory cells after ex-
posure to SFA or AgNW3. Minor aggregations of inflam-
matory cells around terminal bronchioles and in alveolar
airspaces were observed with AgNW5 and AgNW10 but
these were more extensive in the AgNW14 and LFA
samples showing early stages of granuloma development
in the terminal airways/ proximal alveolar region. The
histological response to LFA was strongest showing ex-
tensive aggregates of inflammatory cells. However, the
BAL fluid from LFA-exposed mice, whilst showing an
increase in the mean number of granulocyte that was al-
most 4 times the mean number in the mice exposed to
SFA did not attain significance. Additionally, lavage from
lungs exposed to LFA resulted in a smaller number of
BAL granulocytes than AgNW14 and this contrasted
with the histology data that showed more lung inflam-
mation with LFA than AgNW14. The low PMN in the
lavage from LFA-exposed lungs was possibly due to a
poor return from the inflammation-congested areas of
the lungs. The final scoring of LFA equal to AgNW14 for
BAL granulocytes (Table 2) therefore took into account
both the histological and lavage data to provide the best
assessment of their relative inflammogenicity. The lack
of an inflammatory response with shorter AgNW, which
can be considered to be equivalent to silver particles, is
consistent with experimental studies demonstrating the
minimal lung toxicity or inflammogenicity of nanosilver
in a subacute murine and 28-day rat inhalation model
[19,20]. The role of silver ion release and its impact on
silver nanoparticle toxicity is a controversial topic and
experimental situations where soluble silver has been
shown to play a role is mainly based on extremely high
doses [21]. There is no reason to believe that silver ions
played any role here as discussed extensively in our re-
cent paper using the same panel [9] due to the low tox-
icity of silver nanoparticles and their proclivity to form
silver chloride in biological systems. The study presented
here focuses on short-time response due to the fact that
the AgNW used in this study appear not to be biopersis-
tent beyond a few days [9]. It is highly likely that the
same length dependent effects would be shown by
wholly biopersistent fibres and that the inflammation
would be chronic. However, the determination of the
threshold length for long term chronic inhalation studies
is of utmost importance and biopersistence remains a
key factor in the pathogenicity of long nanofibres.
The clearance efficiency of deposited fibres from the
lower respiratory tract plays a major role in the develop-
ment of pulmonary diseases since the retained dose,
which is the dose accumulated in the alveolar region of
the lungs after clearance mechanism accounts for the
chronic pathogenic effects of inhaled fibres [22].
Fibres deposited in the conducting airways are cleared
rapidly via cilia in the mucociliary escalator and subse-
quently swallowed or expectorated. If fibres reach the re-
spiratory bronchioles, alveolar ducts or alveolar sacs
they are cleared slowly via alveolar macrophages (AM)
phagocytosing the deposited fibres and transporting
them upwards to the ciliated airways for mucociliary
clearance. It has been noted in many studies that there
is selective retention of long biopersistent fibres of vari-
ous sorts from the slow-clearing compartment with
more effective clearance of the shorter fibres [11,23].
The mechanism by which fibre-laden alveolar macro-
phages are drawn to the terminal bronchioles at the foot












Treatment Control + - No - NA
SFA + - No NA NA
LFA +++ ++++ Yes NA NA
AgNW3 + - No - +
AgNW5 ++ + No + +
AgNW10 ++ + No ++ NA
AgNW14 +++ +++ Yes +++ ++
* BAL granulocytes: <0.5 million (+); 0.5-1.0 million (++); 1–2 million (+++).
** Lung histology subjectively scored on the basis of the severity of lung inflammation (see results).
*** Frustrated phagocytosis on the basis of evaluation of cytospins for presence of frustrated phagocytosis.
**** Impaired migration on the basis of degree of significant impairment compared to control (see Figure 6A).
***** Δ kinase phosphorylation based on subjective examination the levels of phosphorylation of the treated compared to the control levels of phosphorylation
(see Figure 7). NA = not applicable.
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of the ciliated airways is obscure. Possible explanations
include the passive transport with alveolar fluid or
amoeboid movement of AM either by random migration
or directed migration along a chemotactic gradient [24].
Other pathways of clearance, usually only important
during high dust exposure or disease are intra- and
transcellular pathways by which fibres can reach lung
interstitium and lymph nodes from where they subse-
quently may reach the blood stream [22,25,26]. A recent
study investigated the effects of MWCNT on cell migra-
tion and adhesion of human dermal fibroblasts and mur-
ine fibroblasts, reporting a significant decrease in cell
adhesion which was confirmed by the decrease of
mRNA levels of important cell adhesion proteins FAK,
fibronectin and laminin [27]. In addition fibroblast mi-
gration in a wound- healing assay was greatly impaired
by MWCNT treatment and was accompanied by cyto-
skeletal derangement [27], although it should be noted
that the dose of MWCNT used in this study was cyto-
toxic to human fibroblast which could influence the ad-
herence and migration properties of the cells.
We set out to investigate whether fibre length has an
effect on the migration behaviour of BMMs in vitro after
fibre exposure using a wound-healing assay, a surrogate
for in vivo clearance of fibrous material to the mucocili-
ary escalator by AM migration. We used a very low dose
to study effects on BMM migration, based on 2.5 μg/cm2
for AgNW14 and all the other length classes were
adjusted to provide the same fibre number. The dose
used had no significant effect on cell metabolism or cell
viability for any of the length classes, ensuring that the
observed effects were not due to simply impaired cell via-
bility. A clear length-dependent trend for inhibition of
BMM cell migration was measured at fibre lengths of 5,
14 and 28 μm and at 28 μm there was more-or less
complete inhibition of motility. Presumably as a conse-
quence of cell surface extension of AM during engulf-
ment of long fibres, increased cell spreading was
observed and correlated with increased inhibition of mi-
gration. The BMMs in this study had an average diam-
eter of 13 μm [28] whilst human alveolar macrophages
have an average diameter of 21 μm [29]. Due to this dif-
ference the threshold length for clearance of fibres by al-
veolar macrophages in humans may be slightly higher.
An initial screening of 46 kinase phosphorylation sites
was performed to get a snapshot of the kinase activation
status of fibre- treated BMMs. We hypothesised that this
might reveal whether there was any fundamental change
in the activation/metabolic state of the cells when they
were impaired in their ability to migrate by phagocytos-
ing long fibres. The 3 μm long exposed cells act as a
control for normal phagocytosis and when compared to
the untreated kinase profile this showed most of the
kinases (~32) remained unchanged. The kinases GSK-3
α/β, Akt 473, β-catenin and PLC-γ showed activation in
all treatment groups suggesting a link to normal phago-
cytosis. Comparing the kinase phosphorylation profile of
BMM exposed to 3 μm with those exposed to 14 μm
should reveal differences associated with the long fibre-
dependent loss of motility and 5 kinases out of 46
(STAT3, p53 (S392), p27 (T198), p27 (T157) and p70
S6 (T389)) exhibited increased phosporylation with
AgNW14 compared to AgNW3. Tyrosine kinases of the
Src family were noticeably induced by treatment with
long fibres. These kinases have been implicated in intra-
cellular signalling in macrophages influencing the ampli-
tude of many pathways [30]. One of the Src downstream
effectors is STAT3, a major modulator of inflammation,
which is required for activation of macrophages [31]. A
marked Induction of STAT3 following the AgNW14
treatment is a likely result of Src activation. It’s worth
mentioning that a constitutive activation of STAT3 is a
common feature in many solid tumours [32], therefore
persisting activation of STAT3 in a chronic inflammation
caused by long fibres may contribute to pro-oncogenic
changes. Macrophage motility is known to be negatively
regulated by p53 [33] and the latter was induced in
BMM treated with longer fibres, and might have con-
tributed to impairment of their migration. The role of
p27 in regulation of cellular migration remains unclear,
however, our finding would support the reports showing
suppression of migration by induction of p27 [34]. No
kinases were down-regulated in the long fibre treated
BMM compared to the controls confirming that there
was no generalised loss of viability associated with fail-
ure to migrate. It is reported in the literature that a
number of different kinase pathways are involved in the
migration and adhesion processes among these are
kinases that showed an increase in their phosphorylation
state after long fibre treatment [35-41]. The results from
the screening of the phosphorylation sites was mainly
performed to see if crucial cellular signalling processes
are impaired by the treatment of AgNW which might
indicate that decreased cellular function, apoptosis/necrosis
underlay the decrease in cell mobility. Our results showed
that the long-fibre treatment did not negatively affect the
cellular function of the BMMs as assessed by metabolic
function, loss of membrane integrity or kinase profile. In
fact long fibre treatment and inhibition of motility were
associated with increased phosphorylation of some kinases
involved in migration and adhesion. Clearly the interplay
between adhesion and motility is complex since focal
adhesion is required for motility and a more sophisti-
cated analysis of mechanism underlying loss of motility
with long fiber treatment is required but is outwith
the scope of the present paper. The results give an in-
dication that cellular processes are intact in long fiber
treated BMM and therefore that inhibition of locomotion
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can be best explained via a mechanical obstruction to
motility. By this we suggest that the presence of long
fibres inside the cells physically interferes with the neces-
sary rearrangement of the cytoskeleton, membrane and
other structures that are necessary for locomotion. This
however has to be confirmed by an in depth investigation
of the molecular mechanism involved in inhibition of
migration which is beyond the scope of the present
manuscript.
Conclusion
In conclusion we have shown that there are length-
dependent effects on the lung and on BMM summarised
in Table 2. These show length-dependent increases in in-
flammation by BAL and severity of lung injury by hist-
ology in vivo and evidence of accompanying impairment
of macrophage migration by BMM in vitro; frustrated
phagocytosis was only evident at the longest fibre
lengths indicating that complete uptake of longer fibres
still causes cell impairment, in the absence of classical
frustrated phagocytosis as we previously reported [9,12].
A threshold length for acute pulmonary inflammation
after pharyngeal aspiration of AgNW was evident be-
tween 10 and 14 μm in length. This compares with our
previous studies on the threshold length for pleural in-
flammation of 5 μm, determined using a panel that uti-
lised the AgNW used here [9]. No previous study has
used tight length- restricted fibre populations to demon-
strate thresholds as shown here and in our previous
study in the pleural space [9]. The present study show-
ing that the threshold length for induction of pulmonary
inflammation is longer than the threshold length for
pleura inflammation is in accordance with extrapolations
using asbestos fibres [8]. The difference in thresholds
can be explained by the differences in clearance mechan-
ism between the lung the pleural space. In the pleural
space clearance is through stomata [6] whilst clearance
of deposited fibres from beyond the ciliated airways is
via uptake by AM and subsequent migration to the
mucociliary escalator. Using an in vitro wound healing
assay we showed that fibre length-dependent macro-
phage mobility, with a threshold for impairment at a
length of 5 μm and increasing impairment with increas-
ing length, until at 28 μm there was almost complete in-
hibition of motility. An explanation for the decrease in
locomotion could be mechanical obstruction caused
simply by the bulky long fibres interfering with the
movement process since there was no loss of viability or
respiration in the long fibre-treated cells and an initial
screen of a number of 46 kinases showed no decrease
kinase phosphorylations. We note however that this is a
small-scale aspiration study with acute inflammation
and short term inhibition of migration in vitro as the
endpoints. Our results need to be confirmed in long
term inhalation studies using a range of different nanofi-
bres at plausible exposure before we can confidently




The panel of particles investigated here consisted of four
silver nanowires (AgNW) samples (Figure 1), a silver
nanoparticle control (AgP) and two amosite asbestos
samples, long amosite asbestos (LFA) and short amosite
asbestos (SFA) as previously described in Schinwald
et al. [9]. AgP was purchased from Nanostructured &
Amorphous Materials, Inc. with a diameter of 35 nm, a
purity of 99,5% and a specific surface area of 30–50 m2/g.
The AgNW samples were kindly provided by Seashell
Technology, San Diego (www.seashelltech.com). The
polyol process was used for the synthesis of the AgNW
which is described in patent number 7,922,787 B2.
Detailed description of particle panel characteristics in-
cluding concentration of soluble metal and dissolution
can be found in Schinwald et al. [9]. AgNW synthesis
and reaction conditions to obtain different lengths did
not affect the chemical composition of the different
nanowires and no coating of the nanowires was per-
formed. The panel was dispersed in isopropanol and
diluted to a working concentration of 1 mg/ml in 0.5%
bovine serum albumin (BSA; Sigma-Aldrich, Poole, UK)/
saline. For light microscope images the AgNW (1 mg/
ml) were were mixed with 10 μl of glycerol (Sigma-
Aldrich, Poole, UK) to reduce the flow of AgNW. The
suspension was placed on glass slide and covered with a
glass coverslip and sealed [15]. Images were captured at
x40 magnification using QCapture Pro software (Media
Cybernetics). As a control panel mixed length amosite
asbestos enriched for long fibres (100% fibres ≥5 μm,
50.3% fibres >15 μm, 35.2% fibres >20 μm), hereafter
referred to as long fibre asbestos (LFA), and shortened
amosite asbestos (SFA; 3.1% fibres ≥5 μm, mean length
1 μm, mean diameter 300 nm) [42] were used.
In vivo
Experimental animals
Nine week old female C57BL/6 strain mice (Harlan, UK)
were used in this study. Mice were kept in a group size
of five in standard caging with sawdust bedding within a
pathogen-free Home Office approved facility. Mice were
maintained on a normal 12 hour light and dark cycle.
Prior to the treatment mice were kept for 7 days in the
facility to acclimatise. The work was carried out by staff
holding a valid UK Home Office personal licence under
a Home Office approved project licence.
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Pharyngeal aspiration and bronchoalveolar lavage
The dose of AgNW panel for pharyngeal aspiration was
equalised to fibre number since fibre exposure is regulated
on the basis of the fibre number and so relative potency
needs to be determined on a per-fibre basis. To equalise
for fibre number a dose of 50 μg/mouse for AgNW14 was
chosen as the standard in vivo dose based on previous
measurement of membrane integrity and proliferation.
Based on 50 μg/mouse for AgNW14, concentrations for
the other length classes AgNW panel were calculated as-
suming that fibres thickness was constant in the different
length classes (Table 1). Particle panel was dispersed in
0.5% bovine serum albumin (BSA; Sigma-Aldrich, Poole,
U.K.)/saline and briefly vortexed to assist dispersion. Ve-
hicle control (VC) consisted of 0.5% BSA/saline.
Mice were anesthetized with isoflurane (2-chloro-2-
(difluoromethoxy)-1,1,1 trifluoroethane) and the tongue
was gently held in full extension while 50 μl of particle
suspension was pipette onto the base of the tongue [43].
The tongue was held extended until at least two breaths
were complete. To stimulate inhalation and to induce a
gasp reflex the nasal cavities of the mice were covered.
Mice were observed until full recovery.
Mice were sacrificed at 24 hour by terminal anaesthe-
sia. 0.5 ml of pentobarbitone (200 mg/ml) (2, 2, 2-Tri-
bromomethanol) was injected in the peritoneal cavity
followed by exsanguinations via the abdominal aorta.
The thoracic cavity was exposed and the trachea cannu-
lated using a 23 gauge needle and legated. The lungs
were lavaged three times with 800 μl of ice-cold sterile
saline. The first lavage was retained separately for LDH
and total protein measurements and the subsequent
lavages were pooled.
Calculation for total fibre number: e.g. AgNW3
Length of NW (average) [μm] =3.00
Diameter of NW [μm] =0.115
Density of NW [μg/ml] =1.05 x 10−7







Weight of NW μg½  ¼ 3:116 10!14  1:05 10!7
¼ 3:272 10!7
Dose [μg] per mouse = 10.70
Number of NW ¼
10:70
3:272 10!7
¼ 32719592:52≅32:71 106 fibers
Lung dissection
For histological examination of lung pathology no for-
going BAL was performed and n = 2 for each treatment
was used. 10% formalin was instilled into the lungs to fix
the lung tissue and removed ‘en block’ with the heart.
The lung and heart were kept for 4 hours in fixative prior
to processing. The heart was removed and the lung was
dissected into individual lobes and placed flat in a tissue
cassette. The tissue was dehydrated through graded alco-
hol (ethanol) and embedded in paraffin. 4 μm sections
were cut from the block covering all lobes of the lung
and stained with H&E to show gross pathology.
Differential cell count/ total protein and lactate
dehydrogenase measurement
The cellular fraction was separated from the supernatant
of lavage fluid from BAL by centrifugation for 5 minutes
at 2000 g at 4°C in a Mistral 3000i centrifuge (Thermo
Fisher Scientific, Inc., MA, USA). Total cell count was
performed using a NucleoCounter (ChemoMetec, 7 A/S,
Allerød, Denmark) and cyto-centrifugation with follow-
ing Diff-Quik staining using Diff-Quik stainset (Dade
Behring Gmbh, Marburg, Germany) were prepared for
differential cell counts.
In the supernatant, membrane integrity using the
Cytotoxicity Detection Lactate Dehydrogenase kit (Roche
25 Diagnostics Ltd., Burgess Hill, UK) and protein con-
tent using the bicinchoninic acid (BCA) protein assay
(Sigma-Aldrich, Poole, UK) were measured following the
manufacturer’s instructions.
In vitro
Generation of bone marrow derived macrophages
Bone marrow-derived macrophages (BMMs) were gener-
ated from 8 week old wild-type C57/Bl6 mouse femurs
and tibias. In brief, the bone marrow was flushed with
PBS using a 24 gauge needle, resuspended, passed
through a cell strainer and centrifuged at 15000 rpm for
3 min. Cells were resuspended in red blood cell lysis
buffer Hybrid Max™ (Sigma- Aldrich, UK) for 5 min at
room temperature. Cells were centrifuged, resuspended
in DMEM (Dulbecco's Modified Eagle Medium, Life
Technologies) containing 10% FCS, 1% penicillin/
streptomycin and 20% L929 cell media and plated in a
10-cm2 non tissue coated dish and cultured for 7 days.
Wound healing assay
After 7 day differentiation BMMs were seeded in 24 well
plates at a density of 0.5x106/ml in DMEM containing
10% FCS, 1% penicillin/ streptomycin and 20% L929 cell
media and culture for 2 days as a confluent monolayer.
The medium was replaced with DMEM containing 0%
FCS and 1% penicillin/ streptomycin. Cells were treated
with AgNW equalised to fibre number. To equalise for
fibre number a dose of 2.5 μg/cm2 for AgNW14 was
chosen as the standard in vitro dose based on previous
measurement of membrane integrity and proliferation.
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Based on 2.5 μg/cm2 for AgNW14, concentrations for
the other length classes AgNW panel were calculated as-
suming that fibres thickness was constant in the differ-
ent length classes (Table 3). For the control particle,
AgP, a dose of 0.5 μg/cm2 was used, equal to the shortest
fibre (AgNW3). The panel was dispersed in 0.5% BSA/
cell culture medium (DMEM, 0% FCS) and added to the
cells. An artificial wound was created by scraping with a
pipette tip and the number of cells migrating into the
wound was monitored microscopically and photographs
were taken immediately and after 30 hour. Images were
acquired through a Zeiss Axiovert S100 microscope
equipped with a 30x objective lens and were captured
using RS Photometrics CoolSnap. The number of cells
migrated into the wound was counted and expressed as
percentage compared to vehicle control. Results are
given as the mean ± SEM of 3 independent experiments.
Backscatter scanning electron microscopy
Backscatter scanning electron microscopy is based on
elastic scattering of high energy electron further inside
the sample. Elements with high atomic numbers (Z)
such as silver give a stronger signal then lower Z ele-
ments. The signal is in general weak and can therefore
only provide a contrast between regions with a larger
difference in atomic number [12].
BMM cells were prepared as described above and
seeded into 24 well plates on ThermanoxR Plastic Cov-
erslips (NUNC™, Rochester, NY USA) at a density of
0.5*106/ml. The cells were treated for 30 hours using
concentration as described above at 37°C in 5% CO2 at-
mosphere. After the treatment they were washed 5x with
0.1 M sodium cacodylate (pH 7.2) buffer. Cells were
fixed overnight in 3% glutaraldehyde/ 0.1 M sodium
cacodylate (pH 7.2) buffer and subsequently washed
three times in sodium cacodylate buffer.
BSE of carbon-coated specimens was carried out using
a Hitachi 4700 II field emission SEM (Hitachi High-
Tech, Maidenhead, UK) at a beam accelerating voltage
of 10 kV and a working distance of about 8 mm. Second-
ary electron (SE) and BSE images were taken simultan-
eously using an annular YAG crystal BSE detector and
the upper SE detector to produce perfectly-synchronised
image pairs. Both images were superimposed using
Adobe Photoshop. The SE and BSE image were con-
verted to grayscale, the BSE image was pasted into the
SE image by using the layer function “lighten”. This
newly merged image and the SE image were converted
to RGB mode, and overlayed by pasting the red channel
of the BSE image into the red channel of the greyscale
SE image, thus colour coding in red the strong BSE sig-
nal from the nanowires, the SE image appearing in grey.
Measurement of membrane integrity and proliferation of
BMMs
Supernatant of the wound healing assay was collected
and analysed for membrane integrity using using the
Cytotoxicity Detection Lactate Dehydrogenase kit (Roche
Diagnostics Ltd., Burgess Hill, UK) following the manu-
facturer’s instructions. TritonX (Sigma) was used as a
positive control for cell death and was added at a final
concentration of 0.1% for 30mins. The supernatant was
centrifuged for 5 mins at 2000 rpm, transferred and cen-
trifuged again for 5 mins at 13000 rpm. The conversion
of lactate to pyruvate was detected using a microplate
reader (BioTekW SynergyHT) to measure the optical
density at 490 nm. Results are given as the mean ± SEM
of 3 independent experiments.
Cells in the culture dish were used to measure their pro-
liferation and metabolic activity via a chemical reduction
of AlamarBlueW (Invitrogen). 150 μl of PBS and 15 μl of
AlamarBlueW was added to each well and incubated for
3 hours at 37°C in 5% CO2 atmosphere. Absorbance was
monitored at 570 nm and 600 nm as a reference wave-
length. Data are normalized to 600 nm value. Results are
given as the mean ± SEM of 3 independent experiments.
Proteome profiler array
BMMs were differentiated as described above and
seeded at 0.5x106/ml in DMEM containing 10% FCS, 1%
penicillin/ streptomycin and 20% L929 cell media and
culture for 2 days as a confluent monolayer in a 60 mm
tissue culture dish. The medium was replaced with
DMEM containing 0% FCS and 1% penicillin/streptomycin
and the particle panel was added at the concentrations
described above and treated for 30 h. The cells were
rinsed with cold phosphate-buffered saline (PBS) and
immediately solubilised in lysis buffer by pippeting up
and down and rocking the cell lysate at 4°C for 30 min.
The lysate was centrifuged at 14,000 x g for 5 min, the
supernatant was transferred into new test tubes and the
protein concentration was measured using the bicincho-
ninic acid (BCA) protein assay (Sigma-Aldrich, Poole,
UK) following the manufacturer’s instructions. 500 μg of
lysates were diluted and incubated with the Human-
Phospho – MAPK Array Kit (Proteome ProfilerTM, R&D
Systems) as per manufacturer’s instructions. Plots were
Table 3 Calculation for the mass adjustments for
equalisation of fibre number in vitro
Length class
[μm]
Calculation to equalise for





3 3/14 × 2.5 0.5 1528953
5 5/14 × 2.5 0.9 1568374
14 standard 2.5 1638164
28 28/14 × 2.5 5 1638164
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developed on X-ray films following exposure to chemi-
luminescent reagents.
Statistical analysis
All data are shown as the mean ± s.e.m. and these were
analysed using one-way analysis of variance (ANOVA).
Multiple comparison were analysed using Tukey-HSD
method and in all cases, values of P < 0.05 were consider
significant. (GraphPad InStat Software Inc., CA, USA).
Additional file
Additional file 1: Figure S1. 24 hour wound healing assay in BMMs.
SEM images showing the closer of the wound after 24 hour at different
treatments with AgNW. Table S1: Phosphoproteomic analysis of BMMs
exposed to AgNW. A phospho- kinase array (R&D) was performed to
screen the phosphorylation state of 46 kinases in BMMs after treatments
with AgNW. Relative pixel density in % compared to VC is shown for all
kinases measured (n=1). Figure S2: Phospho-kinase array immunoplots.
A) VC, B) AgNW3, C)AgNW5, D) AgNW14.
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Figure S1: 24 hour wound healing assay in BMMs. SEM images showing the closer of the wound after 












Table S1: Phosphoproteomic analysis of BMMs exposed to AgNW. A phospho- kinase array (R&D) 
was performed to screen the phosphorylation state of 46 kinases in BMMs after treatments with 
AgNW. Relative pixel density in % compared to VC is shown for all kinases measured (n=1).  
 VC AgNW3 AgNW5 AgNW14 
p38 a 100 74.85336 159.0873 121.9645 
ERK 1/2 100 93.41407 86.15658 74.33238 
JNK pan 100 107.5308 82.98289 86.15175 
GSK -3 a/b 100 288.9975 256.3521 327.8246 
MEK1/2 100 115.8622 97.57284 129.8732 
MSK 1/2 100 77.76693 96.80675 79.47691 
Akt  473 100 221.5099 137.8032 261.4832 
mTOR 100 94.12129 92.45151 138.5429 
CREB 100 52.63563 29.98924 78.0085 
HPS27 100 128.6365 131.5996 141.1714 
AMPK a2 100 175.9596 105.3152 140.0264 
β-Catenin 100 306.2233 249.1231 293.5133 
Chk-2 100 54.88571 97.62734 103.0031 
Src 100 86.62845 87.61551 178.408 
Lyn 100 52.63225 45.04333 67.13648 
Lck 100 43.72153 32.89619 171.7983 
Fyn 100 51.26141 57.08296 104.4002 
Yes 100 50.55822 72.43423 108.4889 
Frg 100 69.26241 111.4022 132.6036 
Hck 100 100.0667 132.3898 162.4953 
FAK 100 96.46324 132.2894 126.2003 
STAT2 100 126.9072 97.20593 120.5616 
STAT3 100 109.6658 101.5223 247.599 
STAT 5a 100 115.5917 122.0649 135.4271 
STAT5 b 100 93.40943 90.0274 117.703 
STAT5 A/B 100 121.4369 116.3074 154.2314 
STAT7 100 110.9859 93.45342 112.7044 
 p53  S392 100 83.20326 356.6267 198.7431 
p53  S 46 100 105.0083 189.0473 147.1997 
p53   S15 100 38.12322 190.13 152.7404 
Akt 308 100 131.3407 172.3985 161.1092 
p70 S6 T421/S424 100 134.2128 104.9497 134.3285 
p70S6   T229 100 93.99121 142.352 136.8473 
cJun 100 107.2125 141.3437 160.8311 
PLC-γ1 100 263.5613 266.5383 363.6785 
Pyk -2 100 126.6551 115.0751 152.8664 
 p27  T198 100 0.000239 459.7914 326.2103 
p27  T157 100 107.9484 480.6506 363.2138 
paxillin 100 159.0782 250.3517 152.2328 
RSK1/2/3 100 87.01548 99.49556 89.35632 
RSK1/2 S221 S227 100 78.24321 111.3611 104.9323 
STAT1 100 123.3307 100.8336 170.8514 
STAT4 100 85.94709 101.5377 160.658 
eNOS  S1177 100 156.1881 173.3605 94.30464 
p70 S6 kinase T389 100 100 74681710 3.26E+08 
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Two-dimensional graphitic carbon, graphene is a new form of nanomaterial with great potential in a wide 
variety of applications.  It is therefore crucial to investigate the behavior of graphene in biological 
systems to assess potential adverse effects that might follow from inhalation exposure. In this study we 
focused on medium term effects of graphene in lung tissue by investigating the pulmonary inflammation 
6 weeks after pharyngeal aspiration of unoxidised multi-layered graphene platelets (GP) in mice and 
assessed their biopersistence in the lung tissue using Raman spectroscopy. Additionally, GP degradation 
in vitro was examined after horseradish peroxidase (HRP) treatment up to 1 week. Building on our 
previous report showing acute inflammation in mice lungs at 1 day, pristine GP showed minimal 
inflammation  in mouse lungs after  6 weeks even though no degradation of GP in lung tissue was 
observed and large deposits of GP were evident in the lungs. Raman analysis of GP in tissue sections 
showed minimal oxidation and in vitro examinations of enzymatic oxidation of GP via HRP and H2O2 
showed only slight increases in ID/IG ratio and the appearance of the Raman D’-band at 1620 cm
-1
 
(surrogates of graphene oxidation). Our results showing non-inflammogenicity at medium timepoints 
have important implications in the hazard identification of GPs following inhalation exposure and for 
their use in biomedical applications. Additionally, the biopersistence of pristine GP in vivo with no 










Graphene is a two dimensional honeycomb lattice of carbon atoms which has been hailed as ‘a rapidly 
rising star’ and ‘the mother of all graphitic forms’(Geim and Novoselov 2007). The physicochemical 
properties of graphene including its high elasticity, flexibility and adaptability make it a promising tool 
for a range of biomedical applications including drug delivery and tissue engineering as structural 
reinforcement of films, hydrogels and other scaffold materials (Sanchez et al. 2011).  As tissue 
engineering material it is important to assess the extent to which graphene is stable in vivo and for safe 
handling and medical application of graphene it is crucial to assess its toxicological profile. Graphene is 
defined as a nanomaterial, and can be further classified as a high aspect ratio nanomaterial due to its 
width-to-diameter ratio which is higher than 10:1 (Hankin and Poland 2012). Recent in vivo studies on the 
toxicity of graphene and its derivatives, including graphene oxide (GO) have shown that pristine graphene 
nanoplatelets with a diameter of ≥5 µm lead to acute inflammation in the lung after aspiration exposure in 
mice due to its extended lateral dimensions (Schinwald et al. 2012a). In contrast, in the nanometer size 
range, pristine graphene produced minimal lung inflammation whilst GO caused severe and persistent 
lung injury (Duch et al. 2011). The resistance of carbon nanomaterials to biological degradation is a 
major concern for their potential in vivo toxicity but recent investigations have shown that carbon 
nanomaterials, including graphene oxide and oxidized carbon nanotubes, are degraded by oxidase 
enzymes including horseradish peroxidase and neutrophil myeloperoxidase (hMPO) in vitro and in vivo 
(Kagan et al. 2010; Kotchey et al. 2011; Shvedova et al. 2012) causing them to exhibit less inflammatory 
potential. Functional groups and structural defects introduced during oxidative processes have been 
shown to play a major role in acute lung toxicity and reduction of oxygenated carbon functionalities and 
annealing of defects have been shown to minimize the inflammatory potential (Duch et al. 2011; Fenoglio 
et al. 2008). 
Our study aimed to investigate the medium term pulmonary effects of pristine GP after aspiration 
exposure in relation to in vivo oxidation and degradation of pristine GP in lung tissue. The correlation 
between the biological effect study and the investigation of the material oxidation in vivo is based on the 
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link between the decrease in biological effect with increased degradation of material due to oxidation. To 
aid in the interpretation of in vivo data, additional in vitro enzymatic degradation of pristine GP via 
horseradish peroxidase and chemical oxidation were also performed. The GP used in this study possess a 
high lateral dimension (≥5 µm) and are therefore classified under the term high aspect ratio nanomaterials 
(HARN). In a previous study we showed that the GP used in the present study were inflammogenic 
following short term in vivo exposure, due to their extended lateral dimension (Schinwald et al. 2012a). 
Furthermore, the translocation of deposited long asbestos fibres from the lung to the pleural space is a 
prerequisite for the development of fibre-related pleural diseases and there has been concern that HARN, 
including CNT and various forms of nanofibres, could have the potential to show asbestos-like 
pathogenicity in the pleural space due to their extended lateral dimensions (Murphy et al. 2011; 
Schinwald et al. 2012b)  in addition to adverse health effects in the lung. It has been proven that CNT can 
translocate to the pleural space after aspiration exposure and subsequently induce a pleural inflammatory 
response (Murphy et al. 2012) however so far we do not know whether extended micrometer sized 
platelet shaped particles would be able to translocate to the pleural space after inhalation exposure. 
Therefore, the second aim of our study was to examine the translocation of GP to the pleural space up to 6 
weeks post aspiration exposure in order to identify whether GP pose a similar risk as fibrous materials in 
inducing pleural diseases after inhalation exposure.  
 
Materials and Methods 
Characterization of Graphene PlateletsThe particles investigated in this study consisted of few-layered 
graphene platelets (GP) and nanoparticulate carbon black (CB) as previously described in Schinwald et al. 
(Schinwald et al. 2012a) (Table 1). CB (Printex 90) was purchased from Evonik Degussa GmbH, 
Germany and used as an amorphous carbon particle control with known toxicological profile. GP were 
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produced via chemical exfoliation and purchased from Cheaptubes.com. The size distribution of the GP 
ranged from 5 µm (57.4%) to 30 µm (0.3%) projected area diameter in vehicle solution with an 
aerodynamic diameter of 1.33 to 3.26 µm, respectively (Schinwald et al. 2012a). The aerodynamic 
diameter is based on a theoretic calculation of GP suspended in vehicle control using a projected area 
diameter. GP consisted of up to 10 sheets of graphene, and are therefore classified as few-layered GP. The 
thickness of the GP aggregates was measured by atomic force microscopy (AFM) and visulised by 
scanning electron microscopy (SEM) (details see below). Trace metal and endotoxin levels were 
previously tested and reported in (Schinwald et al. 2012a). CB and GP stock solution was prepared at 1 
mg/mL in 0.5% BSA/saline for in vivo work and dispersed by sonication in an ultrasonicating water bath 
at 230 V, 50 Hz, 350W (FB11002, Fisherbrand, Thermo Fisher Scientific, Inc., MA, USA) for 6 h to 
break up aggregates.  Detailed characterization can be found in Schinwald et al. (Schinwald et al. 2012a). 
 
Scanning electron microscopy of CB and GP  
GP were dispersed in 0.5% BSA (heat-shocked fractionate) (Sigma-Aldrich, Poole, UK)/saline at a 
concentration 50 µg/ml by ultrsonication. The suspension was filtered onto an Isopore™ membrane filter 
(Millipore), dried and gold sputter coated. Scanning electron microscopy was carried out using a Hitachi 
S-2600N digital scanning electron microscope (Oxford Instruments, Oxfordshire, UK). 
 
 
Light microscopy of  GP  
For light microscopy images a concentration of 100 µg/ml was used to demonstrate the dispersion of the 
materials. 10 µl of GP solution were mixed with 10 µl of glycerol (Sigma-Aldrich, Poole, UK) to reduce 
the motion of GP. The suspension was placed on glass slide and covered with a glass coverslip and 
sealed. Images were captured at x100 magnification using QCapture Pro software (Media Cybernetics).  
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Atomic force microscopy (AFM) for thickness measurement of GP 
GP samples were prepared at a concentration of 0.1 mg/ml (diluted) and 1mg/ml (concentrated) in 0.5 % 
BSA/saline solution and sonicated for 6 hours before use. Freshly cleaved mica (atomically flat) was used 
as a substrate. A thin film was formed on the substrate using spin coating at 4000 rpm, for 90 sec. Atomic 
force microscopy was carried out on a Bruker Multimode/ Nanoscope IIIa AFM (Bruker AXS, Santa 
Barbara, CA).The scanners used were a J-scanner (x-y scan range ca. 140 microns) and an E-scanner (x-y 
scan range ca. 14 microns). RTESP Bruker cantilevers were used in these measurements with nominal 
spring constant of 40 N/m, resonance frequency of 300 kHz and nominal tip radius of 8 nm, as specified 
by the manufacturer. The measurements were performed under tapping mode in air at room temperature. 
Acquired images were post-processed by simple flattening and analyzed using the software Scanning 




Nine week old female C57BL/6 strain mice (Harlan, UK) were used in this study. Mice were kept in a 
group size of five in standard caging with sawdust bedding within a pathogen-free Home Office approved 
facility. Mice were maintained on a normal 12 hour light and dark cycle. Prior to the treatment mice were 
kept for 7 days in the facility to acclimatise. The work was carried out by staff holding a valid UK Home 
Office personal licence under a Home Office approved project licence. 
 
Pharyngeal aspiration, pleural and broncho-alveolar lavage 
The given particle dose for pharyngeal aspiration was 50 µg per mouse of CB and GP in 0.5% BSA/ 
saline. The dose of 50 µg was selected to allow direct comparison to a previous study investigating the 
medium term effects of CNT aspiration. Vehicle control was 0.5% BSA/saline. Mice were anesthetized 
with isoflurane and the tongue was gently held in full extension while 50 µl of particle suspension was 
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pipette onto the base of the tongue (Rao et al. 2003) The tongue was held extended until at least two 
breaths were complete. To stimulate inhalation and to induce a gasp reflex the nasal cavities of the mice 
were covered. Mice were observed until full recovery.  
Mice were sacrificed 24 hour (n=4), 1 week (n=4) and 6 weeks (n=7) post exposure by terminal 
anaesthesia by injection of a single dose of 0.5 ml of pentobarbitone (200 mg/ml) into the peritoneal 
cavity followed by exsanguinations via the abdominal aorta. The pleural space was lavaged with three 1 
ml washes of sterile saline and kept on ice. After the pleural cavity was lavaged the thoracic cavity was 
exposed and the trachea cannulated using a 23 gauge needle and legated. The lungs were lavaged three 
times with 800 µl of ice-cold sterile saline. The first lavage was retained separately and the subsequent 
lavages were pooled.   
 
Differential cell count/ total protein and lactate dehydrogenase measurement 
To separate the cellular fraction from the supernatant the lavage fluid from BAL and pleural lavage was 
centrifuged for 5 minutes at 2000 g at 4°C in a Mistral 3000i centrifuge (Thermo Fisher Scientific, Inc., 
MA, USA). Total cell count was performed using a NucleoCounter (ChemoMetec, 7 A/S, Allerød, 
Denmark) and cyto-centrifugation with following Diff-Quik staining using Diff-Quik stainset (Dade 
Behring Gmbh, Marburg, Germany) were prepared for differential cell counts. In the supernatant, 
membrane integrity using the Cytotoxicity Detection Lactate Dehydrogenase kit (Roche Diagnostics Ltd., 
Burgess Hill, UK) and protein content using the bicinchoninic acid (BCA) protein assay (Sigma-Aldrich, 
Poole, UK) were measured following  the manufacturer’s instructions. 
 
Dissection of lung, diaphragm and chestwall 
For histological examination the lungs and heart were removed on-block and fixed by installation of 10% 
ice-cold formalin without foregoing lavage and submerged in fixative for a period of 4 hours prior to 
processing. The heart was removed and the lung separated into individual lobes and transferred to 70% 
ethanol for 24 hour. The tissue was embedded in paraffin, sectioned and stained with H&E to show gross 
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pathology and Pico-Sirius Red (PSR) to show collagen deposition. Images at 20x magnification were 
taken to show higher maginification areas of the lung sections. 
The diaphragm and the lower right posterior portion of the chest wall, approximately an area of 1cm x 0.5 
cm along the spine was cut out from the mice after lavage, washed in ice-cold saline and fixed for 4 hours 
in 30% formalin.  The tissue was excised from the surrounding tissue and either embedded in paraffin, 
sectioned and stained with Haematoxylin & Eosin (H&E) for gross pathology or prepared for scanning 
electron microscopy (SEM). 
 
Lung tissue for Raman Spectroscopy 
Raman spectroscopy on lung tissue embedded in paraffin was used to measure oxidation of pristine GP in 
vivo. In addition to the lung samples collected in this study we used lung samples from a previous study 
to compare the oxidation state of GP in lung tissue after 24 hour, 1 week and 6 weeks aspiration exposure 
(Schinwald et al. 2012a). The procedure of the 24 hour and 1 week aspiration exposure was identical to 
the procedure used in this study; therefore direct comparison of the results can be performed.  
 
Incubation of GP with Horseradish peroxidase and H2O2 
The following protocol for HRP oxidation of GP was adapted from Kotchey et al.(Kotchey et al. 2011). 
Two milliliter of 0.125 wt% GP were dispersed in double distilled water and dispersed by sonication in an 
ultrasonicating water bath at 230 V, 50 Hz, 350W (FB11002, Fisherbrand, Thermo Fisher Scientific, Inc., 
MA, USA) for 2 h to break up aggregates. Lyophilized HRP type VI was solubilized in 1x phosphate 
buffered saline (PBS) (PAA, Austria) at 0.390 mg/ml and 4 ml were added to the GP dispersion and 3.5 
ml of PBS for a total volume of 9.5 ml. H2O2 (Sigma Aldrich, Poole, UK) was added to give a final 
concentration of 40 µM. For the 24 hour incubation time H2O2 was added every hour for 12 hours, for 1 
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week incubation time H2O2 was added daily. Controls included GP incubation with HRP (- H2O2) (control 
I) and GP incubation with H2O2 (-HRP) (control II).  
Plasma oxidation of GP was performed in a SPI Plasma Prep III plasma etcher, at 60W, for times between 
5 mins and 60 mins (as indicated).  
 
Raman Spectroscopy 
Samples for in vitro oxidation of GP via HRP and H2O2 were prepared by adding 10 µl of GP at day 0, 1 
and 7 on a quartz microscope slide and drying. For ex-vivo measurement lung tissue embedded in paraffin 
was used to record GP oxidation. Areas of GP deposited in lung tissue were identified by visual 
inspection. All spectra were collected on a Renishaw inVia Raman microscope using an excitation 
wavelength of 514 nm. Samples were scanned from 1000 to 2000 cm
-1
 to visualize D and G bands. 
Spectra were collected with a 120 s exposure; for ex-vivo measurements and pristine GP at 0h a total of 
20 locations were selected per sample. For in vitro oxidation via HRP and plasma oxidation a total of 6 
locations were selected per sample.  
 
Statistical analysis 
Graphs are shown as the mean ± s.e.m and these were analysed using one-way analysis of variance 
(ANOVA). P-values greater than 0.05 were not considered significant based on one- way ANOVA 
variation among column means and no post tests were calculated. Multiple comparisons were analysed 
using Tukey-HSD method (GraphPad InStat Software Inc., 629 CA, USA). Raman spectra are shown as 






Characterization of GP 
Characteristics and specifications of GP are summarised in Table 1 (more information can be found in 
(Schinwald et al. 2012a). Morphology of multilayered GP was examined using scanning electron 
microscopy (SEM) (Table 1) and dispersion of the GP was examined using light microscopy (Supporting 
Information Figure S1). Thickness of GP aggregates was measured using atomic force microscopy and 
showed an average thickness of  approximately 175±60 nm (further details see supporting information 
Figure S2 and S3) whereby variations in the height are due to inhomogeneity of the orientation of the GP 
on the surface. 
Pathological response at a 6 week timepoint after single aspiration exposure in mice 
To determine whether multilayered graphene platelets (GP) caused inflammation to a greater extent than 
graphene in nanoparticulate form (disjointed sheets)   (Carbon Black, CB), the inflammatory response 
after aspiration exposure to CB or GP were measured 6 weeks post-exposure. The lungs were lavaged and 
the cell types present quantified. The total cell number, consisting mainly of alveolar macrophages with a 
small proportion of granulocytes (neutrophils, basophils and eosinophils) as well as granulocytes on their 
own was measured in the broncho-alveolar lavage (BAL) fluid (Figure 1A). Exposure to GP or CB 
caused no significant increase in the total cell number (p= 0.2660,; one-way ANOVA) however, the total 
granulocyte number was significantly increased when compared to vehicle control (Figure 1A and Table 
S2).  However, this statistical significance, does however not represent a biologically significant increase 
since the percentage of granulocytes in the BAL fluid only increased from 1 %  in the VC treated mice to 
3.7 % in the GP treated mice. Comparison between the extent of inflammation at 24 hour, 1 week and 6 
weeks time points as previously published in Schinwald et al. (Schinwald et al. 2012a) is shown in the 
supplement (Supplementary Figure S4). This figure demonstrates the decrease of inflammation measured 
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as total granulocytes in the lung lavage fluid after GP aspiration. Histopathological changes in the lung 
sections 6 weeks post aspiration were examined in lung sections stained with haematoxylin/Eosin (H&E) 
and compared to VC. No granuloma formations, infiltration of inflammatory cells or epithelial 
hyperplasia was observed in lung section of GP exposed mice (Figure 1B) which is indicative of a lack of 
inflammogenicity. Assaying for lung fibrosis indicated by collagen deposition was determined using 
Picrosirius Red staining but no increase in collagen deposition was observed in association with (Figure 
1C) substantial accumulations of GP in the alveolar airspaces (see  black arrow Figure 1 B,C). In addition 
to CB, the results were compared to the inflammatory response of carbon  nanotubes (CNT; graphene in 
the form of layered tubes)  with a mean length of 36 µm, as previously reported in Murphy et al. (Murphy 
et al. 2012). Experimental procedure and dose of the CNT study was identical to the procedures used here 
and characterization of the CNT sample can be found in the supplement (Table S1) and Murphy et al. 
(Murphy et al. 2012). Mice aspirated with CNTs showed substantial inflammation at 24 hour and 1 week 
and a decrease in inflammation at 6 weeks which was comparable to the VC (Supplement Figure S4) as 
reported in Murphy et al. (Murphy et al. 2012).  In histological sections, mice treated with CNTs showed 
strong interstitial thickening and remodeling of the alveolar spaces, collagen deposition and lymphocyte 
infiltrates at a 6 week timepoint as reported in Murphy et al. (Murphy et al. 2012) (Supplement Figure 
S5).  
 
Pleural response to pulmonary exposure 
To identify whether GP translocate to the pleura following pulmonary exposure, the tissue and alveolar 
macrophages lying immediately beneath the visceral pleura were examined in histological sections. No 
accumulations of GP were seen subjacent to the visceral pleura (data not shown). Additionally the pleural 
space was lavaged and the extent of inflammation measured at the timepoints 24 hour, 1 week and 6 
weeks. At all timepoints no significant influx of inflammatory cells was measured compared to vehicle 
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controls (Supplement Figure S6A). This was verified by failure to detect aggregations of inflammatory 
cells or granuloma formation by scanning electron microscopy (SEM) examination of the mesothelial 
surface of the parietal pleura (Supplementary Figure S6B-C). The translocation of GP was compared to 
CNT at the 6 week timepoint as shown in the supplement figure S6A, B. Aspiration of CNT led to 
translocation to the pleural space at the 6 week timepoint as measured by increase in the total cell number 
and total granulocyte number and accumulation of inflammatory cells on the mesothelial surface of the 
parietal pleura as reported in Murphy et al. (Murphy et al. 2012) (Supplement Figure S6F).  
 
Oxidation of GP in the lung tissue 
Degradation of GP via enzymatic oxidation in lung tissue was assessed using Raman microspectroscopy. 
Section of lungs embedded in paraffin blocks from mice exposed to GP for 24 hour, 1 week and 6 week 
via pharyngeal aspiration were used.  Characteristic graphene Raman spectra were recorded from GP 
within the sections enabling us to directly probe for oxidized graphitic material; data are presented as 
average spectra from 20 locations (Figure 2A and Supplement Figure S7). Oxidation is known to increase 
the ratio of the D (1360 cm
-1
) band, which indicates disorder in sp
2
-hybridized carbon systems to the G 
band (1580 cm
-1
). Graphene spectra recorded in lung sections showed no significant difference between 
ID/IG at the different timepoints, indicating that no systematic oxidation had taken place over the period of 





 characteristic of paraffin wax spectra at 20°C due to the CH2 twisting band and overtones of 
the CH2 bending, respectively (Zheng and Du 2006). Background spectra from the paraffin block did not 
interfere with the specific Raman spectra for GP.   
Enzymatic oxidation of GP via Horseradish peroxidase 
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To determine the capability of peroxidases to oxidize GP, in vitro oxidation of GP was studied using the 
enzyme horseradish peroxidase (HRP). The active site of HRP, Fe(III) porphyrin IX  has been reported to 
be analogous to leukocytic peroxidase in the oxidation of graphenic carbon (Kotchey et al. 2012).  The 
suspensions with GP, HRP and H2O2 were left for 24 hour (H2O2 added every hour for 12 h) and 1 week 
(H2O2 added every day) at room temperature  and Raman spectra were recorded to measure the change in 
the extent of oxidation of GP via the ratio ID/IG as well as a disorder induced Raman D’-band at 1620 cm
-
1
, indicating imperfect crystalline order (Malard et al. 2009). Control samples included GP without HRP 
and GP without H2O2. Between 0 hours and 24 hours the D:G ratio showed a modest increase from 0.12:1 
to 0.22:1, however the disorder induced D’-band was recorded in three out of six spectra for HRP+ H2O2 
treated samples and was not observed in untreated pristine samples. The spectra recorded after 1 week 
incubation with HRP were similar to the spectra recorded after 24 hour with the exception of one 
spectrum, which showed an substantial increase in D:G ratio to 0.76:1 indicating extensive oxidation of 
GP (Figure 2 B). Raman spectra from control samples were similar to those from pristine GP (data not 
shown). All averaged spectra with standard deviation are shown in the supplement (Supplement Figure 
S8). 
Chemical oxidation of GP via plasma ashing 
To compare the spectroscopic data of enzymatic oxidation of GP to that of a chemical oxidation, O2 
plasma oxidation of the GP was performed. Raman spectra of chemical oxidized GP were recorded after 
5, 10, 15, 40 and 60 min of plasma oxidation. An increase in the ratio of D:G band (0.12:1 (0 min), 0:22:1 
(5 min), 0.24:1 (10 min), 0.27:1 (15 min), 0.19:1 (40 min) and 0:25:1 (60 min)) and a disorder induced 
Raman D’-band at 1620 cm
-1
 appeared indicating imperfect crystalline order and  increase in the degree 
of oxidation of the GP (Figure 2C) (Malard et al. 2009). All averaged spectra with standard deviation 




The aim of this study was to investigate the medium term pulmonary inflammogenicity of pristine GP in 
relation to its biopersistence in vivo; parallel in vitro studies using intense enzymatic oxidation were also 
carried out. Additionally the evidence for translocation of GP from the distal regions of the lung to the 
pleural space with subsequent pleural inflammation was investigated. The latter study aimed to shed light 
onto whether GP might have the potential to cause asbestos like effects in the pleural space after 
inhalation exposure. We hypothesized that GP used in this study would lead to an extended inflammatory 
response similar to that seen with CNT due to their extended lateral dimensions which caused frustrated 
phagocytosis at earlier timepoints and possible diminished clearance from the lung (Schinwald et al. 
2012a). 
 The findings on the medium term inflammatory effects of pristine GP in the lung of mice after aspiration 
exposure showed minimal inflammation, or granulomatous aggregations of inflammatory cells in the 
bronchial and alveolar regions, and no alveolar wall thickening or fibrosis.  This contrasts with carbon 
nanotubes, which did show all of these types of effect at these timepoints in mice at the same mass dose 
(Murphy et al. 2012). Even though little is known so far of the pulmonary toxicity of GP, it has been 
shown that the in vivo toxicity of graphene- based materials is closely associated with their surface 
characteristics as summarized in Yang et al.(Yang et al. 2012). Duch et al. showed that graphene oxide 
and aggregated pristine GP caused sustained pulmonary inflammation in vivo compared to well-dispersed 
pristine GP.(Duch et al. 2011).   The lack of pulmonary inflammogenicity after exposure to GP in 
medium term studies is in contrast to recent studies on pulmonary effects of CNT, which reported that 
CNT have the potential to cause severe lung fibrosis and persistent inflammation after aspiration exposure 
at a 6 week timepoint (Mercer et al. 2011; Murphy et al. 2012; Shvedova et al. 2005; Wang et al. 2011). 
Both CNT and GP are composed of graphene yet show very different effects in the lungs and so further 
study is warranted to elucidate the underlying mechanisms for differences in the inflammatory response to 
CNT and GP. Furthermore it has been shown that fiber-shaped CNT can translocate to the pleural space 
after aspiration exposure leading to persistent inflammation and granuloma formation at the surface of the 
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parietal pleura, similar to that seen after asbestos fibre treatment (Mercer et al. 2010; Murphy et al. 2012). 
GP used in this study did not accumulate in the sub- visceral pleural tissue up to 6 weeks after aspiration 
exposure and no inflammatory response was measured in the pleural space up to 6 weeks post exposure. 
The absence of inflammation in the pleural space does not necessarily exclude the possibility of 
translocation of very small GP that are able to negotiate the parietal pleural stomata from reaching the 
pleural space but being cleared (Donaldson et al. 2010). It might be argued that while GP had not reached 
the pleural space by 6 weeks they would get there eventually. However translocation of CNT from the 
airspaces of mice to the pleural space has been seen at 28 days (Mercer et al. 2010) and 6 weeks (Murphy 
et al. 2012) and so we see no reason to conclude that GP translocation might only begin after 6 weeks.  
The difference in translocation behavior of CNT and GP could be explained by their differing 
morphology, whereby the fibrous structure of CNT could facilitate translocation as needles are more 
likely to penetrate cell layers (Mercer et al. 2010). In the case of GP, the platelet shape with its extended 
lateral dimension and no sharp, penetrating tip could limit translocation.  However, one limitation of this 
study is the use of a single sample of GP with a wide distribution of lateral diameter up to 25 µm. We 
cannot exclude that other forms of GP with one dimensions near the threshold fibre length for retention in 
the pleura -5 µm-(Schinwald et al. 2012b)  might be more likely to translocate and be retained in the 
pleural space. 
Biopersistence is a major contributing factor to the toxicity of carbon- based materials and is dependent 
on the surface functionalisation of these materials (Liu et al. 2010; Osmond-McLeod et al. 2011). Recent 
studies on the degradation of oxidized carbon nanomaterials by Kagan and coworkers have shown that 
enzymatic oxidation in vivo and in vitro leads to the disruption of the carbon structure in highly oxidized 
graphene as well as highly oxidized SWCNT and MWCNT (Allen et al. 2008; Kagan et al. 2010; 
Kotchey et al. 2011). In these studies of enzymatic degradation, the carbon nanomaterials were subjected 
to chemical oxidation prior to the enzymatic treatment in order to facilitate peroxidase mediated 
degradation via the interaction of positively charged residues of hMPO with the carboxyl surface of the 
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nanotubes. Based on these studies our aim was to examine the degree of oxidation of non-oxidised 
pristine GP in vivo up to 6 weeks in lung tissue as well as in vitro using horseradish peroxidase which acts 
as a surrogate for leukocyte peroxidase as previously decribed (Kotchey et al. 2011). Raman 
spectroscopic evaluation of oxidative defects in pristine GP present in lung sections in vivo revealed that 
GP did not undergo oxidative change. This is in line with results published on the biopersistence of 
pristine CNT and reduced graphene oxide, showing less effective biodegradation by peroxidase compared 
to oxididized CNT (Kagan et al. 2010; Kotchey et al. 2011). A possible explanation between the 
degradation of pristine and oxidized carbonaceous nanomaterials has been stated by Kotchey et al. as 
being a lack of binding sites for enzymes on the surface of pristine CNT and GP compared to oxidized 
surfaces with its covalently attached oxygen functional groups (epoxides, negative charged carboxyl 
groups) facilitating strong interaction with enzymes (Kagan et al. 2010; Kotchey et al. 2011). A recent 
study has shown that MPO- deficient mice show increased pulmonary inflammation and impaired 
clearance after pharyngeal aspiration of oxidized SWCNT due to impaired degradation compared to wild 
type mice (Shvedova et al. 2012). However the importance of MPO in nanomaterial degradation is 
questionable since neutrophils play only a minor role in phagocytosis and clearance of deposited 
nanomaterials in the lungs, the bulk of particle clearance being mediated through alveolar macrophages 
(Lehnert and Morrow 1985). The persistence of large accumulations of GP was very obvious at 6 weeks 
with no neutrophils in the lavage fluid. Therefore, a role for MPO in the dissolution, breakage and 
clearance of these particles seems most unlikely.  Studies on the peroxidase activity of alveolar 
macrophage in rats during pulmonary inflammation have shown that alveolar macrophages acquire 
peroxidase activity from multiple sources during pulmonary inflammation but only 0.8% of all 
macrophages were positive for cytoplasmic peroxidase in normal rats (Shellito et al. 1987). Therefore 
future studies to clarify the impact of alveolar macrophages, if any, on biodegradation of graphenic 
nanomaterials are a priority.  
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In parallel with the studies on degradation of pristine GP in vivo we examined the potential enzymatic 
oxidation of GP in vitro using HRP and H2O2, as a surrogate for MPO as described in Kotchey et al. 
(Kotchey et al. 2011). No significant increase in ID/IG ratio was observed but another band, the D’ band, 
located at 1620 cm
-1
 appeared, which is documented in literature to be linked to substantial defects in the 
graphene structure (Kudin et al. 2008; Malard et al. 2009). Additionally, the recording of one spectrum 
showing a substantial increase in the ID/IG ratio after 1 week HRP treatment leads to the conclusion that 
the oxidation process may be intrinsically non-linear and that this introduces a large variability to the 
process. Minimal oxidation was seen in pristine GP treated  in vitro with the peroxidase, but the extent of 
degradation was not comparable to complete dissolution of the graphene structure of oxidized GP after 20 
days HRP H2O2 treatment reported  in Kotchey et al. (Kotchey et al. 2011). Therefore, the timeframe for 
oxidation of pristine graphene appears to be much longer than for oxidized graphene. This  is in line with 
the lack of oxidation we describe up to 6 weeks post exposure in vivo and the self-evident persistence of 
GP in lungs evident as large accumulations of particles in the histological section. However, from our 
study we cannot exclude the possibility that a fraction of GP were being oxidized, comminuted and then 
cleared from the lungs and therefore not detected in our study. Future studies have to be performed to 
investigate which fraction of GP are deposited in the lung or translocate to extra-pulmonary tissue. We 
showed that the absence of a biological effect of GP after a 6 weeks timepoint was not correlated with a 




The findings of our study show that pristine GP has reduced inflammogenicity in a 6 week study 
compared to 24 hour and 1 week studies and is non-fibrotic. This has important implications for potential 
biomedical and technological applications of GP. Oxidative degradation of GP in vivo does not account 
for the lack of inflammation since no change in the ID/IG ratio in the Raman spectrum occurred, indicating 
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no oxidation of pristine GP up to 6 weeks in lung tissue and in addition large accumulations were plainly 
seen in lung sections. In vitro oxidation of GP via HRP showed only minimal oxidation of GP indicating 
that pristine graphenic nanomaterials are more biopersistent and may behave differently in vivo to their 
oxidized counterpart. This study suggests that further research is warranted into biodegradation of pristine 
and oxidised carbonaceous nanomaterials via enzymatic oxidation, in particular by alveolar macrophages.      
 
Supporting Information. Light microscopy images of GP. AFM analysis of GP aggregates. CNT 
characterization. Data on lung inflammation of CB, GP and CNT (24 hour, 1 week, 6 weeks), pleural 
translocation and SEM images of chestwall samples; Averaged raman spectra with standard deviation 
from GP in lung tissue, from in vitro HRP+ H2O2 treatment and chemical oxidation.  
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Table 1. Characterization of CB and GP, adapted from Schinwald et al.(Schinwald et al. 2012a) and 
scanning electron micrograph of GP in 0.5% BSA/saline solution. * Aerodynamic diameter from Moller 













Figure 1. Response to GP in the lungs at 6 weeks post aspiration. C57BL/6 mice were exposed to VC, CB 
and GP by pharyngeal aspiration. A) At 6 weeks the lungs were lavaged and total cell number and 
granulocyte (neutrophils, eosinophils, basophils) number were measured. No significant difference was 
measured for total cell number between the VC, CB and GP (total cell number p= 0.2660) however the 
total granulocytes was significantly increased in GP treated mice (p= 0.0111 from one-way ANOVA). 
Data represent mean ± s.e.m. of n=7. Histological lung sections of GP treated mice stained with H&E (B) 
and picrosirius red (C) with higher magnification callouts. No granuloma formations, lymphocyte 
infiltrates or increase in collagen were observed despite extensive deposition of GP is visible (as indicated 
by the black arrows).  
 24 
 
Figure 2. Raman spectroscopy of GP in lung sections, after enzymatic treatment using HRP and chemical 
oxidation. A) Raman spectra of GP in lung section embedded in paraffin from mice exposed for 24 hour, 
1 week and 6 weeks to GP via pharyngeal aspiration. Characteristic D (1360 cm
-1
) and the G band (1580 
cm
-1
) of graphene can be seen. Spectra at 1290 cm
-1
 and 1450 cm
-1
 is characteristic for paraffin wax. No 
statistically significant change in the ratio of ID/IG was measured as shown in the insert. Data represent 
mean of 20 spectra. B) Raman spectra of pristine GP and GP incubated with HRP and H2O2 for 24 hour 
and 1 week. An increase in the D-band and D’-band at 1620 cm
-1
 was observed at 24 hour and 1 week 
compared to pristine spectra however no significant increase in ID/IG ratio was measured. For the 1 week 
timepoint one spectrum was recorded with an increase in D:G ratio to 0.76:1. C) Raman spectra of 
oxygen plasma treated GP for 5, 10, 15, 40 and 60 min. Increase in D- band and disorder induced Raman 
D’-band at 1620 cm
-1
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Fig S2: Thickness measurement of the GP-aggregates at 0.1 mg/ml concentration. A) Typical 
topography image where the contrast has been adapted to simultaneously exhibit the graphene 
platelets (brighter areas) and the underlying BSA layer. B) 3D image of the same area. 
 A flat dendritic BSA structure with cracks (probably grain boundaries) is found on the sample 
surface. On top of this structure a scatter of GP can be readily identified as the taller features. 
Typical height profiles of the platelets acquired according to the lines in (A) are presented in (C). The 
average height of the GP-aggregates at this concentration was calculated to be 178 ±57 nm. Apart 
from the possible polydispersity in thickness and diameter, variations of the value could be affected 
by the following reasons: 1) stacking of more GP on top of each other on the surface and 2) folding 
of the graphene and 3) platelets oriented (‘sitting’) at a different angle on the surface. The third 
reason appears to be the most significant as the platelets are not completely flat on the substrate. 
These measurements are compatible with ca 100 nm thickness for the GP-aggregates in suspension 









Fig S3: Thickness measurement of the GP-aggregates at 1 mg/ml concentration. A) Typical 
topography image where the contrast has been adapted to simultaneously exhibit the graphene 
platelets (brighter areas) and the underlying BSA layer. B) 3D representation of the same area. In this 
case, the protein appears to have formed multilayers. On top of these layers (compared to diluted 
solution- figure S2) more GP-aggregates can be identified, due to higher concentration. Typical 
height profiles acquired according to the lines in (A) are presented in figure (C). The average height 
of the platelets at such samples was calculated to be 171±64 nm.  
 
 
Table S1. Characteristics and morphology of the Carbon Nanotube samples used as a comparison in 





Diameter (nm) 165.02 ± 4.68 
Length (µm) Mean 36 
% fibre greater 
than 15 µm 
84.26 
Source University of 
Manchester 
[Dr. I. Kinloch] 
 
 
Table S2. Number of monocytes/macrophages and granulocytes after pharyngeal aspiration of 50 














































































Fig S4: Time- dependent inflammatory response in the lungs after aspiration exposure to CB, GP and 
CNT. The inflammatory response in the lungs after exposure via pharyngeal aspiration was 
examined. At 24 hour, 1 week and 6 weeks post exposure the lungs were lavaged and total cell 
number (A) and total granulocyte number (B) was measured. Decrease in total granulocyte number 
after GP exposure from 24 hour to 6 weeks is shown (B). Data from 24 hour and 1 week timepoint 
are obtained from Schinwald et al. 
2
 CNT showed significant increase of inflammation at 24 hour and 
1 week, which decreased at 6 weeks to a level comparable to VC. CNT data was obtained with 
permission from Muphy et al. 
1
. Significance versus vehicle control **P <0.01. Data represent mean ± 








Fig S5: Lung pathology 6 weeks post aspiration to CNT. A) Low magnification overview (2.5x) of a 
histological section stained with H&E to demonstrate gross pathology. Extensive lymphocyte 
infiltrates and extreme interstitial thickening (B) and collagen deposition (C) was observed.  Long 






Fig S6: Inflammatory response in the pleural cavity after pulmonary exposure to CB, GP and CNT. The 
inflammatory response in the pleural cavity after CB, GP and CNT exposure via pharyngeal aspiration 
was examined. At 24 hour, 1 week and 6 weeks post exposure the pleural cavity was lavaged and 
total cell number (A) and total granulocyte number (B) were measured. Data represent mean ± s.e.m. 
of n = 4. CNT data obtained with permission from Murphy et al. 
1
. The chestwall was examined by 
scanning electron microscopy (SEM) to identify lesion formation after pulomary exposure to CB (D) 
and GP (E). Normal mesothelium was observed in all treatments which was comparable to VC (C). F) 
To illustrate an inflammatory response on the parietal pleura after aspiration exposure, SEM of 
parietal pleura after aspiration to 50 µg/mouse CNT at a 6 week timepoint is shown. Aggregates of 
inflammatory cells are present on the mesothelial surface indicating a translocation of CNT to the 








Fig S7. Raman spectra from GP in lung tissue after 24 hour (A), 1 week (B) and 6 weeks post exposure 





Fig S8. Raman spectra from pristine GP (A) and GP treated with HRP and H2O2 for 24 hours (B) and 1 
week (C). Average and standard deviation of 20 locations (pristine) and 6 locations (HRP treatment) 






Fig S9. Raman spectra from pristine GP (A) and chemical oxidised GP using oxygen plasma for 5 min 
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The hazardous potential of fibrous materials was first recognized at the turn of the 20th century and 
later studies indicated the importance of fibre dimension in the development of diseases from 
inhaling asbestos fibres. The definition of a fibre for the purposes of occupational health and safety 
has existed now for over forty years and is based around strict morphological criteria for length and 
diameter defining what is and what is not, a fibre. However the scientific basis of this definition, in 
particular the length threshold, is shrouded in uncertainty and it is the purpose of this article to 
discuss the basis of this in light of recent advances in nanotechnology. These advances have allowed 
a critical evaluation of the role of fibre length that is shown to have surprising concordance with the 
original fibre definition and its serendipitous grounding in particle toxicology.  
In addition to helping solve critical questions surrounding fibre definition and toxicology, 
nanotechnology also presents new concerns in terms of hazard and potential for occupational 
exposure, with key questions raised as to the suitability of current detection methods for 
determining airborne concentrations.  The challenges for accessing workplace exposure raised by 
these new breed of industrial fibres is summarised in this article as well as new methods that may 




1. Introduction: Fibres, Exposure and Disease 
The hazardous potential of fibrous materials, in particular asbestos, has long been known although it 
was only with the widespread use of asbestos fibres at the turn of the 20
th
 century that the strong 
link between occupational asbestos exposure and health problems was defined. As the use and 
exposure to asbestos continued through much of the 20
th
 century, so did the increasing incidence of 
asbestos related disease, which resulted in the eventual classification of asbestos as a carcinogen by 
the International Agency for research on Cancer (IARC) in 1977 (1977). This was followed by bans on 
crocidolite and amosite asbestos in the UK (1985) (Bottomley 1985) and later a ban on chrysotile 
asbestos (Prescott 1999). Currently asbestos is banned in over 50 countries around the world.  The 
basis of the pathogenicity that has so affected the industrialised world and resulted in the banning of 
asbestos has been the subject of numerous research studies spanning many decades and several of 
these seminal studies along with key events in asbestos history and regulation are summarised in 
figure 1. Of the diseases linked to asbestos exposure, asbestosis, a fibrotic lung disease affecting 
those with heavy exposure to asbestos was the first reported (Cooke 1924) and subsequently tackled 
using dust control measures. Later, lung cancer was linked to asbestos exposure by Sir Richard Doll 
and this was seen to be also associated with asbestosis. In Doll’s cohort of 105 asbestos workers, 18 
developed lung cancer of which 15 were associated with asbestosis (Doll 1993). Whilst lung cancer is 
also associated with many other risk factors including smoking (Darnton et al. 2006), mesothelioma 
is almost exclusively associated with asbestos. This is a uniformly fatal cancer of the pleural or 
peritoneal mesothelium; mesothelioma is rarely found in individuals not previously exposed to 
asbestos although can occur in rare instances after chronic pleural inflammation, radiation therapy 





1.1 Evaluation of Fibres in Workplace Air 
It has long been recognised that the majority of particles of retained in the lungs are relatively short, 
typically less than 7 µm (Walton 1982). During the first half of the 20
th
 Century dust sampling in the 
workplace developed from simple gravimetric assessments of “total” dust to microscopic particle 
counting methods designed to focus the evaluation on the finer fraction of the aerosol, which was 
considered more biologically relevant. At this time the konimeter and thermal precipitator were 
widely used to collect short-term dust samples directly onto a glass substrate to facilitate the 
counting process. Particles with diameter between 0.5 µm and 5 µm were generally counted and the 
concentration was expressed in terms of "particle counts per cubic centimetre” (ppcc) or “million 
particles per cubic foot” (mppcf).  
When occupational hygienists first began assessing exposure to asbestos, regulations which were 
implemented for silica dust were used. These regulations were based on mass dose, neglecting the 
fibre shape as a determining factor relevant for pathogenicity. However, in the earliest toxicological 
studies with asbestos there was a suspicion that long fibres were more pathogenic than short ones. 
For example, Walton  (Walton 1982) cites a  study by Beger reporting that asbestos fibres with a 
length of 25-109 µm were found in a patient who died from asbestosis, indicating the possibility of 
selective retention of long fibres, which might be important in the observed development of disease. 
A series of animal inhalation studies and studies on lung material from asbestosis cases were 
performed to investigate the length fraction of asbestos fibres responsible for asbestosis (KNOX and 
BEATTIE 1954a; KNOX and BEATTIE 1954b; VORWALD et al. 1951). The inhalation models indicated a 
fibre length of 20-50 µm caused peribronchiloar fibrosis whereas human asbestosis cases showed 
that fibres up to 15 µm caused severe asbestosis (KNOX and BEATTIE 1954a; KNOX and BEATTIE 
1954b). Burdett (1998) reports on a survey undertaken in 1938 at the J. W. Roberts Ltd. factory at 
Armley in Leeds where particle and fibre concentrations (longer than 0.5 µm and longer than 5 µm) 
were reported (Burdett 1998). In 1957 the Asbestosis Research Council (ARC) was formed by the 
main asbestos manufacturing companies in Britain, and at the outset they agreed that asbestos dust 
measurements should focus on fibres longer than 5 µm. As late as 1960 limits on occupational 
exposure in Britain was specified as particle counts 177 ppcc for asbestos and the same value for 
dusts containing more than 50% free crystalline silica. In 1969 the ARC published the membrane 
filter method for measuring airborne asbestos dust, which was sampled onto a filter that after 
sampling was rendered transparent so that the fibres could be counted using a phase contrast 
optical microscope (Asbestosis Research Council 1968). A fibre was defined and counted as a 
structure less than 3 µm in diameter (based on the ability of the fibre to penetrate to the alveoli), 
longer than 5 µm (based on the presumed hazardous nature of longer fibres) and had a length to 
diameter ratio more than 3:1 (to focus on fibrous shaped particles). Around the same time the 
British Occupational Hygiene Society (BOHS) published a standard for chrysotile asbestos based on 
this new method (BOHS 1968) to prevent the formation of asbestosis and lung cancer in asbestos 
exposed workers which was later described by the US National Institute for Occupational Safety and 
Health as “the first modern approach to the setting of an asbestos standard” (1976). Indeed this 
fibre definition was later used by the World Health Organisation in the 1985 Reference Method for 
Measuring Airborne Man-made Mineral Fibres (1985). The membrane filter method has evolved in 
the subsequent years but the fibre definition has remained unchanged at <3 µm in diameter > 5 µm 
in length and a length to diameter ratio more than 3:1. 
1.2. Critical Fibre Dimensions for Mesothelioma 
The link between asbestos exposure and mesothelioma was suspected as early as 1943 (Tweedale 
2002)  however the association was only finally confirmed by Wagner and colleagues in 1960 
(Wagner et al. 1960). This study described 33 cases of mesothelioma in the Cape Asbestos fields in 
South Africa and made a clear link to their asbestos exposure. The relative rarity of mesothelioma in 
animals exposed to asbestos by inhalation, as is the case for humans, meant that meaningful 
experimental studies of the mechanism of mesothelioma following inhalation exposure were 
impracticable. This problem was only overcome in the seventies in an extensive series of studies by 
Merle F. Stanton and co-workers at the National Cancer Institute in the USA. This group were the 
first to develop a high yield toxicology assay of mesothelioma, using it to determine the fibres types 
and dimensions important for mesothelioma. The approach used was direct pleural implantation, 
which depending on dose, produced up to 100% mesotheliomas in some groups (Lippmann 1994) in 
a relatively short time. Inhalation of asbestos in rodent exposure studies yields most frequently zero 
and at best, a few percentages of animals with mesothelioma after lifetime inhalation of high levels 
of asbestos.  
In the publications arising from this approach, Stanton first described the role of fibre length, 
diameter and composition for a range of fibrous materials including asbestos, fibrous glass and 
aluminium oxide (Stanton and Wrench 1972). The findings related asbestos type and dimensions, 
especially diameter, to pathogenicity and it was clear that asbestos samples with a substantial 
number of fibres longer than 10-20 µm were most efficient in producing mesothelioma. Whilst long 
asbestos fibres of different types seemed to be similarly potent, a number of glass fibres containing 
a large proportion of fibres >10-20 µm induced much less carcinogenic response that might be 
anticipated from the long fibres present. Whilst not discussed to any great extent, this observation 
preceded the role of biopersistence that was to emerge and dominate the fibre pathogenicity 
paradigm in the future (Donaldson et al. 2010). Ten years later, Stanton had accumulated 
considerably more data and was able to conclude that:  
‘…The probability of pleural sarcoma (mesothelioma) correlated best with the number of 
fibers that measured 0.25 µm or less in diameter and more than 8 µm in length, but 
relatively high correlations were also noted with fibers in other size categories having 
diameters up to 1.5 µm and lengths greater than 4 µm….’. (Stanton et al. 1981) 
 
In other words, thin fibres shorter than 4 µm were low in mesothelioma potential whilst those 4-8 
µm long were almost as effective as those that were longer than 8 µm and those beyond 8 µm did 
not cause a very more marked increase in carcinogenicity described. Pathology studies using direct 
instillation or inhalation of synthetic vitreous fibres, whilst not an efficient way to produce 
mesotheliomas (see below) confirmed the general lack of pathogenicity of short fibres. Kuschner et 
al. (Kuschner and Wright 1974) used vitreous fibres that were ground to be much shorter than the 
parent long fibre material; the short fibres showed virtually no pathology in rats when instilled but 
there was severe fibrosis with the long fibre material. Davis et al. ground long amosite asbestos to 
shortness and again found virtually no pathology with the short after years of inhalation exposure; in 
contrast lung cancer, fibrosis and a single mesothelioma were reported in animals inhaling the long 
parent material (Davis et al. 1986a).  
However Timbrell argued that asbestos fibres from the Northwest Cape in Africa had virtually no 
fibres greater than 10 µm although numerous mesothelioma cases had been reported  (Timbrell 
1982). 
It should be borne in mind that, since the Stanton experiments were achieved using direct 
implantation of fibres, they effectively by-passed the normal mechanisms whereby fibres depositing 
in the airspaces actually reach the pleura. There is, in our opinion, a strong likelihood that this 
translocation process is itself length-dependant and that the potential for longer fibres to reach the 
pleura from the airspaces is likely limited since very long fibres would - I) have a higher likelihood of 
depositing before they reach the distal sub-pleural alveoli; II) find it physically difficult to penetrate 
through the sub-pleural alveoli to the pleural space due to their length. This is also in keeping with 
the argument that inhaled long fibres may not reach the pleural space. This problem is likely to have 
affected a number of studies where the peritoneal assay of mesothelioma was used (Bolton et al. 
1982a; Bolton et al. 1982b; Davis et al. 1986b; Davis et al. 1986c), although the limitations of this 
assay, including the one highlighted here, were raised (Johnson 1993; Rossiter 1991). For example a 
large study examining the role of fibre dimensions and biopersistence in mesothelioma has shown 
length of >20 µm in biopersistent fibres as the length class best related to mesothelioma 
development (Miller et al. 1999). However, such evidence as exists suggests that fibres longer than 
15 µm are very rarely found in the parietal pleura and that short fibres < 5 µm are most common 
(Boutin et al. 1996); the predominant fibre length found in the pleural mesothelioma tissue is 5 µm 
and less (Suzuki et al. 2005). A review by Lippmann of animal and human studies in relation to 
mesothelioma development (Lippmann 1993) concluded that:  
‘..fibres shorter than 5 µm appear to be ineffective, whist an appreciable fraction longer 
than 10 µm appear to be unnecessary..’ 
Taking all these studies into account, it seems that the length of the most pathogenic fraction of 
fibres is between 5-10 µm. It can therefore be seen that indirectly, using the poly-dispersed length 
distributions of fibres of various sorts and correlation analyses, research in the 20th century reached 
the conclusion that the threshold length for mesothelioma was 5 µm.  
 
2. Recent Experimental Demonstration of a Threshold Length for Pleural Inflammation  
As discussed above, naturally occurring fibres are always poly-dispersed for length with the 
exception of milled fibres that can all be short, but all long fibre samples may contain short material 
in addition to longer fibres of varying lengths. This has always provided an obstacle to clarifying the 
threshold length for biological effects of fibres. However the advance of materials science and 
nanotechnologies has enabled the production of tight length distributions of nanofibres; this in turn 
offers the possibility of precise determination of the threshold length for pleural 
retention/inflammation. There has been concern that nanofibres or high aspect ratio nanomaterials 
(HARN) may pose an asbestos-like hazard (Donaldson et al. 2010; Maynard et al. 2006) and so it is 
paradoxical that nanotechnology might hold the key to determining the threshold length for fibre 
effects in the pleura; a possibility indicated in 2008 by one of the authors (Poland et al. 2008). The 
problem that all naturally occurring and man-made vitreous fibres (MMVF) have a wide distribution 
of length, along with non-fibrous material in the case of synthetic vitreous fibres, meant that only 
estimations of the potential threshold length could previously only be made from statistical analyses 
of complex datasets e.g. (Stanton and Wrench 1972). However, in a 2012 study by some of the 
authors, silver nanofibres which were made by the nanotechnological polyol process provided five 
distinct length classes, with mean lengths (range) of 3 (0.5-4.5), 5 (0.5- 8.5), 10 (5.5- 15.5), 14 (2.5-
30.5) and 28 µm (20.5-60.5) (Schinwald et al. 2012b); importantly the diameter of the  different 
length samples was closely similar and the composition was identical so the only variable was the 
length. In addition nickel nanowires in two length classes (4 and 20 µm) and carbon nanotubes in 
two length classes (2 and 13 µm) (Murphy et al. 2011; Poland et al. 2012; Schinwald et al. 2012b) 
were used to further investigate the cut-off length for acute pleural inflammation in mice. A method 
of direct intrapleural instillation of very small masses of the nanofibres was used followed by 
sampling of the pleural space for evidence of acute inflammation (results summarised in Figure 2). 
Whilst acute inflammation is not mesothelioma and mesothelioma is in fact diagnosed after a long 
lag-time after first exposure (Yang et al. 2008), we believe that short-term inflammation may predict 
long-term effects. This is argued on the basis that 1) only retained fibres can cause inflammation so 
inflammation is indicative of retention (Murphy et al. 2011) and that only retained fibres could cause 
mesothelioma; 2) inflammation is implicated in the development of cancer for a range of agents and 
specifically for asbestos (Kane 1996; Nagai and Toyokuni 2010).  
The instillation of a range of fibres within tightly defined length ranges echoes Stanton & Wrench’s 
work with poly-dispersed fibres decades earlier and the results here similarly showed a differential 
response in terms of pleural inflammation as shown in figure 2.  Here we see length dependent 
inflammation with a very clear threshold for fibres ≥ 5µm in length inducing pleural inflammation 
whereas none of the shorter fibres (≤ 4 µm) produced an inflammatory response despite 
considerably different chemical composition. Above the length threshold the response flattened off 
which may be a consequence of long fibres aggregating in the restrictions of the pleural space. This 
is the first study showing a quantitative association between fibre length and pleural inflammation 
using fibres of different kinds in tightly defined length classes. The identified threshold length of 5 
µm (Schinwald et al. 2012b) provides persuasive experimental toxicological confirmation of a 
hypothetical length threshold that had evolved over the previous half century and so represents an 
important step forward.  
2.1. Why Should Mesothelioma Show Such a Distinct Length Threshold? 
The explanation for such a dramatic threshold lies in the method of clearance of particles from the 
pleural space. Whilst several theories for fibre transfer to the pleura exist (Miserocchi et al. 2008), 
the mechanism are not well understood, yet it is apparent that a proportion of all particles that 
reach the lung periphery transit through to the pleura and clear from the pleural space through 
stomata that are restricted in size in all mammals to between 2 and 10 µm (Donaldson et al. 2010; 
Murphy et al. 2011). Fibres may penetrate through the pleural tissues from sites of deposition in 
sub-pleural alveoli (Mercer et al. 2010). In any case particles that clear through the stomata 
accumulate in specific mediastinal lymph nodes (Murphy et al. 2011). Compact particles that reach 
the periphery of the lungs are elutriated by their passage through the airways to be less than about 
3 µm and so particles of this size that find their way into the pleural space exit readily through the 
stomata. Fibres longer than 5 µm are still aerodynamically small and reach the distal lung where they 
can translocate to the pleura. However, their length means they cannot negotiate the stomata and 
so become trapped and accumulate at the parietal pleura where they can trigger inflammation and 
could directly cause genotoxicity in mesothelial cells leading in the long term to mesothelioma if the 
fibres are biopersistent (Donaldson et al. 2010). Since the stomata are tightly defined in size there is 
likely to be a sharp threshold with the physical dimension of the fibres.  
 
2.2. A Single Length Threshold for Lung and Pleural Effects? 
The preceding discussion specifically concerns mesothelioma but it is important to understand 
whether the same fibre length threshold would apply to asbestos-related disease in the lung airways 
and parenchyma. The pleura is an unusual target for particles yet asbestos and other fibres uniquely 
affect this compartment in terms of causing pleural effusion, plaques and mesothelioma; whilst 
pleural fibrosis is not unique to fibres, fibre are peculiarly potent in inducing this effect compared to 
other particles. It has been demonstrated that shorter fibres reach the pleura because of 
translocation/penetration from the site of deposition in sub-pleural airspaces (Mercer et al. 2010). 
As discussed above, the mechanism of size dependent retention in the pleura, constrained due to 
stomatal size, may also mean that there is a shorter threshold length for inflammation in the pleural 
space than in the parenchyma. In the airspaces frustrated phagocytosis of macrophages, as 
demonstrated in figure 3, is the primary mechanism of length-dependent inflammation (Donaldson 
et al. 2010) and this may possess a different length threshold compared to the pleural threshold. 
Recent data indicate that the same silver nanowires described here have 14 µm as a length 
threshold for pulmonary inflammation, which is longer than that for the threshold for pleural 
inflammation (Schinwald et al. 2012a). A precautionary approach for exposure assessment would 
however suggest that the best length standard would be the shortest one, the pleural threshold, 
since it would protect against lung and pleural effects.  
 
3. The Existing Standard and the New Generation of Industrially Relevant Fibres and 
Nanofibres 
The current Health and Safety Executive standard on asbestos fibre sampling is based on the 
definition for ‘fibres’ by the British Occupational Hygiene Society in 1968 whereby countable fibres 
were defined as particles with a length  > 5 µm as determined by a standard membrane filter 
method (BOHS 1968), which was revised 1971 to include an aspect ratio of 3:1 and a width of < 3 µm  
in the definition of a fibre (ARC Technical Note No. 1) as described by the WHO reference scheme for 
man-made mineral fibres (MMMF) in 1985 (World Health Organisation 1985). This standard was 
chosen arbitrarily to ‘allow a margin of safety below the limits of 10-20 µm for pathogenic fibres’, 
the best current opinion held at that point in time (Walton 1982). In the intervening years there has 
been a suggestion using statistical and deductive evidence of a value for the threshold length but it is 
only in the 2012 paper lead by one of the authors that a threshold length for  pleural inflammation 
was finally demonstrated (Schinwald et al. 2012b). This was, paradoxically, only achievable by 
nanotechnological methods for making fibres in clear-cut length categories, whilst the potential 
asbestos-like threat posed by such novel nanofibres was highlighted early (Royal Society 2004; 
Service 1998).  It is extraordinary that the standard for pathogenic fibres set in 1968, drawn from 
investigations of workers exposed to various forms of asbestos fibres and early in vivo studies on 
rodents using fibres with a wide distribution of length and set to provide a ‘margin of safety,’ 
coincided so accurately with the actual threshold length. If the length had been set higher then 
hazardous fibres would not have been counted and if it had been set lower an unnecessary penalty 
could have been applied to industries to comply with an overly-rigorous standard.  The fact that 
synthetic nanofibres were used to define the length threshold highlights that a whole new 
generation of fibres made from novel materials by nanotechnological methods are being synthesised 
or are under test for use in industry.  There is therefore a distinct possibility that workforces will be 
exposed to some of these nanofibres in workplace air and hygiene will be mandatory. As 
summarized by Donaldson et al., high aspect ratio nanomaterials including carbon nanotubes have 
an exceptionally high annual product growth rate (Donaldson et al. 2011). For example, carbon 
nanotubes (CNT) are now manufactured in more than 140 companies around the world and the 
main application sector for CNTs is semiconductors and electronics although applications range from 
sporting goods and military equipment to medical applications and aerospace 
(futuremarketsinc.com 2012).    
 
3.1. New Fibres and New Measurement Challenges 
  
Currently, to assess inhalation exposure to fibres, air is drawn through a filter onto which the fibres 
are deposited. The fibres are then counted using an optical microscopy according to a defined 
method; there are several variants of this method but one widely used approach is that published by 
the World Health Organisation (WHO 1997). Only fibres with diameters less than 3 μm with a length 
greater than 5 μm and an aspect ratio of at least 3:1 are counted. The method incorporates counting 
rules governing size (as above), number of areas scanned (fields of view), number of fibres scanned,  
number density of fibres on the collection substrate, and how to deal with “bundled” or overlapping 
fibres. Typically in assessing occupational exposures, something of the order of 50 to 100 fields of 
view are counted. Efforts to automate this measurement have not generally been found to be 
effective and so this process is typically carried out manually and an experienced assessor may count 
such a sample in around 10 minutes.  
 The scope of application of the World Health Organisation (WHO) method is broad and it is 
considered to be appropriate for all natural and synthetic fibres, including the various asbestos 
varieties, other naturally occurring mineral fibres and synthetic vitreous fibres (WHO 1997). Carbon 
nanotubes (CNT) and other nanofibres could be considered to fall within the scope of the WHO 
method and it has been suggested that fibre counting could be an appropriate method to assess 
exposure to CNT and other types of HARN (2007). However there are several problems with this 
approach as summarised:  
· Optical microscopy is very insensitive for very fine fibres (of diameters less than 200-300 nm) 
so given that the diameter of nanofibres are in the nano-range and so, substantially less than 
300 nm, these would not generally be detected (although bundles, ropes or other 
aggregations of nanofibres may be).  
· Scanning or Transmission electron microscopy may overcome the resolution limitation of 
optical methods using much higher magnification (2007). However since the size of the field 
of view is inversely proportional to the square of the magnification used, many more 
individual field would have to be counted in order to assess the same proportion of the 
sample. An increase in magnification of 10 would decrease the size of the field of view by 
100. 
· A further complexity is the higher magnifications employed would (as intended) detect very 
fine fibres which would not be observed by optical microscopy. This would lead to difficulties 
in making comparison with limit values for fibres set using optical microscopy. 
· Finally, it is clear that many of the forms CNT’s observed are highly entangled. Strict 
application the WHO counting rules would require that touching fibres would not be 
counted.  
 
Relatively few published studies have attempted to measure particle release and / or   occupational 
exposure to CNTs in workplace settings. Maynard et al. looked at the exposures associated with 
production of single walled carbon nanotubes (SWCNT) and in a simulated mixing operation 
(Maynard et al. 2004).  Han et al. measured the release of multi-walled carbon nanotubes (MWCNT) 
during CNT manufacture and in a laboratory scale mixing process (Han et al. 2008) whilst Bello et al. 
reported on exposure to CNT during machining of advanced composites containing carbon 
nanotubes (Bello et al. 2009).  In addition, Johnson et al. measured the release of fullerenes (C60), 
MWCNT and carbon black during laboratory tasks, weighing and sonication (Johnson et al. 2010) and 
Tsai et al. reported measurements during the CNT production by CVD (Tsai et al. 2009). A range of 
measurement approaches were used by these investigators. For example, Bello et al. collected 
samples from the air on to a filter for electron microscopy analysis, but no fibres were identified 
during the analysis (Bello et al. 2009). In contrast, Johnson et al. observed clumped MWCNT on filter 
sample taken close to a laboratory sonication process but did not quantify these (Johnson et al. 
2010).  Other investigators used condensation particle counters (CPC), optical particle counters 
(OPC) and scanning mobility particle sizers (SMPS) to try to detect the release of CNT although these 
devices provide no morphological information and are not able to distinguish fibres from other types 
of particles. Only Han et al. used an approach based on the WHO method whereby they collected 
samples on to a filter, which were analysed by TEM to quantify fibre concentrations. However, 
despite this, it is clear that in this study not all of the formal WHO counting rules were applied, yet 
no statement concerning compliance of these rules was made.  Specifically many of the images 
shown in the paper indicate clumped or overlapping fibres but it is not stated whether or not these 
were counted.  Fibres counted were short; the maximum length of fibres observed was reported as 
1.5 µm, which is too small to be considered a fibre under the WHO criteria, where the minimum 
length of a fibre is 5 µm.  Of the samples taken, the ‘fibres’ were only found in one scenario, 
blending, and were found on both personal and area samples. The reported number concentration 
was very high (193.6 and 172.9 fibre.ml
-1
), although this was reduced by four orders of magnitude 
when a control system (enclosure) was applied.  The German ‘Frauenhofer-Informationszentrum 
Raum und Bau’ published guidelines to measure fibrous particles (including chrysotile and 
amphibolasbest-fibres) using a raster-electron microscopy approach coupled with energy dispersive 
X-ray analysis (Verein Deutscher Ingenieure 2004). The detection limit of this method is 300 fibres 
per m
3
. These studies indicate that there is potential for applying fibre counting measurement 
approaches, either by using TEM or perhaps even SEM in order to quantify more effectively the level 
of exposures however, significant effort will be required to turn this into a viable (e.g. efficient), 
routine method. Despite these limitations no alternative approaches for assessing fibre number 
concentration for nanofibres have yet been developed and it is difficult to see how quantification of 
fibre number concentration could be achieved if not by a method derived from the WHO approach. 
Whilst number concentration is the standard and most robust metric for reporting exposure to 
fibres, mass has classically been used for quantifying all other particulates and for CNT, assessment 
of release and or exposure in terms of mass has been reported in the literature. Mass based 
exposure measurements are recommend in the recent NIOSH Current Intelligence Bulletin- 
Occupational Exposure to Carbon Nanotubes and Nanofibers  (NIOSH 2010).  The NIOSH approach is 
based on analysis by NIOSH method 5040 for Diesel Particulate Matter as Elemental carbon (Birch 
2002), which by its nature is non-specific for fibrous materials or even carbon nanotubes. This 
method is based on a thermal-optical analysis technique for organic and elemental carbon (OC and 
EC). The analysis quantifies total carbon (TC) in a sample as the sum of OC and EC. NIOSH claim an 
upper limit of quantitation (LOQ) of NIOSH Method 5040 of 7 μg.m
-3
. At the current time there is 
very little published experience about this method or its utility in quantifying exposure to CNT.  
A recent review of approaches to detect and analyse CNT concluded that the ELPI spectrometer may 
have some utility in this respect (2010). Various off line measurement approaches reviewed by 
Tantra et al. concluded that none were immediately appropriate for measurement of occupational 
exposure (Tantra and Cumpson 2007). Currently there is no consensus on the most appropriate 
approach. While mass measurements are clearly possible, much more work is need to routinely 
detect and quantify CNT and other fibrous nanomaterials.   
 
4. Conclusions  
Exposure to pathogenic fibres has left a legacy of disease and suffering that is still with us today. The 
methods of assessing exposure were developed long before toxicity studies identified the 
morphological parameters that make fibres hazardous. The method published by the British 
Occupational Hygiene Society defined countable (relevant) fibres as having a length of 5-100 µm, an 
aspect ratio of 3:1 and a width of < 3 µm. The lower length cut-off was based on the best available 
evidence and was chosen arbitrarily to ‘allow a margin of safety below the limits of 10-20 µm for 
pathogenic fibres’, the best current opinion held at that point in time (Walton 1982). This has proven 
serendipitous as the 5 µm cut-off for countable fibres appears to fall exactly at the threshold for 
fibre retention and pleural effects; with cut-off being both rigorous enough to identify pathogenic 
fibres whilst not being unduly stringent and encompassing shorter fibres of lower pathogenicity.  
Such toxicological corroboration of the current definition and standard is heartening however the 
very materials technology that allowed the further investigation of this threshold length also heralds 
new challenges in assessing exposure to new nanofibres. Whilst the threshold length appears to hold 
firm for nano and non-nano fibres alike, the methods for counting such fibres must be suitable for 
counting of the small diameter nanofibres, which are beyond the optical resolution of phase contrast 
optical microscopy. New methods that take heed of the standard counting rules for fibres have been 
suggested but the practicality of such methods compared to the robustness and efficiency of the 
phase contrast optical microscopy still requires investigation.    
When considering the interaction between toxicology and exposure science, it is evident that the 
development of a fibre standard represents a strong synergy between the two disciplines that has 
allowed the identification of the most appropriate metric and assessment criteria. Wherever 
possible, such synergy should continue and this is more and more evident when considering the 
challenges of nanotechnology.          
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Figure 2:  The vertical axis shows the number of neutrophilic leukocytes in the pleural lavage 
indicative of inflammation. The horizontal axis shows the mean length. There was tight distribution 
about the mean for all samples expect nanotubes samples which were more dispersed. All labels 
show the mean length as a subscript - AgNW= Silver nanowires; NiNW = Nickel nanowires; NT= 
carbon; VC = vehicle control; NPCB = nanoparticulate carbon black; AgP = Silver nanoparticles. Figure 

















Figure 3: Frustrated phagocytosis by amosite asbestos fibres. Image of rat alveolar macrophages 
(NR8383 cell line; white arrow) attempting to phagocytose long amosite asbestos fibres (white 
chevron). The resultant elongation of the cells as demonstrated by the black arrows is the frustration 
of the macrophage as they attempt to fully enclose the fibre which is much longer than itself.  
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1 Introduction  
Fibres are very useful to industry and the archetypal industrial fibre was asbestos, first mined in bulk 
at the end of the 19th century in Canada and rapidly incorporated into many products, structures 
and buildings. The pandemic of disease that was a consequence of the mining and use of asbestos 
was met by a huge research effort into toxicology and experimental pathology which attempted to 
understand how asbestos was pathogenic and what characteristics of the fibre were involved. The 
banning of asbestos on safety grounds resulted in increased use of ‘asbestos substitute’ fibres, which 
had similar or higher performance than asbestos in insulation or other properties; most of these 
fibres were glassy and eventually classified as Synthetic Vitreous Fibres (SVF). A considerable thrust 
of research into the relationship between structure of natural and synthetic fibres and their toxicity 
took place in the 1980s and 90s culminating in ‘the fibre pathogenicity paradigm’ (FPP). The FPP is  a 
structure:toxicity model that has stood the test of time and it predicts the potential pathogenicity of 
fibres. The FPP highlights thinness, length and biopersistence as the factors that determine 
pathogenicity. The overarching question in the modern era of nanotoxicology is whether nanofibres 
of different types, especially carbon nanotubes in the context of the present article, conform to the 
FPP. This article describes the FPP and uses it as a framework for assessing the similarities and 
differences between asbestos and CNT. 
2 Not all carbon nanotubes are in the form of fibres 
CNT can exist as particles if they have defects and therefore ‘grow’ as tangles, like balls of string. 
Whilst the CNT in such bundles are tubular, they  are particulate as far as cells are concerned, since 
the bundles of tubules are in a compact form. However, if the CNT have few defects, the tubules can 
grow straight and the CNT can adopt a fibrous, high-aspect shape [1,2]. We have demonstrated that 
the long CNT behave like fibres causing effects such as frustrated phagocytosis leading to 
pathogenicity, whilst short or tangled ones do not behave like fibres in this sense [2-4]. It is therefore 
important to define whether any CNT exposure is to CNT in the form of  fibres or particles and for 
these reasons, the following discussion pertaining to CNT and the FPP only relates to CNT in a fibrous 
shape.   
3 Pathogenic effects of fibres 
Exposure to asbestos causes the human  diseases shown in Figure 1, demonstrating the unique 
proclivity of asbestos in causing pathogenic effects in the pleura as well as in the lungs themselves. 
In animals, asbestos and some other fibres cause similar types of pathology.  Asbestosis is a bilateral 
interstitial fibrosis with accumulation of fibrous/scar tissue in the interstitium of the lung, 
obstructing the diffusion of gas from the blood to the airspaces and restricting lung expansion. 
Bronchogenic carcinoma is a malignant cancer of the cells lining the bronchi or airways and is the 
same as the lung cancer that is common in smokers. Mesothelioma is an unusual tumour arising 
from the mesothelium lining the pleural space that is slow–growing and that does not metastasise 
and so is well- advanced before diagnosis leading subsequently to a very poor prognosis. Pleural 
fibrosis is a diffuse accumulation of scar tissue in the pleura that may lead to pleural effusion, an 
accumulation of fluid in the pleura seen in individuals exposed to asbestos.  Pleural plaques are 
raised hard fibrous lesions that arise on the parietal pleura that are smooth and composed of a 
basketwork of pure collagen; they are almost acellular that do not appear to cause any adverse 
effects on the lungs. Since, in the classical toxicology, paradigm response follows dose it is evident 
that fibres depositing in the lungs accumulate to high dose at various sites in the lining epithelial 
cells and parenchyma, leading to the pulmonary effects  and that they accumulate in the pleura, 
where they cause the pleural pathologies described in Figure 1 and below. 
 
Figure 1 Diagram showing the situation of the types of pathology caused by fibres 
 4  Fibre characteristics and disease; the fibre pathogenicity paradigm  
Not all fibres are equally pathogenic as pathogenicity depends on the structure and composition. 
Decades of fibre toxicology have led to an over-arching fibre toxicology structure:activity paradigm 
involving diameter, length and biopersistence that is reviewed elsewhere [5,6] termed the Fibre 
Pathogenicity paradigm (FPP). The FPP recognises the geometry of fibres as their most important 
toxicological characteristic and not the chemical make-up, except in so far as the composition makes 
a contribution to biopersistence (see later). Independence from composition means that the 
paradigm embraces fibres composed of a number of diverse materials including amphibole and 
serpentine asbestos, vitreous and ceramic fibres and an organic fibre (reviewed in [5]).  
 
 
Figure 2 Diagram summarising the fibre pathogenicity paradigm. Three biophysical characteristics 




3.1 Diameter  
The central role of diameter is in the important relationship it has with aerodynamic diameter (Dae) 
which dictates the efficiency and site of pulmonary deposition [7]. The fact that fibres longer than 
50mm can reach and deposit  beyond the ciliated airways is explained on the basis that, regardless of 
length, the Dae of a straight fibre is around 3 times its actual diameter [6]. Thin fibres equal to or less 
than about 1mm in diameter are therefore ‘respirable’ and can deposit beyond the ciliated airways.  
Clearance from beyond the ciliated airways is effected by slow, macrophage-mediated clearance and 
so fibres which deposit there have the potential to contribute most to build-up of dose. 
 
3.2 Length 
Length impacts little on Dae [8] of respirable fibres except when length is sufficient to cause 
interception, a mechanism of particle where the tip of a fibre makes contact with the wall, resulting 
in deposition. This means that long fibres can readily penetrate beyond the ciliated airways. The 
evidence demonstrating that length is a key factor in pathogenicity of fibres comes from a number of 
sources but the best data are from experimental toxicological studies where it is possible to 
characterise the length of the fibres in the exposure or isolate length categories and assess their 
effects; this approach contrasts with the poorly-characterised nature of human exposures. In the 
seventies Stanton implanted fibres of various types and lengths directly onto the pleural  mesothelial 
surface [9,10] and  identified that carcinogenicity was related to biopersistent fibres longer than 
about 8mm [9]. Davis et al.  exposed rats for one year to long and short amosite asbestos fibres and 
there was a substantial tumour and fibrosis response in the rats exposed to the long amosite, but 
virtually no response in rats exposed to the short amosite [11]. Adamson et al. used long and short 
crocidolite and following deposition in mouse lungs reported fibrosis [12] and proliferative 
responses [13] at the pleura with the long, but not the short samples. The mouse peritoneal cavity 
has been used as a model of direct mesothelial exposure and much greater toxic [14], inflammatory 
[15] and granuloma-generating [16] responses were evident in mice that were exposed to long fibres 
than was seen with shorter fibres.  In vitro systems have also demonstrated the greater potency of 
long compared to short fibres in assays of pro-inflammatory and genotoxic activity [17-19].  
Length also affects retention, with long fibres being retained with a much longer retention half-time 
than short fibres [20,21]. In the lungs this is a consequence of :- 
a) long fibres not being completely  enclosed by macrophages [22] leading to frustrated 
phagocytosis (see below) and inflammation producing chemotaxins that retain the long 
fibre-loaded macrophages [4] preventing migration to the mucociliary escalator 
b)  direct effects of long fibres in inhibiting macrophage locomotion [23]. 
c) long fibres that reach the pleural space being retained at the parietal pleura stomata [3].  
 
3.3 Biopersistence  
The biopersistence of a particle is defined as its ability to resist damage or modification that would 
substantially alter its structure within tissue such as the lungs. Since long fibres are the effective 
dose (see above), it is the action of the lung milieu on long fibres that is most important for fibre-
specific effects. Non-biopersistent fibres that do not release toxic ions or other components 
undergoing dissolution dissolve, break and shorten.  However a soluble fibre releasing toxic/reactive 
components may generate localised or even systemic accumulation and toxicity; this especially 
applies to contaminating bioavailable metals [24]. Soluble ion release has been shown to be a cause 
of toxicity for particles [25].  The role of biopersistence in fibre effects is well understood and has 
been shown to have a profound effect on the clearance and toxicity of fibres [21]. For example 
McConnell and colleagues reported on a long-term (78 wk) inhalation study comparing SVF of 
differing solubilities, with insoluble amosite asbestos on an equal fibre number basis. They found 
that the type and severity of pulmonary and pleural effects differed between the samples in direct 
relation to in vitro dissolution rates  - “the faster the dissolution, the lower were the cumulative lung 
burdens and the less severe the effects” [26]. Within the lung, the less durable fibres may split 
longitudinally, as seen with fibrils of chrysotile asbestos, or break transversely as in the case of glass 
fibres making it possible for these to be cleared by alveolar macrophages leading to the removal of 
long fibre dose. Alternatively they may dissolve in the milieu of the lung, especially the acidic 
environment of macrophage phagolysosomes resulting in weakening and breakage.  
The use of such results in developing safer insulation products by altering biodurability is well 
described in a review article by Hesterberg [27] and shows the importance of considering physico-
chemical properties in designing materials that are ‘benign-by-design’ which is of great relevance to 
manufactured nanomaterials.         
For the above reasons the durability of carbon nanotubes has come under scrutiny. In one study, 
single walled carbon nanotubes were exposed to a simulated phagolysosmal fluid (pH 4.5) for 90 
days in vitro (with the addition of H2O2 to simulate the oxidising environment). The conclusion was 
that durabilty was dependent on nanotube functionalization with carboxylated nanotubes 
undergoing degradation leading to length reduction whilst unmodified, ozone-treated, and aryl-
sulfonated nanotubes did not [28]. The suggested explanation for this was that the act of 
carboxylation causes damage to the graphenic backbone resulting in the formation of active sites 
that provide points of attack for further oxidative degradation [29]. A similar mechanism may have 
been in action when carboxylated single-walled carbon nanotubes were shown to be catalytically 
degraded over several weeks by horseradish peroxidase whilst hypochlorite and reactive radical 
intermediates of myeloperoxidase also catalysed the degradation of single-walled carbon nanotubes 
in vitro [30]. 
Using a similar in vitro approach, Osmond-McLeod and colleagues [31] compared the durability of 1 
single walled carbon nanotube sample and 3 multi-walled carbon nanotube samples to that of 
soluble and non-soluble control fibres. They found that after 24 weeks agitation in simulated 
phagolysosmal fluid (pH 4.5) the control fibres behaved as expected with the bio-soluble glass fibres 
and chrysotile asbestos both losing appreciable mass whilst the durable amosite asbestos did not. 
Three out of 4 of the carbon nanotubes tested showed no or minimal loss of mass or change in fibre 
length or morphology but one multi-walled carbon nanotube sample lost 30% of its original mass 
within the first three weeks of incubation, after which there was no further loss. The authors then, 
assuming no reduction in fibre mass, injected these samples into the peritoneal cavity of mice and 
noted that a loss of mass and fibre shortening was accompanied by a loss of pathogenicity when 
compared to fibres incubated briefly. This approach mirrored a similar study by Donaldson [32] 
whereby non-biopersistent fibres pre-treated in a physiological buffer at pH 5.0 or 7.0 to mimic 
residence in the lung lost some inflammogenic potential. What these studies show is that similarly to 
pathogenic and non-pathogenic fibres, carbon nanotubes can vary in their durability and this has 
implications for their long-term residence and toxicity. Interestingly, surface modification of the 
carbon nanotubes is a major factor in enhancing biosolubility and hence offers a method of reducing 






Figure 3 Summary of how length and biopersistence interact to lead to the accumulation of long 





5  Fibres and the lungs 
 
The accumulation of long fibres in lung tissue can lead to numerous adverse responses including 
oxidative stress, inflammation and genotoxicity which if sustained may manifest as more severe lung 
pathologies including fibrosis, i.e. asbestosis, and lung tumours [33]. Although lung disease 
associated with CNT exposure has yet to be identified in human populations, rodent studies 
examining the pulmonary toxicity of CNT have revealed a pattern of effects similar to those observed 
following exposure to asbestos including acute neutrophilic inflammation [34,35], cytokine 
production [35], granulomatous inflammation [36,37], interstitial thickening [38] and fibrosis [35,39]. 
No study has as yet reported the presence of lung tumours in CNT-exposed animals primarily  due to 
the short-term nature of the majority of these studies; however short-term endpoints such as 
inflammogenicity and fibrogenicity may have the potential to predict long-term carcinogenicity [40]. 
 
Considerable evidence suggests that reactive oxygen species (ROS) such as hydrogen peroxide 
(H2O2), superoxide anion (O2 
–
) and the hydroxyl radical (HO˙), and reactive nitrogen species (RNS), 
which can be generated directly by the fibres themselves or indirectly through interactions with 
inflammatory cells, are important mediators of asbestos toxicity [41,42]. Direct release of free 
radicals from the asbestos fibres is mediated by iron integrated into the crystalline structure of the 
asbestos fibres which can contribute to redox-cycling reactions leading to the production of 
damaging hydroxyl radicals [43]. Similarly in a number of studies the pro-inflammatory response to 
CNT in the lung has been attributed to the presence of contaminating transition metals, a by-product 
CNT synthesis, or structural defects in the CNT generating free bonds in the graphenic backbone of 
the CNT [44].  
 
A second mechanism by which asbestos fibres can increase lung ROS and oxidative stress  
is by activating inflammatory cells recruited to the site of asbestos deposition. As discussed above, a 
low aerodynamic diameter will allow deposition of even very long fibres beyond the ciliated airways 
in the pulmonary regions of the lung, where clearance is mediated by alveolar macrophages. 
However, if fibres exceed the maximal length a macrophage can enclose (~15 μm see [23]) the 
macrophage will be unable to successfully remove the fibre and become ‘frustrated’/pro-
inflammatory. Frustrated phagocytosis is accompanied by the release of oxidants [45] and cytokines 
[46,47] as well as lysosomal destabilisation [48], increasing recruitment of inflammatory cells to the 
lungs and activating the surrounding epithelial cells, leading to an inflammatory response. The ability 
of long CNT to stimulate frustrated phagocytosis in macrophages in vitro has been described in 
studies which have shown specific length-dependent increases in the release of superoxide anion 
and pro-inflammatory cytokines after macrophages were treated with long fibre-containing CNT 
samples [4,46].  
 
Asbestos-induced free radicals activate signalling cascades and cause DNA damage that results in 
altered gene expression and cellular toxicity important in the pathogenesis of asbestos associated 
pulmonary diseases [49]. Alternatively fibres may also prove to be directly genotoxic where long 
fibres may physically interfere with mitosis by interacting with the mitotic spindle and chromosome 
segregation resulting in aneuploidy in daughter cells [33]. There is evidence analogous to asbestos 
that CNT can interfere with normal mitosis leading to the induction of aneuploidy. Treatment of 
airway epithelial cells with SWCNT in vitro led to a variety of genetic abnormalities including multiple 
mitotic spindle poles, anaphase bridges and aneuploidy [50]. Due to the small diameter of the 
SWCNT the authors proposed that the similarity in structure may have allowed the incorporation of 
the SWCNT into the mitotic spindle leading to abnormal cell division. Fibres can also stimulate 














Figure 4 Diagram summarising the hypothesised mechanistic events mediated by long fibres that 
lead to genotoxic and carcinogenic effects in bronchial epithelial or the mesothelial target cells. 
 
6 Fibres and the pleura 
Anatomy and function of the pleural space  
The pleura is the serous membrane that covers the lung parenchyma, the mediastinum, the 
diaphragm and the rib cage. The pleura is divided into the visceral pleura which covers the lung 
parenchyma with its interlobar fissures and the parietal pleura which lines the inside of the thoracic 
cavities. The parietal pleura is composed of connective tissue layers covered by a monolayer of flat 
and cuboidal mesothelial cells [52].  The pleural space is the cavity between the visceral and parietal 
pleura and contains a film of pleural fluid which acts as a lubricant during respiratory movements 
while avoiding direct contact between visceral and parietal mesothelial surfaces, thus preventing cell 
damage. Pleural fluid or lymph drains from the parietal pleura via numerous lymphatic vessels in the 
pleural connective tissue layer which start off as gaps within the endothelial lining, called lymphatic 
stomata. These stomata have a diameter of 2-12 µm and are predominantly found in the dorsal, 
caudal intercostal spaces and to a lesser degree in the ventro-cranial region of the pleura [53]. 
Across mammalian species there is a remarkable consistency in the reported size of stomata on the 
diaphragm or parietal pleura as summarized in [54]. Through stomata the pleural fluid flows directly 
into the lumen of the lymphatic vessels [55] which run along the intercostal spaces and drain 
towards nodes near the head of the ribs.  
The report confirming the link between asbestos exposure and mesothelioma  development in the 
pleural space appeared in 1960 by Wagner et al. [56] who made a connection between asbestos 
exposure and mesothelioma in the asbestos fields in North Western cape province [56]. In addition to 
mesothelioma, other forms of pleural diseases such as pleural effusion, a build-up of pleural fluid due to an 
imbalance of influx and efflux of fluid in the pleural space [57], and pleural plaques, areas of hyaline 
fibrosis, were recognised as asbestos exposure-related disease in the pleural space.  
In an extensive study by Stanton & Wrench in 1972 the role of fibre length, diameter and 
composition of a range of fibrous materials including asbestos, fibrous glass and aluminium oxide 
was investigated. The fibres were surgically introduced onto the pleural surface in a gelatine pledget  
[58,59] and the pathological outcome was that carcinogenicity was related to fibres with a length 
between 10 and 80 µm and a diameter below 2.5 µm; it was notable that the physiochemical 
properties of the fibre samples had no influence on the carcinogenicity outcome [58,59]. A threshold 
length ≥ 10 µm for pathogenic fibres was hypothesised and became known as the ‘Stanton 
hypothesis’. This  was modified downwards when Timbrell showed that exposure to asbestos fibres 
from the Northwest Cape in Africa with virtually no fibres greater than 10 µm was associated with 
numerous mesothelioma cases [60] .  
This length-dependent relationship of fibre exposure in the pleural space and disease development 
was recently further investigated by one of the authors (FM), comparing the severity of pleural 
inflammation in response to carbon nanotubes or amosite asbestos fibres after direct intra-pleural 
injection  [61]. The study compared different forms of multi-walled CNT including two tangled and a 
short CNT, which were composed of non-fibrous material and two long CNT, with a mean length of 
13 µm and up to 56 µm. Short and long amosite asbestos fibres (SFA/LFA) and nanoparticulate 
carbon black (NPCB) were included as control fibres/particles [62].  This study demonstrated that 
CNT, like  asbestos,  exhibit length-dependent pathogenicity. This was evident in the findings that 
long CNT caused a substantial inflammatory response in the pleural space and granuloma formation 
on the diaphragm and parietal mesothelial layer up to 24 weeks, similar to the response observed 
after exposure to LFA fibres. Even though this study provided valuable insight into the inflammatory 
potential of CNT, the threshold length for pleural inflammation could not be determined. Therefore, 
a follow up study used silver nanowires and nickel nanowires purpose-synthesised in very distinct 
length classes [54] was carried out. This study revealed a cut-off length for nanowires in causing 
acute pleural inflammation after direct intra-pleural injection, with 4 µm being non-inflammogenic 
and ≥ 5 µm being inflammogenic [54]. This clear threshold can be explained by the clearance 
mechanism from the pleural space through stomata as discussed above. Even though the study on 
the threshold length was a short term inflammation study, the results can predict long term effects 
based on the above argument that only retained fibres can cause inflammation and inflammation is 
implicated in the development of asbestos related cancer [33,63]. Overall, the latest studies 
performed on predicting the pathogenicity of newly designed high aspect ratio nanomaterials in 
relation to asbestos fibre exposure in the pleural space showed that nanofibres may pose an 
asbestos-like hazard if they are if they are long enough to be retained as well as biopersistent. 
Although carbon nanotubes were not available in strict length classes the generality of the length 
threshold for nanofibres was demonstrated and it may be assumed that any fibre or  nanofibre  that 
is longer than 5mm, is less than 1um in diameter and is biopersistent poses a risk of causing asbestos 
–like pathogenicity i.e. causing flung fibrosis, lung cancer and pleural disease including 
mesothelioma and pleural fibrosis. 
 
7 Use of the peritoneal cavity to study mesothelioma –inducing potential  
The peritoneal cavity has long been used as a model for fibre pathogenesis spanning the eras of 
asbestos, synthetic vitreous fibres and most recently, engineered nanofibres. The rationale for the 
model is simple yet often misinterpreted and misunderstood. It can be summarised by the fact that 
some fibres cause pathogenic effects in the pleural space and can give rise to mesothelioma but it is 
difficult to introduce fibres into the pleural space, although this issue has recently been much 
improved via a direct injection technique developed by some of the authors [3]. The peritoneal 
cavity is the other mesothelium-lined coelomic cavity and therefore provides an easily –accessed 
and logical surrogate for the pleural cavity. The clearance mechanisms from the pleural space and 
the peritoneal cavity are strikingly similar being mediated through size (2 to 12 µm [64]) restricted 
clearance via pore-like structures called stomata which overlie a specialised network of sub-
mesothelial lymphatic channels (reviewed in [5]). The relevance of this similarity in structure and 
clearance mechanisms between these two serosal cavities is that particles which cannot negotiate 
the narrow (2-12 µm) stomatal openings are retained where they can interact with the mesothelium 
as well as inflammatory cells and generate a pathogenic response.  
The peritoneal assay has been used for decades and was initially used to compare between asbestos 
types. Long -term studies focused on the development of mesothelioma as the endpoint of interest 
whilst shorter term ones examined inflammation and fibrosis. Although there were early acute high 
dose studies it was the studies of the late 1980’s to early 2000’s which marked the main use of the 
peritoneal assay for the purpose of understanding the basis of fibre pathogenicity. One such study is 
that of Moalli  [16] who looked at the role of length on the acute toxicity of asbestos fibres to the 
mesothelium using a single injected dose of long or short crocidolite or silica/ titanium dioxide as 
non-fibrous toxic and non-toxic particles respectively. The authors noted that within 6 hours the 
short asbestos fibres, silica and titanium dioxide particles (all <µm in size) were cleared through the 
stomata without causing an inflammatory reaction or mesothelial injury. In stark contrast, the long 
asbestos fibres were trapped at the draining stomata and provoked an intense inflammatory 
reaction including accumulation of activated macrophages at the mesothelial surface and localised 
mesothelial cell death [16]. In a later study, the authors showed that 5 daily injections of short fibres 
eventually blocked the stomata and short fibres were then retained [14].  These studies first showed 
that retention and accumulation of long fibres at the mesothelial surface is key to the elicitation of 
inflammation/ fibrosis. Whilst early studies showed the role of length and in fibre toxicity in the 
peritoneal cavity the general  applicability of the length paradigm was later shown for carbon 
nanotubes and other nanofibres [2]. The first study published using the peritoneal model for carbon 
nanotubes [65] used a susceptible p53 +/- mouse model to study the ability of carbon nanotubes to 
generate mesothelioma. The authors injected a large dose (3 mg) of long carbon nanotubes into the 
peritoneal cavity or crocidolite as a positive control and C60 fullerenes as a carbon control. The 
authors reported large granuloma formation and the induction of mesothelioma in the asbestos and 
carbon nanotube-treated mice yet a minimal response in the fullerene treated mice. However, the 
exceptionally large dose resulted in the formation of large agglomerates (reported as 50-200µm in 
diameter), drawing the relevance of such results into question. Shortly after this a study was 
published using wild-type mice and much lower doses (50µg/mouse) of long carbon nanotubes in 
comparison to compact nanotubes with, carbon black as well as short and long amosite asbestos as 
controls. Similarly to the Moalli study, this work showed length dependent retention of long carbon 
nanotubes and asbestos but not short at the mesothelial surface resulting in a rapid induction of 
inflammation, accumulation of macrophages leading to the formation of foreign body giant-cell 
granulomas [2]. The importance of the consideration of length was evident in a study where carbon 
nanotubes were injected into the peritoneal cavity of rats at a dose of 2 or 20 mg and observed over 
a period of 24 months for mesothelioma. The results showed no significant mesothelioma yield  [66] 
but the carbon nanotubes used were very short , 0.7mm in length, far shorter than the fibres used in 
the Moalli or Poland studies. Currently, the it is not known if the early inflammatory and fibrotic 
response to CNT in the peritoneal cavity are portents for the induction of mesothelioma. However 
the similarity in response to asbestos and role of length in the structure:toxicity relationship seen for 
carbon nanotubes still raises considerable concerns and shows the need for targeted definitive 
studies.   
As a model, the peritoneal cavity is useful but interpretation of results should be performed with 
care and in light of these caveats. Specifically these are that injection into it is non-physiological   and 
at high dose and dose-rate, the dose normally reaching the pleura from the distal airspaces at very 
low dose rate and dose. In addition, biopersistence as it impacts the fibre in transit from the 
deposition site to the pleura  (dealt with elsewhere in this article) is not taken into consideration 
during direct injection and fibre diameter which is important for fibre deposition into the lung may 
not be taken into account. However all models are subject to caveats and this does not diminish 
their utility as long as they are taken into consideration  during interpretation.  
 
8 Molecular changes associated with asbestos or CNT in the pleural mesothelium 
7.1 in vitro findings The molecular mechanisms leading to mesothelial cell transformation and the 
development of mesothelioma are unclear. It has been suggested that there may be a gradual 
progression from mesothelial hyperplasia to mesothelioma, with intermediate stages characterised 
by the presence of fibrous adhesions and pleural nodular lesions [16,67] thus highlighting the likely 
role for chronic inflammation in mesothelioma carcinogenesis. However, characterization of the 
sequential changes preceding the onset of mesothelioma in animal models is limited and therefore 
as yet the key molecular mechanisms driving these events are unknown. 
Efforts have been made to delineate the molecular mechanisms contributing to the transformation 
of mesothelial cells using in vitro models. After direct interaction with mesothelial cells, asbestos 
fibres trigger a number of signalling cascades involving mitogen-activated protein kinases (MAPK) 
and nuclear factor-kappa B (NF-kB) [68,69]. The activation of MAPK and NF-kB signalling pathways, 
either directly by binding of asbestos fibres to surface signalling receptors or indirectly via oxidative 
stress, has been shown to cause the activation of multiple transcription factors such as activator 
protein-1 (AP-1) which promote cellular responses such as proliferation and pro-inflammatory 
changes [70]. In particular, the sustained activation of MAPK signalling in asbestos-exposed 
mesothelial cells has been linked to the induction of Fra-1, a component of the AP-1 complex that is 
causally related to anchorage-independent growth in mesothelioma cells [71]. To date, even less has 
been done to examine the pro-carcinogenic changes induced in mesothelial cells upon exposure to 
CNT. However, similar to asbestos fibres, direct effects of SWCNT and MWCNT on normal and 
malignant mesothelial cells include a decrease in cell viability, activation of pro-inflammatory 
transcription factors and pro-inflammatory MAPK pathway activation [72,73].  
 
Although direct exposure of mesothelial cells to asbestos fibres in vitro has been shown to induce 
sustained signalling pathway activation [74,75], inflammatory mediator production [76], oxidative 
stress [77], genotoxicity and chromosomal changes [78,79], exposure of normal human mesothelial 
cells to asbestos fibres in vitro has not been shown to lead to cell transformation. The essential role 
played by the chronic inflammatory environment in tumorigenesis has been demonstrated by Wang 
et al [80] who examined the transformation potential of erionite, a naturally occurring long 
biopersistent fibre which causes mesothelioma in man and rodents [81-83]. While erionite alone had 
no effect on mesothelial cell transformation, a cocktail of pro-inflammatory cytokines, IL-1β and 
TNFα, could stimulate anchorage-independent growth of mesothelial cells in soft agar; a marker of 
mesothelial cell transformation [80]. The pro-inflammatory cytokine, TNFα, has also been shown to 
inhibit asbestos-induced cell death by activating the NF-κB signalling pathway in mesothelial cells 
[76]. This led the authors to propose that the activation of NF-κB and subsequent activation of 
multiple pro-survival genes allows mesothelial cells with asbestos-induced DNA damage to divide 
and proliferate rather than die and, if key genetic alterations accumulate, to eventually develop into 
mesothelioma [76]. 
 
The pro-inflammatory cytokines which support cell transformation may be released by the 
mesothelial cells upon direct exposure to pathogenic fibres [76], or alternatively be released from 
immune cells recruited to the area to clear the fibres. A recent study demonstrated that, although 
the mesothelial cells were refractory to treatment with CNT directly, exposure to conditioned media 
from macrophages undergoing frustrated phagocytosis after treatment with long fibres stimulated a 
potent pro-inflammatory response from the mesothelial cells [84]. It is well documented that cross-
talk between macrophages and mesothelial cells is important in the normal inflammatory and repair 
processes in the serosal cavities [85]; however, if these processes are aberrantly sustained due to 
the presence of biopersistent fibres, they may also help to promote the development of 
mesothelioma. This highlights the need to examine both the effects of direct interactions between 
fibres and mesothelial cells and also the role of the activated immune cells on normal mesothelial 
cells when considering the molecular mechanisms leading from mesothelial cell activation to 
transformation. 
 
7.2 in vivo findings Most in vivo studies that have assessed the carcinogenic hazard of CNT in intact 
or genetically modified rodents have been limited to obtaining histological evidence of tumour 
development [84,86-88].  Although the histological changes observed are similar to those induced by 
asbestos exposure in murine models and faithfully replicate human mesothelioma, the molecular 
mechanisms involved and how they compare with asbestos-induced tumours in animals or humans 
are yet to be investigated.  It is well documented that CNT cause sustained inflammation of the 
parietal pleura [84,89,90].  However, recent studies have highlighted that the molecular changes 
underlying CNT-induced carcinogenesis need to be examined in the context of a cross-talk and co-
dependence of different cell types in the exposed tissues. Up-regulation of genes encoding cytokines 
(IL-1β, IL-6) in macrophages after injection of MWCNT in the rat peritoneal cavity [91], and an 
elevated release of cytokines and chemokines as part of the inflammatory response to intratracheal 
instillation of CNT in mice [92], suggest that mesothelial cells are subjected to persistent stimulation 
by inflammatory factors.  The recruitment of macrophages to the exposure site (e.g. subcutaneously 
injected MWCNT in the model used by Yang et al)  is a continuous process [93] that would be 
accompanied by persistent  interaction of the inflammatory factors with membrane molecules, for 
example RTKs and growth factor receptors, causing sustained activation of pro-oncogenic pathways 
and eventually leading to epithelial-mesenchymal transition (EMT) [94].  Alternatively, an epigenetic 
switch could provide another mechanism whereby CNT-induced carcinogenesis develops following 
chronic inflammation. In support of this, our recent in vivo findings have shown a sustained 
activation of STAT3 in CNT-induced inflammatory lesions in a pleural instillation model (unpublished 
data) and, in another independent study, STAT3 activation was demonstrated to connect chronic 
inflammation and cancer via an epigenetic switch in vitro [95]. In addition, the tissue response to 
MWCNT  exposure in vivo (intratracheal instillation)  included  changes in apoptosis- related proteins 
(p53 and caspase-3)  and tissue damage-associated proteins (COL1A1, MMP-2 and MMP-9) [92]; 
importantly, these matrix proteins are also known to be a part of the chronic inflammation-cancer 
axis [94].   
 
 
9 Conclusion regarding the similarities and differences between asbestos and CNT.  
Since asbestos types are not all the same composition or pathogenicity and they conform to the FPP, 
it makes more sense to aim to conclude whether or not CNT  conform to  the FPP in terms of 
benchmarking them against asbestos. In terms of pathogenicity and mechanism CNT produce 
oxidative stress, inflammation, toxicity and genotoxicity and produce fibrosis in medium term 
studies and these are similar to the effects of asbestos. Importantly the effect of asbestos are length 
depended and so are some of the effects of CNT, making them compliant with the FPP for a 
pathogenic fibre. Carbon nanotubes can be manufactured as tight tangles of nanotubes that are 
essentially particles, or as high aspect ratio ‘fibres’ [1].  Effects of CNT as particles would be limited 
to the lungs (fibrosis and cancer) but CNT as fibres would have pulmonary effects but also affect the 
pleura (fibrosis and mesothelioma). Importantly, to conform to the FPP, these effects would be 
anticipated to be length-dependent. Exposure of the both the pleural cavity [3] and the peritoneal 
cavity as a model mesothelium [2], revealed that long carbon nanotube fibres had the ability to 
produce inflammation and fibrosis that was similar to that produced by long asbestos. In contrast, 
neither short asbestos fibres nor short or tangled CNT caused any significant  inflammation or 
fibrosis in the two cavities. Frustrated phagocytosis of long fibres as it likely applies to asbestos and 
carbon nanotubes is illustrated in Figures 2 and 3. Biopersistence is the other key component of the 
FPP and pristine carbon nanotubes are durable using in vitro assay [31]. However there is some 
evidence that highly oxidised single wall carbon nanotubes can be further broken down by the 
enzyme peroxidase [96] although the is doubtful that CNT encounter this enzyme to any great extent 
at a plausible inhalation exposure; it is also that non-oxidised multi-walled CNT, the most common 
form of CNT in industrial use, would be affected by this enzyme. Therefore in terms of the fibre 
pathogenicity paradigm, it is possible for carbon nanotubes to be pathogenic by being thin, long and 
biopersistent. However it should be noted that CNT exist in forms that are non-fibrous would not be 
expected to comply with the paradigm for a pathogenic fibre and would not produce fibre-specific 
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